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SUMMARY
Lymph node cells from mice which have undergone primary 
cutaneous sensitization (responder cells) were cultured with 
either in vitro haptenated cells or hapten-bearing dendritic 
cells from hapten sensitized mice. By utilising the fluorescent 
hapten FITC and flow cytometry the stimulator cells hapten 
status was established and related to any enhancement in 
responder cell proliferation.
In vitro haptenation failed to generate immunogenic hapten 
presenting cells but rather, hapten-coated cells whose 
stimulatory activity, while hapten-specific, was dependent on a 
silica-sensitive cell within the 'responder' population. The 
inadequacy of in vitro haptenated cells as a model for hapten 
presentation was thus established and a role for endogenous 
hapten processing cells is proposed.
Hapten-bearing dendritic cells from hapten-sensitized mice were 
used as stimulators within the proliferation assay. Such cells 
were prepared (on density gradients) from FITC-sensitized mice 
and characterised in terms of morphology and flow cytometric 
parameters: these results correlated with a marked stimulatory 
activity for responder cells. Avoidance of potent sensitizing 
regimes enabled the isolation of dendritic cell-enriched 
fractions with hapten-specific stimulatory activity. 
Significantly, this activity could not be created by in vitro 
haptenation of naive dendritic cells. I concluded that the 
stimulatory activity of in vivo 'haptenated' dendritic cells 
within my proliferation assay was a good model for hapten 
presentation in vitro.
Finally I examined the ability of in vivo administered, 
partially purified IFN gamma preparations (and relevant 
controls) to modulate cutaneous sensitization and in particular 
the generation of immunogenic dendritic cells. While not all 
the effects detected were IFN gamma specific, the changes 
measured in the hapten status and resulting stimulatory activity 
of dendritic cell-enriched fractions were so. Proposals aré 
made as to how antigenically foreign proteins and lympnokines, 
including IFN gamma, may regulate the role of dendritic cells in 
cutaneous sensitization.
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Almost a century has elapsed since von Pirquet introduced the term 
'allergy' to describe an "altered reactivity" within hosts 
subjected to a repeated (antigenic) challenge (von Pirquet, 1906 
as quoted in Bray 1937). His proposal was based on an increasing 
understanding within that scientific community of the generation 
of anaphylaxis following injection of animals with a variety of 
foreign proteins, including dogs with hen egg white (Magendie, 
1840 as quoted in Bray 1937), xenogeneic serum (Flexnor, 1840 as 
quoted in Bray 1937), and anemone extracts (Portier and Richet 
1902 as quoted in Bray 1937). The famous studies of Robert Koch 
on the intradermal injection of Mycobacterial filtrates should 
also be mentioned. Such "altered reactivity" has more recently 
been defined as hypersensitivity and encapsulates any exaggerated 
and/or inappropriate immune response causing a pathological 
condition in the host, usually involving tissue disruption or 
destruction.
Hypersensitivities may result against a variety of antigens or 
foreign substances, including viral, bacterial, metazoal proteins, 
alloantigens, low molecular weight protein reactive chemicals and 
drugs. Given the diverse aetiology of the response, a rational 
subdivision has been proposed in terms of the speed of development 
of clinically manifest symptomology.
Thus an immediate type hypersensitivity was detectable within 
minutes of secondary exposure to antigen, while delayed type 
hypersensitivity was only apparent some 24hrs beyond secondary 
exposure. This distinction invoked and was supported by the
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discrete activity of particular immune cells. Thus immediate type 
responses may be transferred to naive recipients by serum alone 
(antibody, classically reagin) while delayed type responses were 
dependent on transfer of leucocytes but not serum alone 
(Landsteiner and Chase 1942). As will be seen later, the 
complexity of hypersensitivity responses has superseded this 
rather simplistic distinction (eg early v late contact sensitivity 
cells) although it is generally still accepted as a central facet 
of hypersensitivity dogma. Within this immediate and delayed type 
framework Coombs and Gell have defined four hypersensitivity 
mechanisms (Coombs and Gell 1975).
Type I Hypersensitivities
Mediated by the allergen binding to allergen-specific antibodies 
of the IgE (immunoglobulin E) subclass and this complex binding to 
mast cells causing mast cell degranulation.
Type II Hypersensitivities
Mediated by cytotoxic and/or cytolytic activities directed against 
the hosts tissues.
Type III Hypersensitivities
Mediated by the formation, deposition and consequent immuno- 
stimulatory potential of immune complexes (formed between excesses 
of antibody and antigen).
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Type IV Hypersensitivities
Mediated by the infiltration of mononuclear cells to the site of 
antigenic challenge, classically the dermal layers, following skin 
challenge with tuberculin. These responses are termed DELAYED 
TYPE because of the delay in inflammation following secondary 
antigenic challenge. This reflects the complex cellular activity 
necessary for the generation of the response.
The type IV delayed type hypersensitivities consist of a group of 
comparatively slowly developing tissue inflammatory reactions 
directed against a variety of antigens including, as described 
earlier, low molecular weight protein reactive chemicals. The 
mechanism for development of the response will be described in 
later chapters.
The delayed type hypersensitivity responses have been divided into 
four specific responses as follows
1 Granulomatous responses against persistent Mycobacterium 
tuberculoid antigens and others leading to major pathological 
tissue damage (Turk 1976).
2 Tuberculin responses against transient M tuberculoid antigens 
(and others) following intradermal injection, leading to less 
severe but significant inflammatory responses in the skin - 
histological distinctions also define granulomatous from 
tuberculin responses (Kaplan et al 1983).
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3 Cutaneous basophil hypersensitivity response against
intradermally injected protein antigens (Dvorak et al 1970) 
with the classical time course for inflammation but an 
uncharacteristic involvement for basophils (Galli and Dvorak 
1979).
4 Contact hypersensitivity against a variety of low molecular 
weight chemicals applied to the epidermis (epicutanous 
exposure). Secondary elicitation has classically been 
characterised as a delayed inflammatory response at the site 
of secondary challenge.
Contact hypersensitivity is the phenomenon I have studied because 
of its importance in industry (Abel and Wood 1986; Adams 1986), 
and in particular to my industrial sponsor Imperial Chemicals 
Industries (ICI). Thus contact sensitivity has a history of 
prevalence in industry and ICI are at the forefront of developing 
bioassays indicating the potential contact sensitizing nature of a 
broad spectrun of chemicals. Techniques had been established at 
ICI for generating murine contact sensitization. My work aimed to 
develop an assay for measuring antigen presentation in vitro and 
further to define the activity of antigen presenting cells during 
thymus educated (T)-lymphocyte activation in contact sensitivity.
The following four chapters provide an introduction to this work.
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1.1.1
In the last twenty years, the nature, activation and function of 
T-lymphocytes has been elucidated in considerable detail. 
Accordingly, our knowledge of T-lymphocyte immunology is large. 
Here I wish to emphasize two main points.
1.1.2 Thymic education
Lymphocytes 'educated' (or allowed to mature) in a thymic 
environment, consisting of numerous cellular and hormonal signals 
(reviewed Owen et al 1989) constitute a crucial component of the 
intact immune system of higher vertebrates. Animals lacking a 
thymus either through genetic constitution or surgical procedures 
at the neonatal stage are immunodeficient and this correlates with 
the absence of T-lymphocytes (Kindred 1979; Erard et al 1979). 
Studies on T-lymphocyte maturation during foetal thymus ontogeny, 
mainly in the mouse, indicates a temporal succession of gene 
activation, best characterised by the expression of the alpha 
chain/beta chain heterodimer constituting the T-cell antigen 
receptor (Farr et al 1985). Thus, passage through the thymic 
environment induces the expression of a characteristic set of 
antigens, including Thymus-derived antigen 1 (Thy 1; Owen and 
Jenkinson 1981), cluster of differentiation antigen 3 (CD3; 
Compana et al, 1989) and the T-cell receptor (TCR; Kappler et al 
1987; Owen et al 1989) which will be discussed in 1.2.5. This 
common set of antigens is complemented by additional antigens 
which define functionally distinct subsets of T-lymphocytes.
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Work in the late 1960's demonstrated that T-lymphocytes could 
'help' antibody generating responses (Claman et al 1966; Mitchell 
and Miller 1968; Mitchinson 1971) and also could transfer cell 
mediated inmunity to naive recipients.
A correlation between phenotypically distinct T-lymphocytes and 
functionally distinct T-lymphocyte roles, was demonstrated in the 
mid 1970's by Cantor and co-workers (Cantor and Afoski 1975; 
Cantor and Boyse 1975), who partitioned two Thy 1+ subpopulations, 
designated Lyt 1+, 23- and Lyt 1-, 23+. The two phenotypes proved 
to have distinct roles in cell mediated responses and this also 
correlated with distinct requirements for antigen presentation 
(see 1.2.2). The phrases T-helper and T-cytotoxic were adopted at 
this stage, the T-helper phenotype being Thy 1+, Lyt 1+ 23- and T- 
cytotoxic Thy 1+, Lyt 1- 23+.
This phenotypic partitioning has been significantly advanced in 
recent years with numerous T-cell associated molecules being 
identified by cell surface markers. Indeed the nomenclature 
rapidly became both unmanageable and so specialised as to be 
meaningless. An attempt to unify nomenclature by designating 
universal "clusters of differentiation" is in terms of scientific 
advance arguably the most significant. Of significance here, the 
T-helper phenotype is designated CD3+, CD4+ while the T-cytotoxic 
phenotype is CD3+, CD8+ (CD4-). Before specifically analysing the 
CD4+ T-helper p>henotyp>e, I should mention one point. Within the
1.1.3 Functional heterogeneity within T-lymphocytes.
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0)8+ phenotype there is reported to be a T-suppressor phenotype. 
While the role for such a cell in regulating immune responses is 
logical, definitive characterisation of this phenotype has yet to 
be achieved. For a balanced review, I refer the reader to Green 
et al 1983; Mitchison and Eichman 1988. Suppressive effects, 
possibly attributable to T-suppressor cells, are widely observed 
and in the context of contact sensitivity, findings in this 
laboratory (ICI) are as noteworthy as most (Kimber et al 1987^)
While there are such gaps in our knowledge of T-lymphocyte 
phenotype-function relationships, new, functionally related 
definitions of T-lymphocyte subsets must be a high priority. As 
will become clear in the next section on the CD4+ T-lymphocyte, 
such an approach, utilising distinctive lymphokine-production and 
sensitivity profiles of CD4+ subsets is a positive step towards a 
rationalisation of lymphocyte nomenclature.
1.1.4 The definition of two murine CD4+ T-lymphocyte subsets (T- 
lymphocyte helper subset 1 and 2) by lymphokine profiles
The CD4+ T-lymphocyte has numerous functional activities. Its 
central role, as the "conductor of the immune orchestra" has 
perhaps been most vividly demonstrated by the damage caused to the 
immune system in man by its selective depletion by human 
immunodeficiency viruses (Spickett and Dalgleish 1988). Similar 
findings are observed in mice depleted of the CD4+ subset, with 
major immunodeficiency prevailing.
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Specific functions for the CD4+ subset in mice have been widely 
reviewed. They include mediating antigen specific class II major 
histocompatibility complex (la)-restrieted delayed type 
hypersensitivity (Bianchi et al 1981) of particular significance 
to my studies and also the induction and in some cases suppression 
of bursa-derived (B)-lymphocyte antibody secretion (Imperiale et 
al 1982; Asamo and Hodes 1983).
The various activities of CD4+ T- lymphocytes reflects a 
diversification of function and phenotype within CD4+ T- 
lymphocytes and this has been established in recent studies 
characterising discrete subsets of T-lymphocytes within CD4+ T- 
cell lines (Mosmann et al 1986; Cherwinski et al 1987). Such 
classification, based on the differential expression and secretion 
of the lymphokines interleukin-2 (IL-2), interleukin-4 (IL4), 
interleukin-5 (IL-5), interferon-gamma (IFN gamma) and lymphotoxin 
(LT) has led to a division of CD4+ T-lymphocytes into two groups. 
Phenotypically, T-helper 1 lymphocytes (TH1) produce IL-2, IFN 
garnna and lymphotoxin but not IL-4, IL-5 or interleukin-€(lL-6^ T- 
helper 2 lymphocytes (TH2) in contrast produce IL-4, IL-5 and IL-6 
but not IL-2, IFN ganina or lymphotoxin. Both subsets produce 
interleukin-3 (IL-3) and granulocyte/macrophage-colony stimulating 
factor(GM-CSF).
Functional analysis of isolated cells and clones within each of 
these subsets has established that the differential expression of 
lymphokines and differential lymphokine requirements for in vitro 
culture of TH1 compared with TH2 (Carding et al 1989) correlates
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with distinct functional activities (Kim et al 1985; Bottomly 
1988; Grun and Maurer 1989). Specifically, the TH1 subset 
mediates the late or classical 24hr elicitation responses in 
contact sensitized mice (Cher and Mosmann 1987) and is referred to 
as the T-inflamnatory subset; this subset has cytolytic activity 
for major histocompatibility complex (MiC) class II bearing target 
cells and suppresses Ig secretion by B-lymphocytes.
The TH2 subset is characterised by a set of reciprocal functional 
activities. Thus TH2 activates B-lymphocytes, in particular to 
secrete IgG and IgE. Such TH2 clones fail to mediate delayed 
type hypersensitivities (DTH) responses and have no cytolytic 
activity, as described for TH1 (Mosmann et al 1986; Stevens et al 
1988). The TH1/TO2 distinction within murine T-cell lines has 
also been applied to fresh murine CD4+ T-lymphocytes which were 
subdivided initially by differential expression of surface 
antigens recognised by monoclonal anti T-cell autoantibodies 
raised against thymocytes (Determinants 3G11, BC10). Such 
divisions within CD4+ T-lymphocytes were then demonstrated to 
correlate with differential lymphokine expression and functional 
activity (Hayakawa and Hardy 1988).
The diverse function of CD4+ T-lymphocytes is apparent. While TH1 
and TH2 clearly possess distinct functional activity they are 
generally considered to have a similar requirement for antigen 
presentation prior to activation.
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Thus it is generally the case that CD4+ T-lymphocytes are 
activated by antigen presented to the T-cell receptor in 
conjunction with class II MHC-encoded protein products and 
additional factors, including the lymphokine IL-1. The role of 
these elements in activation of CD4+ T-lymphocytes and in 
particular that of antigen presentation in the context of class II 
MHC will now be examined.
While it is generally accepted that a nunber of cellular 
phenotypes can perform these basic functions and act as antigen 
presenting cells, most of our understanding has originated from 
studies on the macrophage and to a lesser extent B-lymphoblastoid 
cells. As such, these studies will now be reviewed, but I 
emphasize that the macrophage is just one antigen presenting cell 
- others, including dendritic cells may fulfil this task in 
different ways.
1.2 General antigen processing and presentation
The early studies of Rosenthal and Shevach (1973) and their 
proposals based on these, were perhaps the starting point for 
'modernist' antigen presentation theories. Evidence from 
Rosenthal and Shevach supports a proposal that the macrophage 
performed at least two essential roles leading up to the 
activation of lymphocyte proliferation.
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1 Internalization and possibly processing of antigen by 
macrophage: cells incapable of internalizing antigen failed 
to stimulate T-cell proliferation.
2 Productive interaction of macrophage and lymphocytes, 
leading to lymphocyte proliferation, was dependent on both 
cells sharing MHC-encoded antigens or closely linked gene 
products. The interaction was thus restricted to syngeneic 
combinations.
3 Other elements.
1.2.1 Requirement for internalization and processing of protein 
antigens by macrophages
The proposal for a role for antigen processing by adherent 
peritoneal exudate cells, (75% macrophages) prior to lymphocyte 
stimulation was examined, most notably by Ziegler and Unanue in 
the early 1980's. They established that the particulate antigen 
Listeria must pass through temperature dependent (Ziegler and 
Unanue 1981) chloroquine and ammonia-sensitive processing pathways 
before it could be recognised by class II-restricted T-lymphocytes 
(Ziegler and Unanue 1982). Similar requirements were established 
for soluble protein antigens including lysozyme (Allen and Unanue 
1984) and pigeon cytochrome C (Kovac and Schwartz 1985). These 
data implicated enzymic activity within the lysosomotrophic 
intracellular compartment as critical in the generation of 
immunogenic antigen determinants from native protein. This was
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supported by the demonstration that the intracellular processing 
step may be replaced by limited proteolysis in vitro 
(Shimonkevitch et al 1983).
Detailed characterisation of the enzyme activity responsible for 
protein cleavage during antigen processing has indicated that a 
particular activity is inevitably restricted to a particular 
system and no common motif for antigen processing has been 
established within macrophages, to ray knowledge. (See Buus and 
Werdelin 1986, for the role of cysteine proteases.) Further, 
while no universal pattern for processing, in terms of enzyme 
specificity can be demonstrated, it has also become clear that 
some antigens, for example fibrinogen, may be presented by 
metabolically fixed macrophages to T-lymphocytes, leading to T- 
lymphocyte activation (Lee et al 1988), while others, eg myoglobin 
and lysozyme appear to simply need denaturation, ie unfolding, but 
not proteolysis. This area has been reviewed concisely (Allen 
1987). It should be noted that Klein (Walden et al 1985) argues 
that processing is not always necessary, as liposomes with 
inserted class II MHC-encoded antigens can present antigenic 
proteins. The integrity, however, of these inserted antigenic 
proteins was not established and they could therefore have been 
partially 'degraded'.
These differential requirements for enzymic processing may reflect 
the accessibility to CD4+ T-lymphocytes of particularly 
significant peptide sequences within the structure of native 
proteins. Thus, Heber-Katz et al (1983) have proposed that
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successful antigen (peptide) presentation to T-lymphocytes is 
dependent on two fundamental sequences within the native peptide. 
One linear sequence of amino acids (the epitope) must be 'visible' 
to the T-lymphocyte, while a second sequence (the agretope) helps 
position the peptide relative to the la molecules on the antigen 
presenting cell. Of course, the position of the epitope and 
agretope in the native protein will dictate the degree of 
processing necessary to 'expose' them to T-lymphocyte receptors 
and la molecules. [This theory for antigen presentation will be 
discussed in the next section.]
Thus, the precise definition of antigen processing depends on 1) 
the antigen and the T-lymphocytes used to recognize the antigen, 
and 2) the class II MHC-encoded proteins with which the antigen is 
recognized.
A final area of study within antigen processing has been the 
demonstration that antigen processing by macrophages is sensitive 
to cyclohexamide (Jensen 1988) and is thus dependent on protein 
synthetic activity. It has yet to be established what 
contribution this protein synthetic activity makes to antigen 
processing, although the recent studies of Unanue and co-workers 
(Harding and Unanue 1989) suggest that this effect is independent 
of la synthesis and therefore affects either processing enzymes or 
cofactors essential for processing, prior to peptide association 
with la.
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Clearly, for those antigens requiring processing prior to 
efficient presentation, there are complex enzymic pathways leading 
to suitable proteolysis; the precise nature of these pathways 
remains to be elucidated. I would now like to consider the role 
of MHC-encoded restriction within antigen presentation, a stage on 
from intracellular processing.
1.2.2 Requirement for antigen presentation - class II MHC- 
restriction and putative ligands for the alpha-beta 
heterodimer T-cell receptor on CD4+ T-cells
The role of MHC-restriction for T-lymphocyte recognition of 
antigen has been elucidated. Zinkemagel and Doherty (1974), in a 
series of classical, experiments, established that virus-specific 
cytotoxic T-lymphocytes (Lyt 2+, ie CD8+) recognized viral antigen 
only in the context of haplotype matched class I-MHC expressing 
target cells. Similarly, helper T-lymphocytes (L3T4+, CD4+) were 
shown to only recognize foreign protein antigens in the context of 
haplotype-matched class II MHC-expressing antigen presenting cells 
(Fathman and Fitch 1982). Such MHC restriction defines the two 
broad classes of T-lymphocyte, helper (L3T4+) and cytotoxic 
(Lyt2+) as class II and class I MHC restricted, respectively 
(Cantor and Boyse 1975), although this distinction of function is 
not necessarily absolute (Shinohara et al 1986; Swain 1981).
T-lymphocyte responses are regulated by the protein products of 
genes mapping to the MHC-region on IX linkage group or chromosome 
17 in mice (Bach et al 1976). This was originally defined as the
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genetic locus controlling the rejection of transplanted grafts 
(see Klein 1975; Sijnpson 1987). The presentation of peptides by 
macrophages to T-lymphocytes in vitro has been mapped to the I- 
region within the H-2 system or MIC complex of mice (Ziegler and 
Unanue 1981). The I-region had previously been mapped as the area 
of MHC controlling high and low antibody responses to simple 
antigens in mice (McDevitt and Benaceraf 1974). Such results led 
to the proposal that immune response genes within the I-region 
code MHC class II antigens which regulate T-helper (L3T4+, CD4+) 
mediated immune responses.
Conclusive demonstrations that I-region associated (la) antigens 
were in fact class II MHC antigens were provided by Flavell and 
co-workers (Flavell et al 1985) who performed molecular analysis 
on la genes and confirmed previously elucidated protein structures 
for class II MHC antigens (for brevity I will now use the la 
nomenclature). Additionally, studies in transgenic mouse strains 
proved that a particular (allele) la coding for high 
responsiveness against a particular antigen could be transferred 
to a low responder and confer high responsiveness to the same 
antigen in the recipient (Le Meur et al 1985).
The work of Heber-Katz and Schwartz (Hedrick et al 1982) is also 
significant to this review. This group isolated T-cell clones 
from BIO.A mice which had cross-specificity and were able to 
recognize moth or pigeon cytochrome C when presented by BIO.A 
hybridomas. Pigeon cytochrome C was more stimulatory than moth 
cytochrome C for the same T-cell clone. Significantly, BIO.S (9R)
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hybridomas, with an altered I-E haplotype (from K to S) also 
stimulated the same clone with either peptide but moth cytochrome 
C was now more stimulatory than pigeon cytochrome. Clearly la 
molecules influenced the strength of the response.
All these results suggest then, that la molecules are an essential 
restriction element in peptide activation of CD4+ T-lymphocytes.
1.2.3 Determinant selection
As well as pondering on the genetic and protein structure of MHC- 
encoding loci and products, the real intrigue for immunologists in 
recent years has been an explanation for the mechanism by which 
MHC-encoded protein products can regulate antigen recognition by 
T-lymphocytes. This intrigue has been heightened by the 
identification and molecular characterisation of the T-lymphocyte 
receptor (Hedrick et al 1984; Yanagi et al 1984) which has 
demonstrated the analogy between T-cell receptor and the antibody 
molecule. The functional characterisation of B-lymphocytes and T- 
lymphocytes however demonstrates that while B-lymphocytes may 
recognize soluble antigen with the help of T-lymphocytes (reviewed 
by Jones 1987), T-lymphocytes must see antigen in the context of 
cell-surface bound MHC-encoded antigens. I would like to briefly 
review current proposals of how MHC-encoded antigens, in 
particular la antigens, regulate the recognition of antigen by the 
T-lymphocyte receptor.
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The best documented hypothesis to account for control of T-cell 
recognition of antigen is termed the determinant selection 
hypothesis. This proposes that MHC-encoded molecules may act as 
specific receptors for antigen (peptide) and that such an 
interaction forms a moiety recognizable by T-cells. The consensus 
view on antigen-specific T-cell recognition is that the single 
alpha-beta T-cell receptor (TCR; Yague et al 1985) on CD3+ T-cells 
recognises this MHOencoded molecule - peptide complex.
Determinant selection was postulated in its early form after the 
studies of notably Heber-Katz and Schwartz (Hedrick et al 1982) 
who proposed that a peptide consists of two distinct types of 
determinants, an agretope recognised by MHC-encoded molecules and 
an epitope, recognized by TCR (reviewed in Male et al 1988).
A number of groups have indeed demonstrated that antigenic 
peptides and la molecules interact specifically, as measured by 
affinity binding (Babbitt et al 1985; Buus et al 1986). In 
addition, the ability of particular allelic variants of la 
molecules to serve as restriction elements for T-cell recognition 
of particular antigenic peptides correlates well with the binding 
affinity of that peptide with la (Buus et al 1987). A two log 
difference in the binding affinity for antigen was observed 
between la molecules stimulating high and low T-cell responses.
Antigen competition studies have also demonstrated that T- 
hybridomas specific for random glutamic acid-alanine-tyrosine 
(GAT) polymers require GAT presented by antigen presenting cells
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for stimulation. If antigen presenting cells were pre-incubated 
with the la binding but non-stimulatory glutamic acid-tyrosine 
(GT) polymer (Rock and Benaceraf 1983) the proliferative 
interaction was blocked. A similar phenomenon has been described 
for peptide interactions with la (Guillet et al 1986).
Studies on the nature of a putative ternary structure between TCR 
foreign antigen and la antigen by an ingenious method of measuring 
energy transfer between fluorochrome tagged moieties have 
demonstrated that the TCR stabilizes a trimolecular interaction 
between peptide and la during T-cell activation (Watts et al 
1986). All these results are consistent with the reasonable 
proposal that la forms a receptor for antigenic peptides. The 
serendipitous finding of peptide within the groove of MHC-encoded 
protein molecules, during X-ray crystallographic analysis of class 
I MHC molecules, also adds weight to this theory (Bjorkman 1987 a, 
b).
1.2.4 Site on la responsible for agretope binding and agretope 
motifs
It has been established that there are multiple appropriate sites 
on a given Ia-peptide complex which may be involved in T-cell 
activation. A multiplicity of immunogenic determinants can be 
generated between a small peptide and a class II MHC I-A* 
molecule, as assessed by the number of activated T-cells (Allen et 
al 1985), following stimulation with these la peptide complexes. 
Hypervariable regions in the N-terminal domains of cloned class II
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A q( and A p genes account for the bulk of allelic variation 
within the and p  chains (Larkhammer et al 1983; Benoist 
et al 1983).
A series of studies have confirmed that these hypervariable 
regions are involved in la restriction of T-cell recognition. For 
example, in "exon shuffle" experiments, the N-terminal domain of 
both E p  (Folsom et al 1985) and A p (Germain et al 1985) 
chains have been shown as essential for la restriction. The 
transfer of recombinant A p  genes, with domains contributed by 
high and low responder haplotypes has demonstrated clearly that 1) 
allele specific contributions from both A and A p  chains 
within I-A are critical in la restricted recognition and 2) that 
polymorphism in A p  1 domain can account entirely for the 
contribution of Ap chain in la restriction (Lechler et al
1986) .
The structure on antigenic peptides which is recognized by la (the 
agretope) has recently been tentatively elucidated. Howard Grey 
and his co-workers have reported a primary sequence of six amino 
acids, defining a core region in ovalbumin derived (Sette et al
1987) and various other (Sette et al 1988) peptides which controls 
peptide binding to I-A^ molecules. In addition, another core 
motif, defining peptides which bind I-E1* molecules (Sette et al 
1989a) supports the existence of a master sequence and it has 
recently been demonstrated that such sequences, while relatively 
broad in definition, can be used to predict 'peptide binding to 
la' affinities, with 75% success (Sette et al 1989b). Thus the
16
model allows prediction of la binding by peptides, one critical 
facet of a peptides potential imnunogenicity although this is 
obviously not the whole story (Buus et al 1987). It should be 
noted that no strong relationship could be demonstrated between 
peptides binding to I-A^ and I-E^: as expected, the different 
motifs were discrete, reflecting different structural requirements 
for peptide binding by the different la molecules.
1.2.5 Epitope motif structure
Peptide epitopes, determinants recognized by T-lymphocytes, have 
also been assigned putative common motifs or structures in recent 
years. Berzofsky and co-workers (1985) noted that all known class 
II-restricted T-cell epitopes could adopt amphipathic alpha 
helical segments which may facilitate peptide binding to cell 
membranes (DeLisi and Berzofsky 1985) although a specific role for 
la was not established. Later, Taylor and Rothbard each, 
independently, elucidated a linear amino acid pattern, centred on 
two hydrophobic residues, within the sequence of most T-cell 
epitopes (Rothbard and Taylor 1988). The generality of this motif 
incorporating many la restriction alleles and a number of 
different species makes it controversial and of debatable 
significance.
1.2.6 Effects of quantitative variation in la expression
As I have mentioned.allelic variation, ie polymorphism within la 
molecules expressed on antigen presenting cells is responsible for
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the fine specificity of MHC-restriction exhibited by T-helper 
cells. In addition to qualitative regulation of la, the 
quantitative expression of la molecules is also important in 
controlling T-helper responses. Lechler and co-workers (Lechler 
et al 1985) demonstrated that there is a proportional relationship 
between the level of la expressed on murine I-A transfected L- 
cells and the degree of IL-2 production by T-helper hybridomas 
restricted for this I-A molecule, when the two cells were cultured 
together in the presence of antigen. These studies also 
implicated a minimum level of I-A for T-lymphocyte activation, 
suggesting that T-cell activation requires T-cells to make a 
minimum number of receptor: ligand (Ia/peptide) interactions. The 
mechanisms whereby the expression levels of la may be regulated 
will be discussed in chapter 2 where, in particular, the 
inmunoregulatory role of the interferons will be considered.
1.2.7 Other (costimulatorv factors)
A number of groups have demonstrated that while antigen-specific 
CD4+ cell activation is dependent on antigen presenting cells 
presenting la and (processed) peptides to clonotypic receptors on 
T-lymphocytes, there are other important 'factors', or
costimulators involved in T-cell activation (Unanue 1984). These 
other factors can generally be divided into two groups:
a) Soluble accessory factors, typically the lymphokine IL-1, 
secreted by antigen presenting cells,
b) Membrane-bound molecules on antigen presenting cells or T- 
cell which bind as ligand-receptor during cellular 
interactions, leading to signalling of T-cell activation.
Interleukin 1 (IL-1) (general review see Oppenheim et al 1986)
IL-1, in active form a 17kDa protein which may be produced in both 
membrane-bound and secreted form (Lomedico et al 1984; March et al
1985) is widely reported as a costimulator of CD4+ T-cell 
activation amongst its range of activities. The costimulatory 
role of IL-1 has largely been attributed to two activities of IL- 
1: IL-1 enhances the transcription and secretion of autocrine T- 
cell growth factor IL-2 (Gillis and Mizel 1981; Lowenthal et al
1986) and the membrane bound IL-2 receptor (IL-2R; Kaye et al
1984). IL-1 might thus be predicted to enhance T-cell 
proliferation in the absence or presence of stimulation to T-cell 
receptors. However, it has recently been reported that IL-1 
costimulates (with an immobilized anti CD3 antibody) the 
activation of TH2 but not TH1 subsets of CD4+ T cell clones, 
(Lichtman et al 1988; Cherwinski et al 1987). That IL-1 only 
costimulates for IL-4 producing TH2 clones reflects the presence 
of high affinity IL-1R on TH2 (Greenbaum et al 1988) but not TH1 
clones. These results, demonstrating that IL-2 producing TH1 
clones are NOT stimulated by IL-1 conflict with the putative role 
of IL-1 as acting on IL-2/IL-2R expression. As TH^ is of 
particular interest as the CfTH mediating T-lymphocyte, this 
observation is important.
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For IL-2 producing TH1 clones, it is proposed that lymphokine (IL-
2) production is again activated by ligand binding to T-cell 
receptor but that another undefined costimulatory factor (not IL-
1) then interacts, leading to TH1 growth (Lichtman et al 1988).
These findings, then, confirm the general proposal that T-cell 
activation requires two signals - the two signal hypothesis. 
Recognition of Ia-peptide complexes presented on macrophage 
(antigen presenting) cell surface constitutes the first signal. 
The second signal consists of the binding of autocrine lymphokines 
(IL-2 or IL-4) and interaction with a costimulatory factor (IL-1 
for TH2 clones), leading to T-clone proliferation. In the light 
of these results it is significant that mature peripheral resting 
T-lymphocytes fail to proliferate on addition of IL-1 (Kreiger et 
al 1986). This presumably reflects the facts that most such T- 
lymphocytes are producers of IL-2 rather than IL-4 (Powers et al 
1988; Sidéras et al 1988) and in terms of the TH1/TH2 designation 
would be refractory to IL-1 because of lack of expression of IL- 
1R. This use of the clone-derived TH1/1H2 definitions has 
recently been validated within T-lymphocyte populations (Hayakawa 
and Hardy 1988).
The production of IL-1 has largely been attributed to the 
macrophage (Koide and Steinman 1987) and it is proposed that 
macrophage expression/secretion of IL-1 is stimulated by T-cell 
interaction with the macrophage (Koide and Steinman 1988; Weaver 
et al 1989). Thus it is apparent that within secondary Ia- 
restricted responses, the interaction of sensitized T-blasts (but
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not fresh T-lymphocytes) with antigen-bearing macrophages leads to 
the production of IL-1 mRNA by macrophages. It is notable that 
the same macrophages stimulated both sensitized and fresh T-cells 
to proliferate (Weaver et al 1989) and these findings might 
therefore reflect the TH1/TH2 distinction. Thus, the T-blast 
population, enriched for IL-4 producing and thus IL-1 sensitive T- 
cells were capable of stimulating macrophage production of IL-1 
and thus were stimulated to proliferate. The naive T-lymphocytes, 
largely IL-2-producing, IL-l-insensitive T-cells would be 
predicted to induce production of a factor with activity like IL- 
1, but not IL-1, as was observed.
However, this area is complicated by the different IL-1 inducing 
activity of fresh and sensitized T-lymphocytes and is likely also 
to reflect the differential requirement for antigen-presenting 
cells demonstrated by resting and sensitized T-lymphocytes (Inaba 
and Steinman 1984), an area which will be developed. It is 
apparent, however, that lymphokines are critical during the two 
signal activation of CD3+ T-lymphocytes by Ia+, antigen-bearing 
antigen presenting cells and that due regard to this T-cell 
requirement is given, particularly when assessing in vitro 
antigen-presentation, as a poorly defined lymphokine environment 
may give misleading results.
While a number of lymphokines, in addition to IL-1, notably IL-2 
and IL-4 are known to be involved in T-lymphocyte proliferation, 
as previously mentioned, these tend to function as autocrine
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rather than accessory molecules and as such have been dealt with 
in the section on CD4+ T-lymphocytes (Cantrell et al 1988).
1.2.8 Membrane-bound costimulatory factors
In addition to those described, the interaction between antigen 
presenting cells and CD4+, CD3+ T-lymphocytes may depend on 
ligand-receptor-like interactions between other cell-bound 
moieties. For instance, during the induction of T-cell activation 
by guinea pig antigen-presenting-macrophages, in addition to T- 
cell recognition of antigen-la complex, another additional step is 
necessary. However, unlike the IL-1 studies, this step depended 
on cell-cell contact; like the IL-1 studies, the accessory cell 
needed to be metabolically intact (Roska and Lipsky 1985). This 
work did not discount the role of membrane bound IL-1 which has 
been reported by other groups (Kurt-Jones et al 1985) although 
addition of exogenous IL-1 could not substitute for the second 
step.
L3T4/CD4
Other studies have implicated yet other T-cell-antigen presenting 
cell interactions as critical in augmenting the cell-cell 
interaction. In particular, L3T4 (CD4) positive T-lymphocytes 
have long been designated as broadly class II MHC-restricted 
(Swain 1983; Cantor and Boyse 1975; Dialynas et al 1983). Such 
'specificity association' (Janeaway et al 1989) was proposed to 
reflect an interaction between L3T4 (CD4) and la and a number of
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groups have reported an essential interaction between L3T4 (CD4) 
and la during antigen driven la-restricted T-helper cell 
proliferation (Pont et al 1986; Portoles and Janeaway 1989).
Similar functions have been described for interactions between a) 
lymphocyte function associated antigen 1 (LFA-1) and intracellular 
adhesion molecule 1 (ICAM-1) (reviewed in Springer et al 1987) and 
also between CD2 and lymphocyte function associated antigen 3 
(LFA3) (Krensky et al 1983; Haynes 1986). While a detailed 
description of the role of all these factors is not appropriate 
here, they may prove very important in T-cell activation. I will 
return to this area in chapter 2, when I examine the induction of 
expression of these factors by lymphokines and how this may 
regulate their activity and function.
1.2.9 Resume
The studies of many groups, presented in this chapter, have built 
on the initial findings of Rosenthal and Shevach, contributing to 
the formulation of a model for how macrophages may process and 
present peptides in an la restricted fashion to CD4+ T-lymphocytes 
in vitro. The molecular basis for the specificity of this 
interaction and the requirement for a number of accessory factors, 
including lymphokines, during antigen presentation have been 
described.
Recent years have seen the emergence of other antigen presenting 
cells including B-lymphocytes and dendritic leucocytes as at least
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as important as macrophages in particular immune responses leading 
to CD4+ T-lymphocyte activation. As the dendritic leucocytes are 
considered particularly important in the initiation of delayed 
type hypersensitivities and especially contact sensitivity, the 
rest of this chapter considers their phenotype and specialist 
antigen presenting functions. While I will demonstrate that 
dendritic leucocytes are critically involved in the early phase of 
many immune responses, the precise mechanism whereby such cells 
process antigen, prior to presentation to T-lymphocytes is not 
established.
As the dendritic leucocyte differs from macrophages in terms of 
their intracellular processing activity, it seems likely that the 
generation of immunogenic peptide-antigen (or just antigen) 
complexes prior to presentation in conjunction with la may differ. 
This said, it is clear that the presentation of antigen to CD4+ T- 
lymphocytes is 'classically' restricted by la on the dendritic 
leucocyte. As such, the detailed model for antigen presentation, 
invoking theories of agretope-epitope restriction etc, as 
described earlier may be as relevant to the dendritic leucocyte as 
it is to the macrophage.
1.3.1 The dendritic leucocyte lineage
The lymphoid dendritic leucocytes are characterised by distinct 
morphological features combined with potent antigen presenting 
activity. These cells play a central role in much of my 
experimental work, and as such are considered below in detail.
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This section is arranged with a phenotypic description of the 
dendritic leucocyte lineage followed by a description of their 
functional activity. The dendritic leucocytes are then compared 
with the macrophage, in table 1.
Phenotype
Dendritic cells were originally isolated from a variety of 
peripheral lymphoid tissues in mice and were characterized by 
their highly irregular plasma membrane, dense granular cytoplasm 
and large, refractive nuclei (Steinman and Cohn 1973). In 
addition, dendritic cells, particularly when isolated from spleen 
and lymph nodes were shown to be bone marrow-derived and to stain 
with the monoclonal antibody 33D1 which was specific for these 
cells (Steinman and Witmer 1978; Nussenzweig et al 1982).
In addition to 33D1+ dendritic cells there are several other cell 
types (Langerhans cells, veiled cells of afferent lymphatics, 
interdigitating cells of the T-rich paracortex) which are widely 
considered as broadly equivalent. All these cell types constitute 
the 'dendritic leucocyte lineage' (Austyn 1987) and a comparison 
of their phenotypes follows. The term dendritic leucocyte is used 
to refer to all four cells mentioned above.
Morphology
Dendritic leucocytes are irregularly shaped cells, producing a 
variety of cell processes giving a pseudopodic and veiled (or
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ruffled) appearance (Pugh et al 1983; Steinman and Cohn 1973; 
Kraal et al 1986;Stingl et al 1977).
In addition to cellular shape, the dendritic leucocytes also have 
distinctive low buoyant density, non-adherence to plastic and are 
further characterized by their weak/negligible phagocytic activity 
(Schuler and Steinman 1985). A number of groups have examined 
this final point and it is apparent that unlike macrophages, 33D1+ 
dendritic cells, veiled cells (Pugh et al 1983) and Langerhans 
cells (Wolff and Schreiner 1970) fail to phagocytose. It is
however significant that recent work on Langerhans cells has 
suggested that there are both qualitative and quantitative changes 
in ultrastructure and morphology after exposure to the recognised 
contact sensitizing chemical 2,4-dinitrofluorobenzene (DNFB) in 
vivo (Kolde and Knop 1987). These changes included cell
enlargement and increases in lysosomal, endocytic and protein 
synthetic activity, which may indicate a) phagocytosis 
pinocytosis and b) antigen processing activity.
One distinctive facet of Langerhans cell morphology is the 
expression of the CD1 surface antigen recognized by the antibody 
T6 (Murphy et al 1981; van Voorhis et al 1982b) in conjunction 
with possession of the intracellular, racquet-shaped Birbeck 
granule (Wolff and Stingl 1983) which also stains T6 positive 
(Takahashi and Hashimoto 1985). The significance of T6 and the 
function of the granule are yet to be established.
1.3.2 The membrane antigens of dendritic leucocytes
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Cellular antigens restricted to dendritic leucocytes have been 
identified in mice. The monoclonal antibody 33D1 (Nussenzweig et 
al 1982) recognizes an antigen limited (to date) to lymphoid 
dendritic cells isolated from lymph nodes and spleens (Crowley et 
al 1989) as assessed by antibody mediated-fluorescent staining and 
complement cytotoxicity. The other dendritic leucocytes do not 
express this antigen in detectable amounts.
Monoclonal antibodies NLDC-145 and MIDC-8 (Kraal et al 1986; Breel 
et al 1987) recognize related membrane and cytoplasmic epitopes of 
an antigen restricted to murine dendritic lymphocytes. The 
distribution of this antigen warrants description. In particular, 
in vitro isolated (33D1+) dendritic cells from spleens and lymph 
nodes stain strongly, with both antibodies, as do the 
interdigitating cells of T-cell dependent areas of secondary 
lymphoid tissue (classically of the reticulo-endothelial system). 
This observation supports a theory (described later) that 
interdigitating cells are the in vivo counterpart of the in vitro 
isolated, 33D1+ dendritic cell (Steinman and Cohn 1973; Kamperdijk 
et al 1985). The proposal that Langerhans cells and veiled cells 
are also directly related is supported by these cells also 
staining (although less strongly) with NLDC-145 and MIX-8 
antibodies (Breel et al 1987). [No dendritic leucocyte-specific 
markers in rat or man are known by me. ]
Early studies demonstrated that dendritic cells did not express B 
or T cell markers (Steinman and Cohn 1974). Expression of the 
leucocyte comnon antigen, which correlates with bone-marrow
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origin, has been established for 33D1+ dendritic cells (Steinman 
and Cohn 1973), Langerhans cells (Katz et al 1979; Wolff and 
Stingl 1983) and rat veiled cells (Pugh et al 1983) and this is 
analogous to the macrophage-monocyte lineage, amongst others.
The analogy between macrophages and the dendritic leucocytes, as 
we have seen in terms of phagocytic activity and dendritic 
specific markers, is unlikely to be more than superficial. Thus, 
analysis of the murine macrophage-restricted marker F4/80 
indicates that the 33D1+ dendritic cell is not related to 
macrophages (Austyn and Gordon 1981) (same for 3C10 in man, van 
Voorhis et al 1983). However, fresh murine Langerhans cells do 
express F4/80, Fc and iC3b (complement fragment)receptors (Stingl 
et al 1977) and the cytological activities of nonspecific esterase 
(NSE) and ATPase (Bergstresser et al 1983;
Schuler and Steinman 1985). This does suggest some analogy with 
the macrophage monocyte lineage, which others have commented on 
(Hume et al 1983). In addition, this creates a clear distinction 
between 33D1+ dendritic cells and fresh Langerhans cells, as the 
former do not express detectable levels of FcR (Unkeless 1979; 
Fleit et al 1982) and are only weakly positive for iC3b receptor 
(Schuler and Steinman 1985). Note that the 'related' veiled cells 
(isolated from the rat) are similar to freshly isolated Langerhans 
cell in expressing NSE and ATPase and yet also resemble 33D1+ 
dendritic cells in lacking significant expression of F4/80, FcR or 
iC3bR (Pugh et al 1983).
28
Clearly, any proposal at this stage suggesting that the four cell 
types constituting the dendritic leucocyte family are related 
cells needs substantiating. Perhaps the most remarkable findings 
from this area of research are those that do indeed provide 
evidence in support of this relationship (described in 1.3.4).
1.3.3 Phenotypic indicators of dendritic leucocyte antigen 
presenting function
Dendritic leucocytes in the mouse express la molecules. 33D1+ 
dendritic cells express consistently high levels (Steinman et al 
1979) of la and this correlates with their apparent 
unresponsiveness to the la-inducing lymphokine IFN gamma (Austyn
1987). High levels of class II MHC-expression are also reported 
on dendritic cells of rat (Klinkert et al 1982) and man (Hart and 
McKenzie 1988), compatible with a widely distributed antigen 
presenting function.
Murine Langerhans cells (Klareskog et al 1977; Stingl et al 
1978a), rat veiled cells (Pugh et al 1983) and murine 
interdigitating cells all express class II MHC-encoded antigens, 
although to a lesser extent than 33D1+ dendritic cells. This is 
reflected in their significant but reduced antigen presenting 
activity when compared with the 33D1+ dendritic cell, which is 
examined in the following section.
As I described in 1.2 there are a number of secreted and membrane 
factors produced by antigen presenting cells which play an
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important role in antigen presentation. The production of these 
factors by dendritic leucocytes has yet to be satisfactorily 
defined although evidence available indicated that 33D1+ dendritic 
cells do not produce IL-1. The role of IL-1 in providing an 
essential second signal for T-lymphocyte proliferation during 
antigen presentation by macrophages was described previously.
It is unclear how dendritic cells, unable to produce IL-1 can 
facilitate this second signal although, as I will described in 1.4 
they are highly stimulatory for CD4+ T-lymphocytes involved in 
contact sensitivity.
1.3.4 Variation in the expression of Langerhans cells 
differentiation antigens during culture
Many of the characteristics of cultured Langerhans cells have been 
elucidated by Ralph Steinman and co-workers. It was initially 
established that beyond two days in culture, Langerhans cells had 
developed a considerably altered phenotype and stimulatory 
activity (Schuler and Steinman 1985). These phenotypic changes 
included loss of F4/80, FcR intracytoplasmic Birbeck granules, NSE 
and ATPase activity. Level of iC3bR expression was unchanged. 
These changes confer a (33D1+) dendritic cell phenotype on the 
Langerhans cell, although it is notable that Langerhans cells do 
not at any stage express the 33D1 surface marker. [As will be 
described later in this chapter, these changes were matched by a 
marked increase in the antigen presenting cell capacity of the 
'Langerhans cell'.] These phenotypic changes are consistent with
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the Langerhans cell and the dendritic cell being related. As 
mentioned previously, the veiled cell had an intermediate 
phenotype, between the Langerhans cell and the dendritic cell 
(Pugh et al 1983). It is not unreasonable to suggest that the 
cultured Langerhans cell may pass through this intermediate stage 
in attaining its 'dendritic cell-like' phenotype. This, together 
with the evidence, described earlier, that 33D1+ dendritic cells 
and interdigitating cells may be the same cell (Breel et al 1987) 
provides the background for a widely acknowledged (although not 
universally accepted) proposal that all four cells constituting 
the dendritic leucocytes are the same cell, differing only in 
their stage of functional activity (and site of anatomical 
localization).
1.3.5 The relatedness of Langerhans cells, veiled cells, 33D1+ 
dendritic cells and interdigitating cells
In vivo studies on the tissue distribution of Langerhans cells and 
33D1+ dendritic cells suggests the two cells are physiologically 
distinct from each other. As I have described, however, veiled 
cells of the afferent lymphatic system, which connects the skin 
(Langerhans cell 'domain') with the lymph nodes/spleen (33D1 
dendritic cell 'domain') are of dendritic lineage and related to 
both Langerhans cells and dendritic cells. Thus, there is a 
cellular basis for the communication which, as we will see in 
chapter 3, must necessarily exist between epidermis and draining 
lymph nodes during induction of particular delayed type 
hypersensitivities, including contact sensitivity. Note that the
31
veiled cell exists in the afferent draining lymphatics of a number 
of species (Hoefsmit et al 1982; Drexhage et al 1979; Pugh et al 
1983) - an important role is implied.
Indeed, veiled cells (Fossun 1988) and peripheral lymph cells 
(Kelly 1970; Kelly et al 1978) have a demonstrable affinity for 
the T-cell rich paracortical regions of lymph nodes and once at 
the node, adopt a morphology and localization distinctive of 
interdigitating cells. That is, they form intimate and extensive 
surface contact with T-lymphocytes (Kamperdijk et al 1985) and 
share considerable, phenotypic analogy (see earlier), including 
high expression of la molecules (Dijkstra 1982), with in vitro 
isolated 33D1+ dendritic cells.
1.3.6 Dendritic cell migration patterns in vivo -
Elegant studies by Austyn and his co-workers at Oxford
have demonstrated the existence of defined migration patterns for 
In-labelled murine dendritic cells in vivo (Kupiec-Weglinksi et 
al 1988; Austyn et al 1988). The protocol, based on earlier
studies by Gowans and Knight 1964, utilised small numbers of 
radiolabelled splenic, 33D1+ dendritic cells and demonstrated that 
intravenous (iv) administered dendritic cells pass transiently 
through murine lungs and localize principally in the spleen.
It was demonstrated that this localization depended on T- 
lymphocytes, as the splenic localization of dendritic cells was
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reduced in nude mice but reinstated when the nude mice were 
reconstituted with T-lymphocytes prior to receiving dendritic 
cells. In addition, this group also demonstrated that dendritic 
cells in the blood could not enter peripheral lymph nodes in 
normal or splenectomized mice, indicating a fundamental non­
interaction between dendritic cells and the blood-high endothelial 
venule (HEV)-lymph node barrier. These results were consistent 
with the findings of similar studies in the rat (Sedgeley and Ford
1976).
As would be expected, however, Austyn et al did observe dendritic 
cells passing readily from skin sites (foot pads) to local lymph 
nodes, as had previously been reported in the draining auricular 
lymph nodes of nude and normal mice painted on the ears with 
picryl chloride (Knight et al 1985b). This afferent entry into 
the lymph node was thus independent of T-lymphocyte influence, 
unlike entry to the spleen.
The major criterion for these patterns of dendritic cell migration 
was that the dendritic cells were viable: glutaraldehyde fixed 
dendritic cells lost their migratory activity. It was notable 
that the migration was unaffected by major histocompatibility. 
Evidently, the elements necessary for dendritic cell recognition 
are less polymorphic than the MHC-encoded antigens.
In an attempt to establish more about what regulates dendritic 
cell transfer into spleens or lymph nodes, the same group 
considered the binding of dendritic cells to spleen or lymph node
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sections and the relative localization of fluorescent labelled 
dendritic cells to particular tissue areas (Austyn et al 1988). 
It was reported that initially (3hrs) dendritic cells associate 
with the red pulp but quickly home to the T-dependent periarterial 
lymphatic sheath in spleen (PALS) occupying a 'niche' usually 
frequented by interdigitating cells by 24hrs. These findings are 
in agreement with studies on the migration of the closely related 
veiled cell of afferent lymphatics (see chapter 2) which 
demonstrated the predisposition of the veiled cell for 
paracortical regions in the lymph node and the adoption of a 
morphology and localization identical to the interdigitating cell 
(Fossum 1988). The relationship between interdigitating cells and 
33D1+ lymphoid dendritic cells was established earlier.
The fact that dendritic cells initially localize to the red-pulp 
demonstrated that the dendritic cell infiltration, while dependent 
on T-lymphocytes, was not mediated by clustering with T- 
lymphocytes. Further studies suggested dendritic cells bind 
initially to marginal zone endothelium. It is postulated that 
dendritic cells express an endothelium-specific homing receptor 
(but not specific for HEV) enabling binding to the marginal zone 
prior to crossing the red pulp and entering the PALS. 
Significantly, T-cells or their products are predicted to 
condition the endothelium, allowing receptor binding: in addition, 
such conditioning and thus dendritic cell admittance could occur 
at nonlymphoid sites where T-cells accumulate. This proposal will 
be examined again in chapter 2, when I consider a possible role 
for IFN gamma in regulating dendritic cell migration. I should
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mention that while the phenotype of dendritic cells is quite well 
elucidated, the marker for any putative homing receptor has yet to 
be identified as such.
These studies, on dendritic cell migration and its similarities to 
the mobility in vivo of veiled and Langerhans cells are further 
evidence for the similarity, if not relatedness of these cells. A 
good deal of evidence from studies on the antigen presenting 
activity of dendritic cells also supports this relatedness and it 
is to this area which I now turn.
1.4.1 Dendritic leucocytes - antigen presentation and stimulatory 
activity
A considerable amount of evidence has accrued in the last five 
years demonstrating that the dendritic leucocytes in general and 
the 33D1+ dendritic cell in particular have antigen presenting 
activity and thus are able to stimulate T-lymphocyte activation 
and proliferation. Most work has considered 33D1+ dendritic cells 
or 33Dl-ve Langerhans cells and it is these two which I will 
concentrate on.
33D1+ dendritic cells
The 33D1+ dendritic cell, defined initially by distinctive 
morphology (1.3.1), has been shown to stimulate in vitro both 
primary and secondary allogeneic mixed leucocyte reactions 
(Steinman and Witmer 1978), the generation of cytotoxic T-
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lymphocytes (Boog et al 1988), the initiation of T-cell dependent 
antibody responses (Inaba et al 1983 a, ) and the stimulation of 
oxidative mitogenesis (Austyn and Morris 1988).
In addition, the 33D1+ dendritic cell stimulates primary and 
secondary, hapten-res trie ted T-lymphocyte proliferative responses 
in vitro and this correlates with their ability to adoptively 
transfer contact sensitivity to naive recipient mice (Knight 1985 
a, b): these hapten-restricted responses will be fully described 
in chapter 3 as they relate directly to my experimental work. 
Lastly, 33D1+ dendritic cells are considered to be the 'passenger 
cell' involved in the phenomenon of graft rejection (Austyn 1987). 
All these activities utilise the high, constitutive expression of 
la molecules on the dendritic cell, whether it is to present 
nominal antigens to T-lymphocytes or to stimulate anti-la 
allogeneic responses.
With this point established, it is appropriate to comment that the 
mechanism of how dendritic cells stimulate these responses appears 
to be similar for each response. That is, while la alone or la 
plus nominal antigen may be presented by the dendritic cell, the 
interaction of the dendritic cell with T-lymphocytes is, at least 
in contemporary publications, the same, and is described below.
1.4.2 Mechanism for dendritic cell activation of CD4 T-lymphocvte 
activation
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The consensus, initially proposed by Ralph Steinman, suggests that 
the 33D1+ dendritic cell clusters with T-lymphocytes in an antigen 
non-specific fashion (Inaba and Steinman 1984). This is followed 
by activation of CD4+ T-lymphocytes expressing the TCR specific 
for antigen presented on the dendritic cell, whether this is la 
alone (giving allogeneic proliferation) or la plus nominal antigen 
(giving la-restrieted, antigen specific proliferation). Thus, 
there is antigen-specific clonal expansion of CD4+ T-lymphocytes.
Of fundamental significance is the fact that for the responses 
described in 1.4.1, and possibly others, it is ONLY the 33D1+ 
dendritic cell which can initiate clustering with naive (or 
resting) T-lymphocytes. These in vitro studies suggest that 
dendritic cells are ESSENTIAL for activation of primary T- 
lymphocyte responses. The point is emphasised by a detailed study 
of the in vitro antigen presenting function of Langerhans cell 
which I have summarised below.
1-4.3 The maturation of Langerhans cells antigen presenting 
activity in culture
The antigen presenting activity of Langerhans cells in vitro 
increases markedly as the cell culture period passes 12hrs and 
this is paralleled by the phenotypic changes described in 1.3.4. 
In particular, compared with freshly isolated Langerhans cells, 
cultured Langerhans cells stimulate primary mixed lymphocyte 
reactions and polyclonal mitogenesis of periodate-modified T- 
lymphocytes (Schuler and Steinman 1985). Similarly, stimulation
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of hapten and soluble protein-specific T-lyraphocyte proliferation, 
as measured by IL-2 production also increased (Shimada et al 
1987). The stimulatory activity was attributable to la-bearing 
'Langerhans cells', and a large part of the enhancement of 
stimulatory activity can be attributed to increases in la 
expression on Langerhans cell within 12hrs of culture (Shimada et 
al 1987; Witmer et al 1986).
However, enhanced stimulatory activity was not solely attributed 
to increases in la expression, as it was demonstrated that 12hrs 
and 3d-cultured Langerhans cells had similar levels of la but 
different stimulatory activity. Such functional maturation after 
12hrs in culture correlated with the development of dendritic 
cell-like phenotype and morphology (see 1.3.4) and also with an 
enhanced clustering activity, characteristic of the interaction 
between T-lymphocytes and 33D1+ dendritic cells (Inaba and 
Steinman 1984). This may be the step predisposing Langerhans 
cells to stimulate naive T-lymphocytes (and is thought to be 
regulated primarily by GM-CSF (Witmer-Pack et al 1987; Strelein et 
al 1990).
Thus, it has been demonstrated through the use of Langerhans cell- 
T-lymphoblast binding assays (Inaba et al 1986) that Langerhans 
cells cultured for periods up to 12hrs cluster with primed T- 
lymphocytes in an antigen-restricted manner. Older Langerhans 
cells cultures may cluster with naive T-lymphocytes in an antigen 
independent manner. It is this latter interaction, clustering in 
the absence of antigen, which is correlated with functional
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maturity. A variety of cells, including B-lymphocytes and
macrophages can present antigen to primed T-lymphocytes as 
described in 1.2 but only post 12hr cultured Langerhans cells and 
33D1 dendritic cells can initiate antigen non-restricted 
clustering and thus prime naive T-lymphocytes.
The review presented in 1.3 and 1.4 is summarised in table 1: the 
references have been presented in the text.
1.5 Conclusion
At the beginning of this chapter I briefly described the 
functional activity of the CD4+ T-lymphocytes. The diverse 
activity can be partly reconciled with the recent establishment of 
TH1 and TH2 CD4+ T-lymphocytes and thus the apparent delegation of 
different functions to one or other subsets. Such functional 
distinctions between TH1 and TH2 seem rational and valid in the 
light of our current understanding of immune responses.
The requirement of all CD4+ T-lymphocytes for activation is the 
recognition of nominal antigen presented in the context of la 
molecules in an appropriate lymphokine or 'accessory factor' 
environment. I have presented a resume of conventional views on 
antigen presentation to CD4+ T-lymphocytes in 1.2. These studies, 
largely based on the antigen processing and presenting activity of 
macrophages, serve to establish a model for antigen presentation.
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Of particular relevance to my experimental work is the antigen 
presenting activity of dendritic cell. As such, I describe the 
phenotype of dendritic leucocytes in 1.3 and the antigen 
presenting activity of these cells in 1.4. I establish that the 
dendritic cell is a potent antigen presenting cell, possibly with 
unique T-lymphocyte priming activity. This specialist activity 
during the induction of contact sensitization will be developed in 
chapter 3.
The development of CD4+ T-lymphocyte mediated immune responses, 
that is cell-mediated immunity, will obviously be restricted by 
the availability and quality of antigen presented on antigen 
presenting cells. As we have seen, this is an essential step in 
T-lymphocyte activation. In addition, the development of cell- 
mediated immunity will be restricted by a) the access of antigen 
and antigen presenting cells to T-lymphocytes and b) the provision 
of appropriate accessory factors, for example lymphokines at the 
site of antigen presentation. Both these aspects will be 
regulated by both general and local lymphokine conditions within 
the lymphon and it is these aspects of regulation within cell- 
mediated immunity which will form the basis of chapter 2. In 
chapter 2 I aim to provide a brief resume of proven and potential 
lymphokine effects on cell-mediated immune responses, with 
particular regard to the activity of IFN gamma.
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The Phenotypic Characteristics ofDendritic Leucocytes
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2.1 A role for lymphokines in cell-mediated immunity
The CD4+ T-lymphocyte has a central role in the orchestration of 
immune responses, including cell-mediated immunity (1.1). The 
activation of these cells is dependent on interaction with 
immunogenic antigen presenting cells. This interaction, while 
critical, is not the only instance of cell-cell communication 
within cell-mediated immune responses. Firstly, it is significant 
that a number of steps are required before antigen presenting 
cells actually reach T-lymphocytes, as I will describe in chapter 
3 for contact sensitization. Secondly, the activation of T-
lymphocytes is often only the beginning of an immune 'crescendo' 
involving a host of cells, leading eventually to clearance of 
antigen. Obviously, in all this, molecules which communicate 
between cells will be critical and it is to a particular family of 
these, the lymphokines, which I now turn.
In this chapter I wish specifically to consider the role of IFN 
gamma on the development of cell-mediated immune responses. This 
reflects three crucial points.
1 The CD4+ T-lymphocyte, produces far more than two
lymphokines, including IL-2 and IFN gamma: in line with this 
cells immune responsibility, these lymphokines are likely to 
be centrally involved in cell mediated immunity (Mosmann et 
al 1986; Andersson et al 1986 in T4 human mononuclear cells).
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2 As I will describe, there is much experimental evidence 
demonstrating that IFN gamma a) directly produces 
inflamnatory responses, and b) significantly regulates the 
cells known to be involved in cell-mediated irnnune responses.
3 IFN gamma preparations had some effects on the early stages 
of initiation of contact sensitization, as described in my 
experimental results (chapter 9). As such, this chapter acts 
as an introduction to the immunomodulatory activity of IFN 
gamma in particular and of lymphokines in inflammatory and 
cell-mediated responses in general.
2.2 The production of and sensitivity to lymphokines by murine 
CD4+ T-lymphocytes has been extensively characterised 
(Mosmann et al 198&; see chapter 1). One conclusion from 
these studies was that the TH1 lymphocyte subset is the T- 
lymphocyte that mediates delayed type hypersensitivities 
(Cher and Mosmann 1987). It seems likely therefore that the 
THl-produced lymphokines IL-2 and IFN gamma will regulate 
development of delayed type hypersensitivities. Consistent 
with this, the same workers demonstrated that IFN gamma makes 
a considerable contribution to the swelling and vascular 
leakage associated with DTH reactions, which corroborated 
similar findings by other groups (Pace et al 1983). In 
addition, a number of in vivo studies demonstrated the 
influence of IFN gamma on the development of DTH lesions 
(Krammer et al 1989). Some of the evidence I review in this 
chapter reflects the influence of IFN gamma on the expression
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of la molecules and thus the progression of cell-mediated 
murine responses. I also consider the activity of IFN gamma 
on regulation of other molecules involved in antigen 
presentation, notably the expression of adhesion molecules 
and the level of nominal antigen expressed on antigen 
presenting cells. This latter effect may result from any one 
of a number of possible activities of IFN gamma, which 
influence not just the antigen presenting cell.
IFN gamma immune activity - common motifs from disparate models
2.3 Cell sensitivity to IFN gamma
The cell surface receptor for IFN gamma appears to be a single 
chain polypeptide in both mouse and man (Schreiber et al 1989) and 
is therefore unlike the dual chain receptor identified for a 
number of lymphokines including IL-2 (reviewed Shimizu et al 1989; 
Williams 1987). The IFN gamma receptor, molecular weight 70-100kD 
is expressed ubiquitously on most primary, normal cells 
constituting tissues and peripheral blood, including mononuclear 
phagocytes, T-lymphocytes and fibroblasts (Luquette et al 1989) as 
assessed by immuno-histochemical staining. The major exception 
was erythrocytes.
As will become apparent, it was significant from these studies 
that a number of specialized cell types, including vascular 
endothelial cells and skin epidermal cells displayed extremely 
high levels of the IFN gamma receptor. (It has yet to be
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established whether lymphoid dendritic cells express the IFN gamma 
receptor.) The same workers demonstrated that the IFN gamma 
receptors on all these cell types were similar, differing only in 
their glycosylated residues (Khurana-Hershey and Schreiber 1989). 
One would predict that these cells would be sensitive to IFN gamna 
and of particular importance is likely to be the antiviral 
activity conferred on these cells during infection. Such a widely 
distributed anti-infective mechanism is an evolutionary astute 
development but of more relevance here, all such cells may also 
express other, IFN gamma-induced, immunomodulatory changes. For 
example, a variety of seemingly disparate cell types, including 
immunologically isolated brain cells may be induced to express 
high levels of la molecules by exposure to IFN gamma (Wong et al 
1983; Basham and Merigan 1983; Tomkins et al 1988). Cells which 
express high levels of IFN gamma receptor will be particularly 
sensitive to the effects of IFN gamma. For example, human 
fibroblast cell lines which are trisomie for the IFN gamna 
receptor-gene-bearing chromosome 21 have high receptor expression 
and are very sensitive to IFN gamma (A Morris pers comn).
Of course, the cellular response to IFN gamma will be dictated by 
intact mechanisms of signal transduction together with the cells 
potential repertoire of responses after IFN gamma binds the 
receptor. Thus, possession of the IFN gamma receptor is a good 
indicator of IFN gamma sensitivity but only part of the story. 
There is little data available as to the signal transduction 
following ligand binding to the IFN gamma receptor: there are some 
unsurprising suggestions that protein kinase C may be involved
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(personal communication AGM). Much more is known about the 
repertoire of cellular responses to IFN gamma and I would like to 
now consider these, with particular regard to implications for 
cells involved in DTH responses.
2.4 IFN gamma regulation of la expression
It was initially observed that the supernatants of activated 
spleen cells induced enhanced la expression on murine macrophages 
(Steeg et al 1980). IFN gairnia is able to induce expression of 
both class I and class II MHC-encoded antigens both in vitro 
(Basham and Merigan 1983; Wong et al 1983) and in vivo (Scheynius 
et al 1986) on a number of cell types across a variety of species 
including mouse and man. This activity on the class II or la 
molecules distinguishes functionally between immune IFN gamma and 
IFN alpha/beta which only affect class I MHC-encoded molecules.
The induction of la has been partially characterised in terms of 
induced gene expression and while the details are not appropriate 
here, it is reported that cell stimulation with IFN gamma gives an 
increase in cytoplasmic I-A-coding mRNA (Chang and Lee 1986). 
This is prior to increases in expression of the I-A molecules on a 
murine myelomonocytic cell line, which occurs in a dose and time 
dependent manner (Celada and Makii 1989). These observations are 
applicable for la expressing cells in vivo and of particular 
interest to me, in delayed type hypersensitivities.
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Thus, in mice, IFN gamma influences the expression of la molecules 
during hypersensitivities (Scheynius and Tjemlund 1984). In mice 
undergoing delayed type hypersensitivity, the intravenous 
administration of anti-IFN gamma antibodies enhances the 
development of hypersensitivity (Skoglund et al 1988). This 
correlated with the down regulation of la-expression on cells in 
and around the inflamed areas, indicating a possible suppressive 
role for high la expression. Other groups have described the role 
of la molecules during immunomodulation (Janeaway et al 1984; 
Matis et al 1983). These data establish that IFN gamma regulates 
la expression and thus may modify la-restricted immune responses: 
as I will outline in a later section, this activity of IFN gamma, 
along with others, is likely to be important in the development of 
cell-mediated immune responses, including contact sensitivity.
2.5 Adhesion molecules and IFN gamma
The potentially significant role of adhesion molecules, notably 
the interaction of CD4 with la and a number of LFA antigens: I-CAM 
antigens was introduced in chapter 1. Cell-cell adhesion is 
demonstrably regulated in vitro by CD4 interaction with la 
molecules (Doyle and Strominger 1987) and also CD8 interaction 
with class I-MHC-encoded antigens (Norment et al 1988). Adhesion 
molecules are clearly important at this level.
A fundamentally more important role for CD4, however, as critical 
in T-cell activation rather than simply as just facilitating cell­
cell adhesion, is suggested by the demonstration that crosslinking
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of CD4 (and L3T4) molecules inhibits T-cell activation (Haque et 
al 1987; Pont et al 1987). Further, CD4 may transduce activation 
signals (Owens et al 1987); it also co-precipitates with tyrosine 
kinase in T-cell lysates (Rand et al 1988; Veillete et al 1988). 
A number of workers have proposed that adhesion molecules 
including CD4 (Janeaway et al 1988) and LFA-1 (Pierres et al 1982; 
Fischer et al 1986) may be important in T-lymphocyte activation by 
transducing appropriate signals.
The influence of IFN gamma on adhesion molecules has been examined 
in in vitro systems using vascular endothelial cells. These cells 
are essential in regulating cellular migration out of blood into 
extra-vascular spaces and may therefore be highly relevant to my 
studies on inflammatory and hypersensitivity reactions. Vascular 
endothelial cells are conditioned and activated by a number of 
lymphokines, including IFN gamma in vitro (Pober and Cotran 1989). 
The particular activity of IFN ganrna is summarised below:
1 Induction of class II and class I MHC expression (Pober et al 
1983; Wagner 1985) thus enhancing antigen presenting activity 
to T-lymphocytes;
2 increased expression of ICAM-1 (Pober et al 1986) which as 
described in chapter 1, is considered important in cell-cell 
interactions;
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3 increased expression of cytoplasmic antigen normally found in 
lymph node high endothelial venules (Duijveskiju et al 1986); 
and
increased adhesion of T-lymphocytes to endothelial cells (Yu 
et al 1985; Hendriks et al 1989).
From these reports, one would predict that in vivo the overall 
response would be increased T-lymphocyte adhesion to endothelial 
cell walls. This is supported by the observations that injected 
IFN gamma causes increased, localized vascular permeability 
(Martin et al 1988) and vascular leakiness (Williams et al 1988). 
This reflected initial increases in leucocyte adhesion and similar 
effects have been reported as a complication of clinical treatment 
with IFN gamma (bear in mind possible species differences).
2.6 The influence of interferon on cellular migration
The suggestion that IFN gamma influences lymphocyte migration is 
supported by other data. Thus it has been established that 
virally-infected mice present significantly altered lymphocyte 
counts and this correlated positively with the serum interferon 
levels (Schattner et al 1982 a, b). In addition, it has been 
reported that injections of interferon (Gresser et al 1981) or the 
interferon inducer polyinosinic-polycytidilic polyribonucleotide 
(Schattner et al 1983) significantly effect both peripheral lymph 
node weight and blood lymphocyte numbers. Also, rat thoracic duct 
lymphocytes treated in vitro with interferon-alpha showed a
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preferential localization at peripheral lymph nodes, on 
reinjection into rats (Kimber et al 1987 b).
It is clear that IFN gamma regulates some lymphocyte migration and 
it seems likely that such influence depends on the induction of 
cell surface molecules which themselves regulate cellular 
interactions. IFN gamma may also influence the movement of 
antigen presenting cells, including lymphoid dendritic cells 
although I am unaware of evidence which supports this. As such, I 
describe a possible role for IFN gamma during dendritic cell 
migration at the end of this chapter after a brief review of some 
evidence indicating that IFN gamna directly influences the 
progression of delayed type hypersensitivities, the immune 
response which I studied.
2.7 Direct evidence for IFN gamma influencing delayed type 
hypersensitivity
Ihree specific observations show that IFN gamma is significant in 
the progression of delayed type hypersensitivity.
Firstly, it has been demonstrated that injections of IFN gamma 
into mice, at the site of exposure to contact sensitizing 
chemicals can enhance the development of contact sensitivity 
(Maguire et al 1989). While this was not attributable solely to 
enhanced la expression on local antigen presenting cells, such an 
explanation could account for at least part of the effect, as 
described earlier (see 2.1.4).
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That this effect is at the level of the CD4+ T-lymphocyte rather 
than the antigen presenting cell is suggested by studies in CD4- 
raice. Such mice have no delayed type hypersensitivity: such 
responses however are restored if IFN gamma is administered 
suggesting that IFN gamma is crucial in activating effector (non 
CD4+?) T-lymphocytes in the progression of delayed type 
hypersensitivity (Diamenstein 1988).
Finally in this section, a number of workers have demonstrated 
that virally infected mice, with high IFN gamma titres, host 
reduced delayed type hypersensitivity responses (pers comm A 
Morris). This no doubt reflects the changes in lymphocyte 
migration described in 2.1.6 but is not totally compatible with 
the studies of Maguire and co-workers. This demonstrates the 
difficulty of ascribing definitive in vivo activities for IFN 
gamma in a dynamic immune system; it also reflects the absolute 
requirement for highly purified, widely available interferon 
(lymphokine) preparations, enabling meaningful across-laboratory 
comparisons - a problem which will be emphasised later in this 
thesis.
2.8 Conclusions
Clearly, IFN gamma has a number of well characterised effects in 
vitro on the two cells considered to be central in cell mediated 
immune responses, the CD4+ T-lymphocyte and the antigen presenting 
cell. While there is no evidence for direct activity on lymphoid 
dendritic cells, it is likely that any cellular migration prior to 
T-lymphocytes contacting antigen presenting cells could be
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influenced by IFN gamma, as could the interaction of these cells, 
which will undoubtedly depend on expression of IFN gamma-sensitive 
molecules such as la and CD4. It is therefore not surprising that 
in vivo administered IFN gamma influences the progression of 
delayed type hypersensitivity. The contention lies in defining at 
what point the IFN gamma has its regulatory effects during such 
responses and it is to this point that the experimental work I 
present in chapter 9 is directed.
The two major components of the initiation of an effective cell- 
mediated immune response have now been introduced. I have 
described the necessity for a) effective antigen presentation and 
b) the regulatory role of lymphokines, in particular IFN gamma. 
With these central facets established I will now describe the 
initiation and progression of contact sensitivity which is the 
model of cell-mediated immunity examined in my experimental work. 
Contact sensitivity, as will be seen, is arguably the most 
comprehensively characterised experimental immune response.
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3.1.1
In this chapter I will review the initiation and generation of 
contact sensitivity. I begin by describing briefly the visually 
apparent changes in a mouse following exposure to a contact 
sensitizing chemical - this will establish the classical criteria 
for defining the contact sensitized state and delayed type 
inflammatory responses in general. I will then concentrate on the 
following main areas:
1) Contact sensitizing chemicals and putative interactions with 
proteins (hapten-protein immunogens).
2) The role of T-lymphocytes in contact sensitivity - classical 
cell-mediated immunity.
3) The site of induction of primary CD4+ T-lymphocyte 
proliferation during contact sensitization.
4) The lymphoid dendritic cell during induction of contact 
sensitization - cellular conmunication between the skin and 
the local lymph node.
5) The mechanism for the induction of contact sensitization.
6) Evidence for sequential T-lymphocyte activity during the 
induction of contact sensitivity: early and late inflammatory 
responses.
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7) Conclusions - Consensus.
3.1.2 Classical contact sensitivity and its nomenclature
The induction of contact sensitization occurs over some 3-7 days 
following exposure of the skin to a sensitizing chemical. (Such 
exposure is facilitated by skin painting.) Induction is defined 
here as the series of events occurring in an animal with no previous 
exposure to a chemical (naive) leading to that animal being 
sensitized to that chemical. This induction is also termed the 
afferent phase (or 'arm') of contact sensitization.
There are no direct, non-invasive methods for determining the 
completion of induction. Instead, the sensitized state has (and is) 
classically tested for by an animal's ability to host a detectable, 
chemical-specific skin-inflanmation, after re-exposure to a dilute 
concentration of chemical on the ear. Such a sensitized animal is 
described as exhibiting a positive elicitation response - the events 
leading to an elicitation response involve the activation of 
previously primed cells and it is therefore a secondary immune 
response. These events constitute the efferent phase of contact 
sensitization. In mice, the elicitation response is most 
conveniently measured as an increase in ear-thickness, usually at 
24hrs (and 48hrs) following ear-painting with chemical (reviewed in 
Kimber and Weisenberger 1989; Kimber 1989).
In brief then, the steps in experimental contact sensitivity may be 
summarised as follows. Naive mice are painted on the ears with a
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sensitizing chemical, for example 2,4-dinitrochlorobenzene (DNCB). 
The afferent phase, ie the sensitization of the mouse is completed 
3-7 days later. These mice are therefore a source of DNCB- 
sensitized cells. Such mice are also capable of mounting a 
secondary or elicitation response on re-exposure to DNCB, reflecting 
the activity of the DNCB-sensitized cells.
This chapter considers the generation and activity of such 
sensitized cells following exposure to contact sensitizing 
chemicals. It is appropriate to therefore examine the nature of 
sensitizing chemicals as a preliminary.
3.1.3 Contact sensitizing chemicals
A wide variety of chemicals, including a profusion of benzene 
derivatives, which were the agents of choice in the early studies on 
contact sensitization in animals, are able to induce contact 
sensitization (a selection are reviewed in Kimber and Weisenberger 
1989). It has been proposed that the protein reactivity of a 
chemical determines its sensitizing potential (Eisen et al 1952) and 
in general, low molecular weight, protein reactive chemicals are 
contact sensitizing agents. However, while these criteria may be 
the general rule, there is clear evidence that the relationship 
between protein reactivity and sensitization potential is not 
absolute. For instance, nickel, a low protein reactive metal is a 
contact sensitizing agent in both mice (Kimber et al 1990) and man 
(Res et al 1987).
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3.1.4 Generation of a chemical-derivatized immunogen in vivo
Following exposure of naive skin to a contact sensitizing chemical, 
it is possible for the chemical to interact with a number of 
components in the epidermis. Thus, the generation of an immunogenic 
chemical-protein complex may be achieved by chemical binding to 
matrix skin proteins or alternatively to protein structures present 
at the surface of epidermal cells.
There is clear evidence that after skin painting mice with the 
fluorescent contact sensitizing chemical fluoroscein isothiocyanate 
(FITC), fluorescence is distributed throughout epidermal skin 
proteins (pers. comm. David Baker). That such derivatized proteins 
may constitute an imnunogen, stimulating a chemical-specific contact 
sensitized state, has previously been demonstrated by studies 
considering the immunogenic properties of chemical-derivatized 
epidermal proteins when administered in Freunds adjuvant (de Week
1977) to mice.
The immunogenic potential of such complexes is almost certainly 
dependent on the antigen processing activity of specialised cells 
within the mice (discussed in chapter 1). That such cells may act 
in the epidermis has been suggested by studies which considered the 
site of induction of T-lymphocyte activation. These reports 
indicated that both epidermal skin proteins and epidermal cells were 
likely to be significant in the generation of the contact sensitized 
state, as described later.
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3.2.1 Role of T-lymphocytes in contact sensitization
As I described in the preamble to this thesis, contact sensitivity 
is a delayed-type response and would therefore be predicted to be 
mediated by T-lymphocytes. Several pieces of evidence support this 
view.
The role of T-lymphocytes in the afferent (or induction) phase is 
suggested by increases in the weight of lymph nodes which receive 
lymphatic drainage from the site of skin exposure (de Sousa and 
Parrott 1969), together with lymph node hyperplasia (Oort and Turk 
1965) and a selective enlargement of the T-lymphocyte-rich 
paracortical region of the lymph node (Kimber and Weisenberger 
1989).
In addition there is an induction of T-lymphocyte proliferation 
within the lymph node cells, as reflected by an IL-2-sensitive 
increase in %-TdR incorporation (Asherson and Barnes 1973; Kimber 
et al 1987; Kimber and Weisenberger 1989). This latter evidence 
implicates the proliferating T-lymphocyte as a member of the CD4+, 
TH1 subclass (see, section 1.1) although a role for a less frequent 
but proliferating CD8+ cell has now also been implicated (Kimber et 
al, in press). Tne activation is also suggested by increases in the 
node of RNA-synthesizing, large, pyroninophilic cells (Turk and Stone 
1963).
Functional studies have conclusively demonstrated the role of T- 
lymphocytes. Thus, the contact sensitized state is transferrable to
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naive recipient mice by cells (but not serum) from contact 
sensitized mice (Asherson and Ptak 1968). Further, thymectomy 
effectively prevented the induction of paracortical blast cells and 
the development of contact sensitization (de Sousa and Parrott 
1969): a similar inactivity was observed in congenitally athymie 
(nude) mice (Pritchard and Micklem 1972).
3.2.2 Phenotype and function of T-lymphocytes mediating contact 
sensitization
It has clearly been established that enriched T-lymphocytes 
(Moorhead 1978) expressing the murine Lytl+ surface marker (Vadas et 
al 1976) transfer an ability to host hapten-specific elicitation 
responses and have been termed effector T-lymphocytes of contact 
sensitivity. It seems probable that such T-lymphocytes (classically 
referred to as Tes) passively transfer the ability to host the 24hr 
elicitation response in recipient mice, although a putative role for 
CD8+ cells should not be ignored. Thus, Moorhead demonstrated the 
lack of class II MHC-encoded products on the cell fractions used to 
transfer contact sensitivity which would preclude these cells from 
activating contact sensitization. This is consistent with Tes 
passively transferring the contact sensitized state. 1^ »« pxMiy/ h a * t f * r  
d v d i H  o f C h a r  Mes****»*’'  (M il )  Tc*
cue p h t h o t y p i u J l y  and. fow.îioicJl^  Hu tell ♦
In addition, while different laboratories report differences in the
minimum time necessary between receipt of Tes and challenge of the 
recipient for there to be a 24hr elicitation response, in all cases, 
this period of consolidation in the recipient was considerably less 
than that necessary if recipients received hapten-lymphoid dendritic
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cells. Thus naive mice receiving hapten-bearing lymphoid dendritic 
cells need a consolidation period of 5 days prior to their hosting 
an elicitation response (Macatonia et al 1987) while mice receiving 
the sensitized T-lymphocytes are reported to require as little as 
lhr (Moorhead et al 1978) to 12hr (Van Loverem et al 1983). The 
difference between dendritic cell and Tcs-conferred response time is 
likely to reflect the fact that dendritic cells actively stimulate 
host sensitization, while Tcs passively mediate the effect of 
contact sensitization.
The phenotype and function of Tcs has been examined by fractionating 
Lytl+ T-lymphocytes from contact sensitized mice and analysing the 
elicitation response within naive mice which have received fractions 
of Lytl+ cells upon exposure to chemicals. From such results, one 
may interpolate which Lytl+ lymphocytes were activated and clonally 
expanded during the afferent or primary sensitization. The Tcs 
lymphocyte has been implicated as responsible for the classical 24hr 
elicitation response in contact sensitized mice (Van Loverem et al 
1984). The failure of athymic nude mice to generate late phase 
elicitation responses on secondary challenge with chemical (Herzog 
et al 1989) demonstrates the crucial role of T-lymphocytes during 
late phase. (Athymic nodes are grossly deficient in this cellular 
phenotype (MacDonald et al 1986 and 1987; Kruisbeck et al 1984). It 
has also been established that Tcs have a characteristic T-helper 
surface phenotype, that is positive for Lytl, Thyl, L3T4 (CD4) and 
negative for Lyt2 (CD8) (Herzog et al 1989b). The ability of Tcs to 
mediate elicitation responses has been previously cited by a number 
of groups (Bianchi et al 1981; Cher and Mosmann 1987).
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3.2.3 The site of induction of CD4+ T-lymphocyte proliferation
during contact sensitization
There have been conflicting reports regarding the site of activation 
of antigen-specific T-lyraphocytes in naive animals following 
exposure to contact sensitizing chemicals.
Early studies in guinea-pigs considered the efficiency of contact 
sensitization through alymphatic skin islands ie areas of skin 
surgically isolated from the lymphon by cutting lymphatic ducts. 
These failed to establish conclusively whether afferent lymphatic 
traffic from the skin (peripheral site) to the local draining lymph 
nodes was necessary for induction of sensitization (Frey and Wenk 
1957; Machler and Chase 1969; Friedlander and Baer 1972).
Analysis of the lymph of cannulated, porcine, afferent lymphatics 
during DNFB sensitization has revealed the presence of unconjugated 
DNFB, DNP-protein conjugates and DNP-labelled cells (McFarlin and 
Balfour 1973; Balfour et al 1974) in lymph leaving site of skin 
exposure. While the phenotype of the labelled cells was not 
established, these observations suggested that hapten in a variety 
of immunogenic forms is available in both the skin and the draining 
lymph nodes - thus hapten presentation and CD4+ T-lymphocyte 
activation could occur at either or both sites.
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Thus it was proposed that cells in the epidermis may bind hapten in 
the epidermis (Shelley and Juhlin 1976) and migrate via lymphatics 
to the draining lymph nodes where activation of naive, resting T- 
lymphocytes may occur, termed central sensitization (Silberberg et 
al 1976 b).
It has also been proposed however, that hapten-associated antigen 
presenting cells, namely the epidermal Langerhans cells, could 
activate T-lymphocytes in the skin, which then migrated to local 
nodes where they could then differentiate into effector T- 
lymphocytes, termed peripheral sensitization (Silberberg-Sinakin et 
al 1978). Additionally, free hapten or hapten-protein conjugates 
could flow into the node and associate with antigen presenting cells 
in the node, prior to T-lymphocyte activation. The three proposals 
are not mutually exclusive and all could be consistent with the 
observations of lymph node cell activation following skin-painting, 
as described earlier in this chapter.
Suffice to say, these early studies stimulated a detailed analysis 
of the role of both T-lymphocytes and epidermally-sited antigen 
presenting cells in the initiation of lymph node activation and 
contact sensitization. The results of these studies supported the 
role of a hapten-bearing lymphoid dendritic cell, originating in the 
hapten-painted epidermis, as important in the activation of T- 
lymphocytes in the local draining lymph node. Indeed, my own 
results (presented in Chapter 7) indicate that lymph node cell 
activation following skin-painting is dependent on the appearance of 
hapten bearing dendritic cells in the node.
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3.3.1 The role of lymphoid dendritic cells in contact sensitization
The phenotypic and functional homology between Langerhans cells, 
veiled cells and 33D1+ dendritic cells was established in Chapter 1. 
I also indicated that each of these cells may be isolated from its 
own anatomical domain. For example, Langerhans cells are recovered 
from the epidermis while 33D1+ dendritic cells are found in the 
lymph node. Together, the evidence supported the view that the 
lymphoid dendritic cell lineage consisted of related cells, each 
with a particular role during immune responses but each united by 
potential antigen presenting function. This theme is developed and 
corroborated by evidence presented below. Thus, a number of workers 
have demonstrated that the Langerhans cell, veiled cell and 
dendritic cell are critical in the development of contact 
sensitization in mice. In addition, each dendritic leucocyte may 
predominate in a particular stage during the induction of contact 
sensitization. This section ends with a consolidated view of how 
dendritic leucocytes facilitate communication between the skin and 
local draining lymph nodes.
3.3.2 Role of Langerhans cells in contact sensitization
Analysis of the cellular components of the stratified, squamous 
epithelia and epidermis of the skin, which constitute the first 
component of the hosts' immune system to experience skin-sensitizing 
chemicals, have identified two, resident bone-marrow derived 
dendritic cells. These are the Langerhans cell (Katz et al 1979;
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Wolff and Stingl 1983) and the Thyl+ epidermal dendritic cell 
(Bergstresser et al 1983 and 1984; Breathneach and Katz 1984).
Studies on contact sensitivity to haptens such as DNFB, in both man 
and guinea-pigs, has suggested that the epidermal Langerhans cell 
originally described by Paul Langerhans (1868) was important in the 
development of such immune activation (Silberberg et al 1976a). 
Analysis of epidermal skin sheets isolated after exposure to various 
sensitizing chemicals demonstrated the role of ATPase-positive, 
dendritic-like Langerhans cells in selectively uptaking antigen 
(Shelley and Juhlin 1976) and led to a proposal that Langerhans 
cells form a highly competent, antigen-capturing net, the 
reticuloepithelial system.
The function of the Langerhans cell within this network has been 
proposed to be that of a specialized, phagocytic macrophage, 
responsible for binding and processing of hapten, with subsequent 
transfer of hapten to local draining lymph nodes (Silberberg et al 
1976b). The weak phagocytic activity of these cells, along with 
their distinctive phenotype is described in chapter 1.
More direct evidence for Langerhans cells involvement in contact 
sensitization comes from experiments examining the success of 
sensitization through Langerhans cell-depleted skin. Thus, the tail 
skin of mice is known to be relatively devoid of ATPase positive 
Langerhans cells (Schweizer and Marks 1977), as are skin areas 
irradiated with short course ultra violet irradiation(uVR} Toews et 
al 1980; Lynch et al 1981), painted with corticosteroids (Lvnch et
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al 1981) or painted with cis-urocanic acid (Harriot-Smith and 
Halliday 1988). Typically, such skin has less than 7% of normal 
quantities of Langerhans cells (estimated at 450 Langerhans cells 
mm"2 in man; Berman et al 1983) and in these cases, application of 
various sensitizing chemicals failed to induce contact 
sensitization. Notably, application to normal, non-depleted sites 
induced sensitization. Significantly, it was reported that 
application to Langerhans cell-depleted skin lead to hapten-specific 
unresponsiveness, as assessed by further hapten exposure (Toews et 
al 1980).
The adoptive transfer of contact sensitization to naive recipient 
mice by administration of hapten-derivatized Langerhans cells has 
been comprehensively studied by Sabra Sullivan and co-workers 
(Sullivan et al 1986). They established that trinitrophenylated 
(TNP)-derivatized Langerhans cells adoptively transfer TNP 
sensitivity, when administered by all routes tested. The results of 
these in vivo studies suggest that the Langerhans cell is 
significant during the induction phase of contact sensitivity. That 
such cells possess the potential to be potent antigen presenting 
cells to CD4+ T-lymphocytes was described in chapter 1.
3.3.3 Role of 33D1+ dendritic cells in contact sensitization
A number of studies both in vivo and in vitro have demonstrated the 
importance of 33D1+ dendritic cells during the induction of contact 
sensitization.
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Early studies in the pig (McFarlin and Balfour 1973) and mouse 
(Asherson and Mayhew 1976) demonstrated the capacity of 
unfractionated in vivo primed lymph node cells (from the draining 
lymph nodes of mice exposed to antigen on the skin) to adoptively 
transfer contact sensitivity to naive recipients and .that the 
recipients actively generated contact sensitivity rather than 
passively received the condition. This was suggested by a necessary 
latent period of several days between receipt of cells and 
generation of contact sensitization. Also, the 'adopting' cells 
were insensitive to irradiation (2000r) (Asherson et al 1977) unlike 
T-lymphocytes [contrast is hours for passive T-cell transfer]. In 
addition, for successful adoptive transfer, there was a requirement 
for histocompatibility at the I-A locus, between donor and recipient 
(Asherson et al 1979).
Recent work using the contact sensitizing chemicals picryl chloride 
(PIC) and FITC have established that there are marked quantitative 
and qualitative changes in the dendritic cells isolated from such in 
vivo primed lymph node cells, when compared with dendritic cells 
from naive lymph node cells (Knight et al 1985a; Macatonia et al 
1986).
Firstly, it is apparent that within 24hrs of skin-painting, the 
number of dendritic cells recoverable from draining lymph nodes 
increases 4-5 fold for both PIC and FITC treatment (Kinnaird et al 
1989). Flow cytometric and microscopical analysis has established 
for FITC treated mice that antigen is preferentially located on the 
dendritic cell (Macatonia et al 1987) and significantly, that such
66
in vivo primed, dendritic cell-enriched populations confer antigen- 
specific contact sensitivity on syngeneic naive recipients after 
adoptive transfer (Macatonia et al 1986). This transfer was 
abrogated if dendritic cell-enriched populations were depleted of 
33D1+ lymphoid dendritic cells (Macatonia et al 1986; Nussenzweig et 
al 1982) confirming the role of lymphoid dendritic cells within 
primed lymph node cell populations as initiators of contact 
sensitization.
Hapten-bearing lymphoid dendritic cells, in vitro studies: 33D1+ 
dendritic cells stimulated resting T-lymphocytes
Lymphoid dendritic cell populations capable of adoptively 
transferring contact sensitivity have been shown to have marked 
stimulatory activity in lymphocyte cultures in vitro. Thus, under 
conditions where normal dendritic cells had no stimulatory activity 
for naive or antigen-sensitized syngeneic lymph node cells, 
dendritic cell-enriched preparations from mice sensitized with PIC, 
oxazolone (Knight et al 1985a) or FITC (Macatonia et al 1986) were 
able to induce both primary and secondary T-lymphocyte proliferative 
responses. The dendritic cell activity was highly efficient, with 
marked increases in ^H-TdR incorporation of T-lymphocytes when the 
dendritic cells constituted less than 17. of cells present.
These studies have demonstrated the highly immunogenic nature of in 
vivo primed 33D1+ dendritic cells, consistent with their role as the 
central antigen presenting cell during the induction of contact 
sensitization.
67
A summary of how CD4+ T-lymphocytes, Langerhans cells and 33D1+ 
dendritic cells are widely acknowledged to interact, during the 
induction of classical contact sensitivity is presented in the next 
section.
3.4.1 An overview of the cellular interactions involved during the 
induction of contact sensitization
Epidermal Langerhans cells, which may constitute immature lymphoid 
dendritic cells (chapter 1), selectively acquire hapten following 
epicutaneous exposure to contact sensitizing chemicals (Shelley and 
Juhlin 1976). Subsequently, Ia+ epidermal Langerhans cells are 
known to be activated (Kolde and Knop 1987; Gschnaif and Brenner 
1979) and triggered to migrate out of the epidermis (Aiba et al 
1984). It has not been conclusively shown whether hapten-bearing 
Langerhans cells could activate resting (naive) T-lymphocytes in the 
skin at this stage, although the possibility exists. Peripheral 
sensitization is thus a possibility.
It has, however, been demonstrated that hapten-bearing Langerhans 
cells and veiled cells appear in the afferent lymphatics draining 
the area of epicutaneous exposure (Silberberg-Sinakin et al 1976b): 
hapten-bearing cells within lymph nodes receiving this afferent flow 
of lymph have been shown to be 33D1+ lymphoid dendritic cells, as 
will be described in chapters 7 and 8.
This, in combination with the earlier studies by Schuler and 
Steinman suggesting that Langerhans cells mature to lymphoid
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dendritic cells, indicates that hapten-bearing Langerhans cells may 
mature into hapten-bearing dendritic cells during the migration from 
the epidermis to the lymph node.
Once within the node, dendritic cells readily migrate through the 
node (Kupiec-Weglinski et al 1988), where they localize in the 
paracortex and are identified microscopically as interdigitating 
cells (Fossum 1988; Breel et al 1988). These paracortical, 
interdigitating, dendritic cells form an extensive and intimate 
apposition with CD4+ T-lymphocytes prior to detectable lymphocyte 
activation and proliferation (Kamperdijk et al 1985).
The appearance of hapten-bearing dendritic cells in draining lymph 
nodes is detectable 12hrs following skin-painting (see chapter 7) 
and over the succeeding 2-3 days there are marked increases in T- 
lymphocyte activity within the lymph node, consistent with clonal 
expansion of hapten-specific T-lymphocytes. This may be considered 
the late stage of induction of contact sensitization, the induction 
being completed when the expanded T-population is disseminated 
throughout the host's lymphatic system. At 7 days following skin­
painting, the induction may be considered complete: certainly, as 
will be shown in chapter 6, the primary T-lymphocyte proliferative 
response has considerably reduced, compared with its peak at 3 days, 
consistent with the predominant hapten-specific CD4+ T-lymphocyte at 
this stage being a T-memory lymphocyte rather than a T-Lymphoblast.
At this stage, the sensitized mouse may host a secondary elicitation 
response. It is predicted that many of the same cells will be
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involved during the secondary or efferent phase of contact 
sensitization and for completeness I will summarise a putative 
mechanism as follows.
3.4.2 An overview of the efferent phase of contact sensitization
It is probable that secondary exposure to a hapten by a primed 
animal will result in the following:
a) the interaction of Ia+ epidermal Langerhans cells with hapten 
in the skin,
b) the activation of sensitized, hapten-specific T-lymphocytes 
by a variety of Ia+, hapten-bearing cells, including (but not 
necessarily exclusively) Langerhans cells and 33D1+ dendritic 
cells. This activation could occur either peripherally (in 
the skin) or centrally (in the nodes); while the former would 
be most likely, the latter cannot be discounted,
c) the secretion of a cocktail of lymphokines by activated 
hapten-specific T-lymphocytes at the site of hapten exposure 
(restricted to sites with hapten-bearing Ia+ cells), leading 
to
d) rapid invasion of the skin and local extravasculature by 
'inflammatory cells', leading to characteristic skin 
inflammation at 48hrs following secondary exposure.
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While idealised, these overviews of afferent and efferent 
sensitization constitute a working model with which I could compare 
and relate my experimental results. Thus, as will be described in 
chapter 4, the thrust of my research has been to measure the 
stimulatory activity of hapten-bearing cells (particularly dendritic 
cells) in vitro and to correlate changes in such stimulatory 
activity with changes in the efficiency of hapten presentation in 
the mouse. The model I have described is adequate for this. 
However, I am of the opinion that this model is simplistic. A 
number of studies purport to show this and I present below a resume 
of a considerable body of work which refine and indeed alter the 
standard or classical model for the induction of contact 
sensitization. While the scientific community seems reluctant to 
lend much c re d e n c e  to what I term the "Askenase model" for contact 
sensitization (in fact delayed type hypersensitivity in general), 
his data and conclusions are substantial and, at the least, provide 
explanations for how many of the cellular and histological events 
characteristic of contact sensitivity may occur. An examination of 
these studies will therefore form a useful addendum to this chapter.
3.5.1 Early and late phase inflammatory responses indicate that 
two, discrete T-lymphocytes are activated during the 
induction of contact sensitization.
A major event in primary sensitization is the generation of an 
expanded population of antigen-specific Lytl+ DTH effector cells 
(Tcs). Detailed examination of the inflammatory response following 
secondary chemical exposure on the skin of contact-sensitized mice
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or after primary exposure on the skin of naive mice which have 
received the Lytl+ T-lymphocyte fraction from sensitized donors has 
revealed that in addition to the characteristic 24hrs inflammation, 
there is an early or inraediate (2hr) inflammation (Van Loverem et 
al 1983). Analysis of this biphasic phenomenon, notably by P W 
Askenase and co-workers, has established that each of the two phases 
can be attributed to the activity of discrete T-lymphocyte subsets 
within the Lytl+ phenotype (Van Loverem et al 1984) and that these 
two subsets act sequentially during elicitation of contact 
sensitization (both presumably primed during the afferent phase).
The mechanistic distinction is based on evidence that the early 
(2hr) response is initiated by a hapten-specific, MHC-unres trie ted 
Lytl+ T-lymphocyte while the conventional late phase (24hr) is 
dependent on a hapten-specific, MHC-restricted Lytl+ T-lymphocyte 
(Herzog et al 1989). I would now like to consider the evidence in 
support of this sequentially acting T-lymphocyte.
Early phase Lytl+ T-lymphocytes
Antigen specific, MHC class II-unrestricted early Tes may be 
isolated from the lymph nodes and spleen within one day of 
sensitization (Van Loverem and Askenase 1984). It is proposed that 
such cells release an antigen-specific factor which circulates (Van 
Loverem et al 1986) and which may passively sensitize peripheral 
tissues, presumably by binding to a particular cell. The early 
phase (2hr) elicitation response may be adoptively transferred to 
naive recipient mice by either Lytl+ T-lymphocytes (phenotype
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described later) or Lytl+-T-cell-derived hapten binding factors (Van 
Loverem et al 1983), implicating the antigen specific factor as 
crucial in sensitization.
Studies on the nature of the antigen specific factor have indicated 
that while the factor may act like IgE, with the ability to 
sensitize mast cells (Meade et al 1988), the factor is
distinguishable by a number of immunological and biochemical 
criteria. Thus, unlike IgE, the factors are sensitive to reduction 
or alkylation, they fail to transfer elicitation of passive 
cutaneous anaphylaxis in rat skin and the factors are retained on an 
anti-T-cell factor column (Ptak et al 1982; Askenase et al 1982^ Van 
Loverem et al 1986). It seems likely that the 'early' inflammatory 
activity is mediated by release of an IgE-like, hapten-specific T- 
cell factor from the MHC-class II unrestricted Lytl+ T-lymphocyte. 
This cell and its secreted factor/s have been predicted to 
facilitate the generation of late or classical DTH secondary 
responses by 'preparing' sensitized mouse tissues for cellular 
infiltration. In particular, it is proposed that production of. 
hapten-specific factor during afferent sensitization leads to 
hapten-specific factor binding to mast cells. A secondary exposure 
to hapten at the localized site of epicutaneous application would 
interact with the specific factor - mast cell complexes, leading to 
local mast cell degranulation, release of vasoactive amines, 
particularly 5-hydroxy tryptamine (5HT) and thus increased 
vasopermeability at the site of hapten. Increased vasopermeability 
reflects 5KT-mediated gap formation between endothelial cells 
constituting the endothelium.
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Increased local vasopermeability in the epidermal area would enable 
the characteristic, late phase Lytl+ T-lymphocyte to enter tissues 
(from the circulation), through endothelial gaps (Askenase et al 
1980). This initial influx may account for the early or 2hr 
inflammation which is observed. Following this influx, the hapten- 
specific, MIC-res trie ted, Lytl+ T-lymphocytes may then interact with 
processed hapten in conjunction with la expressed on the surface of 
local antigen presenting cells, including Langerhans cells 
(Silberberg et al 1976a; Stingl et al 1978c) and possibly Ia+ 
kératinocytes. ») IFN gamma induces la on kératinocytes - Basham et al 
1984; 2) such kératinocytes suppress proliferation in T-cells - 
(Skoglund et al 1984; Barclay and Mason 1980; Scheynius and Tjemlond 
1984). Resultant activation of the classical Lytl+ T-lymphocytes 
could then generate classical lymphokine release (see chapter 2), 
leading to a chemo-attraction for non-specific, bone marrow-derived 
mononuclear leucocytes which mediate hapten clearance: such cells 
constitute the classical perivascular infiltrates which characterise 
the 48hr inflammation in DTH (Cohen et al 1967).
Arguably the most controversial point in this proposal is the role 
for mast cells during the afferent and efferent stages. While 
controversial, development of classical D1H histology has been shown 
to be influenced by (Roberts et al 1988) and indeed dependent on 5HT 
(Askenase et al 1980) and may be blocked by 5HT antagonists 
including ketanserin and ritanserin (Ameisen et al 1989). The 
principal producer of 5HT is degranulating mast cells and this fact, 
combined with reports that contact sensitivity fails to develop in 
the mast cell deficient mice strains W/Wv and SI/SId (Van Loverem
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et al 1983; Askenase et al 1983) implicate mast cells in contact 
sensitization. It is pertinent to state that this is controversial. 
A number of groups report that contact sensitivity may be induced in 
mast cell-deficient strains, with less than 5% of the normal mast 
cell complement (Mekori and Galli 1985; Tai-Ypu Ha et al 1986; 
Mekori and Chang 1987). It is unclear how many mast cells a mouse 
needs to host contact sensitivity, 5% could be sufficient. In 
addition, the mast cell deficiencies may only be significant if 
particular mast cell subsets are depleted (Jarrett and Haig 1984). 
Finally, while 5HT release may be critical, cells other than mast 
cells may produce it (Galli and Hammel 1984).
3.5.2 Phenotype of the early phase, factor-producing LytH- T- 
lymphocyte
The phenotype of this cell has been implied from studies which
examined elicitation of early (2hr) inflammation in athymie nude and
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severe combined immune deficient mice (SCID - Herzog et al 1989). 
The results of this work demonstrated that while nude mice failed to 
show the classical 48hr inflammatory elicitation response on 
challenge with hapten, the early (2hr) inflammation was apparent. 
SCID mice undergoing identical immunizing regimes hosted neither 
early or late inflammation. It has thus been claimed that the early 
T-lymphocyte is thymus independent and requires some genetic re­
arrangement for antigen recognition (SCID mice are recombinase 
deficient) - the cell is also unlikely to be a natural killer (NK) 
cell. A complex phenotyping protocol, using antibody-mediated 
complement lysis to deplete the early T-lymphocytes transferable
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activity (Herzog et al 1989) has demonstrated this cells indistinct 
origin. Its phenotype has been described as follows: Thyl+, Lytl+, 
LY-5+, IL-3R+, factor*-, CD4-, 0)8-, 0)3-, IL-2R-. Interestingly it 
does express IL-3R and hapten-specific factors. A mechanism for how 
such a cell may recognize antigen remains speculative.
3.5.3
0.
It is apparent from this that considerable effort is being made to 
elaborate on the 'current' model of contact sensitivity which I 
described in 3.4. The proposal that two distinct Lytl+ T-lymphocyte 
subsets act during the afferent phase of contact sensitization is 
not that surprising; what seems less acceptable is that these two 
cells produce OTH inflammation by the intermediate activity of mast 
cells, whose role in delayed type hypersensitivity generally, is a 
contested issue. Clearly much work needs to be done.
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The initial aim of this work was to consider the effect of changes 
in the cell surface expression of a) class II MHC-encoded antigens 
and b) hapten on antigen presenting cells and correlate this with 
changes in their stimulatory activity for T-lymphocytes in vitro. 
My colleagues at ICI offered considerable expertise and 
understanding in contact sensitivity which as I described in 
chapter 3 is a well established experimental model of cell- 
mediated immunity: thus, the starting point was to be the 
establishment of an in vitro assay for detecting the stimulatory 
activity of hapten bearing lymphoid cells.
The assay I chose to develop was based on and developed from the 
lymphoblast transformation assay. Thus, lymph node cells were 
prepared from mice sensitized with a contact sensitizing chemical 
(or at least cells passed through primary activation). These 
cells were cultured with various in vitro haptenated, killed cells 
and the increase in culture proliferation was attributed to 
hapten-driven stimulation in the sensitized responder lymph node 
cells. These studies are presented in chapter 6 and provide a 
solid background for understanding how in vitro haptenated cells 
stimulate lymphocyte proliferation in vitro. The results also 
demonstrated that as a model for antigen presentation, in vitro 
haptenated cells are not ideal. In fact, in vitro haptenated 
cells were shown to be unsatisfactory antigen presenting cells for 
this research, because they were almost certainly not the cell 
which actually presents antigen to T-lymphocytes. However, at 
this stage it became clear that in vivo haptenated dendritic 
cells, ie dendritic cells involved in hapten sensitization within
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the mouse (see chapter 1.3) were likely to have a marked 
stimulatory activity within my assay system and my work logically 
extended to consider hapten-presentation by dendritic cells.
Accordingly, I examined in detail the kinetics of dendritic cell 
appearance in the lymph node draining the site of skin painting 
and also analysed the hapten bearing nature of dendritic cells 
within such nodes by utilising the fluorochromic sensitizing 
chemical FITC and measuring the FITC-bearing nature of dendritic 
cells by fluorescence microscopy and predominantly fluorescent 
cell cytometry. These results are presented in chapter 7.
The stimulatory activity of these dendritic cells was measured 
within the proliferation assay, thus correlating the stimulatory 
activity with the hapten-bearing nature of the dendritic cells and 
these results are presented in chapter 8. These studies 
demonstrated that the stimulatory activity of the partially pure 
dendritic cell population was largely but not absolutely hapten- 
specific and a significant effort was made to establish why this 
was so. The results of these studies enabled me to define 
sensitizing conditions within the mouse leading to hapten- 
specific, dendritic cell-driven, proliferative responses in vitro.
Based on the significant amount of data supporting the role of 
lymphokines, including IFN gamma, as modulators of immune 
activity, I decided to analyse the ability of IFN gamma 
administered in vivo to modulate the dendritic cells role in 
afferent sensitization. My colleagues at Warwick University have
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a considerable and growing expertise in the preparation of IFN 
garrma and the elucidation of its immuno-modulatory properties both 
in vitro and in vivo. I therefore considered it pertinent and 
politic to consider how in vivo administered IFN gamma could 
modulate a) the appearance of hapten-bearing dendritic cells 
within lymph nodes draining the site of skin-painting with FITC 
and b) the stimulatory activity of such hapten-bearing dendritic 
cells within my proliferation assay. The results and conclusions 
from these studies are presented in chapter 9.
The materials and methods I utilised in the experimental work 
presented in this thesis are described in chapter 5.
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Materials
5.1.1 Medium; RPMI 1640 Growth Medium
Roswell Park Memorial Institute 1640 medium buffered with Hepes 
(RPMI) was obtained from Gibco Ltd either prepared or in 
preconstituted form. The later was reconstituted by Mrs B Wood 
(University of Warwick).
Foetal calf serum (FCS) was obtained from both Gibco Ltd and 
Northumbria Biologicals Ltd. Prior to use, FCS was heat treated 
for 45 minutes at 56°C in order to inactivate complement. 
Batches of FCS were routinely screened for their mitogenic 
properties in a s ta n d a rd  proliferation assay (see later). 
Routinely 500ml aliquots of medium were prepared. RPMI was 
supplemented with 10% heat-inactivated FCS (RPMI-FCS), glutamine 
(2mM) (Flow Laboratories Ltd), Penicillin (60ug/ml) and 
streptomycin (lOOug/ml) (Glaxo Laboratories Ltd).
FACS medium - as above but with 5% FCS and 0.1% sodium azide.
5.1.2 Mice
Male and female 5-8 week old (18-25g) BALB/c (H-2^) mice were 
obtained from breeding colonies within the Deptartment of 
Biological Sciences, University of Warwick (origin OLAC 
Bicester, Oxon) or the Animal Breeding Unit at Alderley Park, 
Imperial Chemical Industries.
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Within a given experiment all groups were matched in terms of 
size, age and sex, thus minimalizing variation. Group size was 
never less than 4 mice.
5.1.3 Contact Sensitizing Chemicals
2, 4-dinitrochlorobenzene (DNCB) and 4-ethoxymethylene-2- 
phenyloxazol-5-one (oxazolone) were obtained from Sigma Chemical 
Co and used as commercial preparations dissolved in 4:1 acetone 
olive oil (A00).
Fluoroscein isothiocyanate (FITC) and te tra  rh o d a m in e
isothiocyanate (TRITC) were obtained from Aldrich Chemical Co 
Ltd and were dissolved in 1:1 acetone/dibutyl phalate (BDH).
5.1.4 Interferons (IFN)
Murine and human interferon gamma (IFN gamma) were prepared in 
the laboratory at University of Warwick.
Initially, Chinese hamster ovary (CHO) cells were transfected 
with the mammalian expression vector pUSVIO containing a cDNA 
copy of the murine or human IFN gamma mRNA (Morris and Ward 
1987). The culture supernatants from these cell lines were then 
harvested and the IFN gamma content partially purified by 
affinity chromatography on cibricron blue sepharose (Sigma 
Chemical Co). Specific activity at this stage was about 
lO U^rag-1.
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These partially pure IFN gamma preparations were further 
purified by irnnunopurification (to approximately lO^Umg”  ^
specific activity).
5.1.5 IFN gamma Titration
a) IFN titres in each preparation were determined by the 
INAS5Q method (Atkins et al 1974) using Semliki Forest 
virus challenge of L9 2 9 cells- IFN was frozen in small 
aliquots at -70°C prior to use.
The IFN preparations had a relatively low specific 
activity with the major contaminant by protein gel 
analysis appearing to be BSA (bovine serum albumen; 
Darley, pers. comm.). The total protein concentration of 
those IFN preparations was determined utilising a 
Coomassie blue standard protein assay kit (Sigma Chemical 
Co) and was confirmed at lmgml“ .^ Control protein 
solutions were therefore adjusted to this level.
b) IFN preparations or relevant control solutions, were 
administered by intraperitoneal injection to mice 24hrs 
prior to receiving a sensitizing dose of chemical on the 
dorsum of both ears. The injection volume was routinely 
250-300ul, consisting of 60000 antiviral units of 
interferon activity.
5.1.6 Radiochemicals
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Me thy 1 - %1- 1  hymid ine (%-TdR; 2.5Ci/mmol) was obtained from 
Amersham International pic.
5.1.7 Buffered Solutions
Phosphate buffered saline (PBS; pH7.4 was prepared in bulk for 
laboratory use by Mrs B Wood (University of Warwick) or ICI CTL 
Alderley Park.
Warwick
137mM Sodium chloride 
2.7mM Potassium chloride
8mM Disodium hydrogen phosphate 
1.5mM Potassium dihydrogen phosphate
5.1.8 Other Materials
A23187, ionophore (Sigma)
Acetone (Fisons)
Aluminium Foil (Alcan Ltd)
Calibrite beads (Becton-Dickinson Ltd) 
Concanavalin A (Sigma)
Conical bottomed test tube (Cel-Cult) 
2,4-dinitrochlorobenzene (Sigma)
Disodium hydrogen phosphate (BDH)
Dissection scissors and microforceps (Harris) 
Emetine hydrochloride (Sigma)
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Eppendorf tubes (Sarstedt Ltd)
Ethanol (James Burroughs Ltd)
4-ethoxymethylene-2-phenyloxazol-5-one, oxazolone (Sigma) 
Filter paper analytical grade (Whatman Ltd)
Flow pore 0.45um filter sterilizing units (Flow Labs Ltd) 
Fluoroscein isothiocyanate, FITC (Aldrich Chem Co Ltd)
Glass fibre filter paper (Whatman)
Hypodermic syringes 21, 25 and 26% gauge (Sabre International) 
Lympholyte M (Cedarlane via Vector Labs)
Metrizamide [2-( 3-acetamido-5-N-me thy lace tamido-2-4-6- 
triodobenzamido)-2-deoxy-D-glucose], analytical grade 
(Nycomed, Nygaard)
Micropipette tips, 200ul (Costar and Sarstedt)
Micropore filters (Sartorius)
Micotitre 96 well trays round bottomed (Flow 
Laboratories Ltd and Costar)
Mitomycin C (Sigma) 
n-dibutyl phalate (BDH)
Olive oil, pure (Co-op)
Phorbol myristic acid (Sigma)
Plastic bijous and universals (Sterilin)
Plastic conical bottomed 10ml test tubes (Sterilin)
Plastic round bottomed 10ml test tubes (Cel-Cult)
Potassium dihydrogen phosphate (BDH)
Propidium iodide (Becton-Dickenson Ltd)
Scintillation fluid EP (Beckman)
Scintillation tubes, 6ml (LKB Pharmacia Ltd)
Silica (Sigma)
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Sodium chloride (May & Baker)
Stainless steel gauze, 200 mesh 
Syringes, 1, 2, 5, 10, 20ml (Sterilin)
Tetrarhodamine isothiocyanate, TRITC (Aldrich Chem Co Ltd) 
Tissue culture plastic dishes (5cm) (Falcon)
Trypan blue (Sigfna)
5.1.9 Names and Addresses of Suppliers 
Alcan Ltd, Banbury, Oxfordshire
Aldrich Chemical Co, The Old Brickyard, New Road, Gillingham, 
Dorset
Amersham International pic, Amersham Place, Little Chalfont, 
Amersham, Bucks
BDH Ltd, Fourways, Carlyon Industrial Estate, Atherstone, Warks. 
Beckman, Progress Road, Sands Industrial Estate, High Wycombe, 
Bucks
Becton-Dickinson, Between Towns Road, Cowley, Oxford 
Calibrite - see Becton-Dickinson
Cedarlane, Vector Laboratories Ltd, 16 Wulfric Square, Bretton, 
Peterborough
Cel-Cult, c/o G-Ward, Dept Biological Sciences, University of 
Warwick
Costar, 1 Alewife Centre, Cambridge
Coulter Electronics Ltd, Northwell Drive, Luton, Beds LU3 3RH 
Falcon - see Flow Laboratories
Fisons, Farenheit Laboratory Supplies, 47 Alston Road, Milton 
Keynes
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Flow Laboratories, Woodcock Hill, Harefield Road, Rickmansworth, 
Herts
Gibco Ltd, Trident House, P 0 Box 35, Paisley
Glaxo Laboratories Ltd, Greenford Road, Greenford, Essex
Harris Ltd, Lynn Lane, Shenstone, Staffs WS14 OEE
ICI, Hurdsfield Industrial Estate, Macclesfield, Cheshire
James Burroughs FAD Ltd, 70 Eastings Industrial Estate, Witham,
Essex
LKB Pharmacia, Midsummer Boulevard, Milton Keynes, Bucks 
May and Baker Ltd, Liverpool Road, Eccles, Manchester 
Microinstruments Ltd, Oxford
Northumbria Biologicals Ltd, Cramlington NE23 6BL 
Nycomed, P 0 Box 4284, Torshov, N-0401 Oslo 4, Norway 
Olac, Bicester, Oxfordshire
Sabre International Products Ltd, Manor Farm Road, Riding, 
Berks
Sarstedt Ltd, 6 8 Boston Road, Beaumont Leys, Leicestershire 
Sartorius Ltd, 18 Avenue Road, GB-Belmont, Surrey 
Sigma Chemical Co, Fancy Road, Poole, Dorset 
Sterilin Ltd, Hounslow, Middlesex
Whatman Ltd, Unit 1, Coldred Road, Parkwood, Maidstone
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Methods
All mice used were maintained in established animal rooms , in 
group sizes of typically six, with free access to pelleted food 
and water. The animal rooms had controlled temperature and 
fixed day length (electronically controlled).
At the commencement of an experiment I would select matched 
groups of fully acclimatized mice, between 6 - 8  weeks old.
5.2.1 Cutaneous Sensitization (or 'ear-painting') of Mice
25ul of the relevant concentration of the test chemical was 
applied to the dorsum of both ears of all mice in the 
appropriate group. A Gilson pipette was used for this 
procedure.
Mice were then maintained in the standard animal room conditions 
until the designated time period (routinely 18hrs or 7 days) had 
elapsed.
5.2.2 Isolation of Auricular Lymph Nodes
Mice were sacrificed by cervical dislocation (Warwick) or by an 
excess of Halothane followed by cervical dislocation (ICI). The 
dead mice were then laid on their dorsal side, skin washed in 
Savlon and a ventral incision made under the skin along the 
midline from the sternum to the tip of the lower jaw. The skin
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was then 'peeled' back, and the auricular lymph node is observed 
in a position ventral to the base of the ear. Using a fine pair 
of dissecting forceps, the auricular node was freed of a fine 
'encapsulating' membrane and gently teased from the mouse body. 
All auricular lymph nodes from mice of a particular group (two 
per mouse) were placed in PBS in a 5ml Bijoux.
NB All these procedures were performed on an open bench which 
had recently been washed in 70% alcohol and Savlon concentrate. 
All dissecting implements were carefully sterilised prior to use 
and strict aseptic technique was used throughout.
5.2.3 Determining lymph node weight
For experiments described in Chapter 9 it was necessary to 
determine lymph node weight. For such experiments, lymph nodes 
were isolated as above but placed on a small piece of aluminium 
foil rather than in PBS. The 'pool' of lymph nodes for a 
particular group were then weighed on the foil using an 
accurate, pan balance. The lymph nodes were then retained in 
PBS prior to disaggregation and cellular analysis, and the foil 
alone weighed. Thus, a value for total lymph node weight and 
mean weight per node were determined.
NB Cells derived from nodes treated in this fashion were deemed 
to not be sterile and thus were not used in culture.
5.2.4 Preparation of Single Cell Suspensions
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A single cell suspension of lymph node cells for each group was 
obtained by pouring the pooled lymph nodes onto a sterile, 2 0 0- 
mesh stainless steel gauze. A few ml of medium was added and 
gentle pressure applied to the nodes by using a plunger from a 
sterile 5ml syringe. Disaggregation proceeded until the nodes 
(save membranes) had completely broken down.
Wash - the cell suspension was then harvested, adjusted to 10ml 
in fresh median, spun (2',600g) and resuspended in RPMI-FCS.
5.2.5 Isolation of Mouse Spleens/Peripheral Blood and 
Purification of Erythrocytes from Both
Naive mice, usually CBA (H-2k) or C3H-He(H-2k) were sacrificed 
and incision points swabbed in Savlon.
Spleens - sterile technique throughout
Mice were placed on their right side and a lateral incision made 
in the skin on their left, half way up the body cavity. The 
dark, shaped spleen was apparent under the peritoneal membrane. 
This membrane was cut and the spleen gently teased from its 
attachments to the alimentary canal. Spleens so removed were 
retained in PBS.
Disaggregation was performed as described earlier for lymph node 
cells and the splenocyte/erythrocyte suspension adjusted to 1 x 
107 cells ml- 1  in RPMI-FCS.
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Cardiac Puncture - sterile technique throughout
Sacrificed, swabbed mice were laid ventral side up. Skin 
covering the thoracic cavity was cut and peeled away. Gripping 
the xiphoid cartilage at the posterior end of the rib cage, the 
rib cage was cut away, revealing the heart. A 26g hypodermic 
needle was pushed into the heart and blood collected in a 5ml 
syringe. The blood was retained in an Alsevers solution and 
adjusted to 1 x 10^ cells ml"^, yield < 0.3ml per mouse.
Both suspensions (splenocytes and cardiac blood) were 
fractionated into erythrocytes and lymphocytes by separation on 
Lympholyte-M density separation medium.
Briefly, 5ml of Lympholyte-M (at room temperature) was placed in 
a 30ml universal. 10ml of cell suspension was carefully layered 
onto this layer. Centrifugation then proceeded for 20' at 500g 
(room temperature). Deceleration was unbraked.
A well defined lymphocyte layer was apparent at the interphase, 
with erythrocytes in the pellet. Each fraction was carefully 
collected with a Pasteur pipette, washed, and resuspended in 
RPMI-PCS, ready for use.
5.2.6 Cell Enumeration - using Lablynx laboratory microscope
lOul of the single cell suspension was mixed with lOul of 
filtered 0.5% Trypan blue. A few ul was then added to a Neubaer
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counting chamber and the cells ml“* determined by counting at 
least 200 cells. Cell viability by Trypan blue exclusion was 
routinely >95%.
Cells ml" 1  “ cells counted in 25 squares x 2 (dilution) x 10^
Lymph node cell suspensions were routinely adjusted to 5 x 10^ 
cells ml" 1  in RPMI-FCS.
5.2.7 Density Gradient Centrifugation on Metrizamide
Stock solutions of 14.5% Metrizamide (analytical grade; Nygaard, 
Oslo) were made up in RPMI-FCS, filter sterilized and frozen 
down to -20°C in 5 and 10ml aliquots.
Lymph node cells were adjusted to 5 x 10^ cells ml" 1 in RPMI-FCS 
and 9ml of the suspension added to a 10ml conical-bottomed test 
tube (Cel-Cult). The cell suspension was gently underlayered 
with 1ml of the 14.5% Metrizamide solution and centrifuged for 
14' (600g) at room temperature in an MSE 6LB. Deceleration was 
unbraked.
a) A faint band of cells at the Metrizamide-mediun junction, 
called the interphase cells, were collected using a 
Pasteur pipette.
b) After interphase removal, the pelleted cells were also 
obtained using a Pasteur pipette.
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Each fraction was then resuspended in fresh medium, washed once
and then resuspended in a small volume (2 0 0ul) prior to
enumeration, FACS analysis or culture. F or p h e n o ty p ic  stu dy see 
legend 7*1-1.
Each fraction was enumerated as described above.
5.2.8 In vitro Haptenation of Cells
Single cell suspensions of unfractionated lymph node cells were 
adjusted to a concentration of 106 cells ml- 1  in PBS. The cells 
were then incubated for 25min at 37°C with either DNFB (at a 
final concentration of either 0.5, 1.5 or 4.5mM) or FITC (at a 
final concentration of 12ugml_1). Hapten coated cells were 
washed twice with an excess of PBS and then washed and 
resuspended in RPMI-FCS.
5.2.9 Irradiation, Mitomycin C and Emetine Hydrochloride 
Treatment
On occasion (primarily in the experiments described in Chapter 
6 ) it was necessary to kill cells designated as stimulator 
cells.
Cells were adjusted to 1 x 106 cells ml- 1  in PBS and either a) 
irradiated by exposure to a gamma-emitting caesium source (8 ', 
1500Rad) or b) cultured at 37°C/30' with either mitomycin C (at 
a final concentration of 25ugml_1) or emetine hydrochloride (at 
a final concentration of 10“^M).
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Cells receiving any of these treatments were thoroughly washed 
in four changes of excess PBS and resuspended in RPMI-FCS (note 
that FCS inactivates mitomycin C).
5.2.10 Lymphocyte Proliferation Assay
Responder lymph node cells
Untreated mice or mice which had been painted on the dorsum of 
both ears 7 days previously with the relevant chemical were 
sacrificed and the draining auricular lymph nodes excised: 
single cell suspension were prepared as above. These responder 
lymph node cell fractions were then adjusted to 5 x 1 0 6 cells 
ml“ 1 in RPMI-FCS.
Stimulator Cells
Either in vitro haptenated, killed cells or Metrizamide 
fractionated, sensitized lymph node cells were prepared as 
described previously and adjusted to appropriate density in 
RPMI-FCS.
Culture
Responder lymph node cells (lOOul @ 5 x 106 cells ml“1) were 
added to 96-well mic^titre plates. The volume was then made up 
to 200ul with either 1) RPMI-FCS or 2) stimulator cell 
suspension or 3) RPMI-FCS supplemented with the mitogen
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Concanavalin A (giving 5ugml- 1  final concentration) or 
A23187/IPA. Typically, in a well, lOOul responders @ 5 x 10^ 
cells ml“* - 5 x 10^ responders + 30ul stimulators @ 4.5 x 10^ 
cells ml"* “ 13.5 x lCp stimulators + 70ul medium. The
responder to stimulator cell ratio is denoted in each experiment 
but note that the final responder lymph node cell concentration 
was always 2.5 x It)** cells ml"*.
All plates were cultured for 48hrs in a humidified atmosphere of 
5%CC>2 in air at 37°C.
Sixteen hours prior to culture termination 2uCi of %-methyl 
thymidine (specific activity 2.5 Ci nme 1 ) was added to all 
wells.
Culture was terminated by automatic cell harvest (MASH 2)and the 
%-TdR incorporation determined per well by beta-scintillation 
counting. Briefly, the cellular DNA-incorpora ted %-TdR in each 
well was retained on a glass fibre paper disc. Each disc was 
then placed in a scintillation vial, 3ml of scintillation fluid 
(Beckman EP) added, capped, shaken and counted, using an LKB 
scintillation counter.
The counts for each replicate well were then examined and mean 
count per minute calculated for each treatment group.
Silica supplemented culture conditions
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In a few experiments silica was used in the culture (Chapter 6 ). 
These experiments were performed exactly as described, except 
that 2 0ul of autoclaved silica (@ 2mgml“^) giving a final 
concentration of 2 0 0ugml“* was added to the cultures.
5.3.1 Flow cytometric analysis of cell populations
Whole lymph node cell suspensions or dendritic cell-enriched 
(Métrizamide interphase) or dendritic cell-depleted (Metrizamide 
pellet) populations derived from the draining auricular lymph 
nodes of mice exposed to a variety of sensitizing chemicals, 
including the fluorescent hapten FITC were analysed at Warwick 
using a FACStar flow cytometer (Becton-Dickinson) and at ICI 
using an EPICS V flow cytometer (Coulter Electronics). For 
precise operating details the reader is referred to the relevant 
operation manuals.
In brief, flow cytometric analysis (on both machines) may be 
divided into three phases:
(1) Calibration and gating for viable cells
(2) Sample runs and data storage
(3) Data analysis
a) Following start up, a solution of uniformly spherical,
fluorescent labelled latex beads (Calibrite) were run 
through the cytometer, as the sample stream. By 
adjusting a) the amplification of the signal detectors,
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b) the voltage across the signal detecting
photomultiplier tubes and c) the alignment between the 
laser beam (excitation wavelength 488nm) and the stream 
of beads, the output signals for bead forward scatter 
(approximating to size), bead side scatter (granularity) 
and emitted green/red fluorescence were optimized. Beads 
were then flushed from the sample stream by excess PBS.
A sample of unfractionated lymph node cells, "spiked" with 
5ugml“l propidium iodide was run through the cytometer sample 
stream. A familiar forward scatter v cell frequency 
distribution was usually apparent, with the bulk of cells 
centrally positioned on the forward scatter axis. A small peak 
of cells to the left of this distribution were routinely shown 
to stain highly with propidium iodide, indicating these cells 
were dead. It is and was standard practice therefore to 'gate- 
out' those cells and I routinely set a threshold value on the 
forward scatter axis such that these cells were not detected by 
the cytometer.
The cytometer was now calibrated and appropriate gates set, 
ready for sample analysis.
b) A sample for analysis was loaded at the sample port and 
run through the cytometer with the computer automatically 
storing each of the four data points forward scatter(FSC 
or FALS), side scatter (SSC), green fluorescence (FL1) 
and red fluorescence (FL2) for each cell (event)
98
detected. Routinely, 50 x 1(P cells were examined for 
each sample. The sample was unloaded, the system flushed 
with PBS and the new sample loaded etc.
c) The FACS tar offers a comprehensive software package for 
data analysis. A nunber of options were utilised in 
these studies:
i) Standard single parameter histograms of cell frequency (y 
axis) against either forward scatter (x axis) or log 
green fluorescence intensity (x axis).
ii) Dual parameter analysis (or contour profiles) which 
presents forward scatter (x axis) against log green 
fluorescence intensity (y axis) against cell frequency 
(density of contours).
This option constitutes a '3D pic totalisation' of a cell
population.
iii) Quadrant analysis consists of superimposing a grid onto a 
contour profile, enabling the dissection of a population 
of cells into four sub-populations. The supporting 
statistical package enables the quantitative description 
of changes within each of the four phenotypes. 
Routinely, I used this option to characterise dendritic 
cells (high FALS) from lymphocytes (low FALS) and FITC
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hapten-bearing cells (high green fluorescence intensity) 
from low or nil fluorescent cells.
5.3.2 Photography
Cell suspensions were loaded onto a Neubaer counting chamber and 
examined using a Nikon UFXII microscope (Optiphot) with an 
attached Nikon 35nm SLR. Exposure duration was regulated using 
a Nikon UFXIIA Light Box (Microinstruments Ltd). I routinely 
used Kodak ectachrome 160 tungsten film, with a 5-6 minute 
exposure when photographing fluorescent dendritic cells.
5.4.1 Enhancement of Proliferation Ratio
In text and legend I routinely quote a stimulation index or 
increase in enhancement of proliferation. The stimulation index 
is derived as follows:
mean %-TdR incorporation of activated lymph node
_________cells cultured with stimulators__________
mean ^H-TdR incorporation of activated lymph node 
cells cultured alone
This ratio enables the stimulatory activity of stimulator cells 
for different responder populations to be compared irrespective 
of the responder cells background proliferation.
5.4.2 Students T-Test
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t - X - Y  Where X  and 7 are the mean values of
populations X and Y, and riy are the 
nunber of samples in populations X 
and Y.
S2 is calculated thus
S2 - 1_____  (variance X + variance Y)
°x + "y“2
Populations X and Y were deemed significantly different if 
tcalculated > ttabulated at p<0.05 (using + riy-2 degrees of 
freedom).
5.4.3 F-statistic Calculation
For a detailed review of the F-statistic I refer the reader to 
Parker 1983, which also describes the calculation of F. In 
brief the F-statistic enables a determination of whether there 
is a greater variation in sample results or treatment results. 
This indicates, in a large experiment with many replicates 
within a treatment and many treatments, whether treatment 
variation exceeds replicate variation.
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(HAFTER 6
The proliferative response of sensitized auricular lymph 
node cells during culture with in vitro haptenated cells
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6.1.1 Introduction
The initial aim of my studies was to consider the antigen 
presenting cell capacity of in vitro haptenated cells in 
culture. Specifically I intended to consider the role of 
nominal antigen (hapten) and MHC-encoded proteins in the 
generation of an immuno-stimulatory antigen presenting cell 
complex by in vitro haptenated cells.
A proliferation assay was developed, in which lymph node cells 
from mice painted on the ears 7 days previously with skin 
sensitizing chemicals (haptens) were utilised as an indicator or 
responder population. As described in the general introduction 
(chapter3), there is considerable evidence supporting the 
proposal that after topical exposure of mice to haptens, there 
is an intense cellular activity within the skin and associated 
lymphatic tissue directed at the hapten. Such cellular 
activation, as assessed by the proliferative activity of lymph 
node cells in vitro, after isolation from the draining 
(auricular) lymph nodes of mice painted on the ears previously 
with hapten, is described in this chapter.
More significantly, and reflecting on the hapten-sensitized 
nature of in vivo activated lymph node cells, the majority of 
data in this chapter considers the response of activated lymph 
node cells during culture with stimulator cells which have been 
coated with hapten in vitro. The stimulator cells were also 
treated with either gamma-irradiation or metabolic toxins and
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thus had no intrinsic proliferative activity. Therefore, any 
increase in %-TdR incorporation within the culture was 
interpreted as an increase in proliferation within the responder 
lymph node cell population.
The results clearly demonstrated that in vitro haptenated cells 
were stimulatory for activated lymph node cells in a hapten- 
specific manner. However, additional work demonstrated that in 
vitro haptenated erythrocytes, incapable of being time antigen 
presenting cells, because of their lack of expression of MHC- 
encoded proteins (Lanzavecchia and Staerz 1987) also stimulated 
enhanced proliferation by activated lymph node cells. This 
suggested that in vitro haptenated stimulator cells acted merely 
as a source of hapten rather than as a genuine antigen 
presenting cell. I did not utilise allogeneic lymph node cells 
because of the unwanted complication of allo-proliferative 
responses.
My results implicated the activity of phagocytic cells within 
the activated, responder lymph node cells as necessary if any 
stimulation within these responders was to follow addition of in 
vitro haptenated cells. Such 'endogenous antigen presenting 
cells' presumably processed in vitro haptenated cells and in 
addition presented the resulting antigen to responding 
lymphocytes.
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The results do implicate a silica-sensitive, phagocytic cell as 
important in the process whereby in vitro haptenated cells 
stimulate enhanced proliferation by activated lymph node cells.
Attempts were made to fractionate activated lymph node cells 
into hapten-responsive and hapten-presenting cells. While these 
experiments were unsuccessful, I did demonstrate that the hapten 
responsive component of activated lymph node cells was enriched 
within the cells of low buoyant density.
The inability to fractionate hapten-responsive from hapten- 
presenting cells, together with a number of publications 
demonstrating that in vivo haptenated lymphoid dendritic cells 
were a highly efficient antigen presenting cell in vitro (and in 
vivo; Macatonia et al 1986 & 1987) suggested that the dendritic 
cell would be a better subject for my studies and accordingly, 
lymphoid dendritic cells were examined for the majority of the 
further studies presented in this thesis.
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Results
6.1.2 The induction of increased proliferation within draining 
lymph node cells following cutaneous sensitization
In this section, the proliferative activity of single cell 
suspensions isolated from the auricular lymph nodes of mice 
exposed on the ear to contact sensitizing or non-sensitizing 
chemicals is described. The proliferation was measured in the 
absence of any in vitro stimulation and so reflects 
proliferation induced by sensitization in vivo.
As can be seen in figure 6.1.1 the proliferative activities 
within single cell suspensions prepared from mice exposed 4d 
previously to the sensitizing chemicals 2.5% DNCB in A00 or 2.5% 
FITC in dibutylphalate: acetone were markedly enhanced when 
compared with the low levels of proliferation detected for lymph 
node cells isolated from mice treated with the vehicles alone. 
(Proliferation enhanced by x4.3 and x9.7 respectively.) It has 
previously been established in this laboratory and by others 
that DNCB and FITC are contact sensitizing chemicals and 
significantly, that this marked enhancement of primary 
proliferative activity correlated with the sensitization 
potential (Kimber and Weisenberger 1989). The proliferative 
activity of lymph node cells from vehicle-alone treated mice did 
not differ significantly from that seen for naive mice.
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FIGURE 6.1.1
Lymph Node Cell Proliferation Four Days Following Exposure to 
Contact Allergens
Draining lymph node cells were prepared from groups of five mice 
painted on both ears 4 days previously with 25ul of either a) 
2.5% DNCB in A00, b) ADO, c) 2.5% FITC in n-butylphalate: 
acetone (nbp;A) or d) n-butylphalate: acetone (nbp:A). Cells 
from each group were cultured under standard culture conditions 
at 5 x 105 cells per well for 48hrs (pulsed with %-TdR at 
30hrs). Results are shown as the mean %-TdR incorporation +/- 
SD x 10”^ for 4-6 replicate wells per group.
** denotes significant statistical difference from paired
control (*), at p< 0 05.
A time course for the induction of proliferation in lymph node 
cells at increasing times after ear painting (figure 6 .1 .2 ) 
demonstrated that proliferation increased over the first 2 - 3  
days, peaked at 3-4 days and returned to control levels by 8 
days. A similar pattern had previously been reported in this 
laboratory (Kimber et al 1987a.).
These preliminary studies also demonstrated that the induction 
of proliferation in the draining lymph node cells following ear 
painting was a local phenomenon, at least for lymph node cells 
prepared up to 8 days after sensitization. Thus, lymph node 
cells isolated from the left lymph nodes of mice painted 8 days 
previously with 2.5% DNCB on the left ear only, showed a 
characteristic, large increase in proliferation when compared to 
lymph node cells from the right lymph node of the same mice 
(data not shown). The proliferative activity of the right lymph 
node cell pool did not differ significantly from that seen for 
lymph node cells from untreated mice.
6.1.3 Variation in cellular proliferation between different 
laboratories
The organisation of the research presented in this thesis 
involved work at two laboratories. It was noted that the level 
of proliferation measured in lymph node cells from mice 
receiving the same treatment at different laboratories was not 
identical. In table 6.1.1, it is clear that the proliferative 
activity of lymph node cells from mice exposed 7 days previously
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FIGURE 6.1.2
The Kinetics of Lymph Node Cell Proliferation induced by 2.5Z DNCB
Seven groups of four mice were painted on both ears with 25ul of 
2.57. DNCB at various times prior to assay. Auricular lymph node 
cells were then prepared for each group and cultured under 
standard conditions at 5 x 10^ cells per well for 48hrs, (pulsed 
with ^H-TdR at 30hrs into culture). The results are shown as 
mean cpm +/- sd x 10“ ^ for 4-6 replicate wells per group. Seven 
time points (groups) were utilised.
to 2.5% DNCB was generally lower for the ICI BALB/c colony and 
laboratory conditions (average 2.5 x 10^ cpm) compared with the 
Warwick colony and conditions (average 5.5 x 10^ cpm).
In subsequent experiments documented in this thesis, it should 
be noted that hapten-sensitized lymph node cells were used as 
responder populations, and were routinely isolated from the 
lymph nodes of mice painted on the ears 7-8 days previously with 
contact sensitizing chemical. Such lymph node cells will 
therefore have passed through their peak proliferative activity 
(3-4 days for 2.5% DNCB sensitization) and in culture 
proliferate at a level only slightly higher than naive lymph 
node cells. At ICI this level was 2-3 x 1(P cpm per 5 x 10^ 
lymph node cells/well, at Warwick, 5-6 x 10^ cpm per 5 x 10^ 
lymph node cells per well.
6.2.1 The induction of enhanced proliferation in hapten- 
sensitized lymph node cells by in vitro haptenated cells
In this section, the stimulatory activity of cells modified with 
hapten in vitro was assessed within an antigen-presentation (or 
proliferation) assay.
Hapten sensitized lymph node cells from mice painted on the ears 
7 days previously with hapten (designated responder lymph node 
cells) are cultured in the presence of stimulator cells which 
have been coated with hapten in vitro and treated with either g- 
irradiation or metabolic toxins to prevent their proliferation.
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TABLE 6.1.1
Laboratory Variation in Lymah Node Cell Proliferation
LYMPHOCYTE PROLIFERATION 3
3 H - T d R  i n c o r p o r a t i o n ,  m e a n  c p m x  1 0
7 d a y s  p r e v io u s ly  w ith  2 .5 %  D N C B .
V a r ia t io n  b e t w e e n  B a lb / c  c o lo n ie s :
3-3 50
3 7 3-2
74 3-4
1 0 0 4-6
89 1-3
60 32
I O O
43
0 - 9
1*23-7
0 - 9
1-9
25
2-5 3-6
5-2 1-22-8 1-9
2-2 43
9-6 1-5
3-5 1-4
1 0 0 1 0
5-5 ± 3-1 2-5±1-4
p  < 0  0 5
Auricular lymph node cells from groups of four mice painted 7 
days previously with 2.5% DNCB in A00 were prepared on numerous 
occasions at either Dept. Biological Sciences, University of 
Warwick or CTL, Alder ley Park, ICI. Standard culture conditions 
were used (as described in chapter 5) at both sites. The mean 
cpm x lO“^ for 5 x i()5 cells per well at Warwick and ICI are 
recorded.
While not correct in a strictly statistical sense, the average 
Warwick and average ICI values are quoted, together with a t- 
test calculation performed between these average values.
This is significant because in later experiments responder and 
stimulator cell combinations from MiC-mismatched mice are used, 
leaving scope for possible allogeneic mixed lymphocyte 
reactions. The enhancement of %-TdR incorporation is 
interpreted as an increase in proliferation within the responder 
lymph node cell population.
It was established within both syngeneic BALB/c and CBA systems 
that either splenocytes (figure 6 .2 .1 a) or lymph node cells 
(figure 6.2.1b) haptenated with 1.5mM DNFB in vitro, could 
stimulate enhanced proliferation (x2.6 and x4.0 respectively) 
within responder lymph node cells isolated from the draining 
lymph nodes of mice pointed on the ear 7 days previously with 
2.5% DNCB.
It was also observed that the control, PBS-treated stimulator 
cells, failed to cause any enhancement of proliferation in the 
responder lymph node cells. Responder lymph node cells cultured 
with T-lympnocyte mitogen Concanavalin A (ConA), showed markedly 
higher levels of proliferation (data not shown).
6.2.2 The hapten-specificitv of stimulation
It was established that naive lymph node cells, irradiated and 
haptenated in vitro with l»5mM DNFB stimulated DNCB-sensitized 
responder lymph node cells to proliferate (x2.4) while 
unhaptenated stimulator cells (data not shown) or FITC- 
haptenated stimulator cells were not stimulatory (figure 6 .2 .2 ).
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Figure Legend 6.2.1
Responder Lymph Node Cells
5 x 105 auricular lymph node cells were isolated from BALB/c 
mice painted 7 days previously on both ears with 25ul of 2.5% 
DNCB in AOO and cultured under standard conditions, either alone 
or in the presence of 1.5 x 10^ stimulator cells. Therefore, 
the responder cell:stimulator cell ratio 3.3:1.
Stimulator Cells
Splenocytes (a) or auricular lymph node cells (b) were prepared 
from mice painted 7 days previously on both ears with 25ul of 
2.5% DNCB in AOO. Each population was divided, and treated in 
vitro with PBS (mock haptenation) or 1.5mM DNFB (haptenation), 
as described in chapter 5.
All stimulator populations were thoroughly washed in PBS and 
treated with an antiproliferative dose of gamma irradiation (Cs 
source, 2000R), prior to culture with the responder lymph node 
cells.
Data
Results are displayed as the mean ^H-TdR incorporation +/- SD x 
10”^ for 4-6 replicate wells per group.
** denotes significant statistical difference from paired 
control (*).
FIGURE 6.2.1
The Stimulation of Proliferation by DNCB-sensitized Auricular 
Lymph Node Cells During Culture With Either a) DNFB-haptenated 
Syngeneic Splenocytes or b) DNFB-haptenated Syngeneic Lymph Node
Cells
N o  r e s p o n d e r s  R e s p o n d e r  c e l l s  f r o m  
m ic e  t r e a t e d  w i t h  
2 .5 %  D N C B
N o  r e s p o n d e r s  R e s p o n d e r  c e l l s  f r o m  
m ic e  t r e a t e d  w i t h  
2 .5 %  D N C B
FIGURE 6.2.2
The Stimulation of DNCB or FTTC-sensitized Auricular Lymph Node 
Cells by Culturing With DNFB or FTTC-haptenated Syngeneic 
Auricular Lymph Node Cells
Responder Lymph Node Cells
As described in figure legend 6.2.1 except that BALB/c mice were 
painted 7 days previously with either 5% FITC in nbp:A or 2.5% 
DNCB in A00.
Stimulator Cells
As described in figure legend 6.2.1 except that in vitro 
haptenation was with either a) 1.5mM DNFB or b) 120 ugml“  ^FITC. 
All other procedures, responder cell:stimulator cell ratio and 
the format of data were as described for previous figure.
** denotes significant statistical difference from paired
control (*).
The opposite was observed for FITC-sensitized responder lymph 
node cells, for which FITC-haptenated (x2.6) but not DNFB- 
haptenated cells, were stimulatory.
(NB - low levels of proliferation characteristic of ICI 
experiments.)
6.2.3 The effect of in vitro haptenation concentration on the 
proliferative response
The stimulatory activity of DNFB-haptenated lymph node cells was 
shown to depend on the concentration of DNFB within the 
haptenating solution (figure 6.2.3). In vitro haptenation of 
lymph node cells with 1.5mM DNFB conferred optimal stimulatory 
activity, with x5.2 enhancement of proliferation in DNCB- 
sensitized responder lymph node cells at a responder cell: 
stimulator cell ratio of 4:1. At this same ratio, lymph node 
cells haptenated at higher (4.5mM) and lower (0.5mM) DNFB 
concentrations caused a reduced although still statistically 
significant enhancement of proliferation (x 2.8 and x2.4 
respectively).
6.2.4 The dependency of in vitro stimulation on MHC-expression 
on stimulator cells
Experiments were carried out to assess whether the stimulation 
of responder lymph node cell proliferation by in vitro
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FIGURE 6.2.3
The Dependence of the Stimulatory Activity of In Vitro DHFB 
Haptenated Syngeneic Auricular Lymah Node Cells on the Haptenating
Concentration of DNFB
N o  r e s p o n d e r s  R e s p o n d e r  c e l l s  f r o m  
m ic e  t r e a t e d  w i t h  
2 .5 %  D N C B
Responder Lymph Node Cells - as described in figure legend
6.2.1.
Stiinulator Cells - as described in figure legend 6.2.2 except 
that in vitro haptenation was performed with a) PBS (mock), b) 
0.5mM DNFB, c) 1.5mM DNFB and d) 4.5mM DNFB.
All other procedures and the responder cell:stimulator cell 
ratio were as described for the previous figure.
** denotes significant statistical difference from paired
control (*).
haptenated cells was dependent on the expression of MHC-encoded 
antigens on the surface of haptenated stimulator cells.
To this end, erythrocytes were isolated from allogeneic mice. 
Such a population did not express class I or class II MHC- 
encoded antigens (Lanzavecchia and Staerz 1987) and any 
contaminating lymphocytes would be MHC-incompatible with the 
responder lymph node cells. The rationale was that if
haptenated erythrocytes stimulated enhanced responder lymph node 
cell proliferation then this proliferation was not due to direct 
presentation of hapten by the erythrocytes, which lack MHC- 
encoded antigens.
Such allogeneic erythrocytes, haptenated in vitro with 1.5mM 
DNFB were stimulatory for DNCB-sensitized lymph node cell 
responders (figure 6.2.4) and this stimulatory activity 
increased as the ratio of stimulators to responders increased. 
It was significant that for all responder cell: stimulator cell 
ratios tested, the control, untreated erythrocytes, failed to 
stimulate responder proliferation, so discounting any mixed 
lymphocyte type reactivity within my cultures.
6.2.5 In vitro haptenation concentration and the stimulatory 
activity of erythrocytes
The stimulatory activity of DNFB-haptenated erythrocytes was 
shown to depend on the haptenating concentration of DNFB (figure 
6.2.5). Thus, erythrocytes haptenated at 0.15mM, 0.27mM and
Figure Legend 6.2.4
Responder Lymph Node Cells - as described in figure legend
6 . 2. 1.
Stimulator Cells
Allogeneic (CBA strain) erythrocytes were enriched from cardiac 
blood and haptenated in vitro with either 1.5mM DNFB or PBS 
(mock).
After thorough washing in PBS, haptenated erythrocytes were 
cultured with responder lymph node cells at increasing 
concentrations of erythrocytes, ranging from 5 x 10^ responder 
lymph node cells:5 x 10^ erythrocytes (10:1) to 5 x 10^ 
responder lymph node cells:1 x 10^ erythrocytes (1:20).
Data
Results are displayed in graph form, demonstrating mean %-TdR 
incorporation +/- SD x 10“^ for 4-6 replicate wells per group. 
Four groups (or titres of erythrocytes) were used.
FIGURE 6.2.4
Hie Dependence of the Stimulatory Activity of In Vitro DNFB- 
haptenated Allogeneic Erythrocytes on the Nimber of Haptenated 
Erythrocytes Added to Culture
M ean c p m i sd x10-3 
3 H -T d R  incorporation.
Number of e rythrocytes added per
FIGURE 6.2.5
The Dependence of the Stimulatory Activity of In Vitro DNFB- 
haptenated Allogeneic Erythrocytes on Hapten Concentration
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Responder Lymph Node Cells - as described in figure legend
6.2.1.
Stimulator Cells
Allogeneic erythrocytes were used as described in figure legend 
6.2.4 except that erythrocytes were haptenated with a) PBS 
(mock), b) 1.5mM DNFB, c) 0.27n*1 DNFB and 0.15n*1 DNFB.
A responder cell:stimulator cell ratio of 1:10 was used.
Data
The results are displayed as described earlier.
** denotes significant statistical difference from paired
control (*).
1.5mM DNFB showed increasing stimulatory activity at a fixed 
responder cell: stimulator cell ratio of 1:10. The enhancement 
of responder DNCB-sensitized lymph node cell proliferation was 
statistically significant at each of the three haptenation doses 
compared with responder lymph node cell proliferation on 
addition of erythrocytes treated with PBS.
6.2.6 The relative stimulatory activities of in vitro
haptenated lymph node cells and in vitro haptenated 
erythrocytes
A comparison of the stimulatory activity of DNFB haptenated 
erythrocytes and DNFB-haptenated lymph node cells is presented 
in a representative experiment, figure 6.2.6. It was apparent 
that for a given DNCB-sensitized responder lymph node cell 
population, in vitro DNFB-haptenated lymph node cells or 
erythrocytes cause statistically significant enhancement of 
proliferation in responder lymph node cells. It is clear, that 
for a given haptenation concentration, haptenated lymph node 
cells at a responder cell: stimulator cell ratio of 5:1 induced 
markedly more responder lymph node cell proliferation than 
haptenated erythrocytes at fifty times the stimulator 
concentration, ie at 1:10.
A series of repeat experiments performed under these conditions 
demonstrated that DNFB-haptenated erythrocytes induced average 
stimulation of xl.8 (range 0.9 to 3.1) while DNFB-haptenated 
lymph node cells induced an average stimulation of x3.6 (range
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FIGURE 6.2.6
A  Comparison of the Stimulatory Activity of DNFB-haptenated 
Syngeneic Auricular Lymph Node Ceils with DNFB-haptenated
Allogeneic Erythrocytes
Responder Lymph Node Cells - as described in figure legend
6.2. 1.
Stumilator Cells - Syngeneic auricular lymph node cells and 
allogeneic erythrocytes were prepared and haptenated with PBS 
(mock) and DNFB as described in figure legends 6.2.2 and 6.2.4 
respectively.
A responder: stimulator cell ratio of 3.3:1 was used for 
syngeneic haptenated lymph node cells and 1:10 for allogeneic 
haptenated erythrocytes.
** denotes significant statistical difference from paired
control (*).
1.7 to 8.2). The differing stimulatory activity of haptenated 
lymph node cells compared with haptenated erythrocytes no doubt 
reflects the differing size of these cells and therefore the 
amount of hapten they carry: the significant point, developed 
later, is that both have stimulatory activity.
These results were surprising because DNFB-haptenated 
erythrocytes should not function as antigen presenting cells - 
they lack expression of appropriate MHC-encoded antigens and 
extra accessory factors, for example IL-1 expression. Clearly, 
however, some 'product' of the in vitro haptenated erythrocytes 
led to stimulation of responder lymph node cells in vitro.
The results were compatible with a proposal (substantiated later 
in this chapter) that antigen presenting cells within the 
responder lymph node cell population were processing the in 
vitro haptenated cells and presenting this processed antigen to 
lymphocytes within the responder lymph node cell population. 
Thus, DNFB-haptenated erythrocytes (cells) were simply antigen 
substrate for antigen processing/presenting cells within the 
DNCB-sensitized responder lymph node cells.
6.2.7 Stimulation of responder lymph node cells by in vitro 
haptenated cells: dependence on a silica-sensitive 
antigen processing cell within the responder lymph node 
cell population
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There is evidence, described later, supporting the proposal that 
in vitro haptenated cells must be processed by antigen 
processing/presenting cells before the hapten is presented to T- 
lymphocytes in an immunogenic form (Chang et al 1987). That 
such an antigen processing cell was present within the responder 
lymph node cells and facilitated the in vitro haptenated cells 
attaining a stimulatory state was examined by selectively 
depleting processing cells.
The likeliest processing cell was a phagocyte (macrophage) and 
it has been demonstrated that phagocytes are killed by finely 
divided silica (O'Rourke et al 1978) by a physical abrasive 
effect following ingestion of silica (O'Brien et al 1979). I 
therefore examined whether the stimulation of lymph node cell 
proliferation by in vitro haptenated cells was abrogated in the 
presence of silica.
A representative experiment is presented in figure 6.2.7.
Firstly, note that DNCB-sensitized lymph node cells cultured in 
the presence of silica have a slightly reduced, (but not 
statistically significant) proliferative activity compared with 
control responders (no silica).
The proliferation induced in responders cultured with silica, on 
addition of DNFB-haptenated lymph node cells or erythrocytes was 
not significantly enhanced. Ihe same haptenated stimulators at 
equivalent responder cell: stimulator cell ratios gave the
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Figure Legend 6.2.7
Responder Lymph Node Cells
5 x 105 auricular lymph node cells, prepared from BALB/c mice 
painted 7 days previously with 25ul of 2.5% DNCB in A00 were 
cultured under standard conditions (chapter 5) or under standard 
conditions in the presence of silica at a final concentration of 
200ugml“l silica.
Stimulator Cells Syngeneic auricular lymph node cells and 
allogeneic erythrocytes were prepared and haptenated with DNFB 
(or PBS) as described in figure legends 6.2.2 and 6.2.4 
respectively.
A responder cell:stimulator cell ratio of 3.3:1 was used for 
syngeneic haptenated lymph node cells and 1:10 for allogeneic 
haptenated erythrocytes.
Data Results are displayed as the mean %-TdR incorporation +/- 
SD x 10”^ for 4-6 replicate wells per group.
** denotes significant statistical difference from paired 
control (*).
FIGURE 6.2.7
Hie Stimulation of Proliferation in DNCB-sensitized Auricular
Lymph Node Cells by Culturing with DHFB-haptenated Cells in the
Presence of Silica
C o n t r o l W i t h  s i l i c a
characteristic increases in proliferation expected in the non­
silica treated, control responder lymph node cells. (Haptenated 
erythrocytes stimulate xl.8, haptenated lymph node cells x2.7).
The silica sensitivity of hapten driven responses was examined 
in a series of experiments, presented in tabulated form, table
6. 2. 1.
It is apparent that in 4/6 of the experiments, silica causes a 
slight reduction in the proliferation of responder cells (the 
effect of silica on the viability of responder lymph node cells 
is examined in the next figure). Significantly, in 8/9 
experiments, the proliferation stimulated in control responder 
lymph node cells on addition of in vitro haptenated erythrocytes 
or lymph node cells was reduced if silica was present in the 
cultures. In 5/9 experiments, silica reduced the stimulatory 
activity of in vitro haptenated cells by 40% or greater (maximun 
58%).
These results suggested to me that silica did affect the 
stimulatory activity of in vitro haptenated cells.
However, it may be argued that silica could have a number of 
effects on lymphocyte proliferation. While it may influence 
antigen presenting cell activity or simply, physically block 
receptor-hapten/MHC-encoded antigen interaction, it could also 
be toxic for lymphocytes or more specifically interrupt
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Table Legend 6.2.1
For each experiment within the table, responder and stimulator 
cells, culture conditions and the responder cell:stimulator cell 
ratio were as described in figure legend 6.2.7.
The table incorporates, from left to right, A - the individual 
experiment number; B - the culture conditions used within the 
experiment; C - the proliferation of DNCB-sensitized auricular 
lymph node cells when cultured alone, with or without silica; D 
- the proliferation achieved on addition of DNFB-haptenated 
erythrocytes and E, the stimulation index this represents. In 
F, the proliferation of DNCB-sensitized auricular lymph node 
cells when cultured with DNFB-haptenated syngeneic auricular 
lymph node cells and G, the stimulation index this represents.
OT - not tested.
TABLE 6.2.1
A Conparison of Proliferative Responses in DNCB-sensitized
Auricular Lymah Node Cells on Addition of DNFR-haptenated Cells in
the Presence of Silica
A
Expt
No
B
Culture
condition
c
L Y M P H O C Y T E  P R O L IF E R A T IO N . 
D  E F G
9 6 Standard 3 -4 - 5 5 x l -7 9 8 x 2  9
♦Silica. 2 -5 ■ 3-4 x l -4 3 8 x l - 5
105 Standard 3 -6 - 11-3 <3-1 7 0 x 1*9
♦Silica. 2-4 ■ 4 -6 xY? 5 5 x 2*3
143 Standard 5 -5 - N T 9-2 * 1*7
♦Silica. 4 -7 - N T - 4 -8 x 1*0
112 Standard 3 -2
- N T - 6-3 x 2 0
♦Silica 3 -6 N T - 4-4 x 1*2
4 8 8 Standard 0 -8 - 2  7 *3*4 4-1 x  5*1
♦Silica. 0 8 2 -2 * 2*8 1*7 x  2.1
1383 Standard 2 -9 - N T 11-1 * 3*8
♦Silica. ____ L 6 ___ “ ____N T 5 -3 x  3*3
biochemical events downstream of receptor signalling prior to 
proliferation.
To establish the point at which silica influences lymphocyte 
proliferative responses to DNFB-haptenated stimulator cells, the 
response to mitogenic concentrations of phorbol esters and 
ionophores (ie lymphocyte-receptor independent mitogenic 
signals) by DNCB-sensitized responder lymph node cells in the 
presence or absence of silica, was examined.
6.2.8 Retention of T-lymphocyte capacity to proliferate in the 
presence of silica in vitro
To confirm the viability and proliferative activity of T- 
lymphocytes within silica treated, activated lymph node cells, I 
utilised a synergizing combination of the phorbol ester 12-0- 
tetradecanoyl phorbol acetate (TPA) and a calcium ionophore 
(A23187). These reagents are discussed later: it is sufficient 
to state here that this mitogenic cocktail stimulates lymphocyte 
activation as assessed by ^-TdR incorporation (Trunch et al
1985) and IFN gamma mRNA synthesis (Croll et al 1987) in the 
absence of any accessory signals (unlike mitogens such as ConA, 
Gallagher et al 1986) and thus gives a direct measure o f  
lymphocyte responsiveness.
In figure 6.2.8 it is clear that the presence of silica in the 
DNCB-sensitized responder lymph node cells does not 
significantly affect the background proliferative activity.
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FIGURE 6.2.8
The Stimulation of Proliferation in DNCB-sensitized Auricular
Lymph Node Cells by Culturing with DNFB-haptenated Cells or
Phorbol Eaters and Iooophore, in the Presence of Silica
R e s p o n d e r  c e l l s  f r o m  m i c e  t r e a t e d  w i t h  2.5X D N C B  
C o n t r o l  W i t h  s i l i c a
The conditions of this experiment were as described in figure 
legend 6.2.7. In addition, DNCB-sensitized auricular lymph node 
cells were cultured in the absence or presence of silica with a 
mitogenic combination of the phorbol ester 12-0-tetradecanyl 
phorbol acetate (TPA) and the calcium ionophore A23187 at final 
concentrations in the well of O.lugml“* and 1.5ugml"^ 
respectively.
** denotes significant statistical difference from paired
control (*).
While the responders proliferated characteristically, if only 
weakly, on addition of DNFB-haptenated lymph node cells (xl.7), 
this response was blocked if silica was present.
Significantly, the responsiveness to the antigepic cocktail of 
TPA/A23187 was unaffected by silica at 200ugml-1.
These results were repeated in a successive experiment (data not 
shown). In both experiments the effect of silica in abrogating 
hapten-driven response, but not the TPA/A23187, response was 
clear.
The complexity of these experiments, however, with so many 
components all needing to function in vitro together, made them 
difficult to perform satisfactorily. This is reflected by my 
satisfaction with only two attempts.
These results suggested that silica blocked the presentation of 
a proliferative signal (composed at least in part by in vitro 
haptenated cells) to responding lymphocytes within the activated 
lymph node cells, rather than simply being toxic to the 
responding lymphocytes. The implications of this will be fully 
discussed, however, it is pertinent to emphasise at this stage 
two important points.
a) Both the background proliferation of DNCB sensitized 
lymph node cells and the enhanced proliferation on 
addition of in vitro haptenated cells appear sensitive to
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silica, while the response to TPA/A23187 appears 
independent of silica sensitivity. This is consistent 
with the proposal that endogenous antigen presenting 
cells are important in 'mediating' both background and 
stimulated proliferation levels.
b) The enhanced proliferation of responder lymph node cells 
on addition of dendritic cell-enriched lymph node cells 
from hapten sensitized mice is not affected by silica at 
200ugml- ,^ suggesting some processing differences in the 
way dendritic cells (in vivo haptenated) and in vitro 
haptenated cells stimulate responder lymph node cell 
proliferation (see chapter 8).
6.2.9 Summary
The data presented here indicates the difficulties in accounting 
for the various biological activities present within activated 
lymph node cells - a reflection of the variety of cellular types 
constituting the lymph node in particular and the lymphatic 
system in general.
It is therefore desirable to isolate and analyse particular cell 
types from the population and assess their biological 
activities, giving an indication of isolated function but not 
necessarily of their role within the total population. My
attempts to fractionate cells into particular phenotypes in 
order to give subpopulations with no endogenous antigen
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processing/presenting activity were generally unsuccessful and 
as such are only briefly described later in the discussion. 
While ray endeavours to fractionate T-lymphocytes from dendritic 
cells also fell in this unsuccessful category, these experiments 
did prove useful in indicating that proliferating, hapten 
responsive cells within activated lymph node cells were 
generally of low buoyant density.
6.3 Characterisation of the proliferating cell, in terms of 
buoyant density, during hapten-stimulated proliferation
This section considers the proliferating cellular component 
within DNCB-sensitized responder lymph node cells in terms of 
cellular buoyant density. The responsiveness of DNCB-sensitized 
responder to in vitro haptenated cells was partially attributed 
to a cell of low buoyant density, isolated by Metrizamide 
density centrifugation (see chapter 5).
The fractionation of DNCB-sensitized responder lymph node cells 
into fractions of low and high buoyant density has been achieved 
by isolating interphase (low buoyant density) and pellet (high 
buoyant density) cells from Metrizamide gradients, as previously 
described (Knight et al 1985).
It has been established that high buoyant density fractions from 
7d-DNCB-sensitized responder lymph node cells have a reduced 
background proliferative activity in culture when compared with 
the nonfractionated responder lymph node cells. This reduction
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is statistically significant and is documented in table 6.3.1. 
It is also clear that the low buoyant density fraction isolated 
from the same sensitized-lymph node cells has a greatly enhanced 
spontaneous proliferative activity (table 6.3.1, expt 15 & 16).
Utilising the high and low buoyant density fractions from DNCB- 
sensitized responder lymph node cells it was shown that, to a 
large extent, the hapten-responsive element within DNCB- 
sensitized responder lymph node cells fractionates with 
Métrizamide interphase cells, that is low buoyant density cells. 
Thus, in figure 6.3.1a DNCB-sensitized responder lymph node 
cells proliferate characteristically on addition of in vitro 
DNFB-haptenated allogeneic erythrocytes or DNFB-haptenated lymph 
node cells. The stimulator cell-induced enhancement of 
proliferation within responder lymph node cells was x4.2 for 
haptenated lymph node cells and x4.0 for haptenated 
erythrocytes. DNCB-sensitized responder lymph node cells 
depleted of low buoyant density cells had markedly reduced 
hapten-driven responses. Thus increments of enhancement were 
reduced to xl.7 and x2.4 respectively.
As expected, the spontaneous proliferative activity of the 
responder lymph node cells depleted of low buoyant density cells 
was much lower than that measured for unfractionated responder 
lymph node cells.
In figure 6.3.1b it is clear that hapten responsive cells were 
apparent in the low buoyant density cell-enriched fractions of
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Table Legend 6.3.1
Auricular lymph node cells were isolated from mice painted 7 
days previously on both ears with 25ul of 2.5% DNCB in A00 and 
separated into fractions of low and high buoyant density cells 
by centrifugation over a single-step Metrizamide density 
gradient, as described in chapter 5. After separation, low 
(interphase) and high (pellet) buoyant density cells were 
collected, washed and cultured under standard culture conditions 
at 5 x 105 cells per well, except low buoyant density cells, 
which were cultured at 4 x 10^ cells per well.
Data
The results are presented as mean %-TdR incorporation +/- SD x 
10“3 for 4-6 replicate wells per culture. The table is 
organised thus: A - the individual experiment nimber; B - the 
proliferation of unfractionated, DNCB-sensitized auricular lymph 
node cells; C - the proliferation of low buoyant density cell 
depleted, DNCB-sensitized auricular lymph node cells; D - the 
statistical significance (p<) of the difference between B and 
C;E - the proliferation of low buoyant density cell-enriched 
DNCB-sensitized auricular lymph node cells and F - the 
statistical significance (p<) of the difference between B and E.
TABLE 6.3.1
Cells Incorporating % - T d R  Within DNCB-sensitized Auricular Lymph 
Node Cell Populations Fractionate Differentially Between Cells of 
Low and High Buoyant Density
L Y M P H O C Y T E  P R O L I F E R A T I O N .
A B C D E F
Expt No. Unfractionated Depleted of low buoyant density
Enriched for low buoyant 
density cells
11 3*2 t  1*3 1*3 * 0 * 7 0 0 1 N T -
12 1*3 -  0 5 0 * 7  î  0*1 0* 05 N T -
13 2*9 ± 0 6 1* 5*  0 * 6 0 0 5 N T -
15 0 4 1 0*2 0 * 6  t  0*2 ns 1 7 -0 ±  1-6 0 -0 0 1
16 2 -8 1  1*5 0*9 -  0 * 3 0*02 2 1 -5  i  2*3 0 -0 0 1
DNCB-sensitized responder lymph node cells. Within the DNCB- 
sensitized responder lymph node cells there was significant 
hapten-driven proliferation (x3.3). This response was partially 
reduced (x2.5), in the low buoyant density cell-depleted 
responder lymph node cells, as was the spontaneous proliferative 
activity of the responder lymph node cells. The low buoyant 
density cell-enriched responder lymph node cells showed 
significant hapten driven proliferation (x3.2), superimposed on 
a markedly increased spontaneous proliferative activity.
The high proliferative response of all three responder lymph 
node cell populations on addition of an optimized concentration 
of ConA confirmed that the Metrizamide was not toxic to any of 
these fractions of lymph node cells (data not shown).
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Figure Legend 6.3.1
Responder Lymph Node Cells
Responder lymph node cells were prepared from DNCB-sensitized 
auricular lymph node cells and fractionated into low buoyant 
density cell-depleted and enriched fractions, as described in 
table legend 6.3.1.
Both populations (and unfractionated cells) were cultured under 
standard conditions at 5 x 10^ cells per well.
Stimulator Cells
Syngeneic auricular lymph node cells and allogeneic erythrocytes 
were prepared and haptenated with 1.5tnM DNB as described in 
figure legends 6.2.2 and 6.2.4.
Fig a) - the response of unfractionated and low buoyant density 
cell-depleted responders.
Fig b) - the response of a) unfractionated, b) low buoyant 
density cell-depleted and c) low buoyant density cell- 
enriched responders.
Results are presented as the mean -^ H-TdR incorporation +/- SD x 
10" ^ for 4-6 replicate wells per group.
** denotes significant statistical difference from paired 
control (*).
FIGURE 6.3.1
The Proliferative Activity and Hapten Responsiveness of DNQ>-
sensitized Auricular Lymph Node Cells. Different Activities in
High and Low Buoyant Density Cell Fractions
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6.4 Discussion
Auricular lymph node cell activation following ear painting with 
chemicals
I reviewed in the general introduction the studies of a number 
of laboratories which established that a wide range of low 
molecular weight, protein reactive chemicals such as 
dinitrochlorobenzene, oxazolone and fluoroscein isothiocyanate 
are capable of sensitizing a variety of species including 
guinea-pigs, mice and man (Baker et al 1987; Phanuphak et al 
1974; Kimber et al 1986) when applied to the skin. Correlates 
of primary sensitization included the level of lymph node cell 
proliferation as measured both in vitro and in vivo. Data 
presented in this chapter confirmed that auricular lymph node 
cell proliferation after ear painting with chemicals previously 
demonstrated to be contact sensitizers shows a statistically 
significant enhancement when compared with the control 
proliferation level.
The increase in lymph node cell proliferation was also shown to 
be a local, laterally restricted effect, at least for the first 
four days following sensitization. Such restriction, reflects 
the organisation of lymphatic drainage in mice (and other 
species). Normally, the peripheral lymph nodes, including the 
auricular lymph node, which are responsible for antigen (hapten) 
draining from the extravascular space, are arranged in chains
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which run along the anterior-posterior axis (reviewed in Male et 
al 1988). The left and right nodes are isolated from each other 
by the direction of lymphatic traffic, which is centripetal. 
Thus, lymphatic traffic flows into the local node from the 
tissues (skin) along the afferent lymphatic. This node is then 
the site of immune activation (reviewed in McConnell et al 1981 
and Friedlander & Baer 1972). There then follows an efflux of 
activated lymphocytes from the node, along the efferent 
lymphatic and into the thoracic duct, where antigen-specific 
blasts are detectable after 3-4 days (Ford and Atkins 1971) from 
skin-painting.
The events I have described within the lymph node undergoing 
activation broadly correlate with the time course for lymphocyte 
activation, as measured by the increase in %-TdR incorporation 
of local lymph node cells with peak proliferation at 3-4 days 
and a return to naive levels at 7-8 days.
The rapid induction of proliferation over the first day is 
proposed to reflect the summation of a number of events which 
constitute the early stages of the afferent phase of contact 
sensitization, as reviewed in chapter 3.
Regulation of activated lymph node cell proliferation
The characteristic decline of %-TdR incorporation, from a peak 
at 3-4 days post sensitization to naive levels at 7-8 days post 
sensitization has been attributed to the action of an irmiuno-
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suppressive cell induced within the lymph node cells during 
primary activation (Wood et al 1977; Kimber et al 1987). This 
suppressor cell appears to actively suppress proliferation 
rather than proliferation being restricted by a passive effect, 
such as localized toxicity or lack of available antigen (Kimber 
et al 1987a.). In addition, the effect of suppression, or at 
least the suppressive activity of the activated lymph node cells 
was antigen non-specific, with oxazolone sensitized lymph node 
cells able to confer low proliferative response on mice 
challenged later with either oxazolone or the antigenically 
distinct picryl chloride. In the light of these observations, 
the decline in proliferation seen between days 4 and 8 may 
reflect the induction of a generalized, antigen non-specific 
suppressor cell (activity). This suppressor activity reduces 
lymph node cell proliferation and maintains an aquiescent 
restriction on cellular proliferation, while at the same time 
maintaining the contact sensitized state and enabling the host 
to hold secondary elicitation responses in an antigen specific 
fashion.
Phenotypic heterogeneity within activated lymph node cells
The compartmentalized appearance of the lymph node, apparent in 
a number of documented microscopical studies (eg A m o  1981) 
indicates the regionalized distribution of particular cell types 
within the node. This is supported by the demonstration that a 
particular region, for example the paracortex, is rich in a
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particular cell or lymphocyte, in this case the L3T4+ T- 
lymphocyte. These studies, utilising fluorescent labelled 
antibody techniques to visualize particular lymphocyte subtypes 
suggest functional compartmentalization and serve to highlight 
the range of cellular phenotypes likely within a lymph node cell 
population. (Assuming that all cells within node will be 
equally recovered by mechanical disaggregation of node.) Such 
heterogeneity will be reflected in the function of the lymph 
node cell population, although as I have described, the gross 
response of a lymph node cell population may hide a number of 
stimulatory and inhibitory effects.
There are several reasons for assuming that the cell actually 
incorporating %-TdR within lymph node cells is a T-lymphocyte. 
It has previously been reported, that the observed increases in 
lymph node weight and cell number during the afferent phase of 
contact sensitization are attributable to a large expansion of 
the T-lymphocyte rich paracortex, indicating specific activation 
of T-lymphocytes (Turk and Stone 1963). My own preliminary 
studies (data not presented) utilising T-lymphocyte specific 
monoclonal antibodies in an indirect immunofluorescence staining 
protocol on activated lymph node cells, suggested that at 7 days 
post sensitization, such a population consisted of approximately 
70% L3T4 positive T-lymphocytes. This correlates well with 
earlier studies by Moorhead indicating that within activated 
lymph node cells, 60-70% of the proliferative response is T- 
lymphocyte dependent (Phanuphak et al 1974; Moorhead
1978). It should be noted however that B-lymphocyte
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proliferation was shown to provide the remaining 30-40% of 
proliferation, in an antigen non- specific fashion.
In vitro stimulation of activated lymph node cells by in vitro 
haptenated cells
The purpose of these studies was to utilise activated lymph node 
cells as an indicator for antigen presentation in vitro. The 
initial studies in this chapter, together with earlier findings 
in this laboratory, demonstrated that activated lymph node 
cells, 7 days post sensitization, have an intrinsically low 
proliferative activity and yet contain cells which conferred 
contact sensitivity and thus hapten responsiveness. Such 
activated lymph node cells, which contain cells responsive to 
hapten both in vitro and in vivo (Moorhead 1978) were nominated 
as responder lymph node cells and were cultured with in vitro 
haptenated stimulator cells.
As such, the lymphocyte proliferation assay utilised in these 
studies is a widely used modification of the lymphoblast 
transformation assay as described fully in materials and 
methods.
Antigen-induced lymphocyte proliferation in this assay can be 
considered an in vitro correlate of the contact sensitized state 
(Mills 1966; Oppenheim et al 1967) and while there is evidence 
that this relationship is not clear cut, being complicated by 
the complex phenotype of a lymph node cell population (see
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earlier), the responder population does appear to contain 
hapten-specific T-lymphocytes, at least within the DNFB and FITC 
systems.
Data provided by my colleagues at ICI (Kimber et al 1986) showed 
that syngeneic, in vitro haptenated splenocytes were stimulatory 
for responder lymph node cells in culture. This effect was 
demonstrated and is also presented for in vitro haptenated lymph 
node cells.
In both experiments, the stimulator cells haptenated with DNFB 
in vitro caused significantly enhanced proliferation within the 
responder DNCB-activated lymph node cells. It is important to 
note that unhaptenated stimulators failed to induce enhanced 
proliferation. As both stimulator cell populations were derived 
from DNCB-activated mice, it is apparent that the intrinsic 
level of DNCB on the splenocytes or the auricular lymph node 
cells of DNCB-activated mice is at too low a level to stimulate 
responder proliferation in vitro. In chapters 7 and 3 I will 
demonstrate that within such stimulator populations, a tiny 
percentage of cells are high expressers of hapten - without 
enrichment, these cells are evidently too rare to actually 
stimulate enhanced responder proliferation in this assay system. 
If such cells are enriched, however, and used as stimulator 
cells, their stimulatory activity with no need for in vitro 
haptenation, is very large (chapter 8).
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The hapten specificity of the stijnulatory activity of in vitro 
haptenated cells
The stimulatory activity of in vitro haptenated stimulator cells 
was consistent with the responder lymph node cells being 
stimulated in a hapten-(antigen) specific fashion. To prove 
this, an antigenically distinct hapten, FITC, was utilised in a 
cross-over type experiment. Responder lymph node cells had a 
hapten-specific responsiveness to in vitro haptenated stimulator 
cells, with enhanced proliferation only when the responders and 
stimulators were activated by (or haptenated with) the same 
chemical.
The fact that the response of activated lymph node cells was 
antigen-specific made it unlikely that in vitro haptenation 
acted by inducing production of stimulatory factors by 
stimulator cells which might then stimulate non-specific 
responder lymph node cell proliferation. This may have been 
predicted in the light of other researchers' work (Moorhead et 
al 1978). Consider IL-2 as an example. Studies by myself (data 
not presented) clearly demonstrated that activated responder 
lymph node cells isolated from sensitized mice were highly 
responsive to interleukin-2 in vitro and that this response was 
dependent on the titre of IL-2 rather than the specificity of 
hapten used for sensitization. Thus, auricular lymph node cells 
from mice painted 7d previously with either DNCB, FITC or 
oxazolone all responded in vitro on addition of IL-2. This was 
in agreement with published data (Butler et al 1987)
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demonstrating the expression of IL-2 receptors in activated 
lymph node cells. One might therefore postulate, that the in 
vitro haptenation of stimulator cells (but not the control PBS 
treatment or toxin/irradiation treatment) leads to IL-2 
production (or release) by stimulator cells and this IL-2 then 
stimulates responders proliferation. In a given experiment, 
however, the in vitro haptenated population would provide a 
source of IL-2 and would therefore be expected to stimulate all 
activated lymph node cell populations from sensitized mice, 
which is not the case and is incompatible with my results. In 
addition, if one predicts that within a particular experiment 
the DNFB-haptenated stimulator cells acted as a constant source 
of IL-2, then to account for the results presented in figure 
6.2.2, it is necessary to describe responder lymph node cells 
from DNCB-sensitized mice as IL-2 receptor 'positive' and those 
from FITC-sensitized mice as IL-2 receptor 'negative'. Clearly, 
however, FITC-sensitized responder lymph node cells were 
stimulated by 'IL-2' produced from FITC-haptenated stimulator 
cells. This whole explanation is dependent on the production of 
hapten-specific stimulatory factors: in addition, preliminary 
experiments suggested that the supernatants of killed, 
haptenated stimulator cells were not stimulatory for responder 
lymph node cells, implying that the stimulatory factor was 
membrane bound. While there are reports of antigen-specific 
suppressive and stimulatory factors, both membrane-bound and 
secreted I am satisfied that
the likely candidate for the stimulatory factor in my 
experiments is membrane bound hapten.
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My conclusion at this stage, therefore, was that the activated 
lymph node cells recognized hapten in a specific fashion. This 
indicated that the inmune recognition system employed by cells 
participating within my antigen presentation assay was at least 
capable of distinguishing between the haptens DNCB and FITC. 
This was consistent with a recognition system of fine 
specificity and implicated either the alpha-beta heterodimer T- 
cell receptor (Yague et al 1985) or the immunoglobulin molecule 
( reviewed 14  ft I ) as important in the generation of 
a lymph node cell proliferative response.
The restriction of in vitro proliferative responses on the MHC- 
encoded antigens on stimulator cells
As I described in the general introduction, one model for the 
formation of an antigen recognized by T-lymphocytes predicts 
that the complete or immunogenic antigen consists of two 
components, the nominal antigen (or hapten in these studies) and 
the self class II MHC-encoded protein for CD4+ T-lymphocyte 
recognition. Several groups have provided evidence consistent 
with this (Sette et al 1989; Babbitt et al 1985; Hedrick et al 
1982). The role of nominal antigen (or hapten) in the 
proliferative responses I have measured has been confirmed in 
the results just described. It was necessary to demonstrate 
that the proliferative response of activated lymph node cells on 
the addition of-in vitro haptenated cells was also restricted by 
class II MHC-encoded proteins. To this end, in vitro haptenated 
erythrocytes which do not express MHC-encoded proteins
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(Lanzavecchia and Staerz 1987) were used as stimulator cells in 
the proliferation assay.
Erythrocytes from allogeneic mouse strains, typically C3H or CBA 
(H-2k) were utilised: any contaminating lymphocytes would be 
MHC-incompatible with the activated lymph node cells and would 
fail to present hapten to the responding lymph node cells. 
Thus, if haptenated erythrocytes stimulated lymph node cell 
proliferation, then the proliferation was not a consequence of 
hapten presentation by the erythrocytes, which lacked MHC- 
encoded proteins.
The results of these experiments demonstrated that in vitro 
haptenated erythrocytes were stimulatory for activated lymph 
node cells. Unhaptenated erythrocytes were not stimulatory, 
proving that any contaminating, MC-positive, allogeneic 
lymphocytes within the erythrocytes were not stimulating a mixed 
leucocyte or anti-MHC protein reaction (Bach et al 1976). I 
concluded that the enhanced proliferation of activated lymph 
node cells was not restricted by MHC-encoded proteins expressed 
on the added stimulator cells and it follows that haptenated 
lymphoid cells of the wrong MHC would stimulate. I did not 
examine this point, partly because such an approach would 
engender MLR, an unwanted complication. I considered it 
possible that in vitro haptenated stimulator cells were simply a 
source of hapten within the proliferation assay. Another cell, 
within the activated lymph node cells, was presumably 
associating with and then processing/ presenting the hapten, in
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the context of its own class II MHC-encoded proteins to 
responding T-lymphocy tes, leading to enhanced T-lymphocyte
proliferation.
Evidence for endogenous antigen proces s ing/presen ting cells 
within activated lymph node cells
While a role for processing activity within activated lymph node 
cells was not the only explanation for how MHC-negative, hapten- 
coated cells could initiate a proliferative response by 
activated lymph node cells, it was a logical proposal. Thus, I 
have already described the heterogeneity within lymph node 
cellular phenotype and it was possible (likely) that one of 
these phenotypes would be an antigen processing and presenting 
cell. In addition, at about the time of these experiments, a 
publication from the laboratory of John Moorhead (Chang et al 
1987) reported that a class II MHC-restricted, DNP-specific T- 
cell line could not be stimulated simply by adding DNP- 
haptenated syngeneic spleen cells. These results clearly 
indicated that in vitro haptenation may not directly produce an 
immunogenic complex recognizable by T-lymphocytes and was 
broadly compatible with my results and observations. Thus, 
while Chang and co-workers' studies utilised a T-cell line, the 
line was characteristically T-lymphocyte as assessed by its 
hapten and MHC specificity and activity in vivo in mediating ear 
swelling responses. The chloroquine sensitivity of the 
syngeneic filler cell activity described by Chang et al
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suggested that a lysosomal processing step, probably by a 
macrophage or B-lymphocyte, was essential.
I proposed, that within activated lymph node cells there was an 
endogenous antigen processing/presenting cell, responsible for 
reprocessing in vitro haptenated stimulator cells (fragments) to 
the proliferating T-lymphocytes within the activated lymph node 
cells. To test this I aimed to selectively deplete phagocytic 
cell activity within the activated lymph node cells, reasoning 
that phagocytes were the most likely candidate for being the 
endogenous antigen processing/presenting cell. To achieve 
selective toxicity of phagocytes (macrophages) I chose to add 
particulate silica directly to the proliferating cell cultures.
The silica sensitivity of the stimulatory activity of in vitro 
haptenated cells
Results presented in this chapter suggested that endogenous, 
silica-sensitive antigen processing/presenting cells did 
regulate the stimulatory activity of in vitro haptenated cells 
for activated lymph node cells. Thus, when silica was added to 
activated lymph node cells prior to addition of in vitro 
haptenated cells and left in the culture for the full duration 
of culture, then the hapten-dependent proliferation routinely 
measured in control, silica free cultures was partly abrogated. 
The same concentration of silica did not significantly affect 
the background proliferative activity of the activated lymph 
node cells, suggesting that the silica was not toxic to the
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proliferating cells. The results suggested that a silica 
sensitive cell is important in the stimulatory activity of in 
vitro haptenated cells (and also possibly background 
proliferation).
The selective activity of silica on activated lymph node cells
To confirm the viability and proliferative activity of T- 
lymphocytes within the silica-treated, activated lymph node 
cells I utilised the mitogenic stimulus of a synergizing 
combination of the calcium ionophore A23187 and phorbol ester 
TPA. These reagents have a precise mode of action which leads 
to activation of DNA synthesis in T-lymphocytes by a mechanism 
independent of any receptor-ligand interaction. Thus, previous 
studies have demonstrated that the signal for T-lymphocyte 
proliferation in vitro is normally a T-lymphocyte alpha-beta 
receptor binding event, such as the binding of mitogenic lectin 
(Tsien et al 1982) or the appropriate antigen (Nisbet-Brown et 
al 1985). The increased cytoplasmic calcium ion concentration 
which follows ligand binding and initiates cellular activation 
can be mimicked by treating cells with the calcium ionophore 
A23187 (Weiss et al 1984; Luckason et al 1974). Such an 
increased calcium ion concentration is important in the 
activation of the enzyme Protein KinaseC (Wolf et al 1985; May 
et al 1985) which is a critical further event leading to T-cell 
activation. This event can be mimicked by the binding of 
phorbol esters to the Protein Kinase C. Thus, an appropriate
combination of the ionophore and^have a synergistic, mitogenic 
pltcrW atfer
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activity, leading to T-cell activation and DNA synthesis. This 
stimulation is independent of any T-cell transmembrane 
signalling and is also therefore considered independent of any 
accessory cell signalling or crosslinking. The proliferative 
response to the mitogenic combination of ionophore and phorbol 
ester can therefore be considered a direct measure of T- 
lymphocyte viability. This is unlike the response to mitogenic 
lectins such as ConA which are likely to depend on an element of 
accessory cell help, be it through MHC-independent accessory 
cell T-cell contact (Gallagher et al 1986; Hunig et al 1984) or 
some soluble signal released by accessory cells (Hirayama et al 
1987; Maizel et al 1981).
The proliferative response of activated lymph node cells to an 
optimized, synergizing combination of A23187 and TPA was 
unchanged in the presence of silica. Within the same 
experiments, the same concentration of silica abrogated the 
expected proliferative response to in vitro haptenated 
stimulator cells, consistent with the proposal that silica 
blocks the facilitation of a signal to the responding lymphocyte 
receptor, presumably by depleting the endogenous antigen 
presenting cell. The proliferating lymphocytes were unaffected 
by silica, at least in terms of %-TdR incorporation.
These results are readily explainable in terms of the phenotypic 
and functional heterogeneity within the activated lymph node 
cell population. The designation of this whole cell population 
as responder lymph node cells, clearly does not account for
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antigen processing and presenting cells also present within the 
lymph node cells. In particular, a silica-sensitive processing 
cell within the activated lymph node cells appeared to be 
involved in the proliferative response of activated lymph node 
cells when cultured with in vitro haptenated cells. I concluded 
that stimulation of proliferation within activated lymph node 
cells by in vitro haptenated cells was an indirect measure of 
the imnunogenicity of in vitro haptenated cells because 
stimulation was dependent on processing of the added stimulus.
The fractionation of activated auricular lymph node cells
Clearly, to use proliferation of activated lymph node cells as a 
measure of the quality and quantity of antigen (in vitro 
haptenated cells) added to culture it was necessary to 
fractionate proliferating cells (T-lymphocytes) away from 
antigen processing and presenting cells. I utilised a number of 
previously reported procedures to isolate pure T-lymphocytes 
from activated lymph node cells, as listed below:
a) Fractionation of activated lymph node cells down nylon 
wool columns, exploiting the non-adherence of T- 
lymphocytes to wool (Julius et al 1973).
b) Selective adherence to plastic surfaces of T-lymphocytes
and B-lymphocytes, macrophages and dendritic cells.
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c) Antibody-mediated cell panning (McCarron et al 1985); and
d) Antibody-mediated cell cytotoxicity of non-T-lymphocyte 
subsets.
I have not presented data from these experiments because the 
attempts to prepare pure T-lymphocytes proved unsatisfactory. 
While I was able to achieve some enrichment of T-lymphocytes, as 
assessed by antibody-mediated indirect immunofluorescence 
analysis, on no occasion did I achieve a phenotypic purity of 
greater than 95% T-lymphocytes. [Antigen presenting cell 
activity is widely reported as efficient at cell numbers 
representing significantly less than one antigen presenting cell 
for twenty T-lymphocytes.] More significantly, the functional 
purity of the enriched T-lymphocytes was never satisfactory. I 
used the mitogenic activity of ConA as an indicator of antigen 
presenting cell presence within activated lymph node cells, as 
it had previously been reported that ConA responses are 
dependent on antigen presenting cell help (Gallagher et al 1986; 
Hirayama et al 1987). The enriched T-lymphocytes I prepared had 
intact proliferative responses to ConA, in fact often enhanced 
responses, commensurate with a larger fold increase on addition 
of ConA. These enriched T-lymphocytes retained their 
responsiveness to in vitro haptenated stimulator cells.
In the light of reports that the fractionation of T-lymphocytes 
from lymphoid dendritic cells was facilitated by density 
centrifugation on Metrizamide gradients (Knight et al 1985), and
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that lymphoid dendritic cells may possess some antigen 
processing activity commensurate with a role as an endogenous 
antigen presenting cell (Chain et al 1986), I examined the 
efficiency of separating dendritic cells from T-lymphocytes on 
Metrizamide.
The data presented refers to a series of experiments which 
utilised a single step Metrizamide density gradient to deplete 
low buoyant density cells from activated lymph node cells and to 
relate this to any changed response to in vitro haptenated cells 
by the activated lymph node cells. Knight and co-workers 
clearly demonstrate in their publications that the vast majority 
of low buoyant density cells from the lymph node cells of mice 
painted 18 hours previously with sensitizing chemicals are non­
proliferating, lymphoid dendritic cells (Knight et al 1985b). I 
also demonstrate this in following chapters. It is interesting 
therefore, that my results indicate that within activated lymph 
node cells from mice painted 7 days previously with sensitizing 
chemicals, most of the cells of low buoyant density are highly 
proliferating, hapten-sensitive cells. Thus, I demonstrate that 
within activated lymph node cells from mice painted 7d 
previously with 2.5% DNCB, much of the background proliferative 
activity is contributed by cells of low buoyant density and that 
these cells are stimulated by in vitro haptenated cells.
Together with the relatively high yield of low buoyant density 
cells compared with that at 18hrs and the appearance of the 7d 
low buoyant density cells as a mixture of large, dendritic and
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large, non-dendritic cells (data not shown), this data indicates 
that large, proliferating, hapten responsive cells (T-
lymphocytes) fractionate with lymphoid dendritic cells at the 7d 
time point. Thus, the Metrizamide method for separating T-cells 
from dendritic cells is ineffective for activated lymph node 
cells at 7d and also, the proliferating cell within activated 
lymph node cells resembles a blast rather than a resting 
lymphocyte. This suggests that the proliferative responses of 
7d activated lymph node cells is a reactivation of primary T- 
lymphocytes rather than resting T-lymphocytes.
Conclusions
The data discussed in this chapter is extensive and has 
demonstrated a number of points. Firstly, ear painting with 
sensitizing chemicals leads to activation of auricular lymph 
node cells, measurable by an increase in the background or 
spontaneous proliferative activity of the cells when cultured in 
vitro. Such cells readily respond to a stimulus of added in 
vitro haptenated cells. While this response is restricted by 
the use of a matched hapten for both in vivo sensitization of 
responder cells and in vitro haptenation of stimulator cells, no 
such matching is required in terms of MHC-encoded antigen. 
Thus, the stimulatory activity of in vitro haptenated cells is 
independent of the MHC-encoded antigens expressed on the 
stimulator cells.
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This suggested that in vitro haptenated cells were simply a
source of antigen within the proliferation assay and that this 
'antigen substrate' was processed and presented by an endogenous 
antigen processing and presenting cell. Experiments 
demonstrating that the stimulatory activity of in vitro 
haptenated cells is influenced by silica-sensitive phagocytes 
within the sensitized auricular lymph node cells, were 
consistent with this view.
To clarify the responding and processing activities of 
sensitized auricular lymph node cells, unsuccessful attempts 
were made to fractionate antigen processing/presenting cells 
from T-lymphocytes. These studies did reveal, however, that the 
proliferating cell within activated lymph node cells was of a 
low buoyant density similar to T-lymphoblasts rather than 
resting T-lymphocytes.
In view of the difficulties experienced in preparing T- 
lymphocytes free of antigen processing activity and publications 
indicating that in vivo haptenated DC may represent a more 
appropriate antigen presenting cell than in vitro haptenated 
cells, I reviewed my position.
Review
At this stage in my research, I comprehensively reviewed my own 
results and those of others, in particular the research led by 
Stella Knight at Harrow CRC into the antigen presenting activity
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of lymphoid dendritic cells in vitro. I have described the 
studies of Knight, Macatonia and co-workers in chapter 3. The 
major point to reiterate here is that dendritic cells enriched 
from the draining auricular lymph node cells of mice painted 
18hrs previously on the ears with sensitizing chemicals, in 
particular FITC, are carrying that chemical on their cell 
surface and are stimulatory in vitro for hapten-sensitized (or 
naive) purified T-lymphocytes (Macatonia et al 1987). This in 
vitro stimulatory activity was hapten-specific and restricted by 
class II MHC-encoded protein compatibility between the hapten­
bearing dendritic cell and the responding T-lymphocytes.
In the light of these studies, I considered it important to 
assay the stimulatory activity of hapten-bearing dendritic cells 
in my proliferation assay. The obvious advantages of using in 
vivo haptenated dendritic cells as stimulator cells within my 
proliferation assay included the more natural state of the in 
vivo haptenated dendritic cell, compared with in vitro 
haptenated cells. In addition, a possibility existed that the 
quality and quantity of hapten presented on the surface of in 
vivo haptenated dendritic cells would be regulated by 
manipulating the immune system, for example the 'lymphokine 
environment', of mice used for the isolation of dendritic cells.
These studies are presented in the following chapters 7, 8 and 
9.
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CHAPTER 7
The isolation, enumeration and FTTC-bearing nature of murine 
lymphoid dendritic cells following epicutaneous exposure to FITC
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7.1.1 Introduction
The data presented in Chapter 6 described the considerable 
changes measured in the in vitro proliferative activity and 
hapten-sensitized state of lymph node cell populations isolated 
from mice topically exposed to contact sensitizing chemicals. 
Such cellular activation was not usually detectable within the 
first 24 hours following skin-painting. It has previously been 
reported, however, that during this first 24 hours, there are 
marked changes in the cellular composition of the draining lymph 
node cell population. In particular, there is a rapid increase 
in the number of morphologically dendritic, large cells 
recoverable from the lymph node cell population (Knight et al 
1985a; Macatonia et al 1986: reviewed in introduction). These 
reports suggested a likely role for dendritic cells in the early 
stages of lymph node cell activation (proliferation), as they 
possess potent hapten-presenting cell activity both in vivo and 
in vitro. I wished to consider the role of such hapten-bearing 
dendritic cells as stimulatory cells within my antigen 
presentation assay. I therefore needed to characterise their 
appearance within (and isolation from) activated lymph node 
cells. The isolation of dendritic cells in these studies was by 
Metrizamide gradient fractionation.
Dendritic cells were isolated in the low buoyant density cell 
fraction of lymph node cells isolated from mice painted on the 
ears up to a maximum of 24hrs previously. At this stage, unlike 
lymph node cells from mice sensitized 4 days previously, there
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is no detectable increase in lymph node cell proliferation in 
vitro compared with that measured for lymph node cells from 
naive mice. Thus, at post 18hr ear painting, non-proliferative 
dendritic cells are isolated in the low buoyant density cell 
fraction. At four days, as described in chapter 6, the low 
buoyant density cell fraction contains detectable numbers of 
non-dendritic, highly proliferative cells (chapter 6, table 
6.3.1).
I present data which demonstrates that increased numbers of 
dendritic cells are recoverable from the auricular lymph nodes 
of mice painted 12hrs previously with the sensitizing chemical 
FITC, compared with recovery from naive mice. This appearance 
of dendritic cells was dose dependent. Enumeration of 
dendritic-cells was achieved by counting cells with the 
morphological features of dendritic cells within lymph node cell 
populations on a haemocytometer and also by flow cytometric 
analysis. This later method (fully described in chapter 5) in 
combination with the use of the fluorescent contact sensitizing 
chemical FITC, also enabled the relative size profile and FITC- 
bearing nature of lymph node cells from FITC-painted mice to be 
determined. These experiments established that within the 
auricular lymph node cells of mice painted 18hrs previously with 
FITC (but not other sensitizing chemicals) there is a small 
percentage of highly fluorescent, ie FITC (hapten)-bearing cells 
and that these cells are of low buoyant density. In agreement 
with earlier studies (Macatonia et al 1987; Kinnaird et al 
1989), these highly fluorescent cells were shown to be
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morphologically dendritic in character. The identification of 
fluorescent, FITC-bearing dendritic cells by the complementing 
methods of flow cytometry and fluorescence microscopy is 
documented.
The appearance of FITC-bearing dendritic cells in auricular 
lymph node cells following ear painting with FITC can be 
explained in terms of dendritic cell precursors (Langerhans 
cells) migrating from the skin site of FITC-exposure via 
afferent lymphatics into the auricular lymph node, (discussed in 
Chapter 3). To examine this further, I chose to consider the 
effect of sequential skin exposure to hapten on the appearance 
of FITC-bearing dendritic cells within the lymph node. Flow 
cytometric data are presented for dendritic cell-enriched 
auricular lymph node cell fractions isolated from mice subjected 
to consecutive applications to the same ears of firstly the non- 
fluorescent haptens oxazolone or DNCB and secondly FITC. The 
results demonstrated that such a regime of challenges on the 
skin surface markedly reduced the relative frequency of FITC- 
bearing dendritic cells within the local lymph node compared 
with non-FITC bearing dendritic cells. The effects were 
dependent on the relative dose of the two haptens and the time 
elapsed between administration of the two haptens.
The results in this chapter can thus be conveniently divided 
into three interrelated sections:
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i) Isolation and enuneration
ii) Hapten-bearing nature of dendritic cells
iii) Kinetic studies on dendritic cell appearance in the node
This is reflected in the data and discussions which follow. 
7.1.2 The enumeration of dendritic cells
Auricular lymph node cell suspensions were prepared from groups 
of mice painted on both ears 18hrs previously with 2.5% FITC. 
Utilising Metrizamide gradient centrifugation (see chapter 5) 
such cell suspensions were fractionated into low buoyant density 
cell-enriched and depleted fractions. The microscopical 
appearance of cells within both fractions was analysed and it 
was routinely observed that the low buoyant density cell- 
enriched fraction was enriched with cells of a characteristic 
dendritic cell morphology, in agreement with previous published 
work from both this laboratory (Kinnaird et al 1989) and others 
(Knight et al 198?).
Having established the criteria for dendritic cell enumeration, 
I then describe increases in dendritic cell recovery from 
auricular lymph node cells following ear-painting with 2.5% 
FITC. These increases are shown to be dose and time dependent, 
again in agreement with earlier published studies (Kinnaird et 
al 1989) from this laboratory.
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Photographs 7.1.1 and 7.1.2 demonstrate the morphological 
features of dendritic cells and lymphocytes as they appeared on 
an improved Neubaer haemocy tome ter. The characteristic 
dendritic cell morphology, consisted of a relatively large cell, 
with a fluffy or diffuse appearance, difficult to focus on, with 
occasional cells showing branching dendrites. I wish to 
reiterate, that these photographs are intended to demonstrate my 
criteria for counting dendritic cells: they do not purport to be 
a photographic study of dendritic cell morphology - for such 
work I refer you to Macatonia et al 1987 and Kinnaird et al 
1989).
In photograph 7.1.1 a low buoyant density cell-depleted, or 
dendritic cell-depleted, auricular lymph node cell fraction is 
shown. Characteristically, such a population was rich in small, 
spherical lymphocytes, arrowed. In photograph 7.1.2 the low 
buoyant density cell-enriched, or dendritic cell-enriched, 
auricular lymph node cell fraction is shown. This population 
was rich for large, diffuse dendritic cells (arrowed) with a few 
contaminating lymphocytes (marked L) also present.
It was routinely observed, that within the dendritic cell- 
enriched fraction, 65-70% of cells counted were of large, 
diffuse, dendritic appearance.
NB. The fractionation of auricular lymph node cells on 
Metrizamide yields a low number of low buoyant density cells at 
the early time points in lymph node activation used in this
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chapter, ie less than 24hrs post sensitization. Counting was 
therefore performed at least four times on each sample, with 
such replicate counts until at least 200 cells were counted.
7.1.3 Relationship between dendritic cell yield per node and 
sensitizing dose or duration
With this technique, I measured the recovery of dendritic cells 
from auricular lymph node cell suspensions derived from groups 
of mice painted on both ears with 2.5% FITC at various times 
prior to lymph node harvest. The results of a representative 
experiment, displayed in figure 7.1.1 clearly show that as the 
time between ear-exposure to FITC and the isolation of auricular 
lymph nodes increases (between 12hrs and 18hrs) then the 
recovery of dendritic cells also increased. Thus at 12hrs post 
painting, there were 3.8 x 103 dendritic cells per node. At 
18hrs, the figure has trebled, to 10.5 x 103 dendritic cells per 
node. This data was in close agreement with that published 
(Kinnaird et al 1989).
In table 7.1.1 it is clear that the recovery of dendritic cells 
also depended on the dose of FITC used for painting mice ears 
prior to lymph node harvest. Thus, in this representative 
experiment mice painted 18hrs prior to sacrifice (harvest) with 
0.25% FITC in n-butyl phalate: acetone (w/v) yielded 5.8 x 103 
dendritic cells per node, while at 5% FITC this value was 
significantly increased, at 12.1 x 103 dendritic cells per node.
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Figure Legend 7.1.1 and Table Legend 7.1.1
In figure 7.1.1, groups of 10 BALB/c mice were painted on both 
ears with 2.5% FITC at time points of 18hrs, 15hrs and 12hrs 
prior to mouse sacrifice and auricular lymph node harvest.
In table 7.1.1, groups of 10 BALB/c mice were painted on both 
ears with either 0.25%, 0.5% or 5.0% FITC at a time point 18hrs 
prior to mouse sacrifice and auricular lymph node harvest.
Dendritic cell isolation and enumeration in both experiments 
A single cell suspension in standard medium was prepared from 
the pooled lymph nodes (ie 20) of each group.
For each suspension, the total volume of cells (adjusted to 5 x 
106 cells ml“ )^ was separated into low buoyant density cell - 
enriched and depleted fractions by Metrizamide single step 
density centrifugation as described in chapters 5 and 6. 
(Extreme care was taken to ensure the same conditions and 
Metrizamide batch was used within each experiment, so minimising 
any experimental variation between groups.)
Following fractionation, all low buoyant density cell-enriched 
interphase fractions for a particular group were pooled, washed 
and resuspended in 250ul. Dendritic cells were counted in this 
suspension by utilising a Neubaer counting chamber, performing 
numerous counts per group, counting at least 200 dendritic 
cells.
Utilising the following formula, a figure for recovered 
dendritic cells per node was established:
Mean value for dendritic cells ml~^ x 0.25ml - Mean dendritic 
20 nodes cells node-*-
Values of mean dendritic cells per node were presented as a 
function of 1) time elapsed after ear painting and 2) percentage 
of FITC used for ear painting.
Phenotypic analysis of dendritic cell-enriched fractions (prepared 
as described in 5.2.7) from mice painted 18hrs previously with 1 % 
FITC has been published (Cumberbatch and Kimber 1990). Routinely, 
70-80% of cells within the fraction have dendritic morphology and 
stain strongly with anti la antibody. The remaining cells lacked 
distinctive dendritic features and about half (10-15%) were Thyl+, 
non-proliferating small lymphocytes (approximately 1% were 
proliferating T-lymphoblasts). Also identified within the non- 
dendritic cells were a small number (<2%) of cells staining weakly 
with Macl and F4/80 - these cells were unique within the
interphase fraction in being capable of phagocytosing beads. 
Finally, these studies demonstrated that the hapten FITC was found 
at high levels on 50-60% of Ia+ dendritic cells. No FITC was 
associated with the la- non dendritic fraction.
FIGURE AND TABLE 7.1.1
Hie Relationship between Dendritic Cell Yield Per Node and Both 
Sensitizing Dose and Duration
1 4  1 6  1 8
T im e  e l a p s e d  a f t e r  e a r - p a l n t l n g  
w i t h  2 .5 %  F I T C . ( h r s )
Sensitizing dose 
of FITC 
(% w/v)
Dendritic cells node*' 
(x 1 0 ~ 3)
0-25 5-8
0-5 81
5 0 121
7.2 The distribution of FITC-bearing cells within lymph node 
cell populations isolated 18hrs following sensitization
In this section the hapten-bearing nature of cellular fractions 
isolated from local lymph nodes is analysed. By utilising the 
fluorescent hapten FITC and rapid flow cytometric techniques on 
large populations of lymph node cells, it was possible to 
'visualise' and assess quantitatively the level of hapten within 
such populations. In combination with density fractionation of 
lymph node cell populations it has been possible to collate 
meaningful data on which cellular components bear hapten (FITC) 
in lymph nodes during activation. I have described fully the 
use of flow cytometry in chapter 5. In brief, the method allows 
the parameters of cell size, cell granularity and fluorescence 
to be measured and recorded for each of many cells (routinely 50 
x 10^ cells per sample/group). These data points are integrated 
by computer programs and presented as a population of cells 
within a histogram. Thus the population of cells is 
'visualised'.
In this thesis flow cytometric data is presented in appropriate 
histograms, contour plots (basically 3D histograms with cell 
size, fluorescence and frequency) or tabulated, statistical 
format. The amount of data presented established the emphasis I 
wish to put on it.
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7.2.1 The characteristic appearance of fractions of auricular 
lymph node cells using the complementary methods of flow 
cytometry and fluorescence microscopy
A representative flow cytometric analysis is presented in figure
7.2.1 (4 pages), for an experiment analysing a lymph node cell 
population and its component cellular fractions, isolated from 
mice painted on the ears 18hrs previously with 1% FITC. Thus, 
in figure 7.2.1A(i) it is clear that the majority of cells 
within the unfractionated population fell in a tight 
distribution, with a peak frequency at 95 units along the 
forward scatter (cell size) axis. The arrow represented an 
arbitrary marker with 95.4% of cells to the left and 4.6% to the 
right. The low buoyant density cell-depleted fraction isolated 
from these lymph node cells had essentially the same forward 
scatter profile (figure 7.2.1.A(ii)). The low buoyant density 
cell-enriched fraction, however, had a significantly changed 
forward scatter profile [figure 7.2.1A(iii)] with the bulk of 
the cells (65%) shifted to the right of the marker: the low 
buoyant density cell-enriched fraction is enriched for cells of 
high forward scatter. These forward scatter profiles were 
maintained for lymph node cell fractions isolated from naive 
mice or mice treated with a different hapten (DNCB) 18hr prior 
to harvest (see figure 7.2.2A and figure 7.2.3A) and therefore 
reflect fractionation procedures rather than changes induced by 
skin-painting or cellular activation within lymph nodes.
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General Legend for Figures 7.2.1A, B and C
Auricular lymph node cells from a group of 4 BALB/c mice painted 
18hrs previously on both ears with 25ul of 2.5% FITC were pooled 
into a single cell suspension in standard medium (see chapter 
5). This suspension was fractionated into low buoyant density 
cell-enriched (interface) and depleted (pellet) cells by 
Metrizamide single-step density centrifugation as described in 
chapters 5 and 6. For analysis, fractions were collected, 
washed and each transferred at 4°C to a labelled, FACStar 
compatible test tube.
Analysis
Each sample was run through the precalibrated FACStar flow 
cytometer after gates were set for analysis of viable cells only 
(see chapter 5). Data was stored on computer disc for 50 x 10^ 
cells in each sample. This data was integrated by computer to 
generate an analysis of cell distribution as a function of 
(7.2.1A) - forward angle light scatter (cell size)
(7.2.IB) - cell green fluorescence intensity
(7.2.1C) - both A and B, combined in a contour plot
In table 7.2.1 the quadrant analysis superimposed on figure 
7.2.1C contour plots is used as a grid by which cell 
distribution may be quantified.
Figure Legend 7.2.1A
See general legend
Computer-integrated analyses of cell distribution as a function 
of forward angle light scatter (cell size) for populations of 
auricular lymph node cells.
Characteristic histograms are presented for i) unfractionated, 
ii) low buoyant density cell-depleted and iii) low buoyant 
density cell-enriched auricular lymph node cells from mice 
painted on both ears 18hrs previously with FITC.
FIGURE 7.2.1A
FACS Computer-generated Histograms of Cell Nimber v Forward Angle 
Light Scatter for Populations of Auricular Lymph Node Cells from 
FllC-painted Mice 
CELL NUMBER
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FIGURE 7.2.IB
FACS Computer-generated Histograms of Cell Nunber v  Green 
Fluorescence Intensity for Populations of Auricular Lymph Node 
Cells from FITC-pain ted Mice 
C E L L  N U M B E R
10°  101 102 103 104 F L U O R E S C E N C E
Computer-integrated analyses of cell distribution as a function 
of green fluorescence intensity for the same populations as in 
figure 7.2.1A.
The fluorescence profile of the FITC-primed lymph node cell 
populations described in figure 7.2.1A are shown in figure 
7.2.IB. Considering the number of cells (x axis) with a given 
fluorescence intensity (y axis; note fluorescence intensity is a 
logarithmic scale), then unfractionated cells (figure 7.2.1B(i) 
and the low buoyant density cell depleted cells [figure 
7.2.1B(ii)] showed low fluorescence, with the majority of cells 
at less than 3 on the fluorescence intensity axis.
Cells within the low buoyant density cell-enriched fraction 
[7.2.1B(iii)] consisted of cells displaying a range of 
fluorescence from nil up to 10^*^ on the fluorescence intensity 
axis. Within this range, the majority of cells were either 
highly fluorescent (peak 10^*^) or of low (but not negligible) 
fluorescence (peak 10*-). Clearly, there was a biphasic 
distribution of fluorescence within the low buoyant density 
cell-enriched auricular lymph node cells from FITC-painted mice.
The data from figures 7.2.1A and B are presented together in a 
dual parameter population analysis, in contour plots, figure 
7.2.1C.
Using such analysis, it is clear, that large cells were enriched 
within the low buoyant density cell-enriched lymph node cells 
and that the high levels of fluorescence were associated almost 
exclusively with these large cells.
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Figure Legend 7.2.1C
Computer-integrated analyses of cell distribution as a function 
of forward angle light scatter and green fluorescence intensity 
within contour plots, for auricular lymph node cell populations.
Characteristic contour plots, with forward angle light scatter 
on the abcissa, fluorescence intensity on the ordinate and cell 
frequency signified by line density, are presented for the same 
populations displayed in figure 7.2.1A.
FIGURE 7.2.1C
FACS Computer-Generated Contour Plots of Forward Angle T-ipht
0 30 60 F A LS
Table Legend 7.2.1
As can be seen in figure 7.2.1C, a standard quadrant was 
superimposed on each of the three populations displayed. The 
quadrant axes were set to distinguish between lymphocytes and 
dendritic 'sized' cells on the forward angle light scatter axis 
and to distinguish between high and low fluorescent cells on the 
fluorescence intensity axis.
Such a procedure generates four categories of cells:
Quadrant 1, small cells, high fluorescence 
Quadrant 2, large cells, high fluorescence 
Quadrant 3, small cells, low fluorescence 
Quadrant 4, large cells, low fluorescence
In this table, the percentage of the 50 x 10^ cells recorded for 
each population falling in each quadrant is presented.
Quadrant 2 + Quadrant 4 (q2 + q4) gives the percentage of all 
cells that are large (dendritic sized).
Quadrant 2/(Quadrant 2 + Quadrant 4) (q2/q2 + q4) x 100 gives 
the percentage of the large cells which are of high 
fluorescence.
TABLE 7.2.1
Statistical Distribution of Cells Within the Quadrant Analysis 
Superimposed on the Cell Populations Presented in Figure 7.2.1C
C o n s o rt  3 0  s ta t is t ic a l a n a ly s is  o f f lu o r e s c e n c e  
d istrib u tio n .
Percentage of total cells analysed 
within each quadrant.
1 2 3 4 q2+q4 m / f q j « * * )
0 * 2 0*3 96*3 3*2 3*5 8*6
0 * 2 0*1 9 4 * 9 4*8 4 * 9 2*0
4 . 7 2 5 * 6 32*7 3 7 -1 6 2  *7 4 0 * 8
In table 7.2.1, this characteristic distribution of cell size 
and fluorescence is presented quantitatively, with a percentage 
breakdown of cells within each population that are of small 
forward scatter, high fluorescence, etc (see table legend). The 
data clearly demonstrates that the bulk (>95%) of cells within 
the unfractionated and low buoyant density cell-depleted lymph 
node cells are of low forward scatter and low green fluorescence 
intensity. Within the low buoyant density cell-enriched lymph 
node cells, however, 62.7% of the cells were of high forward 
scatter and of these, 40.8% were highly fluorescent.
By examining the distribution of fluorescence amongst 
morphologically discernible dendritic cells using fluorescence 
microscopy, I have demonstrated that the highly fluorescent 
cells were dendritic cells. Thus, in photograph 7.2.1A, 
dendritic cells within a low buoyant density cell-enriched 
auricular lymph node cell population from mice painted 18hrs 
previously with 2.5% FITC are arrowed. It is clear that the 
same cells are highly fluorescent in photograph 7.2.IB. It is 
also notable that other dendritic cells appear to have very 
low/or negligible fluorescence within the same population, a 
point which will be discussed later.
Considering low buoyant density cell-depleted lymph node cells 
from the same mice, it is clear that such a fraction was rich in 
uniformly sized lymphocytes (photograph 7.2.2A) and that these 
cells were very low or negligible for fluorescence (photograph 
7.2.2B).
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PHOTOGRAPHS 7.2.1A AND B
Photomicrographs of Dendritic Cells Using a) Ordinary Field and b) 
Ultraviolet Illumination
a
3 5  u m
b
3 5  u m
AUTOGRAPHS 7.2.2A AND B
Photomicrographs of Lymphocytes using a) Ordinary Field 
Illumination and b) Ultraviolet Illmrination
3 5 u m
7.2 .2  Comparisons between n a iv e  and F IT C -se n s itize d  mice
In figure 7.2.2 (4 pages) the forward scatter and fluorescence 
intensity were compared for auricular lymph node cells from 
naive mice or mice painted on both ears 18hrs previously with 
2.5% FITC. The forward scatter profile for unfractionated and 
fractionated lymph node cells from both naive (figure 7.2.2A) 
and FITC-primed lymph node cells (figure 7.2.2B) were as 
described in experiment 7.2.1 with significant enrichment for 
large cells in the low buoyant density cell-enriched fraction, 
ie dendritic cells [7.2.2A(iii) and 7.2.2B(iii)].
Analysis of the FITC-primed, unfractionated and fractionated 
cells revealed the characteristic peak of highly fluorescent 
cells within the low buoyant density cell-enriched fraction 
[7.2.2D(iii)]. No highly fluorescent cells were detectable in 
naive lymph node cells or fractions thereof (7.2.2C). It was 
also noted, that FITC-primed, low buoyant density cell-depleted 
(pellet) cells, never had high levels of fluorescence, but did 
possess some fluorescence, slightly higher than seen for naive 
lymph node cell populations [figure 7.2.2D(ii) compared with 
7.2.2C(ii)].
7.2.3 The negligible autofluorescence of activated auricular 
lymph node cells
That the high fluorescence on dendritic cells within the low 
buoyant density cell-enriched, FITC-primed lymph node cells was
1 5 3
General Legend for Figures 7.2.2A. B, C and D
Auricular lymph node cells from groups of 4 BALB/c mice painted 
18hrs previously with nil or 2.5% FITC were pooled into two 
single cell suspensions in standard medium (see chapter 5).
Fractionation of both populations and the analysis of cells was 
as described in general legend for figures 7.2.1.
Figure Legend 7.2.2A
See General Legend
Computer-generated analyses of cell distribution as a function 
of forward angle light scatter (cell size) for populations of 
auricular lymph node cells.
Characteristic histograms are presented for i) unfractionated, 
ii) low buoyant density cell-depleted and iii) low buoyant 
density cell-enriched auricular lymph node cells from naive
mice.
FIGURE 7.2.2A
FACS Congxiter-generated Histograms of Cell Nunber v Forward Angle 
Light Scatter for Populations of Auricular Lymph Node Cells from 
Naive Mice
Figure Legend 7.2.2B
See General Legend
Computer-generated analyses of cell distribution as a function 
of forward angle light scatter (cell size) for populations of 
auricular lymph node cells.
Characteristic histograms are presented for i) unfractionated, 
ii) low buoyant density cell depleted and iii) low buoyant 
density cell enriched auricular lymph node cells from mice 
painted on both ears 18hrs previously with 2.5Z FITC.
FIGURE 7.2.2B
FACS Computer-generated Histograms of Cell Number v Forward Angle 
Light Scatter for Populations of Auricular Lymph Node Celia from 
FITC-painted Mice 
C E L L  N U M B E R
FIGURE 7.2.2C
FACS Computer-generated Histograms of Cell Number v Green 
Fluorescence Intensity for Populations of Auricular Lymph Node 
Cells from Naive Mice
Computer-integrated analyses of c e l l  d is tr ib u t io n  as a function
of green fluorescence in ten sity  for the same populations as in
figu re  1.2.2k.
FIGURE 7.2.2D
FACS Computer-generated Histograms of Cell Number v  Green 
Fluorescence Intensity for Populations of Auricular Lymph Node 
Cells from FITC-painted Mice 
C E L L  N U M B E R
Computer-integrated analyses of c e l l  d is tr ib u tio n  as a function
of green fluorescence inten sity  fo r  the same populations as in
fig u re  7.2.2B.
not due to auto fluorescence induced by the immunisation regime 
per se, but rather the FITC applied to the mouse ears, was 
examined in experiments documented in figure 7.2.3.
Auricular lymph node cell populations from mice painted 18hrs 
previously with either 1% FITC or 2.5% DNCB were examined. 
While the forward scatter profile of the low buoyant density 
cell (or dendritic cell)-enriched fractions for both treatments 
were equivalent [compare figure7*Z*3A(ii) and (iii)] it was clear 
that only the dendritic cell-enriched fraction from FITC-painted 
mice contained the highly fluorescent, large cells and 
characteristic biphasic distribution of fluorescence [compare 
7.2.3B(ii) and (iii)].
7.2.4 The dependence of dendritic cell fluorescence on the dose 
of FITC applied to mouse ears
It has also been demonstrated that the intensity of fluorescence 
on fluorescent positive cells within low buoyant density cell- 
enriched fractions of FITC-primed lymph node cells is 
proportional to the dose of FITC applied on the ear. This is 
demonstrated in figure 7.2.4. In this experiment, low buoyant 
density cell-enriched fractions were isolated from the lymph 
node cells of mice painted 18hrs previously with 0.25%, 0.5% or 
1.0% FITC. As can be seen in figure 7.2.4A the forward scatter 
profile of these three populations was characteristic and 
identical [compare 7.2.4A i, ii and iii].
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General Legend for Figures 7.2.3A and B
Auricular lymph node cells from groups of 4 BALB/c mice painted 
18hrs previously on both ears with either 25ul of 17. FITC or 
2.5% DNCB were pooled into two single cell suspensions in 
standard medium (see chapter 5). These suspensions were 
fractionated into low buoyant density cell enriched (interface) 
and depleted (pellet) cells by Metrizamide single-step density 
centrifugation, as described in chapter 5 and 6. For analysis, 
fractions were collected, washed and each transferred at 4°C to 
a labelled, FACStar compatible test tube.
Analysis
As described in general legend for figure 7.2.1 
Figure Legend 7.2.3A
See General Legend
Computer-integrated analyses of cell distribution as a function 
of forward angle light scatter (cell size) for populations of 
auricular lymph node cells.
Characteristic histograms are presented for i) unfractionated 
lymph node cells from FITC-painted mice, ii) low buoyant density 
cell enriched lymph node cells from FITC-painted mice and iii) 
low buoyant density cell-enriched lymph node cells from DNCB- 
painted mice.
FIGURE 7.2.3A
FACS Computer-generated Histograms of Cell Nunber v Forward Angle 
Light Scatter for Populations of Auricular Lymph Node Cells from 
FITC and DNCB-painted Mice 
C E I L  N U M B E R
0 100 200 F A L S
FIGURE 7.2.3B
FACS Computer-generated Histograms of Cell Number v  Green 
Fluorescence Intensity for Populations of Auricular Lymph Node 
Cells from FTTC and DNCB-painted Mice 
C a L  N U M B E R
Computer-integrated an alyses of c e l l  d is tr ib u tio n  as a function
of green fluorescence in te n s ity  fo r the same populations as in
fig u re  7.2.3B.
The fluorescence intensity of these three populations was 
similar, in possession of a peak of highly fluorescent cells 
(figure 7.2.4B). It is clear, however, that the populations 
differ in that as the painting dose increases, so the position 
of this peak to the right also increases (compare figure 7.2.4B 
i, ii and iii). The fluorescence intensity of these three 
populations is presented in table 7.2.2. The markers in figure 
7.2.4B, delineating the highly fluorescent peak of cells within 
populations i, ii and iii enable the computer program associated 
with FACStar to compute the mean fluorescence intensity of the 
highly fluorescent cells. Such a procedure is represented in 
table 7.2.2. Clearly as the dose of FITC increases, so too does 
the mean intensity value for the highly fluorescent cells 
delineated in peak 2. Thus, for 0.25% FITC, the mean 
fluorescence intensity of the 'peak 2' cells is 120.3; at 0.5% 
FITC this value is 294.7 and at 1% FITC 479.4.
7.3.1 The effect of sequential ear painting on the lymph node 
content of FITC-bearing dendritic cells
In this section, experiments are described which build upon some 
initial studies in this laboratory (A Kinnaird, I Kimber, 
Alderley Park) which demonstrated that if naive mice were 
painted on the ears with a non-fluorescent sensitizing chemical, 
for example oxazolone or DNCB, prior to painting with the 
fluorescent sensitizer FITC 24hrs later, then the expected ratio 
of high FITC: low (nil) FITC bearing dendritic cells 18hrs later 
was reduced. Here, this effect of rapid, sequential hapten
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Auricular lymph node cells from groups of 4 BALB/c mice painted 
18hrs previously on both ears with 25ul of either i) 0.25% FITC, 
ii) 0.5% FITC or iii) 1.0% FITC were pooled into three single 
cell suspensions in standard median (see chapter 5).
Low buoyant density cell-enriched fractions for each of these 
populations was prepared and analysed as previously described 
(see figure legend 7.2.1).
The data was integrated for each population, generating an 
analysis of cell distribution as a function of
A - forward angle light scatter 
B - cell green fluorescence intensity.
In table 7.2.2, the markers superimposed on figure 7.2.4B are 
used as a grid by which cell distribution within the marked, 
"peak 1 or peak 2" areas may be quantified.
FIGURE 7.2.4A
FACS Computer-generated Histograms of Cell Number v Forward Angle 
l-ipht Scatter for Populations of Auricular Lymph Node Cells from 
FITC-paixited Mice 
C E L L  N U M B E R
Computer-integrated analyses of cell distribution as a function 
of forward angle light scatter (cell size) for low buoyant 
density cell-enriched auricular lymph node cells.
Characteristic histograms are presented for mice painted 18hrs 
previously with i) 0.25% FITC, ii) 0.5% FITC and iii) 1.0% FITC.
FIGURE 7.2.4B
FACS Computer-generated Histograms of Cell Number v  Green 
Fluorescence Intensity for Populations of Auricular Lymph Node 
Cells from KllC-painted Mice
Computer-integrated analyses of cell distribution as a function 
of green fluorescence intensity for the same populations as in 
figure 7.2.4A.
TABLE 7.2.2
Statistical Distribution of Cells Within the Markers Superimposed 
on the Three Cell Populations Presented in Figure 7.2.4B
Dendritic cell-enriched 
auricular lymph node 
cells from mice painted 
on the ears 18hrs
C o n s o rt  3 0  s ta t is t ic a l a n a ly s is  
of f lu o r e s c e n c e  d is trib u tio n .
W i i « 5 n _____ • 3 3 I S|S'  Mean.
0 .25%  F ITC L .I  O  -  2 6 -7 7 8 0 7 7 8 1 3  2
R, 2  7 -7 -4 3 1 2163 21-6 1 2 0 -3
0 .5 %  F ITC L .K )  -  7 3 -6 8217 82-2 6 -2
R .7 6 -3 -9 9 1 1757 1 7 6 2 9 4  7
1.0% F ITC L .1 -0 -1 2 6 - 0 8 5 9 5 8 6 -0 10-1
R.1 3 1 -0 -1 9 6 8 1396 1 4 0 4 7 9 -4
As can be seen in figure 7.2.4B, markers, delineating the high 
fluorescent cells within each population, were set. Such 
markers enable the marked data to be analysed in isolation from 
the remaining cells, thus the mean fluorescent intensity of 
cells within peak 2, the highly fluorescent cells, can be 
determined for each of the populations.
In this table the figures from such an analysis are presented. 
Considering a given dose of FTTC, then peak 1 and peak 2 are 
separated. For each peak, the following data is cited
a) total number of cells in the peak;
b) the percentage of all cells counted, within the markers; 
and
c) the mean fluorescent intensity of cells within the peak.
application is described, both qualitatively and quantitatively: 
this effect is also related to the stimulatory activity in vitro 
of the resulting dendritic cell-enriched auricular lymph node 
cells.
The effect of exposure to the nonfluorescent hapten oxazolone 
24hrs or 12hrs prior to exposure on the same ears to FITC has 
been analysed by measuring changes in the recovery of highly 
fluorescent, large (dendritic) cells within the low buoyant 
density cell-enriched fraction of auricular lymph node cells.
The timing of treatments was routinely as follows:
-42hr or -30hr
Topical application of non-fluorescent sensitizing chemical on 
both ears
-18hr
Topical application of 5% FITC on both ears 
- Ohr
Sacrifice. Analysis of auricular lymph node cells
An analysis of cell-associated green fluorescence, exactly as 
described in the previous section 7.2, was performed on the low 
buoyant density cell-enriched and depleted auricular lymph node 
cells from mice painted with either oxazolone or vehicle alone 
24hrs prior to FITC painting. The resulting fluorescence v
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forward angle light scatter contour plots are presented in 
7.3.1. The analyses in this section were performed using the 
EPICs flow cytometer and attached computer/ software. The data 
appearance is thus slightly different but the experimental 
procedures and results were interchangeable with FACS tar studies 
at Warwick.
A quadrant analysis superimposed on the contour plots was 
established utilising the same criterion as described in the 
legend to table 7.2.1. Accordingly, the numerical breakdown for 
the cellular distribution presented in figure 7.3.1 is presented 
in table 7.3.1.
It was apparent that unfractionated and dendritic cell-depleted 
lymph node cells (data not shown) and dendritic cell-enriched 
lymph node cells [figure 7.3.1(v)] from mice primed 18hr 
previously with FITC had characteristic patterns of cell 
size/fluorescence, as previously described. Dendritic cell- 
enriched auricular lymph node cells from mice which had received 
1% oxazolone on their ears 24hrs prior to FITC [figure 7.3.1(i)] 
or 12hrs prior to FITC [figure 7.3.1(iii)] had noticeable 
changes in fluorescence/size distribution, with reductions in 
the number of highly fluorescent, large cells, when compared to 
mice which had received FITC only.
From the contour plots, it is clear that if FITC application was 
preceded by oxazolone application at the same (ear) site, then 
the result was a marked reduction in the number of cells of
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General Legend for Figures 7.3.1-3 and Tables 7.3.1-2
Groups of 4 BALB/c mice were routinely painted with two discrete 
doses of hapten on both ears prior to lymph node harvest. The 
treatments were as follows:
1) At 42 (-42hrs) or 30(-30hrs) hours prior to cell harvest, 
groups were painted on both ears with nil, acetone:olive 
oil, oxazolone or DNCB.
2) At 18 (-18hrs) hours prior to cell harvest, groups were 
painted on both ears with 25ul of 5% FITC.
3) At 0 hours, auricular lymph node cells from each of the 
groups were pooled into single cell suspensions in 
standard medium (see chapter 5).
These suspensions were fractionated into low buoyant density 
cell-enriched (interface) and depleted (pellet) cells by 
Metrizamide single-step density centrifugation as described in 
chapters 5 and 6. For analysis, the dendritic cell or low 
buoyant density cell-enriched interphase fractions were 
collected, washed and each transferred at 4°C to a labelled, 
EPICs-compatible test tube.
Analysis
Each sample was run through the precalibrated EPICs flow 
cytometer after gates were set for analysis of viable cells 
only. Data was stored on computer disks for 50 x 10^ cells in 
each sample. This data was then integrated by computer to 
generate an analysis of cell distribution as functions of both 
forward angle light scatter and green fluorescence intensity.
Computer-integrated analysis of cell distribution as a function 
of forward angle light scatter and green fluorescence intensity 
within contour plots, for auricular lymph node cells.
Characteristic contour plots are shown for low buoyant density 
cell enriched lymph node cells from mice treated with 1% 
oxazolone or acetone:olive oil prior to treatment on the same 
ears with 5% FITC. Mice were sacrificed at Ohrs.
FIGURE 7.3.1
EPICs Canputer-generated Contour Plots of Forward Angle f-ipht 
Scatter v  Green Fluorescence Intensity v  Cell Number for Low
large forward scatter and high fluorescence. The 'transfer' of 
cells from quadrant 2 to quadrant 4 can be explained as a 
reduction in the ratio of high fluorescent: low fluorescent, 
large (dendritic) cells. The effect was most pronounced when 1% 
oxazolone was applied 24 hrs prior to 5% FTTC (rather than 12hrs 
prior). It was also clear that application of the 
nonsensitizing chemical A00 at either 24hrs or 12hrs prior to 
FITC exposure did not cause this effect (compare figure 
7.3.1(ii) and (iv) with v). None of the pretreatments 
significantly affected the size-fluorescence profiles of the 
unfractionated or dendritic cell-depleted lymph node cell 
populations (data not shown).
Considering all cells to the right of the quadrant vertical 
axis, ie quadrants 2 + 4, within the low buoyant density cell- 
enriched fractions, it was possible to analyse large (assumed 
dendritic) cells alone.
To achieve this, a gate is superimposed on the contour plots, at 
a position overlaying the vertical axis of the quadrant 
analysis. As described earlier in table 7.2.1 legend, cells to 
the left of the vertical axis are lymphocytes, to the right, 
cells are dendritic (or dendritic-sized).
The biphasic distribution of fluorescence within the large cells 
of quadrant 2 + 4 is represented in the cell number v 
fluorescence intensity profiles of figure 7.3.2. It was 
apparent that the FITC primed, dendritic cell—enriched fraction
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Figure Legend 7.3.2
See General Legend
Computer-integrated analysis of large cell distribution as 
function of green fluorescence intensity within the five 
auricular lymph node cell populations in figure 7.3.1.
To facilitate analysis of large cells only, a gate was 
superimposed on the contour plots in figure 7.3.1 at a point 
overlaying the vertical axis of the quadrant analysis. The 
computer was then programmed to integrate data points falling 
only to the right of this axis.
Thus characteristic histograms are presented for the 
fluorescence distribution.
FIGURE 7.3.2
EPICs Computer-generated Histograms of Cell Nunber v Green 
Fluorescence Intensity for Populations of Lgcgg Auricular Lymah 
Node Cells from Oxazolone and FTTC-painted Mice
T R E A T M E N T  
1 2
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F L U O R E S C E N C E
TABLE 7.3.1
Statistical Distribution of Cells Within the Quadrant Analyses 
Superimposed on the Cell Populations Presented in Figure 7.3.1
TREATMENT 
1 1
EPIC
Percent 
in each
1
s ta tis
ge of to 
quadrant
2
ical ana 
al cells a
3
y s is  of 
nalysed 
4
flu o re s c e
La
q2+q4
n e e  d is t r it
rge c e lls
H ig h  FL1. 
□2/<q2+q4)|
u tion.
Low  FL1. 
q4/(q2+q4)
Nil
A O O / -4 2 h i
1 .0%
Oxazolone
-4 2 h r
A O O / -3 0 h r
~  t o %  
Oxazolone 
-3 0 hrs
5 .0 %  F1TC 
5.0% F IT C  
5.0% FITC  
5.0%  F ITC  
5.0%  FITC
4-6 35-7 28-8 30-9 66*6 53-6 46*4
4-4 42-9 26*3 26*4 69-3 62-0 380
1-2 9-3 33-9 55-7 65*0 14*3 85 *7
4-9 36-1 32*0 26-9 63*0 57*3 42*7
3-3 33-2 28-2 35*3 68-5 48*5 51*5
As can be seen in figure 7.3.1, a standard quadrant was 
superimposed on each of the five populations displayed. The 
axes were set to distinguish between lymphocytes and dendritic 
'sized' cells on the forward angle light scatter axis and to 
distinguish between high and low fluorescent cells on the 
fluorescence intensity axis (see figure 6 .2 . 1  legend).
In this table, the percentage of the 50 x 10^ cells recorded for 
each of the five treatment groups (populations) falling in each 
quadrant is presented.
The q2 + q4 total etc are as described in figure legend 7.2.1.
(figure 7.3.2V) had the characteristic biphasic distribution of 
fluorescence within its large cells. This profile was 
significantly altered, with the bulk of large cells shifting 
from high fluorescence to low fluorescence, when mice were 
pretreated with oxazolone [figure 7.3.2 (i) and (iii)]. No such 
effect was observed when mice were pretreated with A00 [figure 
7.3.2 (ii) and (iv)].
These shifts within the biphasic fluorescence distribution were 
quantified, and the results are presented in table 7.3.1.
As expected, the pretreatment did not significantly affect the 
recovery of large cells in any group. Thus the total 
remained constant at approximately 6 6%. Within this constant 
percentage of large cells, the FITC primed low buoyant density 
(dendritic) cell-enriched fraction consisted of 53.6% high 
fluorescent: 46.4% low fluorescent cells. The oxazolone 
pretreatment caused significant change in this ratio with 14% 
high; 8 6% low fluorescence. The A00 pretreatments failed to 
cause significant changes.
The dependence of this effect on the dose of oxazolone used to 
pretreat mice prior to FITC priming was analysed: the results of 
a representative experiment are presented in table 7 .3 .2 . 
Again, the concentration of oxazolone used to pretreat mice did 
not significantly alter the q2 + total. That is, 
pretreatment did not affect the fractionation of low from high 
buoyant density cells within any of the low buoyant density
159
TABLE 7.3.2
The Percentage of Large (Dendritic) Cells Possessing High, Green 
Fluorescence Intensity Within Auricular Lymph Node Cells from 
FlTC-painted Mice. Dependence on the Dose of Oxazolone Applied 
24hrs Prior to FTTC
6 P IC s  s ta t is t ic a l a n a ly s is  o f f lu o re s c e n c e  d is tr ib u t io n .
T R E A T M E N T  
1 2
Percentage of total cells analysed 
in each quadrant.
_ J _________2________ 3____  4 q2+o4
Large cells.
High FLI Lo w  F L1  
q2/(q2+q4) q 4 / (q 2 + q 4
~  1 0 %  
Oxazolone 5 0%  F IT C 0*5 3*4 41*5 5 4 -7 58-1 5 - 9 94*1
O xSh J cxi. 5.0% F IT C 1 -0 7 -6 3 7 -4 54-1 6 1 * 7 12 -3 8 7 * 7
Q.1%
Oxazolone 5.0% F IT C 1 -9 12-1 47*6 38*4 5 0 5 2 4 -0 7 6 * 0
Oxazoione 5.0% F ITC 4*9 2 8 -8 34-1 3 2 -3 61-1 4 7 -0 5 3 * 0
A O O 5 0% F IT C 2 -7 2 7 -7 4 0 * 0 2 9 -0 5 6 -7 4 8 -9 51*1
See General Legend
In this experiment 5 groups of 4 BALB/c mice were prepared, each 
differing from the other only in the dose of oxazolone received 
24hrs prior to 5 Z  FITC application.
In this table the percentage of 50 x 10^ cells recorded for each 
of the five treatment groups (populations) falling in each 
quadrant of the five contour plots (not shown) is presented.
The q2 + q4 total etc are as described in figure legend 7.2.1.
cell-enriched populations. It was apparent, however, that as 
the dose of oxazolone used to pretreat mice increased, from 
0.05% to 1.0%, then there was a concomitant reduction in the 
number of large cells which were highly fluorescent. Thus, for 
pretreatment with 0.05% oxazolone, 47% of large cells within the 
low buoyant density cell enriched fraction were highly 
fluorescent, 53% low fluorescence: this ratio was similar to 
that recorded for no pretreatment. However, for pretreatment 
with 1% oxazolone, 5.9% of large cells within the low buoyant 
density cell enriched fraction were high fluorescence, 94.1% low 
fluorescence. This dose-dependent change has been presented in 
figure 7.3.3. It has also been demonstrated (data not shown) 
that for pretreatment with a fixed dose (1 %) of oxazolone, the 
period of time elapsing between pretreatment and priming 
determines the size of reduction seen in the number of highly 
fluorescent large cells detected.
7.3.2 The effect of sequential ear painting on the stimulatory 
activity of dendritic cell-enriched lymph node cells
The stimulatory activity of dendritic cell-enriched lymph node 
cells isolated from mice primed at -42hrs with 0.75% DNCB and at 
-18hrs with 0.75% FITC has been analysed. The results, 
presented in figure 7.3.4 demonstrate that equivalent numbers of 
dendritic cell-enriched lymph node cells from mice pretreated 
with 0.75% DNCB are significantly less stimulatory than those 
isolated from mice which received the 0.75% FITC alone. Both 
populations, however, caused significantly enhanced
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FIGURE 7.3.3
The Percentage of Large (Dendritic) Cells Possessing High Green 
Fluorescence Intensity Within Auricular Lymah Node Cells from 
FITC-painted Mice. Dependence on the Dose of Oxazolone Applied 
24hrs prior to FITC
O x a z o l o n e  (X w / v )  u s e d  t o  p a i n t  m i c e  e a r s ,  
2 4 h r s  p r i o r  t o  F I T C - p r l m l n g .
Data extracted from table 7.3.2 and presented in graphical form 
to illustrate the dependency of the percentage of large 
(dendritic) cells bearing high fluorescence on the dose of 
oxazolone used for pretreatment.
Figure Legend 7.3.4 and 7.3.5
Responder Lymph Node Cells
A single cell suspension was prepared from the auricular lymph 
node cells of 4 BALB/c mice painted on both ears 7 days 
previously with 25ul of 5% FITC and adjusted to 5 x 10^ cells 
ml“l in standard medium.
Stimulator Cells
Dendritic cell enriched auricular lymph node cells were prepared 
from two groups of 30 BALB/c mice, as described in figure legend 
7.3.1. Mice in group i) had received 25ul of 0.75% FITC on each 
ear 18hrs prior to sacrifice. Mice in group ii) had received 
25ul 0.75% DNCB on each ear at 42hrs prior to sacrifice and 25ul 
of 0.75% FITC on each ear 18hrs prior to sacrifice.
Each dendritic cell-enriched lymph node cell fraction was 
adjusted to 4.5 x 10^ cells rnl“ -^ in standard medium.
FIGURE 7.3.4
Stimulation of FTTC-sensitized Lymphocyte Proliferation by Low
Buoyant Density Cell-Enriched Auricular Lymph Node Cells from Mice
Hapten Primed with FTTC alone or DNCB Prior to F11G
See General Legend
Culture conditions were standard, as described in chapter 5, 
with 5 x 105 responders: 9000 dendritic cells in 200ul final 
volume, for 48hrs.
Results are displayed as 1) the mean %-TdR incorporator +/- SD 
x 1 0“^ for 4-6 replicate wells per group.
** denotes significant statistical difference from paired
control (*)
proliferation within the FITC-sensitized responder lymph node 
cells. This reduced FITC response induced by DNCB pretreated 
dendritic cell-enriched lymph node cells reflects the expected 
reduction in the number of cells within the large (q2 + 0 4) cell 
fraction which were highly fluorescent after pretreatment 
(figure 7.3.5).
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FIGURE 7.3.5
FACS Computer-generated Contour Plots of Forward Angle Light 
Scatter v Green Fluorescence Intensity v  Cell Humber for Low 
Buoyant Density Cell-Enriched Auricular Lymph Node Cells from DNCB 
and FTTC Painted Mice. Quadrant Distribution
1 2  3 4
i.
5-4 18*8 32-9 42*9 61*7 30*5
*
0-3 2-8 28*5 68*4 71-2 3*9
Data is presented as previously described in general legend for
figure 7.2.1 and table 7.2.1.
7.4 Discussion
The morphology and phenotype of lymphoid dendritic cells has 
been comprehensively described in chapter 1. In brief, these 
studies demonstrated that the murine lymphoid dendritic cell, 
isolated from spleens or lymph nodes was characterised by a 
distinctive complement of cell surface membranes (Crowley et al 
1989). These included the lymphoid dendritic cell specific 
marker recognized by the monoclonal antibody 33D1 (Nussenzweig 
et al 1982) and the pseudo-specific markers recognized by 
monoclonal antibodies NLDC-145 and MIDC- 8  (Kraal et al 1986; 
Breel et al 1987). These workers demonstrated that such 
phenotypic markers belonged to cells with a distinctive, 
irregularly shaped plasma-membrane which often produced 
'pseudopodic' dendrites and a diffuse veiled or fluffy cell 
appearance, readily discernible under microscopic analysis.
The isolation of 33D1+ lymphoid dendritic cells has been 
described from a number of starting tissues and different 
species (reviewed in chapter 1). Of particular relevance here 
are isolates of dendritic cells from murine spleen and lymph 
nodes. In the case of the former the selective adherence of 
dendritic cells was utilised as a fractionation procedure 
(Nussenzweig et al 1982). Complementary to this method, but now 
generally more favoured, lymphoid dendritic cells are separated 
from either lymph node or spleen cell populations by exploiting 
the distinctive low buoyant density of lymphoid dendritic cells, 
as described by Knight and co-workers (1983). Thus, buoyant
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density centrifugation over a Metrizamide gradient enables the 
isolation of low buoyant density cell fractions at the 
Metrizamide-medium interface (described fully in chapter 5). It 
has been widely reported that optimally such low buoyant density 
cell-enriched fractions consisted of 75% large, morphologically 
dendritic, 33D1+ cells. Of the remaining low buoyant density 
cells, less than 5% were lymphocytes and less than 5% were 
phagocytic cells, as measured by expression of the receptor for 
the Fc region of antibodies (the FcR, Knight et al 1983) or the 
macrophage specific marker recognized by monoclonal antibody 
F4/80 (Austyn and Gordon 1981; Cumberbatch and Kimber 1990).
Isolation and characterisation of dendritic cells from auricular 
lymph node cells
I have routinely isolated dendritic cells from the auricular 
lymph node cells of mice painted on both ears up to 24hrs 
previously with contact sensitizing chemicals, usually 2.5% 
FITC. I utilised the Metrizamide centrifugation methodology as 
described earlier and generally achieved dendritic cell 
enrichment to levels of 60-70% dendritic cells. Compare this 
with the very low frequency of dendritic cells within 
unfractionated lymph node cells (<<0.5% cells counted). I have 
presented photographs which demonstrate the differing appearance 
of dendritic cell-enriched and dendritic cell-depleted auricular 
lymph node cell fractions isolated from Metrizamide gradients.
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The enrichment for dendritic cells was also reflected in the 
negligible proliferative activity of dendritic cell-enriched 
lymph node cells (which will be described in chapter 8 ). This 
is a significant point because I demonstrated in chapter 6 that 
at later stages following ear painting with sensitizing 
chemicals (Ad for 2.5% DNCB) the low buoyant density cell- 
enriched auricular lymph node cells consisted of significant 
limbers of highly proliferative, large, non-dendritic cells, 
together with dendritic cells. In this instance, dendritic 
cells constituted less than 60-70% of cells within the low 
buoyant density cell-enriched fraction.
In addition to the morphological criteria used to assess 
dendritic cell recovery within low buoyant density cell-enriched 
auricular lymph node cells it was desirable to identify some of 
the phenotypic markers on these cells. A series of experiments 
were performed in which I measured the monoclonal antibody- 
mediated indirect inmunofluorescence within DNCB-sensitized 
auricular lymph node cell fractions. The results (data not 
presented) indicated high levels of dendritic cell staining when 
the monoclonal antibody HB3, specific for class II MHC-encoded 
antigens (E Culbert ICI) was utilised as the first layer. This 
highlighted the expected high level of dendritic cell expression 
of la and was corroborated by additional staining experiments by 
my colleagues at ICI. I also assessed the staining activity of 
a poorly characterised supernatant from the hybridoma producing 
the dendritic cell specific monoclonal antibody 33D1 
(Nussenzweig et al 1982). Negligible staining of dendritic
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cells was achieved with this antibody. As the temperamental 
staining activity of the 33D1 antibody is widely recognized, an 
ascitic fluid containing higher titres of antibody was not 
obtained, as I did not expect to achieve useful results with 
this antibody.
In conclusion, these studies on the isolation and 
characterisation of lymph node dendritic cells were largely in 
agreement with the earlier cited studies and confirmed that the 
low buoyant density cell-enriched fraction isolated from 
auricular lymph node cells of mice sensitized 18hrs previously 
with sensitized chemicals were enriched in lymphoid dendritic 
cells.
The dependency of dendritic cell yield from auricular lymph node 
cells on the dose of sensitizing chemical applied to mouse ears
I examined the recovery of dendritic cells from the auricular 
lymph node cells of mice at various time-points after ear 
painting with sensitizing chemicals in order to establish the 
kinetics of any changes in dendritic cell recovery during 
sensitization. My studies assessed the change in dendritic cell 
recovery at early stages following ear-painting, before the 
lymph node cell proliferation significantly increased, ie within 
the first 24hrs post ear painting. Such sensitized mice, left 
beyond 24hrs, would go on to develop activated lymph node cells, 
with a peak proliferation and hapten responsiveness as described 
in chapter 6 .
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I established that the recovery of dendritic cells from 
auricular lymph node cells within the first 24hrs was dependent 
on both 1 ) the time elapsed between ear painting with 
sensitizing chemical and isolation of the lymph node cells and 
2 ) the dose of sensitizing chemical used for ear painting prior 
to lymph node cell isolation. Epicutaneous exposure to contact 
sensitizing chemicals such as 2.5% FITC clearly results in a 
rapid increase in the frequency of dendritic cells in the 
draining lymph node. This precedes any significant increases in 
either total cells per node or lymph node cell proliferation as 
measured by %-TdR incorporation in vitro (see chapter 6.1). In 
addition, my data demonstrate that this increase in dendritic 
cell recovery was dependent on the concentration of FITC used 
for painting mice ears.
These experiments were performed in parallel with those of my 
colleague A Kinnaird, who demonstrated similar patterns of cell 
recovery for a number of different sensitizing chemicals (eg 
DNCB, oxazolone, Kinnaird et al 1989) and mouse strains (Kimber 
et al in press). These data were compatible with the earlier 
published findings of S Knight and co-workers (Macatonia et al 
1987).
This correlation between dendritic cell yield from auricular 
lymph nodes and the dose of sensitizing chemical applied to the 
ears is compatible with a broadly cited general proposal for the 
role of the dendritic cell lineage in the initiation of lymph 
node cell proliferation and beyond this, contact sensitization.
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The model basically considers epidermal Langerhans cells, veiled 
cells of the afferent lymphatics, lymphoid 33D1+ dendritic cells 
and interdigitating cells of the T-lymphocyte-rich paracortex to 
be related cells. Each of these cells may represent a 
functionally distinct phase within the life of a lymphoid 
dendritic cell. This is discussed fully within chapter 3. Of 
particular relevance to this section however, are the studies of 
M Breel and co-workers who have demonstrated that 
interdigitating cells of the T-rich paracortex and lymphoid 
dendritic cells are very closely related, if not the same cell. 
In relation to this, data presented in this chapter established 
that the increase (influx) of dendritic cells into nodes 
draining painted ears was partly accounted for by hapten-bearing 
dendritic cells. As such, this provides more evidence 
consistent with the outlined proposal.
The fluorescence profile of auricular lymph node cells following 
ear painting with the sensitizing fluorochrome FITC
I established in the previous section that application of the 
sensitizing hapten FITC to mouse ears initiated an increase in 
dendritic cell yield within the auricular lymph nodes. Here, I 
exploit the fluorochromic properties of FITC to examine the 
localization of FITC on cells within the same auricular lymph 
nodes. These studies primarily utilised flow cytometric 
techniques to measure the characteristic size profile of 
lymphoid cells, particularly dendritic cells, and to then 
correlate this profile with a fluorescence profile (or hapten
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bearing profile) of the same cells. Thus, hapten (FITC) could 
be attributed to cells of particular size within the lymph node 
cells. I have presented comprehensive analyses of cell size and 
fluorescence profiles for dendritic cell-enriched and depleted 
auricular lymph node cells from mice painted on both ears 18hrs 
previously with the fluorescent hapten, FITC, or the non- 
fluorescent hapten, DNCB. The large amount of data reflects the 
emphasis I wish to put on the reproducibility and therefore 
quantitative value of cell cytometry as an analytical approach 
in these studies.
Low buoyant density cell-enriched auricular lymph node cells 
from FITC painted mice had a significantly different forward 
scatter (size) profile when compared with unfractionated or low 
buoyant density cell-depleted auricular lymph node cells. These 
profiles have been previously reported (Kinnaird et al 1989; 
Macatonia et al 1987) and as reported in these instances, 
indicated a significant enrichment for cells of high forward 
scatter in the low buoyant density cell-enriched fraction. 
Morphological analysis of these fractions demonstrated that 
these large cells were primarily dendritic cells and that the 
low forward scatter cells (constituting >95Z of unfractionated 
lymph node cells) were lymphocytes. It was notable that low 
buoyant density cell (or dendritic cell)-enriched auricular 
lymph node cells had the- same forward scatter profile, 
independent of which sensitizing regime the mouse had 
experienced (at 18hrs). It was concluded that the size profile 
was distinctive of fractionation efficiency rather than
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sensitization or cellular activation. As such, the profile is a 
good measure of the uniformity of the fractionation procedure 
when a number of cell populations are fractionated (and 
compared). This was utilised in the results.
Dendritic cell-enriched auricular lymph node cells from FITC- 
painted mice consisted of cells displaying a range of 
fluorescence intensities. Within this range, the bulk of cells 
were either highly fluorescent or of low fluorescence while the 
dendritic cell-depleted cells had negligible fluorescence. The 
biphasic distribution of fluorescence within dendritic cell- 
enriched FITC-sensitized lymph node cells was shown to reflect 
high and low fluorescence dendritic cells rather than dendritic 
cells of high fluorescence and other cells of low fluorescence. 
This was achieved by using the complementary techniques of a) 
considering the fluorescence and forward scatter profiles for 
the dendritic cell-enriched lymph node cells within one profile 
(dual parameter contour profile) and b) examining the 
distribution of fluorescence amongst morphologically dendritic 
cells using fluorescence microscopy.
The qualitative inferences drawn from these studies were 
quantitatively substantiated. A statistical quadrant analysis 
of dendritic cell-enriched lymph node cells, as described 
earlier, was performed. These data demonstrated that typically, 
dendritic cell-enriched auricular lymph node cells from mice 
painted 18hrs previously with 2.5% FITC, consisted of 60-70% of 
cells of high forward scatter which correlates well with the
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figure determined by morphological analysis. Of these high 
forward scatter (or dendritic) cells, 40.8% were highly 
fluorescent. In conjunction with microscopic analysis, these 
results confirm the biphasic distribution of hapten (FITC) 
within dendritic cells.
The fluorescence of dendritic cells is not attributable to 
autofluorescence
That this dendritic cell associated fluorescence was dependent 
on the 'transport' of FITC which was previously applied to the 
skin, rather than the generation of autofluorescence following 
lymph node cell activation after sensitization was examined. 
While sensitization with DNCB (non-fluorescent) or FITC (or nil 
treatment) failed to influence the distinctive forward scatter 
profiles expected for dendritic cell-enriched or depleted lymph 
node cells, the fluorescence profiles did differ markedly. It 
was particularly noticeable that high levels of fluorescence 
were attributable exclusively to dendritic cells (high forward 
scatter cells) within lymph node cells isolated from mice 
painted with FITC only.
My studies to this stage clearly demonstrate that within 18hrs 
of ear painting with the fluorescent sensitizing chemical FITC, 
there appear highly fluorescent (ie FITC-bearing) dendritic 
cells within the draining auricular lymph nodes. These 
dendritic cells are still rare when considered within the whole 
population of lymph node cells, constituting less than 5% of all
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cells. However, by exploiting the distinctive buoyant density 
of lymphoid dendritic cells these cells can be enriched until 
they constitute 60-70% of the low buoyant density cell fraction. 
A significant proportion of these dendritic cells were highly 
fluorescent, the remainder were of low (but not negligible) 
fluorescence, while contaminating lymphocytes appeared to have 
negligible fluorescence.
Possible explanations for biphasic distribution of FITC within 
auricular node dendritic cells
These findings are entirely compatible, but do not prove, that 
dendritic cells transfer hapten from the skin to local lymph 
nodes. The restriction of high fluorescence levels to dendritic 
cells supports their role as FITC-positive 'descendants' of 
FITC-positive Langerhans cells from the FITC-painted epidermis. 
Thus, Langerhans cells could migrate from epidermis to local 
node, bearing FITC. The biphasic fluorescence within lymph node 
dendritic cells could then be explained in terms of resident and 
immigrant dendritic cells, where highly fluorescent dendritic 
cells are derived from FITC-positive Langerhans cells recently 
arrived from the skin. Resident dendritic cells, with low (but 
not negligible) fluorescence may have acquired low levels of 
FITC, and thus fluorescence, from the immigrant dendritic cells. 
While hapten bearing Langerhans cells are stimulatory for T- 
lymphocytes in vitro, this activity is weak compared with 
hapten-bearing dendritic cells (Schuler and Steinman 1985). It 
has yet to be established, however, whether hapten transport and
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hapten presentation/T-lymphocyte activation are functions 
divided between subpopulations of lymph node dendritic cells. A 
suitable approach would be to assess the phenotype of high and 
low fluorescent FITC-primed dendritic cells and to correlate 
this with functional activity, which may differ beyond that 
attributable simply to differing levels of hapten 
(fluorescence). For example, hapten-transporting and hapten- 
presenting dendritic cells may express different levels of class 
II MHC-encoded antigens.
Alternatively, it has been argued that following ear painting 
with FITC, FITC blends with lymph fluid, enters the local node 
and stains cells within the node. (Data from Balfour et al, 
1970S using pigs). This would presumably stain all cells, 
dendritic and lymphocyte alike, which was not observed. While 
one could postulate that FITC does wash into the node but only 
dendritic cells have a selective affinity for the hapten, this 
is unlikely, as sensitizing haptens, including FITC, are 
generally, but not exclusively (nickel is a notable exception) 
protein reactive chemicals. Thus, if the FITC could reach the 
node without contacting protein, then it is hard to imagine that 
a lymphocyte complement of membrane proteins would remain 
unlabelled by any FITC entering the node.
The weight of evidence then, indicates that FITC in particular 
(and probably haptens in general) are transported from the site 
of skin application to the local lymph node by cells of the 
dendritic lineage.
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Dendritic cell fluorescence and the sensitizing dose of FITC
The mean fluorescence intensity of the recoverable dendritic 
cells from the auricular lymph node cells of mice painted 18hrs 
previously with FITC was dependent on the concentration of FITC 
(w/v in vehicle) used for ear painting. This effect on mean 
fluorescence intensity was in addition to the expected increase 
in recovery of dendritic cells from auricular lymph node cells 
as the dose of FITC was increased (described earlier). 
Therefore, the dose of sensitizing chemical used for ear 
painting determined
a) the number of dendritic cells recovered from the draining 
lymph node (presumably reflecting the number of 
Langerhans cells triggered to migrate to the node from 
the site of chemical application) and
b) the quantity of hapten (FITC) present on dendritic cells 
within the draining lymph node.
Following application of a high sensitizing dose to the skin, 
one might predict that many skin-resident Langerhans cells would 
leave the skin, bearing high levels of hapten. This would 
result in the appearance of many, highly hapten-positive 
dendritic cells within the local node and, dependent on the 
speed at which the epidermis was repleted with Langerhans cells, 
a refractory period in the skin site, while few Langerhans cells 
were present. If the Langerhans cell-dendritic cell proposal
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for hapten transfer was true, then during this refractory 
period, secondary application of chemicals to the site would be 
met by an inadequate Langerhans cell migratory response. 
Concomitantly, the appearance of dendritic cells bearing the 
second hapten in the local lymph node would be reduced. 
Evidence for a 'refractory period' could demonstrate a link 
between Langerhans cell migration and lymph node dendritic cells 
during hapten transfer. There is some evidence for the 
existence of this refractory period (Halliday et al 1988). In 
addition, it has been established that Ia+ epidermal Langerhans 
cells leave the skin following epicutaneous exposure to haptens 
(Aiba et al 1984). Studies performed on the cell-cycling of 
human epidermal Langerhans cell (Czemielewski et al 1985) 
suggest that a high percentage of epidermal Langerhans cells are 
non-proliferative and do not divide, indicating that repletion 
following depletion is dependent on an extra-epidermal source of 
Langerhans cells (or precursors, likely from the bone marrow).
In a series of experiments performed jointly with A Kinnaird at 
ICI we examined the kinetics of this putative refractory period. 
We assessed the appearance of FITC-bearing dendritic cells in 
the auricular lymph node when the FITC was applied to mice at 
various time points following earlier exposure at the same site 
to the non-fluorescent sensitizer oxazolone. The rationale was 
that oxazolone would initiate Langerhans cell migration out of 
the skin, leading to appearance of oxazolone-bearing dendritic 
cells in the local node. Subsequent challenge with FITC at the 
same site would result in few FITC-bearing Langerhans cells
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leaving the epidermis, resulting in few FITC-bearing dendritic 
cells detectable in the local node.
Epicutaneous applications of antigenically distinct skin 
sensitizing chemicals in serial and the hapten-bearing nature of 
lymph node dendritic cells
My results have established that if ear exposure to 5% FITC was 
preceded for up to 24hrs by ear exposure to a strong sensitizing 
chemical (1 % oxazolone), then there was a marked reduction in 
the ratio of high: low fluorescent dendritic-size cells from the 
draining, auricular lymph node, as isolated within the low 
buoyant density cell fraction. If pretreatment was with the 
non-sensitizing vehicle A00, then no such reduction in highly 
fluorescent dendritic-size cells was measured. The effect of 
sequential hapten treatments on the ratio of high: low 
fluorescent dendritic size cells from the auricular lymph node 
following ear painting was also shown to depend on the relative 
doses of the two sensitizing chemicals and also the time elapsed 
between initial (non-fluorescent hapten oxazolone) and secondary 
(fluorescent hapten FITC) exposure. For the dosing regime 
utilised in these experiments I established that the 'refractory 
period' of deficient hapten transfer from skin to node was of 
duration greater than 1 day.
There are at least two possible explanations for these results:
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1) In terms of the dendritic cell lineage model previously 
outlined, then following epicutaneous exposure to 
oxazolone, Langerhans cells migrate out of the epidermis 
from the site of skin-painting and eventually appear in 
the draining auricular lymph node, presumably bearing 
oxazolone. (This could be tested for using an anti- 
oxazolone antibody to stain the recovered dendritic cells 
or by use of a red fluorescent sensitizing fluorochrome, 
TRITC and assess red fluorescing dendritic cells.) For 
at least 24hrs following initial skin exposure, the 
epidermis remains significantly depleted of Langerhans 
cells. This may explain the fact that very few dendritic 
cells with high fluorescence are isolated from the 
draining, auricular lymph node at 18hrs post-FITC 
application when FITC application occurs within the 
'refractory period'. Such an explanation could have 
major implications for the integrity of murine immune 
responsiveness to sequential antigenic challenges at the 
skin and is developed in chapter 10. The results suggest 
that rapid, sequential skin challenges are restricted and 
that this may be compatible with a limited number of 
Langerhans cells within epidermal skin sheets. This is 
not a surprising conclusion but I have no direct data 
(for example a Langerhans cell count in treated and 
untreated epidermal skin sheets) to confirm this. 
Others, however, have demonstrated that Langerhans cell- 
depleted skin fails to host skin sensitization responses,
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as reviewed in chapter 3, providing some substance to the 
explanation I have provided.
2) Clearly, the data establish that the hapten-bearing 
nature of dendritic cell populations derived from 
auricular lymph node cells, is a good indicator of the 
combination of haptens applied to the skin. An 
alternative explanation for the data obtained however, 
could be that an increase in the number of oxazolone- 
bearing dendritic cells relative to FITC-bearing 
dendritit cells occurs in the node, giving the impression 
that FITC-bearing dendritic cells are reduced in numbers. 
The effect on consequent lymph node cell activation and 
proliferation was not examined in any detail because this 
work aimed simply to characterise dendritic cell nature 
and recovery. It is however, reasonable to speculate on 
the possible effects of sequential treatment on the 
activation and hapten specificity of the lymph node 
cells.
In the light of results presented in this chapter and the 
previous one, one would predict that the immigration of 
dendritic cells into the lymph node following oxazolone 
treatment would lead to proliferation of auricular lymph node 
cells and consequent oxazolone-restricted proliferative 
responses in vitro. Similarly, FITC treatment would lead to 
FITC-specific responses in vitro. In addition, with due regard 
to the clonal theory of Jeme, 1974 for antigen-specificity
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within a naive T-lymphocyte population, one might predict that 
FITC and oxazolone sensitization may proceed in parallel in the 
same node. Of course, such prediction is hazardous as it takes 
no account of the complex inter-leucocyte milieu within an 
activated lymph node and the effect of, for instance, limited 
interleukin or accessory help, necessary for T-lymphocyte 
activation (described extensively in chapters 1  and 2 ).
I have three pieces of data which relate to this sequential 
activation and subsequent status of auricular lymph node cells. 
Firstly, in a series of experiments in which ear sensitization 
with a dilute (0.75%) concentration of FITC was preceded by ear 
painting with 0.75% DNCB I established the characteristic 
fluorescent cell-depleted dendritic cell population for the DNCB 
pretreated group (data in 7.3.5). Significantly, both dendritic 
cell-enriched populations had negligible proliferative activity 
in vitro (figure 7.3.4). This indicated that both populations 
were devoid of proliferating T-lymphoblasts (see chapter 6.3). 
Thus, the reduction in numbers of high fluorescent dendritic 
'sized' cells within the DNCB pretreated lymph node cells cannot 
be explained by a 'dilution' of these hapten positive cells by 
hapten negative T-lymphoblasts within the low buoyant density 
cell fraction. This was a possible problem because T- 
lymphoblasts and dendritic cells appear to fractionate together 
(6.3). So, while the lymph node cells from DNCB/FITC treated 
mice are in fact 42hrs post sensitization, the low dosage of 
chemicals has yet to activate a significant auricular lymph node
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cell proliferative response (which would be expected for higher 
DNCB doses, see figure 6.1.2).
Secondly, it has been made known to me that in mice pretreated 
with the red fluorochrome sensitizer TRITC prior to FITC 
exposure, both TRITC and FITC positive dendritic cells are 
isolated from draining auricular lymph node cells (Julie 
Mitchell, ICI), ie both haptens arrive in the node.
Thirdly, in the DNCB/FITC experiment described above, I have 
established that dendritic cell-enriched auricular lymph node 
cells from both groups have a qualitatively different 
stimulatory activity for FITC-sensitized auricular lymph node 
cells in vitro. In particular, dendritic cells from the FITC- 
alone treated group were stimulatory for a responder 
proliferative response, while an equivalent number of dendritic 
cells from the DNCB pretreated, FITC treated group were 
significantly less stimulatory. This result reflected the 
number of highly fluorescent dendritic cells added to the 
responding FITC-sensitized lymph node cell population and 
indicated by a functional assay the reduced number of FITC- 
bearing dendritic cells within the low buoyant density auricular 
lymph node cells isolated from the DNCB pretreated mice. (Data 
figures 7.3.4 and 7.3.5).
Conclusions
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In conclusion, the results presented and discussed in this 
chapter provide a description of the increase in dendritic cell 
recovery from auricular lymph node cells following exposure of 
the mouse 18hrs previously with the sensitizing chemicals FITC 
or DNCB.
The increase in dendritic cell numbers is rapid and represents a 
very early event within the lymph nodes following ear painting 
with sensitizing chemicals. That this rapid appearance of 
dendritic cells is causative of the later, measurable increase 
in lymph node cell proliferation rather than coincidental is 
suggested by the hapten-bearing nature of these dendritic cells. 
Thus, significant numbers of auricular lymph node dendritic 
cells from FITC-painted mice are highly fluorescent and are 
bearing FITC. As I described in chapter 6 , at time points 
beyond this appearance of FITC-bearing dendritic cells within 
FITC-sensitized auricular lymph node cells there is a strong 
proliferative response (figures 6.1.1 and 6.1.2). Work 
presented by my colleagues at ICI has demonstrated that the 
strength of this primary proliferation influences the resulting 
degree of hapten-specific contact sensitization (Kimber et al 
1989) and this provides a logical link between hapten-bearing 
dendritic cells and hapten specific contact sensitization within 
the mouse. In addition my own data, presented in chapters 6 and 
8 , from experiments examining the hapten responsiveness of these 
primarily proliferating auricular lymph node cells demonstrates 
that the primary sensitization (activation) is hapten specific,
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again implicating the hapten-bearing dendritic cells in 
sensitization.
All these findings were compatible with a proposal that hapten 
is transferred from epidermal sites to local, draining lymph 
nodes by cells constituting the lymphoid dendritic cell lineage, 
as was evidence gleaned from experiments considering the 
appearance of sequentially applied, distinct haptens within 
draining lymph nodes.
As we have seen in this chapter, the use of the fluorescent 
contact sensitizing chemical FITC enables the hapten-bearing 
status of dendritic cells to be quantitatively assayed by flow 
cytometric techniques. In chapter 8 , I go on to assay the 
proliferative response of post 7 day, hapten sensitized 
auricular lymph node cells when cultured with hapten-bearing 
dendritic cell-enriched lymph node cells. Correlations between 
the hapten-bearing status and stimulatory activity of dendritic 
cells are made. The assay system I use is the antigen 
presentation assay, previously described in chapter 6 , with the 
exception that here the stimulator cells are in vivo haptenated 
dendritic cells.
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CHAPTER 8
The Stimulatory Activity of Hapten-bearing Dendritic Cells 
for Sensitized Lymph Node Cells in vitro
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8.1.1 Introduction
The data presented in the previous chapter provide a description 
of the early changes in the yield and hapten-bearing nature of 
lymph node dendritic cells from mice, following epicutaneous 
exposure on the ears to haptens. The complete explanation for 
how ear-exposure to FITC is related to the appearance, a few 
hours later, of highly fluorescent dendritic cells in the 
draining auricular lymph node has yet to be fully elucidated, 
although a consistent and acceptable explanation, invoking the 
'maturation of the dendritic cell lineage' has been described 
(see earlier and Austyn 1987).
Important to my studies, however, was my knowledge of dendritic 
cell accumulation and their isolation from auricular lymph node 
cells, which enabled me routinely to fractionate low buoyant 
density cell-enriched fractions, consisting of 60-70% dendritic 
cells (of which a significant proportion bear high levels of 
hapten). The work presented in this chapter aimed to assay the 
stimulatory activity of these dendritic cell-enriched fractions 
within the antigen presentation assay, described in chapter 6 . 
These earlier studies established that the hapten-restricted 
proliferative response of sensitized lymph node cells in vitro, 
following addition of in vitro haptenated stimulator cells, was 
a fair indicator, if not a direct measure, of the hapten- 
presenting quality of stimulator cells. The culmination of 
these initial studies was the realisation that the in vitro 
assessment of hapten-presentation by in vitro haptenated
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stimulator cells to sensitized auricular lymph node cells was an 
inadequate model of hapten presentation. In addition, a number 
of studies published at that time suggested that hapten-bearing 
dendritic cells from hapten-primed mice were a more efficient 
and biologically relevant hapten-presenting cell in vitro 
(Macatonia et al 1987).
Reflecting on this, the approach described in chapters 6 and 7 
is united in this chapter, in which I assay the proliferative 
response of post 7d, hapten-sensitized auricular lymph node 
cells when cultured with hapten-bearing dendritic cell-enriched 
lymph node cells. Hapten-bearing dendritic cells are shown to 
influence proliferation in a manner dependent on both the number 
of dendritic cells relative to responder lymph node cells and 
the hapten-specificity of responder and stimulator cells. A 
phenomenon of hapten-unrestricted stimulation is attributed to 
excessive sensitization doses of hapten. In addition, by 
utilising the fluorescent contact sensitizing chemical FITC the 
hapten-bearing nature or fluorescence intensity of dendritic 
cells is quantitatively assayed and correlated with the 
stimulatory activity of the same populations.
Experimental Approach
Hapten-bearing, dendritic cell-enriched auricular lymph node 
cells were isolated from the lymph nodes of mice sensitized up 
to 18hrs previously with various sensitizing chemicals by 
Metrizamide density centrifugation. As no in vitro haptenation
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was utilised, any stimulatory activity of these cells for 
responder populations therefore implicated the dendritic cell- 
enriched lymph node cells as having acquired hapten in vivo 
during the early (first 18hrs) stage of hapten-priming. This 
was confirmed for the FITC hapten system in the previous 
chapter.
It has previously been demonstrated within the 20ul hanging drop 
microculture system that such dendritic cell-enriched lymph node 
cells are highly stimulatory for naive and hapten-sensitized 
responder lymph node cells (Macatonia et al 1986 and 1987; 
Robinson 1989). However, such proliferative responses have not 
to my knowledge been comprehensively described within the 96 
well plate, 200ul culture system, the system of choice within 
these studies. As there is speculation as to how the dynamics 
and kinetics of responder cell and stimulator cell interaction 
may vary between these two systems (Knight 1987), it was 
essential to characterise the proliferative response to 
dendritic cell-enriched lymph node cells in the 200ul system.
In addition, as described in chapter 7, the dendritic cells 
which I isolate within the low buoyant density cell Metrizamide 
fraction consisted routinely of 65-70% dendritic cells by 
morphologic and flow cytometric criteria. It was important 
therefore to be able to account for any activity within the 
proliferation assay of the contaminating, 30-35% of non- 
dendritic cells within the stimulator population. Finally in 
this chapter, data are presented to compare the stimulatory
185

Results
8.1.2 The proliferative activity of dendritic cell-enriched and 
depleted auricular lymph node cells from hapten-painted 
mice
Dendritic cell-enriched lymph node cells were isolated as the 
low buoyant density cell fraction of lymph node cells from the 
draining lymph node cells of mice painted with 2.5% DNCB or 2.5% 
FITC on the ear 18hrs previously (unless otherwise stated).
In figure 8.1.1, it is clear that a relevant titre of cells 
(giving 9,000 dendritic cells in the dendritic cell-enriched 
groups, the usual stimulation titre) from any of these four 
fractions in culture, failed to show significant levels of % -  
TdR incorporation compared with background controls. (Wells 
pulsed with %-TdR but containing no cells.) It was also 
apparent that under optimum conditions of mitogen stimulation, 
which induced a 56-fold enhancement of proliferation in 5 x 10^ 
unfractionated lymph node cells, only the dendritic cell- 
depleted fractions showed any significant enhancement of %-TdR 
incorporation (x4.2 and xl3.0). However, the stimulatory 
activity of the non-proliferative, dendritic cell-enriched lymph 
node cell fractions was marked, as demonstrated in table 8.1.1.
8.1.3 Stimulation of auricular lymph node cell proliferation by 
dendritic cell-enriched fractions; A requirement for both
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Figure Legend 8.1.1
Dendritic cell-enriched and depleted auricular lymph node cells 
were prepared from groups of BALB/c mice painted 18hrs 
previously on both ears with either 25ul of 2.5% DNCB or 5% 
FITC, exactly as described in chapter 7.
Washed fractions were routinely adjusted to 4.5 x 10^ cells ml"1 
in standard medium.
Culture conditions
Standard, as described in chapter 5, with 1.13 x 104 cells 
plated per well*. Wells were made up to 200ul final volume by 
addition of 1) standard medium or 2) standard medium 
supplemented with Concanavalin A.
* In this experiment, dendritic cells constituted 75% of the low 
buoyant density cell-enriched fraction and therefore, 8500 
dendritic cells per well were plated, the usual nunber used in 
the antigen presentation assay.
Results are displayed as described in table legend 8.1.1 in 
histogram format (background proliferation set to stimulation 
index of 1.0).
** denotes significant statistical difference from paired
control (*)
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FIGURE 8,1,1
The Background Proliferative Activity and Mitogenic (Concanaval in 
A) geggonge of Dendritic Cell-enriched and Depleted Auricula 
Lymah Node Cells from DNCB and FTTC-primed Mice
D N C B - p r i m e d  L N C  
( p o s t  1 8 h r s , 2 . 5 % )
F I T C - p r i m e d  L N C  
( p o s t  1 8 h r s , 5 % )
responders and stimulators to be derived from hapten- 
painted mice.
For a dendritic cell-enriched lymph node cell fraction to 
stimulate a statistically significant enhancement of 
proliferation in an auricular lymph node cell population, both 
responder and stimulator elements must be derived from mice 
previously exposed to haptens. In two representative 
experiments (table 8.1.1) it was apparent first (expt 1) that 
naive responder lymph node cells did not show significantly 
enhanced proliferation on addition of dendritic-cell enriched 
lymph node cells from mice painted on both ears with 5Z FITC 
18hrs previously. Under the same experimental conditions 
(responder cell: stimulator cell ratio, 55:1) these stimulators 
induced a 9-fold enhancement of proliferation in FITC-sensitized 
responder lymph node cells.
In expt 2 (table 8.1.1) under conditions where dendritic cell- 
enriched lymph node cells from post 18hr FITC-painted mice 
caused enhanced proliferation in FITC-sensitized responder lymph 
node cells (x4.5), the same number of dendritic cell-enriched 
lymph node cells from naive mice were not stimulatory.
8.1.4 The dependence of enhanced auricular lymph node cell 
proliferation on the number of dendritic cell-enriched 
lymph node cells added to culture
188
Table Legend 8.1.1
Responder Lymph Node Cells
Single cell suspensions were prepared from the auricular lymph 
nodes of BALB/c mice painted on both ears 7 days previously with 
25ul of 5% FITC or from naive BALB/c mice and adjusted to 5 x 
106 cells ml"* in standard median.
Stimulator Cells
Dendritic cell-enriched auricular lymph node cells were prepared 
from BALB/c mice painted 18hrs previously on both ears with 25ul 
of 57. FITC or naive mice, exactly as described in chapter 7. 
Washed, dendritic cell-enriched fractions were routinely 
adjusted to 4.5 x 10^ dendritic cells ml”^ in standard median.
Culture Conditions
Standard, as described in chapter 5 with 5 x 105 responders: 
9000 dendritic cells in 200ul final volume, therefore responder: 
stimulator - 55:1.
Results are displayed as 1) the mean ^-TdR incorporation +/- SD 
x 10 ^ for 4-6 replicate wells per group; 2) a t-test 
calculation comparing matched groups
** denotes significant statistical difference from paired
control (*)
TABLE 8.1.1
Stimulation of Lymphocyte Proliferation by Dendritic Cell-enriched
Auricular Lymph Node Cells: Requirement for Hapten-primed
Dendritic Cells and Hapten Sensitized Lymph Node Cells
S tim u la to r cells. 
D e n d ritic  c e l l -  
e nriche d  a u ricu la r 
lym p h  n o d e  cells from  
m ice tre a te d  w ith  ;
L Y M P H O C Y T E  P R O L I F E R A T I O N .  
3 H - T d R  in c o rp o ra tio n  . m e a n  c p m ± s d  x 1 0 3
Responder cells from  m ice tre ate d  w it h ;  
N IL  5  0 %  F I T C
1.
No
0*8 ±  0 * 2 2 * 8 i  0 - 8
5.0%  R T C 1*21 0 - 2 25*1 ± 1*6
ns *  *
2.
No
stimulator cells. N T 3*2 i  0 - 6
5.0% F1TC N T 1 4 -3 1 0*6
*  *
Nil
N T 3 * 8 - 0 * 6
ns
In figure 8.1.2 the proliferation of FITC-sensitized responder 
lymph node cells has been plotted against the nunber of FITC- 
primed dendritic cell-enriched lymph node cells added. Clearly, 
as the stimulators were increased into the assay so the 
enhancement of responder proliferation became more marked. With 
no stimulators, the spontaneous proliferative activity of the 
responders was 5.5 +/- 0.25 x 10"^ cpm: at 83 responder: 1 
stimulator cell, this value was 20.6 +/- 2.4 x 10"^ cpm, 
(x3.75). Increasing stimulator numbers further, to 28 
responders: 1 stimulator, the %-TdR incorporation was 32 +/- 
3.3 x 10“3 cpm (x5.8).
The proliferative activity of the highest number of dendritic 
cell-enriched lymph node cells used (18,000) was not significant 
compared with background. A similar proliferation pattern was 
recorded for homologous hapten responder: stimulator
combinations within the DNCB and TRITC systems.
8.1.5 The stimulatory activity of dendritic cell-enriched 
fractions compared with dendritic cell-depleted fractions 
of auricular lymph node cells from hapten-painted mice
Data are presented in table 8.1.2 from experiments which 
compared the stimulatory activity of dendritic cell-enriched and 
depleted fractions from both FITC and DNCB-painted mice.
If the proliferative response of FITC-sensitized responder lymph
node cells is examined, then dendritic cell-enriched lymph node
189
Figure Legend 8.1.2
Dendritic Cells
Dendritic cell-enriched auricular lymph node cells were prepared 
from groups of 15 BALB/c mice painted 18hrs previously on the 
ears with 5% FITC. This cell separation was performed exactly 
as described in chapter 7. Washed fractions were routinely 
adjusted to 4.5 x 10-> cells ml“^ in standard medium.
Responder Lymph Node Cells 
As in table legend 8.1.1.
Culture Condition
Standard, as described in chapter 5, with 5 i 105 responders 
plated per well and increasing titres of dendritic cell-enriched 
lymph node cells added, in the range nil to 18000 (ie 11700 
dendritic cells per well maximum).
Results are displayed as the mean %-TdR incorporation +/- SD x 
10 3 for 4-6 replicate wells per group against increasing titre 
of dendritic cell-enriched lymph node cells added to 5 x 10s 
responders.
FIGURE 8.1.2
Stimulation of FITC-sensitized Auricular Lymph Node Cell 
Proliferation on Addition of In crM siry , Ninhm-s of ETTC-primpH 
Dendritic Cells
cells from FITC-painted mice induced an 8-fold enhancement of 
proliferation, compared with the unstimulated proliferative 
activity of the responders. The same number of dendritic cell- 
depleted lymph node cells from FITC-primed mice were not 
stimulatory. A similar pattern of response was observed in the 
DNCB-sensitized responder lymph node cells when cultured in the 
presence of dendritic cell-enriched lymph node cells or 
dendritic cell-depleted lymph node cells from DNCB-primed mice. 
Thus, the stimulatory activity was attributable to cells within 
the dendritic cell-enriched low buoyant density fraction of 
hapten primed lymph node cells.
8.1.6 The hapten specificity of sensitized lymph node cell 
proliferation induced by dendritic cell-enriched lymph 
node cells
In a comparison of interactions within the DNCB and FITC hapten 
systems (table 8.1.2) it was established that responder lymph 
node cells prepared from FITC-sensitized mice were stimulated by 
dendritic cell enriched fractions from mice painted 18hrs 
previously with FITC. FITC-sensitized lymph node cell 
responders showed no enhancement of proliferation when dendritic 
cell-enriched lymph node cells from mice painted 18hrs 
previously with DNCB were utilised as stimulators, compared with 
unstimulated responder proliferation. In contrast, however, 
dendritic cell-enriched populations from either FITC or DNCB 
primed mice were capable of inducing enhanced %-TdR 
incorporation in DNCB-sensitized responder lymph node cells.
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Table Legend 8.1.2
Responder Lymph Node Cells
As in table legend 8.1.1, except groups of 4 mice were painted 
with 2.5% DNCB or 5% FITC.
Stimulator Cells
As in figure legend 8.1.1, except groups of 15 mice were painted 
with 2.5% DNCB or 5% FITC.
Culture Conditions
Standard, as described in chapter 5, with 5 x 10^ responders 
cultured alone or in the presence of 13500 stimulator cells. 
(13.5 xlO^ dendritic cell-enriched lymph node cells @ 65% 
dendritic cells - 8775 dendritic cells.)
Results are displayed as in table legend 8.1.1.
** denotes significant statistical difference from paired 
control (*)
TABLE 8.1.2
Stimilation of Sensitized Lymphocyte Proliferation by Dendritic 
Cell-enriched (but not Depleted) Hapten-primed Lymph Node Cells
S tim u la to r  c e lls L Y M P H O C Y T E  P R O L I F E R A T I O N .
DencXitic cell-enriched 
<DC+) or depleted (D C -) 
auricular lymph node 
cells from mice painted 
18hrs previously with:
3 H -T d R  in c o rp o ra tio n  . m e a n  c p m  sd  x 1 (f 3 
R e sponder cells from m ice tre a te d  w ith
2.5%  DN CB
( N o  s tim u la to rs ) 3*3 ± 0 2  * 2 - 0  ±  0 -5  *
25S,gy,CB 3*8 ± 0 6  ns 1*8 ±  0 * 3  ns
2JMJ“ 7 * 8 -  0 * 7  * * 2 - 9  t  0 -4  ns
5 .0 %  F1TC 
(D C -)
4 * 7  ± 0 - 7  • • 2 * 6  -  0*2 ns
5.0%  F ITC  
(DC-*-)
8 - 2  ± 1*0 ♦ * 15 *8  t  1*7 *  *
The response induced by FITC-primed dendritic cell- enriched 
lymph node cells in DNCB-sensitized responder lymph node cells 
(x2.5) was less than that seen in FITC-sensitized responder 
lymph node cells (x8.0).
Additional haptens were introduced into this system: in table 
8.1.3 the specificity of interaction between DNCB, FITC and 
oxazolone-primed stimulators and sensitized responders is 
recorded. Oxazolone-primed stimulators interacted with 
responders in a fashion more analogous to FITC than DNCB-primed 
stimulators. Thus, oxazolone-primed dendritic cell-enriched 
lymph node cells stimulate enhanced proliferation in responder 
lymph node cells isolated from mice sensitized to DNCB (x4.3), 
FITC (x2.3) and the homologous chemical oxazolone (x6.1). DNCB- 
primed dendritic cell-enriched lymph node cells caused a 
statistically significant enhancement of proliferation only in 
DNCB-sensitized lymph node cells (x4.4). It was again apparent 
that the fold-enhancement of proliferation was always 
significantly more marked when responder lymph node cells were 
stimulated by dendritic cell-enriched lymph node cells isolated 
from mice primed to the homologous rather than heterologous 
chemical.
A large number of experiments were performed to analyse these 
questions of specificity and size of response, the resulting 
data has been summarised in table 8.1.4. Of the specificity, it 
is apparent for the four haptens analysed that:
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TABLE 8.1.3
Stimulation of Sensitized-lymph Node Cell Proliferation by 
Dendritic Cell-enriched Lymph Node Cells Isolated From Hapten- 
primed Mice; the Hapten Specificity of Induced Proliferative
L Y M P H O C Y T E  P R O L IF E R A T IO N . ---------------
S t im u la to r  c e lls  :
3 H -T d R  in c o rp o ra tio n .m e a n  c p m  ± s d  x 1 0  J
dendritic cell-enriche< 
auricular lym ph node
cells from m ice 
painted 18hrs Responder cells from  mice treated w ith
previously with: 2.5%  D N C 8 2.5%  Oxazolone. 5.0%  F ITC
(N o  stimulator cells) 1*1 * 0-1 * 2*1 ± 0 * 1  * 2 -2  -  0*2 
•
2 .5%  D N C B 4 - 8 1 0 * 6 2 -5  * 0*5 ns N T
♦  *
2 .5 %  Oxazolone. A '7 -  0*5 1 2 -9  1 1-2 5 -0  ± 0 * 7
*  * ♦ ♦ *  *
5.0%  FITC. 4 * 0 1 0 -4 5*2 ± 0*4 13*9± 1*3
*  * *  * *  *
Responder Lymph Node Cells
As in table legend 8.1.1, except groups of 4 mice were painted 
with 2.5% DNCB, 2.5% oxazolone and 5% FITC.
Stimulator Cells
As in table legend 8.1.1, except groups of 15 mice were painted 
with 2.5% oxazolone and 5% FITC.
Culture Conditions
Standard, as described in table legend 8.1.1.
Results
As described in table legend 8.1.1.
i) Dendritic cell-enriched lymph node cells from mice
painted 18hrs previously with 2.5% oxazolone always 
stimulated enhanced proliferation in responder lymph node 
cells from mice sensitized to FITC, DNCB, TRITC and 
oxazolone: dendritic cell-enriched lymph node cells from 
mice painted with 5% FITC had virtually the same 
activity.
ii) Dendritic cell-enriched lymph node cells from mice
painted with 2.5% DNCB were only stimulatory for 
responder lymph node cells isolated from mice painted 
with DNCB.
iii) Dendritic cell-enriched lymph node cells from mice
painted with TRITC were stimulatory for responder lymph 
node cells from mice painted with TRITC, DNCB, possibly 
FITC but never oxazolone.
Considering the magnitude of enhancement of proliferation for a 
number of experiments, it is apparent (see small figures, table 
8.1.4) that the interaction of dendritic cell-enriched lymph 
node cells with responder lymph node cells is highest when both 
responder and stimulator originate from mice painted with the 
same chemical. Thus, dendritic cell-enriched lymph node cells 
from mice painted 18hrs previously with 5% FITC induced a mean 
increment of enhancement of 7.7 +/- 2.9 in responder lymph node 
cells from mice painted 7 days previously with 5% FITC. The 
same dendritic cell-enriched lymph node cells stimulate
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Table Legend 8.1.4
The data presented in this table has been compiled from the 
results of a series of experiments considering the hapten 
specificity, as described in table 8.1.3.
Over a period of approximately 1 year such experiments were 
performed, utilising the standard ratio of responder lymph node 
cells: stimulator cells.
For each experiment performed, the stimulator-cell induced 
increment of enhancement was determined for each responder: 
stimulator combination. This enhancement was recorded, and if, 
for example, out of 21 experiments, FITC-primed dendritic cells 
cause a > two-fold enhancement of proliferation in DNCB- 
sensitized lymph node cells on 18 occasions, then this was 
designated as 18/21.
The mean stimulator cell-induced increment of enhancement +/- SD 
for all 21 experiments is recorded in lower case.
TABLE 8.1.4
Stinmilation of Sensitized-lymph Node Cell Proliferation by 
Dendritic Cell-enriched Lymph Node Cells Isolated from Hapten- 
primed Mice
S tim u la to r  c e lls  :
Dendritic cell-enriched 
auricular lym ph node 
cells from m ice painted 
on the ears 18hrs 
previously with :
R esponder cells from nice treated w ith  
2 .5 %  D N CB 5 0 %  F ITC
5.0% F1TC. 4
5
2.
2 f l -
2 L
21
7 7 ±  2 9
2.5%  D N C8
4r 13"
5.0%  TR ITC. A .
6
4
5
1
T
2.5%  Oxazolone 4
T
A -2 1  M
2
~ T
------4 Q U O ___
_ 4 _4
2 7 1 0 A ____
3
" y
2210-2
significant but much weaker enhancements of proliferation in 
responder lymph node cells from mice painted with 2.5% DNCB (2.5 
+/- 0.7), 5% TRITC (4.2 +/- 0.2) or 2.5% oxazolone (2.2 +/- 
0 . 8) .
8.1.7 Detection of secondary but not primary dendritic cell 
driven responses
The lack of complete antigen specificity within the responder- 
stimulator interaction, may have been due to particular 
dendritic cell-enriched lymph node cell populations (notably 
FITC and oxazolone-primed) stimulating primary anti-FITC or 
oxazolone responses within the DNCB-sensitized responder lymph 
node cells. This was examined (figure 8.1.3 ) and it was 
established that within the standard 48hr culture period, 
dendritic cell-enriched lymph node cells from neither FITC-or 
DNCB-primed mice induced enhanced proliferation in naive lymph 
node cell populations (also see table 8.1.1). While %-TdR 
incorporation in naive lymph node cells cultured with dendritic 
cell-enriched populations is slightly higher than that seen for 
naive lymph node cells alone, this difference was on no occasion 
greater than that expected if the counts of responders alone and 
dendritic cell-enriched lymph node cells alone were simply added 
together. The same dendritic cell-enriched lymph node cell 
populations induced characteristic responses in FITC and DNCB- 
sensitized responder lymph node cells. The enhancement of 
proliferation within the naive lymph node cells on addition of
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Figure Legend 8.1.3
Responder Lymph Node Cells
As in table legend 8.1.1, except mice were naive, ie had 
received no sensitizing chemicals, or mice painted with 5% FITC 
or 2.5% DNCB.
Stimulator Cells
As in table legend 8.1.1, except mice were painted with 5% FITC 
or 2.5% DNCB.
Culture Conditions - Standard 
Results - Standard
All groups had positive Concanavalin A responses (data not 
shown).
FIGURE 8.1.3
The Stimulation of Lymphocyte Proliferation Within Lymph Node 
Cells Derived From Waive and Sensitized Mice by Dendritic Cell- 
enriched Auricular Lymph Node Cells from Hapten Primed Mice
N i l  5%  F I T C 2 .5 %  D N C B
ConA (data not shown) demonstrated the ability of the naive 
lymph node cells to respond to appropriate stimuli.
8.1.8 DNCB-sensitization beyond 7 days and the resulting lymph 
node cells proliferative response to FITC-primed 
dendritic cell-enriched lymph node cells
The proposal that responder lymph node cell sensitivity to 
hapten and to non-specific stimulatory factors from haptenated 
dendritic cells may be discrete sensitivities with differential 
kinetics was analysed. It was argued, that while at 7d post 
sensitization, DNCB-sensitized responder lymph node cells were 
sensitive to specific (hapten) and non-specific stimuli, both 
facilitated by a given dendritic cell-enriched lymph node cell 
population, perhaps beyond lOd post sensitization the non­
specific sensitivity, but not hapten sensitivity, would be lost. 
An experiment was performed where DNCB-sensitized responder 
lymph node cells were isolated at 7, 8, 13, 14 and 15d post ear­
painting and stimulated with a constant number of dendritic 
cell-enriched lymph node cells from FITC-primed mice. The 
results are presented in figure 8.1.4.
The spontaneous proliferative activity of DNCB-sensitized 
responder lymph node cells decreased with time from 6.4 +/- 0.4 
x 10"3 cpm at 7d post ear-painting to 1.4 +/- 0.5 x 10" 3 cpm at 
15d post ear-painting. The enhancement of proliferation (at a 
responder: stimulator ratio of 33:1) induced by dendritic cell- 
enriched lymph node cells from FITC-primed mice was 17.2 +/- 2.2
194
Figure Legend 8.1.4
Responder Lymph Node Cells
As in table legend 8.1.1 except that groups of BALB/c mice were 
painted with 25ul of 2.5% DNCB on both ears 7, 8, 13, 14 and 15 
days prior to lymph node harvest.
Stimulator Cells
As in table legend 8.1.1.
Culture Conditions
Standard, as described in chapter 5, with 5 x 105 responder 
cells from each of the 5 groups cultured with (or without) a 
fixed nunber of FITC-primed, dendritic cell-enriched lymph node 
cells at standard 55 responders: 1 dendritic cell ratio.
Results
Results are displayed as the mean ^H-TdR incorporation +/- SD x 
10 ^ for 4-6 replicate wells per group against the period of 
sensitization for the responder lymph node cells.
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FIGURE 8.1.4
Hie Effect of the Period of DNQ> Exposure Prior to Isolation of 
DNCR-sensitized Lymph Node Cells on the Proliferative Response of 
These Cells to Fliu-primed, Dendritic Cell-enriched Fractions
8  9  1 0  11  1 2  1 3  1 4  1 5
T im e  ( d a y s )  f o l l o w i n g  e a r - p a i n t i n g  w i t h  2 .5 %  D N C B .
7
x 1 0 "^ cpra for post 7d responders (x2.68) and 4.0 +/- 1.0 x 10”^ 
open for post 15d responders (x2.85). Evidently, the ratio of 
enhancement of proliferation remained constant, ie the two lines 
were parallel and this means that the 'non-specific' 
responsiveness of DNCB-sensitized responders was not lost 15 
days post sensitization.
8.1.9 The influence of the sensitizing dose of hapten and the 
period of sensitization, prior to dendritic cell 
isolation.
The results presented in table 8.1.4 are compatible with a 
proposal that the non-specific stimulatory activity of 
particular dendritic cell-enriched lymph node cell populations 
may simply reflect a particular dose of hapten. I assessed the 
effect of reducing the sensitizing capacity of a hapten by using 
low doses for dendritic cell priming or reducing the time from 
exposure to a hapten to isolation of the dendritic cell-enriched 
lymph node cell fraction. I established for the chemicals FITC 
and oxazolone that both antigen-specific and non-specific 
stimulatory properties of dendritic cell-enriched lymph node 
cell populations were dependent on both time post priming for 
dendritic cell isolation and the dose used for priming for 
dendritic cell isolation. In table 8.1.5 it is clear that 
dendritic cell-enriched lymph node cell populations from mice 
painted 18hrs previously with 5% or 0.5% FITC induce enhanced 
proliferation in both FITC and oxazolone sensitized responder 
lymph node cells. However, while dendritic cell-enriched lymph
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TABLE 8.1.5
Stimulation of FTTC and Oxazolone-sensitized Lymph Node Cell 
Proliferation by Dendritic Cell-enriched Fractions from trTlC- 
primed Mice: Influence of the Dendritic Cell Priming Concentration 
of FTTC
Stimulator ce lls  : 
Dendritic cell-enriched 
auricular lym ph node 
cells from m ice  painted 
on the ears 18hrs 
previously with :
LY M P H O C Y T E  P  
3H-TdR incorporation
Responder cells fron 
5.0%  F ITC
RO LIFERATIO N.
. mean cpm tsd x10'3
m ice treated with
(N o  stimulator cells) 311  0-2 * 4 010 -4  *
5 .0%  F IT C 12-5 1 10 * * 5 8 10  3 *  *
0 .5 %  FITC. 10-7110 * * 6-31 0-6 * *
0 .25%  FITC. 6-310-7 «  * 4-1 1 0-6 ns
2 .5 %  Oxazolone 7-4 - 0-7 e « 19-5  ^2-1 *  *
Responder Lymph Node Cells
As in table legend 8.1.1 except groups of 4 mice were painted 
with 5% FITC or 2.5% oxazolone.
Stimulator Cells
As in table legend 8.1.1 except groups of 15 mice were painted 
with 5% FITC, 0.5% FITC, 0.25% FITC or 2.5% oxazolone.
Culture Conditions
Standard, as described in table legend 8.1.1.
Results
As described in  table legend 8 .1 .1 .
node cells from 0.25% FITC-primed mice caused significantly 
enhanced proliferation in FITC-sensitized lymph node cells, 
there was no significant response in oxazolone-sensitized-lymph 
node cells. This effect was also observed for DNCB-sensitized 
lymph node cell responders. The observation that FITC-specific 
responses declined as the priming dose of FITC was reduced 
correlates well with the parallel reduction in the intensity of 
fluorescence of fluorescent (high) positive cells within the 
FITC-primed dendritic cell-enriched lymph node cells (figures 
7.2.4B and table 7.2.2).
It was also demonstrated (table 8.1.6) that dendritic cell- 
enriched lymph node cell populations from mice primed 12hr, 
rather than 18hr, previously with either 5% FITC or 2.5% 
oxazolone did not have the ability to stimulate lymph node cells 
from mice sensitized with the heterologous chemicals but 
retained their stimulatory capacity for responder lymph node 
cells sensitized to the homologous chemical. Thus, dendritic 
cell enriched lymph node cells from mice primed 18hrs previously 
with 5% FITC or 2.5% oxazolone were stimulatory for FITC- 
sensitized lymph node cells and oxazolone-sensitized lymph node 
cells. Dendritic cell-enriched lymph node cells from mice 
primed 12hrs previously with 5% FITC were stimulatory for FITC- 
sensitized lymph node cells but not oxazolone-sensitized lymph 
node cells. The converse was true for dendritic cell-enriched 
lymph node cells from mice primed 12hrs previously with 2.5% 
oxazolone.
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TABLE 8.1.6
Stimulation of FITC and Oxazolone-sensitized Lymph Node Cell 
Proliferation by Dendritic Cell-enriched Fractions from FITC and 
Oxazo lone-primed Mice: Influence of the Period of Sensitization 
Prior to Isolation of Dendritic Cells
S tim u la to r  c e lls  : 
Dendritic cell-enriched 
auricular lymph node 
cells from mice painted 
on the ears with :
Im e  of ear painting prior 
to dendritic cell isolation:
L Y M P H O C Y T E  P R O L I F E R A T I O N .  
3 H -T d R  in c o r p o r a tio n .m e a n  c p m  * s d x  1 0 '3
Responder cells from  m ice treated with
5.0%  FITC
No stimulator cells. - 21 1 0 -3 ♦ 2-9:0-2 ♦
5.0%  FITC
18
10 6 1 11 ♦♦ 5-810-8 ♦♦
.2 .5 %  .O x azo lo n e . 3-2 - 0-6 ♦ ♦ 18-7*2-7 ♦♦
5 .0 %  R T C
12
4 -4  î 0-5 ♦ ♦ 3 - 3 - 0 - 3 ns
2 .5 %  Oxazolone 2 0  i  0-3 ns 7-5 i 0-6 ♦♦
Responder Lymph Node Cells
As in table legend 8.1.1, except groups of 4 BALB/c mice were 
painted with 5% FITC or 2.5% oxazolone.
Stimulator Cells
As in table legend 8.1.1 except groups of 15 mice were painted 
12hrs or 18hrs prior to dendritic cell harvest with either 5% 
FITC or 2.5% oxazolone.
Culture Conditions
Standard, as described in table legend 8.1.1. 
Results
As described in  table  legend 8 .1 .1 .
8.2.1 The relative stimulatory activities of in vitro 
haptenated cells and dendritic cell-enriched lymph node 
cells from hapten primed mice
The ability of in vitro haptenated cells and dendritic cell- 
enriched lymph node cells from hapten-primed mice to stimulate 
enhanced proliferation of hapten-sensitized responder lymph node 
cells within the proliferation assay has been demonstrated. In 
this section, these stimulatory activities are compared within 
experiments to give an indication of the relative stimulatory 
activities.
It has been established (figure 8.2.1) that at a responder: 
stimulator cell ratio of 1:10, in vitro DNFB-haptenated, 
allogeneic erythrocytes, but not normal allogeneic erythrocytes, 
induced a 2.4 fold enhancement of proliferation in DNCB- 
sensitized lymph node cells. The same responders, cultured in 
the presence of dendritic cell-enriched lymph node cells from 
DNCB-primed mice at responder: stimulator cell ratio 70:1 gave a 
4 fold enhancement of responder proliferation. It was apparent 
that dendritic cell-enriched lymph node cells from DNCB-primed 
mice were markedly more stimulatory for responder proliferation, 
inducing twice the level of ^KTdR incorporation within the 
responder lymph node at a stimulation ratio of 1/700 that used 
for in vitro haptenated erythrocytes.
8.2.2 The influence of stimulator cell size
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Figure Legend 8.2.1
As in table legend 8.1.1, except a group of 4 BALB/c mice were 
painted with 2.5% DNCB.
Stimulator Cells
1 Dendritic cell-enriched and depleted auricular lymph node 
cells were prepared from a group of 15 BALB/c mice 
painted 18hrs previously on both ears with 2.5% DNCB, as 
described in chapter 7, washed fractions were adjusted to 
4.5 x 105 cells ml"l in standard medium
2 In vitro DNFB-haptenated allogeneic erythrocytes were 
prepared as described in chapter 5, figure 6.2.5.
Culture Conditions
Standard, as described in chapter 5, with 5 x 105 responders: 5 
x 106 erythrocytes (responder to stimulator ratio - 1:10) or 5 x 
105 responders: 11000 dendritic cell enriched or depleted lymph 
node cells. (Responder: stimulator - 45:1 or responder to 
dendritic cells - 70:1.)
Results
Displayed as described in table legend 8.1.1.
Responder Lymph Node C e lls
FIGURE 8.2.1
A  Comparison of the Stimulatory Activity of DNFB-haptenated 
Allogeneic Erythrocytes with Dendritic Cell-enriched and Depleted 
Lymph Node Cells from DNCB-primed Mice
To determine whether this significant difference in stimulatory 
activity was simply due to differences in cell size between 
dendritic cells and erythrocytes, naive dendritic cells were 
haptenated in vitro with FITC and their stimulatory activity was 
assessed in parallel with the stimulatory activity of dendritic 
cell-enriched lymph node cells isolated from FITC-primed mice. 
The results of a representative experiment are presented in 
table 8.2.1. It was established, that naive dendritic cell- 
enriched lymph node cells haptenated in vitro with FITC were not 
stimulatory for FITC-sensitized responder lymph node cells under 
conditions where dendritic cell-enriched lymph node cells from 
FITC-primed mice caused a 6 fold enhancement of proliferation. 
Analysis of the fluorescence intensity of these two stimulator 
populations demonstrated that the in vitro haptenated, naive 
dendritic cell-enriched lymph node cells were at least as 
fluorescent as the dendritic cell-enriched lymph node cells from 
FITC-primed mice (figure 8.2.2).
NB As would be predicted, in vitro FITC haptenated lymph node 
cells were not stimulatory for FITC-sensitized responders at a 
responder:stimulator cell ratio of 62:1.
It has been demonstrated that while in vitro FITC-haptenated 
lymph node cells failed to stimulate enhanced proliferation in 
FITC-sensitized responders, at stimulator numbers where 
dendritic cell-enriched lymph node cells from FITC-primed mice 
were stimulatory, if increased numbers of in vitro FITC- 
haptenated lymph node cells were used, then a weak stimulation
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Table Legend 8.2.1
As in table legend 8.1.1 except that a group of 4 BALB/c mice 
were painted with 5% FITC.
Stimulator Cells
1 Dendritic cell-enriched lymph node cells from mice 
painted 18hrs previously with 2.5% FITC were prepared as 
described in legend to table 8.1.1.
2 Naive auricular lymph node cells were haptenated in vitro 
with 12ugml"1 FITC (as described in chapter 5) with the 
exception that there was no subsequent treatment with 
irradiation or metabolic toxins. The haptenated cells 
were then fractionated in dendritic cell-enriched (and 
depleted) populations, exactly as described in chapter 5.
3 As for 2, but no fractionation.
Culture Conditions
Standard, as described in chapter 5, with 5 x 105 responders: 
8064 stimulator cells, ie responder:stimulator ratio of 62:1 (or 
res ponder: dendr i t ic cells - 95:1 with dendritic cells at 65% of 
the dendritic cell enriched fractions).
Results
Presented as described in table legend 8.1.1.
Responder Lymph Node C e lls
TABLE 8.2.1
The Stimulation of FTTC-sensitized Lynqah Node Cell Proliferation 
by Dendritic Cell-Enriched Lymph Node Cells from FlTC-primed Mice, 
Naive Dendritic Cells Coated with FTTC In Vitro and Naive, 
Unfractionated Cells Coated with FTIC In Vitro
S tim ula to r cells:
L V m P h O C Y T E  P R O L I F E R A T I O N
3 H - T d R  in c o rp o ra tio n , m e a n  c p m  
i s d  x  1CT3
R e sp o n d e r cel Is from  m ice treated 
w it h  5 %  F I T C
N o n e 6  7  t 0 8  ♦
In v iv o  F IT C  _ 
b e a ring  dendritic
3 6 -0 1 1 -7  ♦ ♦ _________________
In vitro  F |TC ~  
hapte na te d  
dendritic cells
2 7  7  1 11 ns
In v itro  F I T C -  
haptenated 
lym ph n o d e  cells^
__________6 -4  •- 1 0  m __________________
FIGURE 8.2.2
EPICs Computer Generated Contour Plots of Forward Angle Light 
Scatter v Green Fluorescence Intensity v Cell Nunber for Dendritic 
Cell Enriched Lymph Node Cells: a) Haptenated In Vitro with FlIC, 
b) Haptenated In Vivo with FTTC
F L U O R E S C E N C E
An aliquot of the stimulator cell populations used in table 
legend 8.2.1 were analysed using the EPICs flow cytometer.
Analysis
The populations were examined as described previously in chapter 
7, with the results presented as a contour plot (see figure 
legend 7.2.1C).
of responders, as previously described (chapter 6), was 
observed. Thus, in figure 8.2.3 in vitro FITC-haptenated lymph 
node cells induced enhanced % T d R  incorporation in FITC- 
sensitized lymph node cell responder: stimulator cell ratio of 
5:1 but not at responder: stimulator cell ratio of 55:1. 
Characteristically, dendritic cell-enriched lymph node cells 
from mice primed 18hrs previously with FITC were strong 
stimulators of enhanced proliferation within the responders, 
causing an 11 fold enhancement of %TdR incorporation at a 
responder: stimulator cell ratio of 55:1.
8.3.1 The resistance to silica of the stimulatory activity of 
dendritic cell-enriched lymph node cells
The sensitivity of the stimulatory activity of dendritic cell- 
enriched lymph node cells to silica has been analysed and the 
data are presented in figure 8.2.4. The proliferative activity 
of FITC-sensitized responder lymph node cells in the presence or 
absence of 200ugml"^ silica did not differ significantly, as 
would be expected from the earlier data in chapter 6. It is 
notable, however, that FITC-primed dendritic cell-enriched lymph 
node cells were stimulatory for responder lymph node cells 
whether silica was present or not. The earlier studies 
demonstrated that hapten-driven proliferation in responder lymph 
node cells when using in vitro haptenated stimulators, was 
silica sensitive.
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Figure Legend 8.2.3
As in table legend 8.1.1, except a group of 4 BALB/c mice were 
painted with 5% FITC.
Stimulator Cells
1 Dendritic cell-enriched auricular lymph node cells were 
prepared from a group of 15 BALB/c mice painted 18hrs 
previously on both ears with 5% FITC, as described in 
chapter 7. Washed fractions were adjusted to 4.5 x 10^ 
cells ml“-*- in standard medium.
2 In vitro FITC-haptenated syngeneic lymph node cells were 
prepared as described in chapter 6, figure legends 6.2.1 
and 6.2.2.
Culture Conditions
Standard, as described in chapter 5, with 5 x 10^ responders: 1 
x 106 or 11000 in vitro FITC haptenated lymph node cells or 5 x 
105 responders: 11000 FITC-primed dendritic cell-enriched 
fractions.
Results are displayed as described in table legend 8.1.1.
Responder Lymph Node C e lls
FIGURE 8.2.3
A Camarison of the Stijaulatory Activity of FTTC-haptenated Lymph
Node Cells with Dendritic Cell-enriched Lymph Node Cells from
FTTC-primed Mice
Figure Legend 8.2.4
As described in table legend 8.1.1 except mice were painted with 
2.5% FITC only.
Stimulator Cells
As described in table legend 8.1.1 except a group of 15 BALB/c 
mice were painted with 0.5% FITC.
Culture Conditions
Culture conditions were standard, with 5 x 10^ responders 
cultured with either no stimulators, 11300 dendritic cell- 
enriched lymph node cells or Concanavalin A at 5ugml”  ^ final 
concentration. In addition, all these groups were prepared, but 
with silica added to the culture, giving a final concentration 
of 200ugml“* silica. All wells had 200ul final volume.
Results
Results are displayed in histogram format, as described in table 
legend 8.1.1.
** denotes statistical significance from paired control (*)
Responder Lymph Node C e lls
FIGURE 8.2.4
Stimulation of FITC-sensitized Lymph Node Cell Proliferation by 
FTTC-primed Dendritic Cell-CTnriched Fractions and the Influence of 
Silica on this Proliferative Response
C o n t r o l W it h  silica
8.4 Discussion
The experiments described in this chapter aimed to establish a 
hapten-specific, dendritic cell-driven proliferative response in 
vitro, which could be utilised as a control or baseline response 
against which to compare the stimulatory activity of manipulated 
dendritic cell-enriched fractions.
Of fundamental importance to these studies was the data I 
presented in chapter 7, which demonstrated the hapten-bearing 
nature of dendritic cells isolated from the draining lymph nodes 
of hapten-painted mice. These data were consistent with the 
proposal that the dendritic cell is a hapten-presenting cell in 
vivo. In addition, a number of published reports implicate 
hapten-bearing dendritic cells as important in the activation of 
T-lymphocyte proliferation in situ (Fossum 1988; Breel et al
1988) and in vitro (Knight et al 1985; Macatonia et al 1987). 
Indeed, dendritic cells are essential for the antigen-specific 
activation of naive T-lymphocytes (Inaba and Steinman 1984). It 
was obviously important to validate (or not) these findings 
within the present assay system and the data in this chapter 
therefore constitutes the characterisation and attainment of 
hapten-specific, dendritic cell-driven proliferative responses 
in vitro within the antigen presentation assay. As such, it 
consists of a detailed analysis of the stimulatory activity of 
dendritic cell-enriched lymph node cells from hapten primed mice 
for hapten sensitized lymph node cells in vitro.
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The proliferative activity of hapten-primed, dendritic cell 
enriched auricular lymph node cells
The stimulatory activity of dendritic cell-enriched lymph node 
cell fractions was to be assayed by their ability to induce 
proliferation within sensitized responder lymph node cells. It 
was therefore essential to establish the background 
proliferative activity of the dendritic cell-enriched fractions. 
In agreement with previous studies, notably by Ralph Steinman 
and co-workers (Steinman and Cohn 1973; Austyn 1987), I 
demonstrated that post 18hr hapten-primed, dendritic cell- 
enriched lymph node cells had negligible %-TdR incorporation 
during culture. This was in spite of my earlier findings 
(chapter 7) which demonstrated that the dendritic cell-enriched 
fractions from such mice usually contained about 30% of non- 
dendritic cells. Evidently, this minority component of 10^ 
dendritic cell-enriched lymph node cells (the usual number used 
per well as stimulators) did not proliferate significantly. 
That the same number of post 18hr, hapten primed, dendritic 
cell-depleted lymph node cells also failed to produce any 
detectable %-TdR incorporation above background levels, 
indicated that these cells had no significant indigenous 
proliferative activity.
One might argue, that the low titre of stimulator cells tested, 
(104 in 200ul final volume) would not proliferate, as their 
dilution and consequent lack of cell-cell contact (or feeder 
effects) would not be conducive to growth. A number of workers
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have demonstrated these effects in cell culture in the past 
( ). Within my experiments, 10^ dendritic
cell-enriched lymph node cells fail to proliferate when cultured 
alone but on addition of 5 x 10^ responder lymph node cells, the 
'feeder' requirement could be met and the stimulator cells could 
proliferate. Any enhanced proliferation would thus reflect 
stimulator and responder lymph node cell proliferation. A 
simple experiment, however, demonstrated that garrma-irradiated 
dendritic cell-enriched lymph node cells induced as high a level 
of culture proliferation as non-irradiated fractions, proving 
that any indigenous stimulator cell proliferation did not 
contribute to the gross proliferation measured in responder
cell/stimulator cell cocultures (data not presented). This 
rolediscounted a possible' tor antigen presentation by B-lymphocytes 
A
which are radiosensitive (Ashwell et al 1988).
In addition, I established that 10^ dendritic cell-depleted 
cells in 200ul final volume are viable, as a ConA response was 
readily induced and measured as an increase in %-TdR 
incorporation. Evidently, Metrizamide treatment, by which all 
stimulator populations were prepared, fails to affect the 
viability of these cells.
It is significant to note that dendritic cell-enriched fractions 
fail to proliferate on addition of a mitogenic concentration of 
ConA. This was consistent with my earlier observation that 
dendritic cell-enriched lymph node cells contain few T- 
lymphocytes, while the dendritic cell-depleted lymph node cells
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have significant numbers of T-lymphocytes and enough accessory 
cells to facilitate the ConA response within the T-lymphocytes 
(Gallagher et al 1986; Hirayama et al 1987).
The dependence of the proliferative activity of low buoyant 
density cell (dendritic cell)-enriched lymph node cells on the 
hapten-priming period
The results discussed above were in marked contrast to those 
obtained for low buoyant density cell-enriched lymph node cells 
from mice painted 4 days rather than 18hrs previously with 
sensitizing chemicals, as described in chapter 6. Such 
populations actively proliferate, containing cells with high 
levels of 3H-TdR incorporation and were therefore more 
characteristic of T-lymphoblasts than dendritic cells. Clearly 
at 18hrs post-priming, the presence of proliferating 'T- 
lymphoblasts' was not detectable within the primed lymph node 
cell populations tested. These results can be explained in 
terms of the progression of activation of T-lymphocytes within 
the lymph node, following ear-painting and are broadly 
consistent with the time course for lymph node cell 
proliferation following ear-painting with 2.5% DNCB, as 
described in chapter 6 (see figure 6.1.2) and previously by 
others (Kimber et al 198^; Asherson and Barnes 1973).
While the proliferative activity and thus presence of 
proliferating 'T-lymphoblasts' was negligible in dendritic cell- 
enriched fractions from mice painted 18hrs previously on both
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ears with either 2.5% DNCB or 5% FITC, it was possible that 
activated T-lymphocytes, not yet proliferating, were present. 
Thus, dendritic cell-enriched fractions (70% dendritic cells) 
could contain activated T-lymphocytes producing T-lymphocyte 
stimulatory lymphokines, including IL-2 and IL-4 (see chapters 1 
and 2 [Cantrell et al 1988; Cher and Mosmann 1987]). It has 
also been established by me (data not shown) and my colleagues 
at ICI (Kimber and Weisenberger 1989; Baker et al 1990) that 
sensitized lymph node cells from mice painted 7 days previously 
with haptens, including 2.5% DNCB and 5% FITC, are responsive to 
exogenous IL-2 in vitro, ie these cells express the IL-2R 
(Leonard et al 1982; Cantrell and Smith 1983) and probably 
receptors for other interleukins.
My expectation from these observations was that on addition of 
dendritic cell-enriched lymph node cells (stimulators) to 
sensitized lymph node cells (responders) there could be some 
stimulation of IL-2 receptor-bearing responder cells by IL-2 
produced by the stimulator cells. This would be in addition to 
any stimulation of hapten-specific T-lymphocytes by hapten­
bearing dendritic cells. The gross result would be stimulation 
of sensitized lymph node cell proliferation in a fashion not 
restricted by the hapten-bearing nature of the dendritic cell- 
enriched lymph node cells added. This effect becomes apparent 
in the next section of this discussion.
The major points to emphasise from these preliminary studies are 
that dendritic cell-enriched lymph node cells from mice painted
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18hrs previously with various sensitizing chemicals failed to 
proliferate in vitro, as would be predicted and so would not
contribute to the proliferation of the responder population. On 
addition of dendritic cell-enriched fractions to sensitized 
lymph node cells, any increased proliferation therefore 
reflected stimulation of sensitized lymph node cells.
The stimulatory activity of dendritic cell-enriched lymph node 
cells from hapten-primed mice for hapten-sensitized lymphocytes
Initial experiments demonstrated that dendritic cell-enriched 
fractions from mice painted 18hrs previously with 5% FTTC failed 
to stimulate any significant enhancement of proliferation in 
auricular lymph node cells from naive mice. Under identical 
experimental conditions, sensitized auricular lymph node cells 
from mice painted 7 days previously with 5% FITC responded with 
a significant enhancement in proliferation. In vitro 
responsiveness to hapten-bearing dendritic cell-enriched 
fractions was therefore a function of previously activated 
lymphocytes within the sensitized responder lymph node cells. 
This again implicated T-lymphoblasts, or their progeny T- 
lymphocytes, as the hapten-responsive cells within sensitized 
lymph node cells. In addition, this evidence demonstrated that 
while dendritic cell-enriched fractions from hapten-primed mice 
do not provide an adequate signal for the activation of resting 
(naive) lymphocytes to proliferate, they do provide enough 
stimulus for activation of previously activated lymphocytes.
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The distinction between the signals required for activation of 
naive T-lymphocytes and activated T-lymphocytes/T-lymphoblasts 
are well established, as is the ability of particular accessory 
cells, antigen presenting cells in particular, to provide these 
signals. Thus, resting (or naive) T-lymphocytes are dependent 
on an essential attribute of antigen-bearing dendritic cells, 
for stimulation. This is in addition to the provision of 
antigen, class II MHC-encoded products and IL-1. This has been 
demonstrated for a variety of antigens including alloantigens 
(Inaba and Steinman 1984) and contact sensitizing chemicals 
(Macatonia et al 1987). The unique 'signal' remains to be 
elucidated but has been related to the ability of dendritic 
cells to initiate antigen non-specific clustering of naive T- 
lymphocytes, which was discussed in chapter 1.
In contrast, activated T-lymphocytes have been shown to respond 
to antigen presented by a variety of class II MHC+ cells 
including B-lymphocytes, macrophages and dendritic cells, of 
which the tatter were most stimulatory cell for cell (Inaba and 
Steinman 1984). The magnitude of induced proliferation in 
sensitized T-lymphocytes depended on the level of class II MHC- 
encoded antigens expressed on the antigen presenting cell, given 
adequate nominal antigen and class II MHC encoded antigens 
(Lechter et al 1985): dendritic cells were shown to express the 
highest levels of membrane expressed class II MHC encoded 
antigens (Inaba and Steinman 1984). Indeed, maximal expression 
of class II MHC-encoded proteins on non-dendritic antigen 
presenting cells by culture with IFN gamma still failed to
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produce the stimulatory activity associated with dendritic cells 
(Austyn 1987). Therefore, it would have been surprising if I 
had failed to demonstrate that dendritic cell-enriched, hapten 
primed lymph node cells were at least stimulatory for sensitized 
lymph node cells (T-lymphocyte rich). It is notable, however, 
that I failed to detect any enhanced proliferation within 
resting lymph node cells when cultured with the hapten-bearing 
dendritic cell-enriched fraction. This no doubt reflected a 
combination of factors including the use of 200ul rather than 
20ul hanging drop cultures and the relatively short culture 
period of 48hrs.
I should add at this point, that dendritic cell-depleted lymph 
node cells, from mice painted 18hrs previously with various 
haptens, were not stimulatory for sensitized lymph node cells. 
This was established for a variety of hapten-primed lymph node 
cells, when the dendritic cell-enriched fraction was shown to be 
highly stimulatory (as indicated by data presented in table 
8.1.2).
The dependence of an enhanced proliferative response on the 
hapten-painted status of mice used for preparation of both 
responder and stimulator lymph node cell populations
I established that the proliferative response of FITC-sensitized 
lymph node cells on addition of dendritic cell-enriched 
fractions required dendritic cells from FITC-primed mice. 
Similarly, an enhanced proliferative response was detected in
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DNCB-sensitized lymph node cells on addition of DNCB-primed 
dendritic cell-enriched fractions: the addition of TRITC-primed 
dendritic cell-enriched fractions gave a similar response in 
TRITC-sensitized responders. Naive dendritic cell-enriched 
fractions consistently failed to stimulate sensitized lymph node 
cells to proliferate. This dependence of the stimulatory 
activity of dendritic cell-enriched fractions on the hapten- 
primed state of the lymph node cells from which they were 
derived, was significant. Thus, a number of groups had 
previously described a dendritic cell-driven proliferative 
response in lymphocytes, termed the syngeneic mixed leucocyte 
reaction (MLR) (Nussenzweig and Steinman 1980), in which 
experimentally naive dendritic cells induced proliferation in 
histocompatability antigen-matched lymphocytes. While the 
antigen stimulating this response remains to be identified, it 
was clear that the culture duration of 48hrs in my experiments 
was insufficient for an autologous MLR to develop.
The relationship between the magnitude of enhancement of 
proliferation in FITC-sensitized lymph node cells and the 
fluorescence intensity of the added dendritic cells
The proliferative response of sensitized lymph node cells on 
addition of dendritic cell-enriched fractions from hapten primed 
mice was dependent on the number of dendritic cells added. 
Thus, for combinations of dendritic cell-enriched fractions and 
sensitized lymph node cells primed/sensitized with the same
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hapten, proliferation increased with the nunber of dendritic 
cells.
In addition, the stimulatory activity of FITC-primed dendritic 
cell-enriched fractions for FITC-sensitized responder 
populations increased with the priming dose (table 8.1.5). This 
correlates with the cytometric analyses and data presented in 
figures 7.2.4B and table 7.2.2, which demonstrated that such an 
FITC-priming regime generates FITC-bearing dendritic cells with 
increasing fluorescence as the priming dose increased. Such 
direct relationships between the proliferative response of 
sensitized lymph node cells and a) the number of dendritic cells 
added and b) the level of hapten on the added dendritic cells 
were encouraging. However, they would only be significant if 
the proliferative response was hapten-specific and as the 
discussion to follow demonstrates, this was not always the case.
The hapten-specificity of sensitized lymph node cell 
proliferation induced by hapten-primed dendritic cell-enriched 
fractions
Further studies, examining the hapten-specificity of this 
stimulation were largely but not absolutely consistent with the 
proposal that the highly stimulatory activity of the dendritic 
cell-enriched fractions was dependent on the cell-associated 
hapten exhibited by lymph node dendritic cells, as described in 
chapter 7. Highly immunogenic antigen has been reported 
detectable in the local lymph nodes following skin painting
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(Asherson and Mayhew 1976). My data is consistent with the 
proposal of Knight and co-workers (see chapter 3) that this 
antigen is associated with (and presented by) dendritic cells to 
hapten-specific T-lymphocytes within the sensitized lymph node 
cell responders.
In a series of experiments which considered the hapten 
specificity of proliferative responses between FITC or DNCB 
sensitized responder lymph node cells and FITC or DNCB primed 
dendritic cell-enriched fractions, I established that dendritic 
cell-enriched fractions from mice painted 18hrs previously with 
5% FITC were highly stimulatory for FITC-sensitized lymph node 
cells. The same cell fraction was also stimulatory for DNCB- 
sensitized lymph node cells, but less than for the homologous 
combination. Clearly, dendritic cell-enriched fractions from 
mice primed 18hrs previously with 5% FITC had some capacity for 
hapten non-specific stimulation of responder lymphocytes. A 
similar phenomenon was not observed when dendritic cell-enriched 
lymph node cells from DNCB-primed mice were used. Thus, such 
fractions had stimulatory activity for DNCB-sensitized lymph 
node cells but not usually for FITC-sensitized lymph node cells. 
A number of explanations might account for this.
One explanation of the stimulatory activity of FITC-primed 
dendritic cell-enriched fractions for DNCB-sensitized lymph node 
cells is that the dendritic cell-enriched fraction stimulates 
the proliferation of the few resting (or naive) T-lymphocytes 
within the sensitized lymph node cells. Thus, the composition
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of sensitized lymph node cell populations has previously been 
described as consisting of clonally expanded populations of T- 
lymphocytes, expressing the alpha-beta T-cell receptor specific 
for particular epitop>es of the sensitizing hapten together with 
non-specific proliferation ("by-stander effects"). A few of the 
remaining cells in this population would consist of resting T- 
lymphocytes with alpha-beta T-cell receptors specific for a 
variety of other antigens, including the FITC-specificity. But 
I demonstrated previously that naive lymph node cells were not 
stimulated by FITC (or DNCB)- primed dendritic cell enriched 
fractions, within my assay system which tends to discount this 
theory. However, the susceptibility of naive T-lymphocytes to 
activation by hapten-bearing dendritic cell-enriched fractions 
in a more complex interleukin environment was not examined in 
these studies, as another explanation for non-specific 
stimulation became more apparent. In theory, however, resting 
T-lymphocytes within an interleukin environment provided by 
activated T-lymphocytes may be more responsive to antigenic 
challenges. This has been demonstrated previously in a number 
of systems, including a model of IL-l-enhanced dendritic cell 
stimulation of T-lymphocytes (Koide et al 1987). The same group 
has demonstrated the production of IL-1 in populations 
containing sensitized T-lymphocytes/lymphoblasts (Koide and 
Steinman 1988). The activation of naive T-lymphocytes could not 
therefore be formally excluded, but seems unlikely.
An alternative explanation for the non-specific stimulatory 
activity of FITC-primed dendritic cell-enriched fractions for
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DNCB-sensitized lymph node cells had its origins in the 
differing sensitizing potency of these two chemicals in 
particular, and all such chemicals in general. The potency of a 
sensitizing chemical may be related to the magnitude of the 
primary proliferative response that chemical induces in murine 
auricular lymph nodes following application to the mouse ears 
(Kimber et al 1989). Thus, 0.5% oxazolone stimulates a large 
primary proliferative response and may be termed a potent 
sensitizer, while 0.5% DNCB is significantly less stimulatory, 
and is termed a weak sensitizer (Kimber and Weisenberger 1989). 
At a given time, say 18hrs beyond application of equal volunes 
of these chemical to mouse ears, the oxazolone-primed lymph node 
cell population will be significantly further along the route to 
generating proliferation. This could reflect a higher number of 
oxazolone-bearing dendritic cells in the lymph node (and a 
consequent advancement of T-lymphocyte activation) when compared 
with DNCB-bearing dendritic cells in the DNCB-primed mice.
I considered it probable that such a difference in the 
'activated status' of the two lymph node populations was 
reflected in a number of aspects, including the production by 
'developing' T-lymphoblasts of T-cell growth factors and the 
expression of membrane bound receptors for these factors. Such 
differences could explain the observation of non-specific 
stimulatory activity within FITC-primed but not DNCB-primed 
dendritic cell-enriched fractions. Necessarily, the weak non­
specific stimulatory activity of hapten-primed dendritic cell- 
enriched fractions would be attributed to a small number of
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these T-lymphoblasts which co-fractionate with dendritic cells 
following priming with potent (but not weak) haptens. In this 
case, while hapten-bearing dendritic cells are the immunogenic 
stimulus for hapten-specific T-lymphocytes within the sensitized 
lymph node cells, interleukin-producing T-lymphoblasts might 
contribute a less specific stimulatory activity. The potential 
contribution of IL-2 and IL-4 to this non-specific stimulation 
was described earlier (Cher and Mosmann 1987; Bottomly 1988).
The significance of hapten potency on the generation of non­
specific stimulatory activity within dendritic cell-enriched 
fractions
I predicted that a potent sensitizer such as 5% F U C  or 2.5% 
oxazolone, would engender non-specific stimulatory activity 
within dendritic-cell-enriched lymph node cells derived from 
mice primed 18hrs previously with those chemicals. Conversely, 
dendritic cell-enriched lymph node cells from mice painted with 
weak sensitizers, for example 2.5% DNCB or 2.5% TRITC would have 
negligible non-specific stimulatory activity. The stimulatory 
activity of dendritic cell-enriched fractions from mice primed 
18hrs previously with potent and weak sensitizers were compared. 
The results demonstrated firstly that when dendritic cell- 
enriched fractions and sensitized responder lymph node cells 
were from groups of mice painted with homologous chemicals, the 
proliferative response was invariably large. I considered it 
likely that such homologous combinations gave strong 
proliferation because they involved a major interaction between
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hapten-bearing dendritic cells and hapten-specific T-lymphocytes 
in a hapten restricted fashion (see chapter 1), ie conventional 
antigen presentation (see introduction).
When stimulators and responders were from mice painted with 
heterologous combinations, some weak but significant 
proliferative responses were measured. The responses were not 
restricted by hapten specificity. The proliferating and non­
proliferating combinations were recorded, as described earlier 
and it was apparent that the sensitizing potency of chemicals 
determined whether dendritic cell-enriched fractions had non­
specific stimulatory activity. Potent sensitizing chemicals 
initiated a strong non-specific stimulatory activity in 
resulting dendritic cell-enriched fractions. In terms of my 
proposal, these dendritic cell-enriched fractions produced non­
specific factor and significantly, all sensitized responder 
lymph node cells tested were apparently positive for an 
appropriate 'factor receptor'. Dendritic cell-enriched 
fractions from mice painted with weak sensitizing chemicals 
(2.5% DNCB, 5% TRITC) had limited non-specific stimulatory 
activity. This was compatible with these fractions producing 
low levels (nil in the case of 2.5% DNCB) of non-specific 
factor. Finally, the different responses to a given dendritic 
cell-enriched fraction can be explained if different responder 
populations have different requirements for stimulation by non­
specific factor (reflecting, for example, different thresholds 
for stimulation).
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The data and these conclusions indicate that levels of non­
specific factor production and expression of different levels of 
the appropriate receptor could explain the hapten non-specific 
stimulatory activity of dendritic cell-enriched lymph node 
cells. If my theory was correct, then clearly, the effect of 
reducing the dose of a potent sensitizing chemical should be to 
reduce the non-specific stimulatory activity of the resulting 
dendritic cell-enriched lymph node cells. Thus, if sufficient 
hapten was applied to the skin to cause the appearance of 
hapten-bearing dendritic cells in the lymph node, while at the 
same time being an inadequate dose for activation of significant 
numbers of T-lymphoblasts 18hrs later, then the resulting 
dendritic cell-enriched fraction would have hapten-specific, 
immunogenic properties only.
Consistent with this theory, in a series of experiments 
documented in this chapter, I demonstrate that the non-specific 
stimulatory activity is lost, while specific stimulatory 
activity retained, if either
a) the priming dose of FITC applied 18hrs prior to dendritic 
cell harvest was reduced or
b) the priming dose of FITC or oxazolone was applied at 
12hrs rather than 18hrs prior to dendritic cell harvest.
In the first instance, it is clear from the data presented in 
table 8.1.5 that if the FITC-priming dose was reduced, then only
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specific stimulatory activity for FTTC-sensitized responders was 
retained. Clearly within the 0.25% FITC-primed dendritic cell- 
enriched fraction, there are significant numbers of FITC-bearing 
(and thus immunogenic) dendritic cells. This is in fact 
corroborated by ray own flow cytometric analyses on 0.25% FITC 
primed, dendritic cell-enriched lymph node cell fractions, as 
presented in chapter 7 (figure 7.2.4B). This population 
evidently has a functionally insignificant number of cells 
producing non-specific stimulatory factors.
In the second instance, examining the non-specific interaction 
between oxazolone and FITC, I established that if the priming 
dose was applied 12hrs prior to dendritic cell harvest, then the 
dendritic cell-enriched fractions had a specific stimulatory 
activity only. This again indicated the absence of any 
functionally significant cells producing non-specific 
stimulatory factors, within the dendritic cell enriched 
fraction, at 12hrs post-priming.
Clearly, both these approaches confirm that the generation of 
non-specific stimulatory activity within hapten-primed dendritic 
cell-enriched lymph node cells depends on the progression of 
sensitization following epicutaneous exposure. While the cause 
of this non-specific stimulation remains to be ascertained, the 
role of lymphoblasts cofractionating with dendritic cells and 
the subsequent release of T-cell growth factors by these cells 
is a possible explanation. Irrespective of the nature of non­
specific stimulation, the data provided demonstrates that
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dendritic cell-enriched lymph node cells with hapten-specific 
stimulatory activity (or immunogenicity) are readily isolated, 
when due regard is paid to the priming dose and period of 
exposure to the priming chemical. The studies I have presented, 
while extensive, have demonstrated a rational approach to 
establishing hapten-specific, dendritic cell-driven
proliferative responses in vitro. See page 224-225.
A comparison of the stimulatory activities of dendritic cell- 
enriched lymph node cells from hapten-primed mice with in vitro 
haptenated cells
As an indication of the mechanism whereby hapten-bearing 
dendritic cells were able to stimulate proliferation of hapten- 
sensitized lymph node cells in a hapten-restricted manner, I 
compared the stimulatory activity of these in vivo haptenated 
dendritic cells with that of in vitro haptenated cells. In 
particular, I required an indication of whether in vivo 
haptenated dendritic cells directly stimulated T-lymphocytes 
within sensitized lymph node cells in vitro or alternatively 
whether these dendritic cells were processed by endogenous 
antigen presenting cells within the sensitized lymph node cells. 
Certainly, numerous reports of the immunogenic properties of 
dendritic cells, which have been described as potent and even 
'the premier' antigen presenting cell (Austyn 1987), suggested 
their ability to directly activate T-lymphocytes both in vivo 
and in vitro. Alternatively, there was some evidence consistent 
with my proposal that an indirect route may be involved in
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hapten-bearing dendritic cell stimulation of lymph node cell 
proliferation. Thus, it has been proposed that hapten-bearing 
dendritic cells interact with viable, non-hapten-bearing 
dendritic cells prior to T-lymphocyte activation.
Additionally, dendritic cell-macrophage interactions 
have also been implicated during the in vitro stimulation of 
sensitized T-lymphocytes (Guidos et al 1987).
In a series of experiments, of which figure 8.2.1 is 
representative, I demonstrated that DNCB-primed, dendritic cell- 
enriched lymph node cells were significantly more stimulatory 
than in vitro haptenated erythrocytes for DNCB-sensitized lymph 
node cells. It was significant that while in vitro DNFB- 
haptenated erythrocytes induced a characteristic, weak 
proliferative response within the sensitized responder 
population, three orders of magnitude less DNC3-primed dendritic 
cell-enriched lymph node cells still stimulated a stronger 
proliferative response by the responder lymph node cells. [NB 
DNCB-primed dendritic cell-enriched fractions give specific 
stimulatory response. ] The DNCB-bearing dendritic cells from 
DNCB-painted mice were unequalled in their stimulatory activity 
per cell.
Additional experiments established that naive dendritic cells, 
haptenated in vitro with FITC, consistently failed to stimulate 
FITC-sensitized lymph node cell proliferation. In contrast, the 
same number of dendritic cells from mice painted 18hrs 
previously with 2.5% FITC stimulated characteristic
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proliferative responses. The equivalent size of naive and FITC- 
primed dendritic cells is apparent in chapter 7 figure 7.2.2A 
and B.
(While 2.5% FITC-primed dendritic cell-enriched fractions had 
some non-specific stimulatory activity, I have demonstrated 
previously that at lower priming doses of FITC, a specific 
response is observed. This specific response is still 
significantly higher than the nil response measured on addition 
of in vitro FITC-haptenated naive dendritic cells.)
It was also highly significant that in vitro FITC-haptenated 
dendritic cells were at least, if not more, fluorescent than 'in 
vivo primed', FITC-bearing dendritic cells. The lack of 
stimulatory activity of the former population could not be 
attributed to the dendritic cells bearing less FITC. While the 
level of fluorescence need not reflect the amount of immunogenic 
or correctly presented FITC by dendritic cells, my previously 
described results did suggest this. Thus, as the dose of FITC 
used to prime mice 18hrs prior to dendritic cell harvest was 
increased, I have observed increases in
a) the total number of dendritic cells per node,
b) the fluorescence intensity of the hapten-bearing 
dendritic cells and
c) the number of dendritic cells bearing high levels of 
fluorescence.
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Studies measuring the stimulatory activity of fixed numbers of 
dendritic cells, indicate that both b) and c) significantly 
affect this stimulatory activity (as described earlier).
Clearly, the stimulatory activity of dendritic cells from 
hapten-primed mice is related to the level of hapten on the 
dendritic cells. In addition, this activity is dependent on the 
provision of more than just a source of hapten to the sensitized 
responder lymph node cells, as in vitro haptenated cells do not 
provide it.
The importance of these results, in parallel with those 
described in chapter 6, needs emphasising. In chapter 6, I 
demonstrated that in vitro haptenated cells were stimulatory for 
sensitized lymph node cells in a manner dependent only on their 
ability to provide appropriate (specific) hapten to sensitized 
lymph node cells. In vitro haptenated cells were considered to 
constitute simply a hapten-substrate, which may be processed in 
culture (if active antigen processing cells were present) into 
an immunogenic complex which may then be presented to T- 
lymphocytes within the sensitized responder population.
In contrast with in vitro haptenated cells, I have shown that 
1 in vivo primed', hapten-bearing dendritic cells are markedly 
more stimulatory than in vitro haptenated cells and provide some 
factor other than simply hapten while stimulating sensitized 
lymph node cell proliferation.
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The silica sensitivity of hapten-bearing dendritic cell-driven 
proliferative responses within sensitized lymph node cells
It is far from established that 'in vivo primed' dendritic cells 
stimulate sensitized T-lymphocytes directly within my assay 
system. My data however, or» certainly indicative of such 
dendritic cells stimulating in vitro proliferation by a 
different (direct?) route/mechanism than that by which in vitro 
haptenated cells are stimulatory. Consistent with this were my 
preliminary studies examining the silica sensitivity of 
proliferation within sensitized lymph node cells following 
addition of dendritic cells. The stimulatory activity of 'in 
vivo primed' dendritic cells appeared to be independent of any 
silica-sensitive, endogenous antigen-processing cell within the 
sensitized responder lymph node cells. I demonstrated that 
utilising silica-supplemented culture conditions, shown to block 
the stimulatory activity of in vitro haptenated cells, the 
stimulatory activity of FITC-primed dendritic cells from FITC- 
painted mice was unaltered. This suggested that ' in vivo 
primed' dendritic cells were not dependent on phagocytic 
activity (macrophages, after O'Rourke et al 1978) within the 
sensitized lymph node cells for their stimulatory activity: this 
is in contrast with the proposal of Guidos and co-workers 
(Guidos et al 1987).
Summary
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The work documented in this chapter characterises hapten-primed, 
dendritic cell-enriched lymph node cells as non-proliferative, 
mitogen-unresponsive populations with a highly stimulatory 
activity, detectable by the enhanced proliferation of sensitized 
lymph node cells in vitro.
Such proliferative responses were dependent on the donor mice 
having experienced sensitizing chemicals on the ears, suggesting 
that the response involved the stimulatory activity of hapten­
bearing dendritic cells and the responsiveness of previously 
activated T-lymphocytes/lymphoblasts. The observation that 
dendritic cell-enriched fractions from hapten-primed mice were 
most stimulatory for responder lymph node cells from mice 
sensitized with the same hapten was significant. It indicated 
that a significant proportion of proliferation per well was 
dependent on hapten recognition (by T-lymphocytes). This was 
not a complete explanation, however, because there was, for some 
particular mismatched hapten combinations, enhanced 
proliferation within the responder lymph node cells. This non­
specific stimulation was dependent on the potency of haptens 
used to prime for dendritic cells or sensitize for responder 
populations.
These results were consistent with responder lymph node cells 
expressing receptors for and thus being stimulated by non­
specific factors produced by contaminating cells within 
dendritic cell-enriched fractions. These two facets acted in 
concert, particularly when the mismatched haptens had widely
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different potencies, to give non-specific stimulation. I 
demonstrated that by regulating the hapten priming dose (or 
duration) prior to dendritic cell enrichment, then the non 
specificity was lost and hapten specific responses were 
attained.
Further studies, building on those performed in chapter 6 
demonstrated that hapten-primed dendritic cell-enriched lymph 
node cells were highly stimulatory when compared with in vitro 
haptenated cells. This reflected two key points. Firstly, 'in 
vivo haptenated' dendritic cell-enriched fractions provide some 
attribute, essential for stimulation of proliferation, which is 
not provided by in vitro haptenated dendritic cells (this is 
after the non-specific factor effect is accounted for). 
Secondly, in vivo haptenated dendritic cell-enriched fractions 
seem likely to stimulate proliferation within sensitized lymph 
node cells by a mechanism differing from that utilised by in 
vitro haptenated cells. Thus, preliminary studies suggested 
that in vivo haptenated dendritic cells may stimulate 
proliferation, while in vitro haptenated cells merely constitute 
a passive hapten substrate which is processed and presented by 
endogenous antigen presenting cells within the sensitized lymph 
node cell population.
Based on all this and a number of previously cited studies, I 
considered my assay system to be a good indicator of the 
immunogenicity of hapten-bearing dendritic cells from hapten 
primed mice. Changes in the immunogenic nature of dendritic
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cells would be detectable as changed proliferative responses in 
ray assay. Utilising this, I wished to consider the effect of 
IFN gamma administered in vivo on the development of immunogenic 
dendritic cells following hapten priming.
Thus a considerable amount of evidence, constituting a 
fundamental thread in modem cellular immunology, supports the 
view that movements and interactions within (and outside) the 
lymphon during immune activation are to a large part modulated 
by lymphokines in general (introduced in chapter 2). Of 
particular interest to me was the putative in vivo role of IFN 
gamma on the activity and appearance within lymph nodes of 
lymphocytes in general and hapten-bearing dendritic cells in 
particular. While I acknowledge the difficulties in 
'experimenting' effectively in vivo with lymphokines, as opposed 
to in vitro studies, my approach reflects a desire to consider 
whole body influences rather than isolated in vitro phenomena.
The results of my studies on this aspect of immune modulation 
are documented and discussed in chapter 9.
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While hapten specificity was established, the MHC restriction of 
the proliferative response driven by in vivo haptenated dendritic 
cell-enriched lymph node cells was not examined. Such studies 
could be performed by considering hapten presentation to responder 
(T-lymphocytes) by MHC la-matched and mismatched dendritic
cells. However, this approach is not ideal because a number of 
groups have reported la-specific haplotype disparity between 
dendritic cells and T-cells leading to an allogeneic MLR 
proliferative response (Inaba & Steinman 1984; Knight et al 
1985a; Austyn 1987; Boog 1988).
An alternative approach is to block T-cell-dendritic cell 
interaction by coculture with haplotype specific anti— la 
monoclonal antibodies. A number of groups have demonstrated that 
antigen restricted T-cell activation by dendritic cells can be 
blocked by coculture with anti—la monoclonal antibodies or F(ab) 
fragments (Van Voorhis 1983; Inaba et al 1983). These studies are 
certainly supportive of antigen bearing dendritic cells 
stimulating T-lymphocyte proliferation in vitro in an Ia- 
restricted fashion. Such blocking approaches are being examined 
within my assay system by my colleagues at ICI.
C h a p te r  8  A d d e n d u m
CHAPTER 9
The influence of IFN gamma and heterologous protein cm 
hapten-induced Lymph node sensitization and dendritic cell 
stimulatory activity
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9.1.1 Introduction
The results in the preceding three chapters have documented 
changes in cells and their antigen presenting/responding 
properties, when isolated from the auricular lymph nodes of mice 
following ear-painting with haptens. These data demonstrated 
that there are significant changes in the recovery of dendritic 
cells from such nodes and that some of these dendritic cells are 
hapten-bearing and have considerable stimulatory activity in 
vitro for previously sensitized lymph node cells. This in vitro 
response has been comprehensively characterised in terms of 
magnitude and hapten specificity: conditions have been 
elucidated whereby these responses are hapten-specific.
Together, these results and those of other workers (see general 
introduction) indicate major functional and migrational changes 
in the auricular lymph node dendritic cells of mice, following 
prior painting on the ear with sensitizing chemicals. These 
changes reflected an ongoing immune response. I therefore 
considered it probable that deviations in the progression of 
this inrnune response would be detectable as a changed 
stimulatory activity of dendritic cell-enriched lymph node cell 
fractions within my assay system.
In this chapter I examine the validity of this proposal by 
presenting data from my extensive studies on the effects in vivo 
of murine IFN garnna on the general progression of lymph node 
sensitizations following ear-painting and in particular, on the
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development of immunogenic, hapten-bearing lymph node dendritic 
cells in vivo following ear-painting. The immunogenic activity 
would be measured within my proliferation assay and correlated 
with any changed levels of hapten (FITC) or class II MHC-encoded 
antigens, both factors considered essential (but not the whole 
requirement) for hapten-presentation to sensitized T- 
lymphocytes.
My decision to examine the effect of IFN gamma in vivo on the 
development of lymph node sensitization and dendritic cell 
immunogenicity was based on several criteria. Firstly, it has 
long been established that lymphokines in general play an 
important role during cellular interactions and communication 
during immune responses; indeed, the classification of 
lymphokines was originally based on the ability of these 
molecules to influence cellular migration in vitro. The 
interferon family of molecules in particular, have recently been 
implicated in the regulation of lymphocyte migration.
Thus, studies in this laboratory have demonstrated that in vitro 
exposure of rat thoracic duct lymphocytes to interferon-alpha 
can modulate the circulation of those lymphocytes when 
reinjected into donor rats (Kimber et al 1987b). Also, a number 
of recent studies considering the effect of in vivo injection of 
IFN gamma into mice, have demonstrated that local injections may 
enhance development of contact sensitivity in mice (Maguire et 
al 1989). In addition to this, IFN gamma has the ability to 
upregulate expression of MHC-encoded molecules, particularly
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class II MHC-antigens (Basham and Merigan 1982 and many others) 
and as such can upregulate antigen presenting cell activity 
(Unanue 1984). It is notable that the high constitutive 
expression of class II MHC encoded antigens by dendritic cells 
appears to be reflected, at least in vitro, by their 
unresponsiveness to IFN gamma (Austyn 1987).
I therefore predicted that murine IFN gamma, administered in 
vivo, would have significant effects on the development of 
sensitized auricular lymph nodes, in mice subsequently painted 
with sensitizing chemicals. My studies would therefore examine 
the sensitizing and dendritic cell priming processes in mice 
within a 'manipulated' interferon environment.
The results documented in the first half of this chapter 
demonstrated that the intraperitoneal administration of murine 
IFN gamma preparations which were not pure, but were the best 
available (and heterologous protein preparations) prior to 
topical exposure of ears to FITC gave marked reductions in the 
recovery of dendritic cells from the draining lymph nodes, as 
well as abrogating the expected increase in the 'activated lymph 
node' weight. It was also noted that lymph node weight was not 
totally accounted for by total cell recovery per lymph node.
However, I found that the effects observed could not be ascribed 
totally to the IFN content.
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The activity of heterologous protein solutions in reducing the 
increases in dendritic cell recovery and lymph node weight 
indicated that interferon was not the active component 
influencing these effects. The data presented was consistent 
with a proposal that heterologous proteins (including BSA within 
the high titre interferon preparations) were stimulating an 
inflamnatory response in the peritoneun and that this unwanted 
immune activity influenced the progression of subsequent hapten- 
challenges at the skin. A mechanism for this explanation is 
discussed later.
Against this background of marked, but interferon-non-specific 
effects on dendritic cell recovery and lymph node weight 
following FITC-priming, I examined the stimulatory activity of 
the dendritic cell-enriched fractions. My studies demonstrate 
that dendritic cell-enriched lymph node cells from mice which 
had received the murine IFN garrma preparation prior to FITC- 
priming had reduced stimulatory activity. This was compared to 
dendritic cell-enriched lymph node cells from mice which had 
been FITC-primed only. This effect reflected a qualitative 
change in the dendritic cell-enriched lymph node cell 
population, relating to the biphasic distribution of 
fluorescence (or hapten) within a dendritic cell-enriched lymph 
node cell population (as described earlier, see chapter 7). 
[Thus, this effect was in addition to the quantitative changes 
in dendritic cell recovery just described. ] In particular, 
intraperitoneal administration of murine IFN gamma preparations 
prior to FITC-priming affects the ratio of high fluorescent to
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low fluorescent dendritic cells within the dendritic cell- 
enriched lymph node cells. This influences the stimulatory 
activity of the dendritic cell-enriched lymph node cells for an 
FITC-sensitized responder lymph node cell population within the 
antigen presentation assay. This effect appeared to be 
interferon specific and is fully discussed later in this 
chapter, with particular reference to its implications for the 
influence of IFN gamma on dendritic cell migration.
9.1.2 The effect of intraperitoneal administration of IFN 
gamma, prior to ear-painting with FITC, on auricular 
lymph node weight
It was clear from the results of a series of experiments, 
recorded in table 9.1.1 that there were significant increases in 
the weight of auricular nodes following ear-painting 18hrs 
previously with 2.5% FITC (consistent with Kimber and 
Weisenberger 1989). Thus, in experiments 30 and 32, the mean 
weight for a naive lymph node was 2.47mg and 2.48mg. In the 
same experiments, lymph nodes from mice painted on the ear 18hrs 
previously with 2.5% FITC were 3.16mg and 2.78mg, representing 
30% and 12% increases respectively. Across a number of repeat 
experiments, the average weight for a naive lymph node was 
established as 2.48mg (9.1.1) and that of a node from a mouse 
primed 18hrs previously with 2.5% FITC as 3.27mg, representing 
+31% increase.
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General Legend for Tables 9.1.1» 9.1.2 and 9.1.3
Intraperitoneal Injections
All mice within groups of 4 BALB/c mice were injected in the 
peritoneum with 250ul of one of a number of test substances:
a) recombinant murine IFN gamma preparations (62500U
antiviral activity per mouse in 1%, protein 
concentration),
b) recombinant human IFN gamma preparations (equivalent 
titre),
c) PBS
d) bovine serum albumin in PBS (BSA) -:1% protein 
concentration
e) mouse serum albumin in PBS (LSA) -:1 % protein 
concentration
f) foetal calf serum in PBS (FCS)
g) fresh mouse serum in PBS (MS)
Time of injection was designated -42hrs.
Ear Painting
Twenty four hours beyond injection, all mice in all groups 
(except naive controls) were painted on both ears with 25ul of 
2.5% FITC. Time of painting was designated as -18hrs.
Eighteen hours after ear-painting, all mice in all groups were 
sacrificed and auricular lymph nodes harvested, retained in 
appropriate groups.
As described fully in chapter 5, the eight lymph nodes 
per group were weighed together, the mean weight per node 
for a particular treatment is presented in table 9.1.1. 
In addition, I have calculated the mean value of mean 
weight per node for each treatment and have compared 
these values by students t-test with the designated 
control value. p<0.05 was considered significant 
(although the statistical validity of the analysis is 
debatable, it does quantitate the point I'm making).
The eight lymph nodes per group in PBS were disaggregated 
as normal and a single cell suspension for each group 
prepared in medium. Each suspension was carefully 
counted; the volume of cell suspension was also 
determined per node. These values, for each treatment in 
each experiment are presented in table 9.1.2. An F- 
statistic determination (see chapter 5) and t-test 
analysis were performed on all data and is presented in 
table 9.1.2b.
Dendritic cell isolation and enumeration was performed 
exactly as described in the figure legend for 7.1.1 and 
table legend 7.1.1. The dendritic cell recovery per node 
for each treatment in each experiment is presented in 
table 9.1.3. An F-statistic determination (see chapter 
5) and t-test analysis were performed on all data and is 
presented in table 9.1.3b.
TABLE 9.1.1
The Effect of Intraperitoneal Administration of Murine IFN
(and Control Solutions), prior to Ear-priming with 2.5Z FITC, on
Mean Auricular Lymph Node Weight
.Lymph node weight (m g node ).
meal
-turnon-O' _ PBS BSA MSA FCS MS
2 5* FITC
•ton 9*3A 1*86
2*90 2*75
2*78 2*69
2*90 3*10 3*50 2*70
3*00 2*50 2*23
3*59 3*35 3*50 3-98
3*31 3*03
3*78 2*83 2*38 2*43
3*10 3*30 3*60 3*10
3*40
3*75 3*50
3*12 2*52 3*40 2*52 2-70
3*16 3*29 2*95 3*57
3*58 3*29 2*96 3-11 ..
2t48
0*007
2*66
0*47
2*43
0*50
3*29
0*39
2*81
0*40
3*06
0*59
2*96
0 0 0 7
3*34
0*33
Intraperitoneal administration of PBS prior to FITC-priming 
occasionally caused a notable fluctuation in the mean lymph node 
weight within a given experiment, eg experiments 36 and 38. 
Usually, however, fluctuations were negligible and the average 
weight for an FITC-primed lymph node from PBS-treated mice was 
3.29mg, not significantly different from the nil pretreated, 
FITC-primed lymph node (control value, 3.27mg). Intraperitoneal 
administration of an equal volume of the recombinant murine IFN 
gamma in PBS (6 x l(Aj antiviral activity per mouse) prior to 
FITC-priming caused a marked reduction in the mean lymph node 
weight (2.66mg) which is significantly different from the 
control value. The specificity of this significant effect was 
assessed, as the interferon preparation was only partially pure.
It was established, that the increase in lymph node weight 
stimulated by ear painting with 2 . 5 7 . FITC could be abrogated by 
injecting, instead of the murine interferon preparation, an 
equivalent protein concentration (and volume) of recombinant 
human IFN gamma in PBS (mean lymph node weight 2.43mg, 
significantly different from control value). The effect did not 
therefore appear to be species specific, as would be predicted 
if interferon was the active component.
As a major component of both interferon preparations was BSA, an 
equivalent concentration and volume of BSA in PBS was 
administered prior to FITC-priming and this also abrogated the 
expected increase in lymph node size (mean lymph node weight 
2.81mg, significantly different from control value). To test
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the possibility that the lymph node effect was dependent on the 
foreign, ie non-self nature of injected proteins, the effect of 
BSA was compared with that of mouse senm albumen (MSA).
It was established in a series of five experiments that 
injection of MSA did cause a weak abrogation in the expected 
increase in lymph node weight after FITC-priming (mean lymph 
node weight 3.06mg) but this was not significantly different 
from the control value. However, the variability within these 
five experiments makes any conclusion about the effect of non­
self proteins tentative. The possibility also existed that 
commercially available MSA could still appear foreign to the 
subtle specificity of the murine immune recognition system. 
Therefore, syngeneic mouse senm (MS) was freshly prepared and 
its effect after injection, prior to FITC-priming, compared with 
that of FCS on the abrogation of an increase in lymph node 
weight. Both injections failed to cause any statistically 
significant abrogation of the increase in lymph node weight 
after ear-painting, however, only two experiments were 
performed, and from these two, it does appear that FCS (mean 
lymph node weight 2.96mg) but not MS (mean lymph node weight 
3.34mg) causes the abrogation effect. Thus, while statistically 
neither FCS or MS cause significant abrogation, this may reflect 
the low number of times the experiment was performed (twice) and 
mask a weak but significant activity. Of the two, FCS has the 
stronger abrogating activity than MS.
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Note that protein free solutions, ie PBS, have no abrogating 
effect, indicating that the phenomenon is not due simply to 
trauma of injection.
9.1.3 The effect of intraperitoneal administration of IFN 
ganina, prior to ear painting with FITC, on total cell 
recovery from auricular lymph nodes
The total cell recovery from lymph nodes of mice which had 
received a) no treatment, b) ear-painting 18hrs previously with 
2.5% FITC or c) pretreatment intraperitoneally with the 
partially purified IFN gamma, (or control solutions) 24hrs prior 
to ear-painting with 2.5% FITC, was analysed. The results, for 
a series of repeated experiments are presented in table 9.1.2.
Routinely, there were no marked changes in total ceil recovery 
between any of the groups. Intraperitoneal administration of 
equivalent volumes and protein concentrations of recombinant 
murine IFN gamma (6 x l(Aj antiviral activity per mouse), PBS, 
bovine or mouse serum albumin, mouse or foetal calf serum (all 
at 0.1% protein in PBS, 24hrs prior to ear-painting with 2.5% 
FITC) caused no significant difference in total lymph node cell 
recovery when compared with lymph node cell recovery from mice 
painted with 2.5% FITC alone. Occasionally, a fluctuation of 
greater than +/-15% of the control value (7.5 x 10^ cells per 
node) was recorded, eg experiment 23 or 47, but no reproducible 
pattern, implicating a particular treatment, was apparent. As 
will be discussed later, this demonstrated that none of the
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TABLE 9.1.2
The Elf feet of Intraperitoneal Administration of Murine IFN gamma 
(and Control Solutions), prior to Ear-priming with 2.5Z FITC, on 
Mean Total Cell Recovery per Auricular Lymph Node
treatments significantly affected the FITC-induced increase in 
total lymph node cell recovery although the effect at later time 
points was not assessed. Some of these treatments did, however, 
influence the FITC-induced increase in lymph node weight, 
suggesting that the increase in lymph node weight was not 
attributable to total cell number in the node. A possible role 
for lymph fluid flow and retention in this phenomenon is 
described later.
To confirm that none of the treatments did influence FITC- 
induced increases in lymph node weight, it was necessary to 
analyse the variance between replicates for a given treatment 
group and compare this with the variance between treatment 
groups. By utilising an analysis of variance all eight 
treatment groups are compared together rather than each in turn 
with the control, as in the t-test. Analysis of variance and 
comparison with F-statistic values is the superior technique in 
these multitreatment group experiments (see Parker 1983) for 
determining treatment - dependent variations over replicate 
variations. The calculated F value (2.94) was greater than F 
tabulated (2.25), suggesting that there was a significant, if 
small difference between the mean total cell recovery for any of 
the treatment groups, attributable to difference between total 
cellularity in naive and FITC-primed mice. As treatment 
variation was greater than replicate variation a routine t-test 
analysis was performed, the results of which are presented in 
table 9.1.2.
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This analysis established, as expected, that there was a small 
but significant increase in total lymph node cell recovery 
between naive mice and mice primed 18hrs previously with 2.5% 
FITC, the later having higher lymph node cell recovery. It was 
also apparent that total lymph node cell recovery was not 
significantly reduced when mice were intraperitoneally treated, 
prior to 2.5% FITC priming, with any of the test protein 
solutions EXCEPT recombinant human IFN gamma in PBS. This 
later, unexpected result was marginal. An explanation is 
proposed later.
9.1.4 The effect of intraperitoneal administration of IFN 
gamma, prior to ear-painting with FITC, on dendritic 
cell recovery from auricular lymph nodes
The dendritic cell yield per node from mice which had received 
a) no treatment, b) ear-painting 18hrs previously with 2.5% FITC 
or c) pretreatment intraperitoneally with partially purified IFN 
gamma (or control solutions) 24hrs prior to ear-painting with 
2.5% FITC, was analysed. The results, for a series of repeated 
experiments are presented in table 9.1.3.
In general, it was observed that dendritic cell yield per node 
was increased in mice primed 18hrs previously with 2.5% FITC, 
compared to the yield from naive mice. This was consistent with 
my earlier results in Chapter 7 and the published data (Kinnaird 
et al 1989, Macatonia et al 1987). Within the FITC-primed 
groups, it was clear that intraperitoneal administration of
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TABLE 9.1.3
The Effect of Intraperitoneal Administration of Murine IFN ganma 
(and Control Solutions), prior to Ear-priming with 2.5Z FTTC, on 
Mean Dendritic Cell Recovery per Auricular Lymph Node
42hr.intrapentc 
injection with
real
Nil
Qendr
Nil
tic.celLre
Munnpr
covery.ix
Hur!W°'
1oi:e1ls.r
PBS
o d e .). 
BSA
? SK. FI TP
MSA PCS MS
Expt No. 23 
24
29
30 
32 
36
38
39
40 
42 
47 
21 
17 
15 
14 
5 
52 
55
6-3 90
14-9 5-6 8-8
8-5 12-2 60
8-9 10-5 7-2 8-9
7-7 7-0 5-4
150 6-4
14-8
7-2
13*8 3-6 no 9-3
11*8 6 0 15-2 3-9 14-5
18-5 10-6 71-8
23-9 12-9 25-6
22-8
4-7 10-2
.Mean
SO
T-test
8-7
0-3
2
NS
13*8
5-4
18
6-5
2-7
13
p<0.001
7-9
1*5
5
p<ao5
13-9
66
13
NS
6-2
3-3
4
p<002
10-5
3-5
3
NS
4-5
0-3
2
p<0 05
9*5
io
2
NS
equivalent volumes (and protein concentrations) of recombinant 
murine IFN gamma, recombinant human IFN gamma, bovine serum 
albumin and foetal calf serum, all made up in PBS caused a 
reduction in dendritic cell yield per node when compared with 
dendritic cell yield per node from mice primed with 2.5% FITC 
only. Intraperitoneal administration of equivalent volumes of 
PBS, MSA in PBS or fresh mouse serum in PBS failed to cause this 
effect. An F-statistic determination for the data presented,
that the
calculated F value (4.11) was greater than F-tabulated (2.25), 
confirming that there were significant differences between the 
mean values for each treatment, considering the variability 
within replicates. The following t-test analysis failed to 
establish a significant increase in dendritic cell yield per 
node between naive mice and mice primed 18hrs previously with 
2.5% FITC. Such an increase \xl petted however, and 
this o l i t r * a \ ( o * is attributed to a) low sample 
number and b) high replicate variability in the 2.5% FITC alone 
treatment group.
It was established that within lymph nodes from FITC-primed 
mice, intraperitoneal injection of recombinant murine IFN gamma 
in PBS abrogated the expected increase in dendritic cell yield 
per mouse (from control value of 13.8 x 10^ DC per node, to 6.5 
x 103 dendritic cells per node). This abrogation was not 
observed if PBS alone was injected prior to FITC-priming (13.9 x 
10^ dendritic cells per node).
2 36
As described earlier in this section, the specificity of this 
strong murine IFN gamma effect was examined in a series of 
experiments. Injection of recombinant human IFN gamma in PBS at 
an equivalent volume/protein concentration also blocked the 
expected increase in dendritic cell yield per node (mean 
dendritic cell yield per node 7.9 x 103 dendritic cells per 
node). Again, the common contaminant of both interferon 
preparations, BSA was prepared at an equivalent dose in PBS and 
injected prior to FITC-priming. The BSA treatment also 
abrogated the expected increase in dendritic cell numbers (mean 
6.2 x 103 dendritic cell per node).
It was notable that in three experiments which compared the 
effect of MSA with BSA, MSA failed to block the increase in 
dendritic cell yield per node (10.5 x 103 dendritic cells per 
node, not significantly different from control value). To 
confirm that the abrogation of increased dendritic cell yield 
was due to the non-self nature of intraperitoneal proteins, the 
effects of injecting FCS and MS in PBS were considered in two 
experiments. In both, it was clear that injecting FCS abrogated 
the increase in dendritic cell yield (4.5 x 103 dendritic cells 
per node), while mouse serum had no significant effect (9.5 x 
103 dendritic cells per node).
The significant effect on dendritic cell yield per node of 
intraperitoneal administration of partially purified recombinant 
murine IFN gamma prior to FITC-priming has been shown to be dose 
dependent. Thus, in figure 9.1.1, it was clear that as the dose
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Figure Legend 9.1.1A and B
Four groups of 4 BALB/c mice were injected intraperitoneally 
with 300ul of the following solutions:
Group a) 87500 antiviral units recombinant murine gamma 
interferon 
" b) 62500
" c) 25000 "
" d) PBS
Time of injection was designated as -42hrs.
Twenty-four hours after injection (at time -18hrs) all mice in 
all groups were painted on both ears with 25ul 2.5% FITC. 
Eighteen hours later (time 0), all mice in all groups were 
sacrificed and mean total cell per node and mean dendritic cell 
per node determined for each treatment group as described in 
general legend for table 9.1.1.
Data is presented in graphical form, with total cell yield per 
node and dendritic cell yield per node plotted against IFN gamma
titre.
FIGURE 9 .1 .1
The Effect of Intraperitoneal AAninistration of Increasing Titres 
of Murine IFN p/miH, Prior to Ear-priming with 2.5Z F1TC» on Mean 
Total Cell (a) and Mean Dendritic Cell (b) Recovery from Auricular 
Lymph Nodes
A n t i v i r a l  u n i t s  o f  m u r in e  I F N g  a d m i n i s t e r e d  l. p  / m o u s e  ( x  1 0 - 4 )
A n t i v i r a l  u n i t s  o f  m u r in e  I F N g  a d m in i s t e r e d  i . p / m o u s e  ( x  1 0 - 4 ).
administered in traperi toneally increased, so the recovery of 
dendritic cells per node decreased (equivalent volumes were 
injected at each dose). It was notable in this experiment, that 
the total cell recovery per node was not significantly reduced, 
even at the highest dose administered.
9.2.1 A comparison of the stimulatory activity of hapten­
bearing dendritic cells isolated from mice primed with 
FITC only and mice injected with murine IFN gamma 
prior to priming with FITC
Dendritic cell-enriched lymph node cell fractions were isolated 
from the draining lymph nodes of mice which had either a) been 
painted 18hrs previously with FITC on the ear or b) received an 
intraperitoneal injection of murine IFN gamma (or control) 24hrs 
prior to FITC priming. While these treatments induced the 
observed effects on lymph node weight, total cellularity and 
dendritic yield, as described previously in this chapter, I 
wished to determine the treatment effects on the stimulatory 
activity of the resulting dendritic cell-enriched lymph node 
cells. In particular, were there qualitative differences in the 
stimulatory activity of the two dendritic cell-enriched 
fractions for FITC-sensitized lymph node cells. The stimulatory 
activity of such dendritic cell-enriched lymph node cells was 
assessed within the proliferation assay, as measured by 
enhancement of %-TdR incorporation in FITC-sensitized lymph 
node cells (as previously described).
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It has been established in a number of experiments (see table 
9.2.1) that dendritic cell-enriched lymph node cells from mice 
injected intraperitoneally with the murine IFN gamma 
preparation, prior to FITC-priming, consistently have reduced 
stimulatory activity when compared with mice which were primed 
with FITC only. Six experiments are presented in table 9.2.1. 
In each, the concentration of FITC used to prime mice 18hrs 
prior to dendritic cell harvest is constant. The groups within 
each experiment differ by the intraperitoneal injection 
administered (or not) 24hrs prior to FITC priming. It should be 
noted that the total tabulated results demonstrate that for both 
non-specific (5%) and specific (0.5%) FITC-priming doses, 
intraperitoneal administration 24hrs earlier of murine IFN gamma 
reduces the stimulatory activity, usually by 50%. Note that 
heat-treated murine IFN gamma lost this activity (only one 
experiment performed).
A representative experiment is presented in 
figure 9.2.1. As described earlier, dendritic cell-enriched 
lymph node cells isolated from mice primed 18hrs previously with 
0.75% FITC have low non-specific stimulatory activity: in 
addition the spontaneous proliferative activity is insignificant 
(0.4 +/- 1 x 10"3 cpm) when compared with background controls. 
Such dendritic cell-enriched lymph node cells stimulated a four­
fold enhancement in ^-TdR incorporation'within FITC-sensitized 
responder lymph node cells at a responder: dendritic cell ratio 
of 166:1. An equivalent number of dendritic cell-enriched lymph 
node cells isolated from mice which had received an
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Table Legend 9.2.1
A series of six experiments are presented in tabulated form. 
Within each experiment, the effect of two or three 
intraperitoneal treatments on the stimulatory activity of FITC- 
primed dendritic cells was examined within the antigen 
presentation assay.
Consider expt 8926
Three groups of 20 BALB/c mice were treated intraperitoneally 
with either murine IFN gamma (62500u), PBS or nil at -42hrs. 
Twenty four hours later, all mice in all groups were painted on 
both ears with 25ul 0.75% FITC (time -18hrs). At time 0, all 
mice were sacrificed, and dendritic cell-enriched lymph node 
cells prepared for each treatment group, exactly as described in 
chapters 5 and 7 (see figure legend 7.1.1).
Thus three washed, calibrated dendritic cell-enriched lymph node 
cell fractions, one from each treatment group, were obtained.
The stimulatory activity of each of these populations was then 
analysed, by culturing with responder lymph node cells isolated 
from mice painted 7 days previously with 2.5% FITC, as described 
previously (see chapter 8, table 8.1.1). Standard culture 
conditions were utilised, with a responder to dendritic cell 
ratio of 55:1.
The results are presented as a stimulation index, showing the 
fold-enhancement in proliferation between an activated group (ie 
dendritic cells + responder lymph node cells) and the control 
proliferation of responder lymph node cells alone.
TABLE 9.2.1
A Comparison of the Stimulatory Activity of FTTC-bearing Dendritic 
Cells Isolated from Mice Primed with FTTC only and Mice Injected 
with Murine IFN gam» (or Control Solutions) prior to Fire-priming
Dendritic cell-enr 
ymph node ceils 
njected intrap-^rit 
-4 2 h r with A and 
-1 8 hrs with B:
A
ched auricular 
rom mice 
oneally at 
sainted at
B
Stim ulator cell-induced increment 
of enhancement of proliferation by 
auricular lymph node cells from 
syngeneic mice painted 7 days 
previously with 2.5% FITC.
5.0% F ITC x ll 'O
69
x 7*0
72 Medium
5.0%  FITC x8*5
. ,  .... x4-Z______________Murine i m
8919 Nil 2.5%  F ITC
x 7*0
x4*0
Nil 0.75%  F IT C x7-0
8926
PBS 0.75%  F IT C x8*7
0.75%  F ITC x4*0
x 5*0
8922
Medium 0.75%  F ITC x 6*0
0 7 5 %  F ITC x 4*0
Nil 0.5% FITC xl2*0
894 H I IFN? 0.5%  FITC X10-0
M yrine-q -iFN ____ 0.5% FITS x 5*0
FIGURE 9.2.1
The Effect of IFN gamma Administration on the Stimulatory Activity 
of FITC-bearing Dendritic Cells from FITC-primed Mice; the use of 
an FITC-priming Dose Consistent with FTTC-specific Responses
As above, but results are displayed as 1) the mean %-TdR 
incorporation +/- SD x 10-3 for 4-6 replicate wells per culture.
** denotes significant statistical difference from paired 
control (*)
intraperitoneal injection of partially purified murine IFN gamma 
24hrs prior to 0.75% FITC-priming had significantly reduced 
stimulatory activity for the same responder population, 
stimulating a two-fold enhancement of proliferation.
The reduced stimulatory activity was apparent across a range of 
responder: dendritic cell ratios, as presented in figure 9.2.2. 
Thus, at a responder: dendritic cell ratio of 166:1 (3,000 
dendritic cells per well), dendritic cell-enriched lymph node 
cells from murine IFN gamma pretreated mice stimulate less well 
than the control, FITC-primed only dendritic cell-enriched lymph 
node cells, a trend which is also apparent at a responder to 
dendritic cell ratio of 90:1 (5,500 dendritic cells per well).
9.2.2 The stimulatory activity of dendritic cell-enriched 
lymph node cells correlated with the biphasic 
distribution of hapten (FITC) within the population: 
influence of murine IFN gamma
The reduction in the stimulatory activity of dendritic cell- 
enriched lymph node cells from FITC-primed, murine IFN gamma- 
treated mice was compared with changes in the fluorescence 
(hapten) profile and biphasic distribution of fluorescence of 
such dendritic cell-enriched fractions. Thus, an analysis of 
cell-associated fluorescence (as previously described) has been 
performed on dendritic cell-enriched and depleted lymph node 
cell populations from mice primed with FITC after 
intraperitoneal administration of partially purified murine IFN
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Figure Legend 9 . 2 .2
Two groups of 5 BALB/c mice were prepared. One group was 
treated with 62500U murine IFN gamma preparation at -42hrs, the 
second with PBS. As described in table legend 9.2.1, all mice 
were primed with 25ul 0.75% FITC, prior to isolation of two 
dendritic cell-enriched lymph node cell fractions.
The stimulatory activity of both populations was then analysed 
by culturing with responder lymph node cells isolated from mice 
painted 7 days previously with 2.5% FITC.
Standard culture conditions were utilised, but a range of 
responder: dendritic cell ratios was used for each dendritic 
cell-enriched lymph node cell population. Responder cell: 
dendritic cell ratios of 666:1, 200:1 and 95:1 were tested for 
each stimulator population.
The results are presented as two lines on one graph, indicating 
the stimulatory activity of 1) control, FITC-primed and 2) IFN 
gamma pretreated, FITC-primed dendritic cell-enriched lymph node 
cells on the %i-TdR incorporation +/- SD of FITC-sensitized
responder lymph node cells,
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FIGURE 9 .2 .2
The Reduced Stimulatory Activity of Dendritic Cell-enriched Lymph 
Node Cells from IFN gamma Treated, FITC-primed Mice Across a Range 
of Responder Cell: Dendritic Cell Ratios
D C - e n r i c h e d  L N C  a d d e d / w e l l  ( x  1 0  s ).
gamma. The resulting fluorescence/forward scatter contour plots 
are presented in figures 9.2.3 and 9.2.4. A quadrant analysis 
of the pattern of cell fluorescence within each population has 
been superimposed upon the contour plots: the percentage of 
cells within each quadrant is recorded in table 9.2.2.
It is apparent from figure 9.2.3 that dendritic cell-depleted 
(9.2.3i) and enriched (9.2.3ii) lymph node cell fractions from 
mice painted 18hrs previously with 2.5% FITC had a 
characteristic distribution, expected for low buoyant and high 
buoyant density Metrizamide fractions, as established earlier 
(compare with figure 7.2.1C). Within the dendritic cell- 
enriched lymph node cells there was a significant enrichment for 
large cells and a proportion of these large cells were highly 
fluorescent (compare quadrant 2, figures 9.2.3i and 9.2.3ii). 
It has been consistently observed, that the dendritic cell- 
enriched lymph node cell fraction from mice intraperitoneally 
treated with murine IFN gamma in PBS, prior to FITC-priming, 
have a reduced number of highly fluorescent large cells 
(9.2.3iii), compared to the number from mice which were primed 
only. This change is quantified in table 9.2.2, expt 8919. 
Thus, dendritic cell-enriched lymph node cell fractions from 
pretreated or no-pretreatment groups consisted of approximately 
the same number of large cells, ie 56% and 58% respectively (q£ 
+ q^ total). This established that the efficiency of 
Metrizamide fractionation was the same for both groups. 
However, of these large cells, a significantly lower fraction 
were fluorescing strongly in the partially purified murine IFN
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General legend for figures 9.2.3, 9.2.4 and table 9.2.2
Groups of 4 BALB/c mice received intraperitoneal injections as 
described in the general legend for table 9.1.1. Group 
assignment of treatments is described in the individual figure 
legends. Injection time designated as -42hrs.
Ear-painting
Twenty four hours after injection, all mice in all groups were 
painted on both ears with 25ul of either 2.5% FITC (expt 9.2.3) 
or 0.5% FITC (expt 9.2.4). Time of painting designated as - 
18hrs.
Eighteen hours after ear-painting, all mice in all groups were 
sacrificed and dendritic cell-enriched and depleted lymph node 
cells prepared for each treatment group, exactly as described 
previously in chapters 5 and 7 (see figure legend 7.1.1).
Contour Analysis by FACS tar
As described previously in chapter 5 and table legend 7.2.1. 
Thus, quadrant 2 + quadrant 4 (q2 + q4) gives the percentage of 
all cells counted that are large (dendritic cell sized). q2/(q2 
+ q4) x 100 gives the percentage of these large cells which are 
of high fluorescence.
Figura legend 9.2.3
Computer integrated analyses are presented of cell distribution 
as a function of forward angle light scatter and green 
fluorescence intensity within contour plots, for auricular lynph 
node cell populations. Characteristic contour plots, with 
forward angle light scatter on the abcissa, fluorescence 
intensity on the ordinate and cell frequency signified by line 
density are presented for i) dendritic cell-depleted lymph node 
cells from mice painted 18hrs previously with 2.5% FITC; ii) 
dendritic cell-enriched lymph node cells from the same mice and 
iii) dendritic cell-enriched lymph node cells from mice which 
had received the IFN ganma treatment 24hrs prior to FITC- 
priming.
Figure legend 9.2.4
As for figure 9.2.3, except the populations were i) dendritic 
cell-depleted lymph node cells from mice painted 18hrs 
previously with 0.5% FITC; ii) dendritic cell-enriched lymph 
node cells from the same mice; iii) dendritic cell-enriched 
lymph node cells from mice which received the heat inactivated 
IFN gamma preparation 24hrs prior to 0.5% FITC priming and iv) 
dendritic cell-enriched lymph node cells from mice which had 
received the IFN gamma treatment 24hrs prior to FITC-priming.
FIGURE 9.2.3
FACS Computer-generated Contour Plots of Forward Angle Light 
Scatter v Green Fluorescence Intensity v Cell Number, for 
Populations of Auricular Lymph Node Cells from Either 2.5Z FITC- 
primed Mice or IFN ganma Treated, 2.5% FTTC Primed Mice
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Table legend 9.2.2
As can be seen in figures 9.2.3 and 9.2.4 (different 
experiments), a standard quadrant was superimposed on each of 
the three populations for a given experiment (standard quadrant 
in 9.2.3 different to standard quadrant in 9.2.4). The quadrant 
axes were set to distinguish between lymphocytes and dendritic 
cells on the abcissa and high and low fluorescent cells on the 
fluorescence intensity axis. Such a procedure 'generates' four 
categories of cells
Quadrant 1, small cells, high fluorescence 
Quadrant 2, large cells, high fluorescence 
Quadrant 3, small cells, low fluorescence 
Quadrant 4, large cells, low fluorescence
In this table the two preceding experiments are presented. The 
percentage of 50 x 10^ cells recorded for each population 
falling in each quadrant is presented.
TABLE 9.2.2
Statistical Distribution of Cells Within the Quadrant Analysis 
Superimposed on the Cell Populations Presented in Figures 9.2.3 
and 9.2.4
Dendritic cell-e 
or depleted CDC- 
lymph node cell 
injected intrape 
-4 2 hr with A an 
-18hrs withB
riched (DC+) . 
) auricular 
from mice 
ritoneally at 
d painted at
Co nso rt 3 0  statistical analysis of flu o re s c e n c e  distribution.
Percentage of total cells analysed 
within each quadrant.
1 2  3  4 q2+q4 q2/(q2+q4) G R O U P
Nil 2.5% FITC. 2 -9 2 1 -7 38*8 36*5 5 8 -2 37*3 ¡ ¡ .D C -
8919 IF N g 2.5% R TC 2 -9
1 4 -6 4 1 -5 4 1 -0 5 5 * 6 26*3 ¡¡¡.DC*
Nil 0.5% FITC 4 -0 18*2 3 9 -6 38*3 5 6 * 5 32*2 ¡¡.D C *
8941
H I
IF N g 5*9 17 .0 3 8 -7 38-2 5 5 * 2 3 0 -8 ¡¡1,DC*
IF N q
s
Q,5* P T C ___
1 .9 13*5 4 2 -9 4 1 -6 55*1 24*5 iv.DC*
gamma pretreated group: that is, only 26% of these dendritic 
cell-enriched lymph node cells were highly fluorescent, large 
cells, compared with 38% in the no pretreatment group.
That this change was specific to intraperitoneal injection of 
protein and not, for instance, a stress response to any 
intraperitoneal injection, a control group, injected with heat- 
treated murine IFN gamma was utilised. The cell associated 
fluorescence distribution from such an experiment is presented 
in figure 9.2.A. Analysis of this data demonstrated that while 
pretreatment with murine IFN gamma reduced the number of high 
fluorescent, large cells (compare 9.2.4ii quadrant 2 with 
9.2.4iv quadrant 2) compared with the no pretreatment group, 
pretreatment with an equivalent volume of heat-treated murine 
IFN gamma failed to cause the effect (9.2.4iii).
A statistical breakdown of this data is presented in table 
9.2.2, expt 8941. While all the dendritic cell-enriched lymph 
node cell fractions consisted of approximately 55% large cells, 
only the group from mice pretreated with murine IFN garnna showed 
a significant reduction in the number of these large cells which 
were highly fluorescent (from 32.2% to 24.5%).
A number of experiments have been performed, which considered 
the effect of intraperitoneal administration of interferon 
preparations prior to FITC-priming on both the number of large, 
high fluorescent cells within the dendritic cell-enriched lymph 
node cell fraction and the stimulatory activity of such
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FIGURE 9.2.4
FACS-computer-generated Contour Plots (as in Figure 9.2.3) for 
Populations of Auricular Lymph Node Cells from Mice Either Primed 
with 0.51 FTTC, Treated with Heat-treated Murine IFN gamna Prior
fractions for FITC-sensitized responder lymph node cells within 
the proliferation assay. The data from these is presented in 
table 9.2.3. Pretreatment with marine IFN gamma confers a 
reduced stimulatory activity on dendritic cell-enriched lymph 
node cell fractions and this parallels a reduction in the 
percentage of dendritic cell-enriched lymph node cells which are 
large and carrying high levels of fluoroscein. For example, in 
experiment 72, intraperitoneal administration of murine IFN 
gamma 24hrs prior to priming with 5% FITC reduced the 
stimulatory activity of dendritic cell-enriched lymph node cells 
from x8.5 to x4.7. This paralleled a reduction in the 
percentage of large cells (dendritic) with high fluorescence, 
from 38% to 27%. Note that in a single experiment performed 
with heat treated murine IFN gamma, this activity was lost 
(8941).
9.2.3 The specificity of the reduction in highly 
fluorescent, large dendritic cells to murine IFN gamma 
activity
Experiments examining the specificity of the protein required to 
cause a reduction in the percentage of large dendritic cells 
with high levels of fluorescence within dendritic cell-enriched 
lymph node cells from FITC-primed mice were carried out. As the 
effect was induced by administration of the IFN garrnia 
preparation, I considered the best control to be an equivalent 
volume/titre of human IFN gamma preparation. Thus, as described 
earlier, interferon acts in a species-specific manner and if the
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Table Legend 9.2.3
The data from four experiments are presented in this table. 
Within each experiment, dendritic cell-enriched lymph node cell 
fractions were prepared from two or three groups of 20 BALB/c 
mice which had received various intraperitoneal treatments 24hrs 
prior to ear priming with one FITC-priming dose, either 5%, 2.5% 
or 0.5% FITC.
For each dendritic cell-enriched lymph node cell fraction, 
prepared exactly as described in figure legend 7.1.1, I have 
presented two pieces of data.
1 the stimulatory activity of the dendritic cell-enriched 
fraction, determined exactly as described in table legend 
9.2.1, and
2 the ratio of high fluorescent to low fluorescent 
dendritic cell giving the q2/(q2 + q4) x 100 total 
(exactly as described in table legend 9.2.2.
TABLE 9.2.3
The Relationship Between the Reduced Stimulatory Activity of 
Dendritic Cell-enriched Lymph Node Cells from Interferon Treated, 
KITC-primed Mice and the Percentage of Large (Dendritic) Cells 
with High Levels of Fluorescence
6 9
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with A and pair
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3 8
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8919 N il 2 -5 % F I T C x7*0 3 8
X4*0 27
N il X 1 2 -0 3 2
8941 H I murine IFNk ( « V l T C xlOO 3 0
murine I F N q ______ *5iQ_________ 2 4
24-H-.
effect on dendritic cell composition was attributable to 
interferon then in the light of current knowledge only the 
murine preparation should affect my results.
NB It is conceivable (but I think unlikely) that human IFN 
gamma, whilst having no antiviral effect in mice, could still do 
something to dendritic cells.
I established that unlike the non-specific effect observed on 
dendritic cell yield per node (table 9.1.3) of the interferon 
preparations, there was some specificity when changes in the 
percentage of large cells with high fluorescence was considered. 
Thus the reduction in large, fluorescent dendritic cells 
appeared attributable to the murine IFN gamma component of the 
murine IFN ganma preparations. In table 9.2.4, the results of a 
series of experiments are presented which considered the effects 
of intraperitoneal administration of equivalent volumes of a) 
murine IFN gamna in PBS, b) human IFN gamma in PBS or c) PBS, 
prior to FITC-priming, on the percentage of highly fluorescent 
large cells detectable within dendritic cell enriched lymph node 
cells. Considering experiment 8929, it was clear that the 
percentage of large cells within the dendritic cell-enriched 
fractions from all four groups was relatively constant at 
approximately 55% (q2 + q4 total). However, there were notable 
differences in the percentage of large cells which were highly 
fluorescent, depending on the treatment group. In particular, 
dendritic cell-enriched fractions from mice treated prior to 
FITC-priming with murine IFN gamma preparations, showed a
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Table Legend 9.2.4
The data from five experiments are presented in this table. 
Each experiment was performed exactly as described in the 
general legend for figures 9.2.3, 9.2.4 and table 9.2.2 except 
that all mice in all experiments received an ear priming dose of 
2.5% FITC. Thus, in experiment 4 (8930) dendritic cell-enriched 
lymph node cells were prepared from groups of 5 mice which had 
received either nil, murine IFN gamma or human IFN gamma 
intraperitoneal treatments 24hrs prior to ear-priming with 2.5% 
FITC.
For each group, the percentage of the dendritic cell-enriched 
fraction which was large cells (q2 + q4) is quoted, as is the 
percentage of those cells with high levels of fluorescent 
(q2/(q2 + q4)) x 100. See table legend 9.2.2 for detail.
The average value for the two totals across the five experiments 
is quoted.
TABLE 9.2.4
The Specificity of Interferon Activity on the Reduction of Highly
Fluorescent Dendritic Cells Within FITC-primed Dendritic Cell-
enriched Lynjjh Node Cells
C o n s o rt  3 0 / E F
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q2+q4 q2/(q2+q4)
IC s  s ta t is t ic a l a n a l>  
murine IF N g
q2+q4 q2/(q2+q4)
s is  of f lu o r e s c e n c e  
h u m an IF N g
q2+q4 q2/(q2+q4
d is tr ib u t io n .
P B S
q2+q4 q2/(q2+q4
Exp t No.
8 9 1 4
7 2
8 9 2 9
8 9 3 0  
________ 8 9 3 2
5 9 -0  39*0 - - 5 6 0  4 0 0
- 3 7 0  2 7 0 - 3 9 -0  3 8 0
5 5 -0  3 6 -0 5 1 -6  1 6 0 5 6 0  3 8 0 5 6 0  3 9 0
5 7 -5  3 9 0 5 4 -4  2 7 0 5 8 -2  4 1 0 -
5 5 -2  3 3 0 5 6*3 2 8 0 5 8 -7  4 1 0 -
A v e r a g e ______ 5 6  *7___1 3 6 -8 — 4 9 -8  1 2 4 -5 5 7 -6  1 4 0 -0 5 0 - 3  1 3 9 -0
markedly reduced percentage of large cells which were highly 
fluorescent (16%), when compared with mice which received no 
pretreatment, human IFN gamma or PBS (36-39%). The additional 
experiments in this table repeat this trend, although it was 
never as marked. This effect is reflected in the mean values 
for the four treatment groups.
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9.4 Discussion
A considerable body of evidence (reviewed in chapter 2) supports 
the view that the cellular movements and interactions which 
constitute imnune activity are regulated events, to a large 
extent modulated by the action of a number of lymphokines, 
chemoattractive factors and other molecules, for example 
prostaglandins. The results and conclusions I have presented so 
far in this thesis have characterised such cellular movements 
and interactions during the activation of auricular lymph node 
cells following ear painting with sensitizing chemicals such as 
DNCB and FITC. The aim of the work presented in this chapter 
was to examine the putative effect of IFN gamma on the activity 
and appearance within lymph nodes of lymphocytes in general and 
dendritic cells in particular, following ear-painting with FITC.
That interferon may regulate lymphocyte and dendritic cell 
migration/ function has been suggested previously. It is still 
unclear however, how interferon stimulates these circulatory 
fluctuations although it is apparent that IFN gamma increases 
the binding of interferon treated T-lymphocytes to endothelial 
cells (Yu et al 1985). It is possible that the ability of IFN 
gamma to upregulate the expression of cell surface molecules 
(receptors), for example class I and class II MHC antigens (Wong 
et al 1983; Tomkins et al 1988) will prove significant in 
determining such interactions.
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The effect of intraperitoneal administration of murine IFN gamma 
preparations on FITC-induced changes in lymph node status
Initial experiments presented in this chapter established that 
intraperitoneal injection of a high antiviral titre of the 
recombinant murine IFN gamma preparation, 24hrs prior to 
painting the ears with the sensitizing chemical 2.5% FITC, had 
significant effects on the expected FITC-induced changes in the 
local, draining lymph node.
Thus, I firstly established that following FITC-priming only, 
there were characteristic increases in draining lymph node 
weight and total lymph node cellularity, as has been previously 
described by my colleagues in mice (Kimber and Weisenberger
1989) and by others (Cahill et al 1976). These later studies, 
examined the effect of antigenic challenge on cannulated ovine 
lymph nodes and demonstrated increases in lymph node weight, 
cellularity and fluid flow which were consistent with short term 
retention of lymphocytes and the phenomenon of cell shutdown. 
Within my studies these increases similarly reflected the 
ongoing activation of the lymph node in response to the topical 
hapten (FITC) challenge.
I observed that if the FITC-painting was preceded by 24hrs with 
intraperitoneal administration of the murine IFN ganma 
preparation, then the increase in lymph node weight was 
abrogated in a dose dependent fashion, while the increase in 
total cellularity was not affected. I concluded, as suggested
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above, that there are at least two 'components' which account 
for the FITC-induced increase in lymph node weight, one of which 
was sensitive to the IFN gamma preparation. Obviously, one of 
the components will be the total number (and size) of cells 
within the node. Significantly, the increase in lymph node 
weight attributable to total cellularity was not abrogated by 
the intraperitoneal treatment. In the light of a number of 
studies demonstrating that activation of lymph nodes entails 
significant changes in the flow of lymphatic fluid and blood 
through the node (Cahill et al 1976; McConnell et al 1981), I 
propose that part of the FITC-induced increase in lymph node 
weight is attributable to the partial retention of lymphatic 
fluid within the node. This 'component' could be IFN gamma 
preparation sensitive and would thus account for the abrogating 
effect of the interferon preparation on lymph node weight but 
not total cellularity.
In addition to the abrogation of the FITC-induced increase in 
lymph node weight, intraperitoneal administration of the IFN 
gamma preparation caused a marked reduction in the expected 
increase in total dendritic cell recovery per node, compared 
with the normal recovery expected after recent FITC-priming (see 
chapter 7). A number of possible explanations for this effect 
are possible. A general explanation would involve the 
interferon-preparation restricting general cellular traffic 
through the lymph node, leading to less hapten-bearing dendritic 
cells recoverable from the node.
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Alternatively, the interferon-preparations may specifically 
influence the migration of hapten-bearing Langerhans cells from 
the skin to the local node after ear painting. For instance, 
the preparation may have prevented Langerhans cells (with 
hapten) leaving the epidermis or alternatively, perturbed the 
lymphokine environment sufficiently to cause aberrant Langerhans 
cell migration. Specifically, the IFN gamma preparation may 
attract the Langerhans or dendritic cells from the epidermis 
towards the peritoneal cavity. This scenario is not 
inconsistent with a recent report that IFN gamma induced the 
appearance of CD4 negative, class IIMHC positive macrophage 
subpopulations, in the rat peritoneum after intraperitoneal 
administration of IFN gamma (Ericsson et al 1989).
In order to establish the active component within the interferon 
preparation, responsible for causing the marked abrogation of 
the expected, FITC-induced increases in lymph node weight and 
dendritic cell recovery, a series of carefully controlled 
experiments were performed. These studies suggest that the 
injected interferon was not directly responsible for the 
abrogation effects. An alternative explanation, involving the 
inflammatory potential of injected heterologous proteins is 
presented. This proposal invokes a role for lymphokine 
regulation of cellular traffic broadly as described above for 
Langerhans cells and dendritic cells specifically, or cellular 
traffic in general.
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The specificity of the abrogating effect of the murine IFN gamma 
preparations
The effect of the interferon preparations on lymph node weight 
and dendritic cell recovery was not specific to interferon 
preparations.
Also, the different abrogating activities of the injected 
substances, including the non-activity of injected PBS 
demonstrated that the simple act of injection per se did not 
cause the abrogation of lymph node activation. Physiological 
stress was therefore discounted as mediating the abrogating 
activity (Khansari et al 1990).
As can be seen from the extensive studies in tables 9.1.1, 2 and 
3, injection of BSA in PBS, but not PBS alone had the same 
abrogating effect as the interferon preparation, when 
administered prior to topical exposure to FITC.
The use of BSA was prompted by the knowledge that the major 
protein contaminant within the blue sepharose-partially purified 
interferon preparations was BSA, derived from the FCS used in 
the culture of the IFN-producing cells. Thus, the recombinant 
murine (and human) IFN gamma preparations, while having a 
relatively high antiviral titre (10^ - 10^ antiviral Uml"^) had 
a relatively low specific activity (about 10^ Umg'^ protein 
compared with International Standard for pure interferon of 2 x 
107 Umg~* protein).
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In addition to this abrogating activity of BSA, it was also 
demonstrated that FCS also caused the abrogating effect when 
administered prior to FITC-priming while neither of the 'self- 
proteins' MSA or fresh mouse serum had strong activity. All 
these results, taken together, indicate that it was the non-self 
nature of injected proteins that cause the restriction on 
expected increases in lymph node weight and total dendritic cell 
recovery.
The potential of proteins injected intraperitoneally to cause 
inflammation restricts the development of early FITC-induced 
lymph node activation
One likely explanation for the abrogating effect revolves around 
the probable inflammatory effect of intraperitoneal 
administration of foreign protein. Thus, it has been reported 
in this laboratory (Warwick, R Darley pers comm) and by others 
(Melnicoff et al 1989; Jutila and Banks 1986; Volkman 1966) that 
foreign proteins, for example thioglycollate broth or serum, on 
injection into the peritoneum, cause marked changes in the 
constitution of peritoneal cell populations, including 
recruitment of mononuclear phagocytes. These changes are 
consistent with the early initiation (within lhr of injection) 
of an inflammatory response in the peritoneum.
Therefore, I propose that the intraperitoneal injection of 
heterologous proteins initiates an inflammatory response in the 
peritoneum which is still continuing twenty-four hours later.
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Routinely at this time, I would topically administer a 
sensitizing dose of FITC to the ears of the same mice. Eighteen 
hours beyond this I routinely recorded reduced draining lymph 
node weight and dendritic cell recovery when compared with the 
measured values for mice which received the topical dose of FITC 
only, or mice injected with inert (PBS) or 'self protein' prior 
to the FITC-priming. This proposal is dependent on being able 
to explain how an inflammatory response in the peritoneum may 
affect the activity and/or migration of lymphoid dendritic cells 
within the distal afferent lymphatics and lymph nodes. In 
addition, the inflammatory response needs to be assayed and 
approaches to this end are proposed in chapter 10.
The immediate response in inflammatory changes in the peritoneum 
is the rapid influx of polymorphonuclear cells and monocytes, 
with the concomitant efflux of resident macrophages (Melnicoff 
et al 1989). This increased cellular activity within the 
inflamed site would lead to and be facilitated further by 
secretion of a variety of lymphokines including IL-1, IFN gamma 
and TNF (reviewed by Oppenheim et al 1986). Significantly, IL- 
1, IFN gamma and TNF have all been shown to become distributed 
systemically during inflammatory responses (rev Oppenheim et al
1986). In addition, all three molecules have been shown to 
regulate lymphocytes binding to endothelial cells in vitro (IL-1 
alpha, Cavender et al 1986; IFN-g, Yu et al 1985; TNF-alpha, 
Cavender et al 1987) and more significantly, to regulate 
lymphocyte migration in vivo. Thus, TNF-alpha is a strong 
stimulus for small lymphocyte migration out of the blood and
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into inflamed skin tissue, while IL-1 alpha and IFN gamma have 
weak individual but strong synergistic effects on lymphocyte 
migration (Issekutz and Stoltz 1989).
The influence of systemically distributed levels of IL-1, IFN 
gamma and INF on lymphoid dendritic cell migration have yet to 
be established, although it is clear that such cells express 
receptors for and are therefore sensitive to a range of 
cytokines. Thus, granulocyte/macrophage colony stimulating 
factor (GM-CSF) is essential for the maturation of Langerhans 
cell accessory cell function in vitro (Witmer-Pack et al 1987). 
This may reflect the role of GM-CSF release by epidermal cells, 
after contact with hapten in vivo. Thus GM-CSF would mobilize 
active Langerhans cells involvement in the sensitization process 
by stimulating the maturation process.
In addition, IL-1 amplifies the accessory cell function of 
dendritic cells in a variety of immune responses (Steinman 
1988). The action of IL-1 is to enhance the clustering of T- 
lymphocytes with dendritic cells (treated previously with IL-2; 
Koide et al 1987). These two effects establish the 
responsiveness of lymphoid dendritic cells to lymphokines and 
cytokines, although what direct influence these molecules have 
on Langerhans cell/dendritic cell migration is unclear.
It has been proposed, as described earlier, that Langerhans 
cells are migratory and are in dynamic equilibrium within the 
epidermis, with an average residence in mouse epidermis of three
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weeks (Katz et al 1979; Toews et al 1980). As discussed 
earlier, such a turnover would need to be significantly enhanced 
if immune surveillance within the epidermis is to be maintained 
following hapten challenge and Langerhans cell migration (see 
chapter 7). It is unclear, however, how hapten-binding to the 
epidermis affects this rate and indeed, whether additional 
signals, for example GM-CSF (Witmer-Pack, et al 1987) or 
epidermal urocanic acid levels (Harriot-Smith and Halliday 1988) 
mediate the response.
While it is unclear as to how lymphokines and cytokines 
specifically affect the migration of lymphoid dendritic cells 
within naive or sensitized mice, there is a growing 
understanding of how the differentiated states of lymphoid 
dendritic cells are related, where each predominates and how 
they may interact in mediating lymphocyte activation following 
topical exposure with sensitizing chemicals (see discussion, 
chapter 7).
Defined migration patterns for lymphoid dendritic cells
While the detailed migration patterns which a number of studies 
revealed are described earlier (chapter 1), of significance at 
this point is the suggestion that dendritic cells bind to T- 
lymphocyte-conditioned (marginal zone) endothelium. Thus, 
Austyn and co-workers (Kupiec-Weglinski et al 1988) speculate 
that dendritic cells may express an endothelium-specific homing 
receptor (but not specific for HEV), enabling dendritic cell
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binding to the splenic marginal zone (prior to crossing the red 
pulp, and entering the periarteriolar lymphoid sheath). Central 
to this proposal, and reflected in the integrity of dendritic 
cell migration being dependent on T-lymphocytes (Austyn et al 
1988), T-cell products are predicted to condition endothelium, 
allowing receptor binding: in addition, such conditioning and 
thus dendritic cell accessibility could occur at non-lymphoid 
sites where T-cells accumulate (a peritoneal cavity hosting an 
inflammatory response?).
As I described in chapter 1 the phenotype of lymphoid dendritic 
cells has been quite well elucidated, utilising monoclonal 
antibodies against a variety of cell surface markers (eg Crowley 
et al 1989). However it is still unclear whether any of these 
markers, or new ones yet to be identified, represent 'homing 
receptors' or their like. While these studies are incomplete, 
they do still remain relevant to my findings. In particular, 
Austyn et al (1988) propose that 'aberrant' dendritic cell 
migration could occur during inflammatory responses and that 
this could result in dendritic cell accumulation at the sites of 
inflammation. This is in agreement with my demonstration that 
the establishment of a putative inflammatory response in the 
peritoneal cavity influences the hapten-induced appearance of 
lymphoid dendritic cells in the draining lymph nodes 
appertaining to the site of skin painting.
I have demonstrated that intraperitoneal administration of
foreign proteins prior to initiating FITC-driven lymph node
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activation has significant effects on the expected increases in 
lymph node weight and total dendritic cell recovery. I have 
presented a reasoned explanation for the results I have obtained 
and have aligned my proposals for the influence of inflammatory 
responses on distal dendritic cell migration with a similar 
proposal from an independent group. While my discussion this 
far has only considered quantitative changes in dendritic cells 
from the lymph nodes of mice which have received the 
intraperitoneal protein preparations prior to topical FITC- 
exposure, I also analysed changes in the quality of the 
stimulatory activity of FITC-bearing dendritic cell-enriched 
lymph node cells from the protein-immunized mice. These 
studies, constituting the second half of the results section in 
this chapter, demonstrate that the intraperitoneal treatments 
did affect the stimulatory activity of dendritic cells, but 
unlike the results so far described, this effect was dependent 
on the interferon activity within the intraperitoneally 
administered protein. As will be apparent, this makes 
interpretation of the results difficult, but a clear pattern 
does emerge and I wish to emphasise at this point that while the 
changes in total dendritic cell recovery were dependent on the 
foreign nature of injected proteins, the change in stimulatory 
activity of dendritic cells appears to be specific to the 
interferon component of the injected protein. The overlap in 
lymphokine activities responsible for these two effects will be 
examined in chapter 10.
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Intraperitoneal administration of murine IFN gamma preparations 
prior to FITC-priming, influences the stimulatory activity of 
the FITC-bearing dendritic cell-enriched lymph node cells
There were clear changes in the stimulatory activity of 
dendritic cell-enriched lymph node cells from mice pretreated 
intraperitoneally with a high titre of the recombinant murine 
IFN gamma preparation prior to FITC-priming on the ears. This 
was compared with the same cell fraction from mice primed with 
FITC only. (NB Considerable care was taken to ensure that the 
quantitative changes in dendritic cell recovery, described 
previously, were completely accounted for. Thus in a given 
experiment stimulator cell nimbers were carefully adjusted, so 
that 10^ dendritic cells from each treatment group were used. 
Changes in stimulatory activity were thus attributed to changes 
within the 10^ dendritic cells.) The murine IFN gamma 
pretreated group showed a consistently reduced stimulatory 
activity, typically giving 50% of the control stimulation. This 
difference was detectable for a variety of priming FITC 
concentrations, including concentrations shown previously 
(chapter 8) to give antigen-specific proliferation in FITC- 
sensitized responder lymph node cells in the antigen 
presentation assay. It is therefore the case that it is 
primarily changes in the level of concentration of imnunogenic 
hapten (the 'specific' element) within the dendritic cell- 
enriched lymph node cell fractions, that determines the 
stimulatory activity, which is regulated by the intraperitoneal 
interferon treatment.
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Correlation between the effect of murine IFN gamma preparations 
on the stimulatory activity of dendritic cell-enriched lymph 
node cells and the ratio of high fluorescent; low fluorescent 
dendritic cells within the dendritic cell-enriched fractions
There was a significant reduction in the fraction of large 
(dendritic) cells which had high levels of fluorescence in the 
murine IFN gamnapretreated, FITC-primed group. That is, there 
were less large dendritic cells bearing high levels of 
fluorescence (FITC) and it was shown in chapters 7 and 8 that 
these cells possess the stimulatory activity in vitro. This 
reduction in the ratio of high to low fluorescent dendritic 
cells if FITC-priming was preceeded by intraperitoneal treatment 
with the murine IFN gamma preparation, was modest in magnitude 
(for example, from 38% to 27%) but reproducible and 
significantly, it correlated well with the reduced stimulatory 
activity of the interferon pretreated, FITC-primed dendritic 
cell-enriched fractions.
The demonstration that the ratio of high to low fluorescent 
dendritic cells is affected by the murine IFN gamna preparation 
indicates that the preparation has a selective effect on either 
the high or low fluorescing dendritic cells. Thus, for 
instance, the murine IFN gamma preparation treatment selectively 
effects the immigration to or appearance of FITC-bearing 
dendritic cells into the node or alternatively the emigration of 
non-FITC-bearing dendritic cells out of the node. It should be 
noted that dendritic cell-enriched lymph node cells from murine
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IFN gamma preparation pretreated, FITC-primed mice failed to 
show any increased proliferative activity in vitro. Therefore, 
increased T-blast formation was not apparent (or countable) 
which was as expected as hapten challenge was at the same 
relative time for all experiments.
Similarly, the dendritic cell-enriched fractions from mice 
painted with 'non-specific' doses of FITC following murine IFN 
gamma pretreatment did not have any significantly increased 
stimulatory activity for responder lymph node cells sensitized 
to heterologous haptens, compared with mice receiving the 'non­
specific' dose of FITC only (data not shown). This indicated 
that the interferon pretreatment did not stimulate enhanced 
production of non-specific factors within the dendritic cell- 
enriched fractions.
The implication of these findings, that high and low fluorescent 
dendritic cells have differing susceptibility to the murine IFN 
gamma preparation may simply reflect my earlier proposal (see 
chapter 7) that the former represents an immigrant, hapten­
bearing dendritic cell within the lymph node, while the later is 
a resident dendritic cell which acquires low levels of hapten 
(from the immigrant dendritic cell population) within the node. 
This theme of hapten-activated and resting dendritic cell 
phenotypes has a number of protagonists (Kolde and Knop 1987; 
Schuler and Steinman 1985) and represents a reasonable 
explanation for the biphasic distribution of hapten within the
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dendritic cells of a dendritic cell-enriched lymph node cell 
fraction.
One can speculate, that the murine IFN gamma preparation may 
influence expression of a lymph node 'homing' receptor on the 
hapten-bearing dendritic cell surface, which would facilitate a 
change in accessibility to the local lymph node and which would 
be detectable as an unusual ratio of high (immigrant) to low 
(resident) fluorescent dendritic cells within the node.
The active component within the murine IFN gamma preparation 
responsible for influencing the ratio of high to low fluorescent 
dendritic cells
A series of experiments were performed which considered the 
effect of injecting PBS, heat-inactivated murine IFN gamma or 
human IFN gamma preparations, in addition to the active murine 
IFN ganma preparation, on the stimulatory activity of dendritic 
cell-enriched lymph node cells and the ratio of high to low 
fluorescent dendritic cells within such populations. Firstly, I 
established that dendritic cell-enriched fractions from control 
groups, injected per se was not sufficient to effect the 
dendritic cell-enriched fractions stimulatory activity. Thus 
simple physiological stress did not account for the changes in 
stimulatory activity.
Significantly, in one experiment where a heat-treated murine IFN
ganma preparation was administered to one group prior to FITC-
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priming, while another group received the standard murine IFN 
gamma preparation, I demonstrated that the active component 
within the preparations was inactivated by incubation at 56°C 
for 30 minutes, indicating that the effect was dependent on a 
conformationally intact protein within the interferon 
preparation.
These effects on stimulatory activity correlated well with 
measured changes in the ratio of high fluorescent to low 
fluorescent dendritic cells within the dendritic cell-enriched 
fraction. As such I concluded that the stimulatory activity was 
determined by the ratio of high to low fluorescent dendritic 
cells. This ratio was influenced by a conformationally intact 
protein within the murine IFN gamma preparation when this 
preparation was administered 24hrs prior to FITC-priming. This 
was consistent with the active murine IFN gamma component 
modulating the ratio of high to low fluorescent dendritic cells 
rather than simply constituting a 'passive' protein dose which, 
following intraperitoneal administration, stimulated an 
inflammatory response in the peritoneum. That is, one would 
predict heat treated protein to provide as good an inflammatory 
impetus, as BSA will not be inactivated at 56°C, but this was 
not observed, at least in terms of dendritic cell influence. 
The biological activity of the murine IFN gamma preparation was 
necessary if dendritic cell migration was to be influenced.
I demonstrated that the active component was likely to be murine 
IFN gamma by comparing the murine interferon preparation's
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activity on high to low fluorescent dendritic cell ratios with 
that of an equivalent titre of human IFN gamma preparations. 
Thus, both the human and murine IFN gamma preparations were 
prepared by my colleagues at Warwick and differed only in the 
transfected cell line from which the starting supernatants, 
prior to interferon purification, were prepared. (The human and 
murine interferon DNA clones, together with the transfected cell 
lines and their yields of interferon are described, Interferons 
and Lymphokines - A Practical Approach, Morris and Ward 1988.) 
The standard purification procedures, involving a series of blue 
sepharose affinity columns, utilised the same columns for both 
human and murine preparations. I therefore reasoned that any 
contaminants within the preparations would be present in both 
preparations. In short, the human and murine IFN gamma 
preparations were identical except for the IFN component.
The results indicated that while the murine IFN gamna 
preparation significantly affected the percentage of dendritic 
cells (which were of high fluorescence) within a FITC-primed 
dendritic cell-enriched fraction, the administration of the 
human IFN gamma preparation had negligible effect. Considering 
the rationale outlined above and the fact that the groups 
received equivalent antiviral titres of interferon (60 x 10^ 
Units per mouse), the results are consistent with the active 
component influencing the high to low fluorescent dendritic cell 
ratio in a species-specific fashion. Interferon activity is 
widely accepted as acting in a host species-specific fashion 
(Celada et al 1984) and I therefore concluded that interferon
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was the active factor in regulating the dendritic cell ratio, 
when administered intraperitoneally 24hrs prior to FTTC-painting 
on the ears. This hypothesis is testable and appropriate 
methods are suggested in chapter 10.
Possible mechanisms for the action of IFN gamma on the ratio of 
high to low fluorescent dendritic cells within the FITC-primed 
lymph node
While the ability of IFN gamma to induce a variety of changes in 
cellular membrane protein expression is well documented (see 
chapter 2) the mechanism by which IFN gamma modulates lymphocyte 
migration (possibly through these plasma membrane effects) is 
less clear. In addition to my own data, a number of workers 
have demonstrated that interferon treatment both in vivo and in 
vitro may modulate lymphocyte migration (Leszczynski et al 1986; 
Kimber et al 1987) and additionally, local administration of 
murine IFN g a i m a  has been shown to regulate the acquisition of 
hapten (oxazolone) sensitization and thus the development of 
allergic contact dermatitis (Maguire et al 1989).
The key to explaining these latter effects is an understanding 
of how lymphocytes in general and dendritic cells in particular 
and the cells with which these interact, are directly influenced 
by interferon. It is fair to say that studies in this area are 
in their infancy.
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If in vivo administered IFN garima has a direct effect on
dendritic cell migration, one scenario consistent with my data, 
then published studies considering the binding of lymphocytes 
and lymphoid dendritic cells to endothelia are relevant. Thus 
while dendritic cells have been shown in vivo to be unable to 
interact with postcapillary HEV (Kupiec-Weglinski et al 1988) it 
has been proposed that dendritic cells will necessarily need to 
interact with certain cells at particular junctions (eg the 
spleen marginal zone, macrophages). Thus, Austyn and co-workers 
propose that dendritic cells express a receptor which mediates 
such interactions, although the identity of this is yet to be 
established. It is likely, however, that such receptors (or 
ligands) will be expressed at cell surfaces and their expression 
will be regulated by lymphokines such as IFN gamma. Certainly, 
the interaction of T-lymphocytes with endothelial cells is 
modulated by the activity of IFN gamma (Yu et al 1985) and this 
is likely to reflect changes in the expression of cell surface 
proteins involved in lymphocyte recognition, and adhesion.
While unsubstantiated, it is nevertheless reasonable to propose 
that in vivo administered, systemically distributed IFN gamma 
may modulate the interaction of dendritic cells with local lymph 
nodes. As such, intraperitoneal administration of interferon 
prior to FITC-priming could restrict the entry of hapten-bearing 
dendritic cells into the lymph node, thus altering the ratio of 
high to low fluorescent dendritic cells and accounting for the 
results I have presented.
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Clearly an in vitro approach, considering the interaction of 
hapten bearing, interferon-pretreated dendritic cells with lymph 
node cells/marginal zones could contribute a lot to the 
understanding of how these interactions occur (reader referred 
to Male and Pryce 1988 and Austyn et al 1988 for the approaches 
which could be adopted) and I am sure will provide a fruitful 
approach for my colleagues.
Of course, while intraperitoneally administered IFN gamma may 
have a direct effect on FITC-bearing dendritic cell appearance 
in the draining lymph node this has not conclusively been 
demonstrated. An alternative explanation could invoke the IFN 
gamma in stimulating a cascade of lymphokine release by 
peritoneal macrophages and these 'secondary' lymphokines may 
affect the dendritic cell appearance in distal lymph nodes. It 
has long been established that IFN ganma may activate a number 
of cells, including macrophages (Nathan et al 1983) and natural 
killer cells (Shalaby et al 1985), both of which may secrete a 
potent cocktail of monokines and lymphokines. The potential 
activity of these secreted lymphokines is significant, 
particularly if they become systemically distributed.
Conclusions
The impetus for the experimental approach and results described 
in this chapter was my desire to consider the effect of systemic 
changes in IFN gamma levels within mice, on the progression of 
an immune response, ie the FITC-induced changes in auricular
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lymph nodes and the dendritic cells therein. This was based on 
the knowledge that systemically distributed interferon was a 
feature of many immune responses and I considered it therefore 
pertinent to ask whether such interferon levels and distribution 
would enhance, suppress or have no effect on other immune 
responses within the same mouse. I therefore considered the in 
vivo interferon treated mouse to be, at least superficially, one 
already undergoing an immune response (any response in which IFN 
produced).
A number of (cited) reports have indicated that interferon 
affects a number of parameters considered essential for immune 
activation and I therefore designed a protocol to examine the 
systemic effects of interferon on the in vitro stimulatory 
activity of FITC-primed dendritic cells.
To administer interferon systemically, two options were 
available. While intravenous administration was a possibility, 
intraperitoneal administration was equally valid and the fact 
that this second approach did stimulate significant and 
reproducible changes in the progression of FITC-induced lymph 
node activation, in a number of preliminary experiments, 
warranted a further investigation.
My results indicated that the hapten-induced changes in draining 
lymph nodes which I have examined, that is increases in lymph 
node weight, the total number of recoverable dendritic cells and 
the fluorescence distribution (and the stimulatory activity)
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within these dendritic cells were markedly affected if FITC- 
priming was preceded by 24hrs with a single intraperitoneal 
injection of partially pure recombinant murine IFN gamma (6 x 
104 antiviral units interferon activity per mouse in 1% protein 
solution). The results also demonstrate that each of these 
parameters was sensitive to different components within the 
interferon preparation.
While the abrogation of hapten-induced increases in lymph node 
weight and total dendritic cell recovery was dependent on the 
foreign (or inflammatory) potential of proteins injected with 
interferon prior to FITC-priming, the reduction in the ratio of 
high: low fluorescent dendritic cells appeared specific to the 
murine IFN gamma.
A number of experiments would help clarify the results and 
proposals I have presented. In particular, further experiments 
considering the acid-lability of the interferon effect on the 
high: low fluorescent dendritic cell ratio and also the in vivo 
use of IFN gamma neutralizing antibody would clarify the role of 
IFN gamma . In addition, a direct measure of the inflammatory 
response caused by intraperitoneal injection of heterologous 
protein, would establish the magnitude and help determine the 
influence of inflammatory responses on FITC-induced cutaneous 
sensitization.
The results do demonstrate that intraperitoneal administration 
of both murine IFN gamma and heterologous protein solutions have
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significant effects on the early stages of FITC-induced 
auricular lymph node activation. Considering anatomical 
compartmentalization, then a form of communication between the 
peritoneum and the epidermis and/or draining lymph node must 
operate in the generation of these effects. The most likely 
contender, based on our current knowledge, is probably a 
lymphokine and that this lymphokine is IFN gamma cannot be ruled 
out at this stage. Certainly, my evidence is consistent with 
the proposal that the act of immune activation, as measured by 
accumulation of hapten-bearing dendritic cells in lymph nodes 
draining the skin is significantly influenced (suppressed) by 
perturbations to the immune environment at distal sites (ie in 
the peritoneal cavity).
The implications of these findings, together with those from the 
preceding three chapters are brought together and discussed in 
chapter 10.
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10.1 Introduction
This final chapter will be limited to a concise and critical 
review of the experimental results and proposals made in this 
thesis, together with suggestions for further experimental work 
which would clarify or extend my findings. The studies 
presented fall into three broad areas as follows:
a) the role of Langerhans cells and dendritic cells in 
hapten transfer from skin to lymph nodes,
b) the stimulatory activity of haptenated dendritic cells 
(and others) in vitro and
c) the influence of IFN gamma and other immunomodulatory 
molecules on dendritic cell migration and function.
10.2.1 Dendritic leucocytes - a predisposition for antigen 
presentation in contact sensitization
This thesis contains extensive characterisation of the lymphoid 
dendritic leucocytes and in particular considers the lymphoid 
dendritic cell as defined by characteristic morphology and 
buoyant density. It is clear that all those cells have a
phenotypic and morphologic predisposition to antigen
presentation, although there are differences between the 
Langerhans cell and the 33D1+ dendritic cell (see chapter 1). A
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significant role for the latter cell in the initiation of 
contact sensitization has been suggested by
a) the rapid influx of such cells into the local draining 
lymph nodes of skin painted mice,
b) the hapten-bearing nature of these 'influxing' dendritic 
cells and
c) the correlation between the hapten-specificity, dose and 
duration of chemical painted on the skin and the number 
of dendritic cells recoverable from the draining nodes, 
together with their associated level of hapten.
I have two comments regarding these results. Firstly, most of 
these studies utilised the fluorescent contact sensitizing 
chemical FITC, allowing for ease of hapten detection on cells. 
Similar results to mine have been reported for difference 
fluorescent sensitizers, eg TRITC (I Kimber, personal 
communication) and from other groups. It is apparent that other 
non-fluorescent sensitizers, for example DNCB and oxazolone, 
cause these dendritic cell fluxes and would no doubt be hapten­
positive if analysed using anti-hapten monoclonal antibodies and 
indirect immunofluorescence, although this remains to be 
confirmed.
Secondly, my data on dendritic cells apply to the local draining 
lymph nodes only. I have not considered the influence of
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sensitization on more distal nodes, although note that 
preliminary studies in chapter 6 (see 6.1.2) suggested that 
lymph node activation, at least for the 4 days following skin 
exposure to hapten was localized. Data compatible with this has 
recently been published (Hill et al 1990). It is proposed that 
skin sensitization may stimulate systemic signalling of 
dendritic cell migration, although hapten bearing dendritic 
cells are largely restricted to the local draining lymph node; 
distal node activation is thus limited.
Beyond these two points, the more significant questions relate 
to establishing precisely what happens in vivo in the few hours 
following skin-painting, leading to the appearance of hapten­
bearing dendritic cells in the local node. How may the proposal 
for the relationship between Langerhans cells, veiled cells and 
dendritic cells be verified? Additionally, what other epidemial 
cells could be involved in regulating antigen presenting 
activity?
10.2.2 Langerhans cell-dendritic cell relationships
I am of the opinion that the extensive evidence reviewed in 
chapters 1 and 3, including the studies on Langerhans cell 
maturation in vitro. dendritic cell-interdigitating cell 
homology and the general phenotypic comparisons, together 
support a common dendritic leucocyte lineage. That is, 
Langerhans cells and veiled cells are the precursors of 33D1+
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dendritic cells and interdigitating cells of the T-lymphocyte 
rich paracortex.
Within this model, the very early role of Langerhans cells in 
associating with hapten requires further elucidation. 
Specifically, how do the levels of Langerhans cells differ 
between naive epidermal skin sheets and epidermal skin which 
have been painted with sensitizing chemicals? How do any 
changes correlate with a) hapten-bearing veiled cell recovery 
from cannulated, draining lymphatics, b) veiled cell 
interactions with lymph node junctions and c) increases in 
hapten-bearing dendritic cells in the draining nodes. Ideally, 
these questions should be addressed in a larger species than the 
mouse. Thus, analysis of cannulated lymphatic traffic will be 
essential in quantifying these results which necessitates use of 
a physically larger species. Therefore the porcine models 
favoured by Brigette Balfour would appear the most obvious to 
develop (Balfour et al 1974). Here there is the advantage of 
large draining lymphatic ducts. The analysis of cellular 
components in the epidermis, in particular Langerhans cells, is 
well established and with adaptations, no doubt applicable (Aiba 
et al 1984) to species other than mouse.
A method for examining the interaction of veiled cells and 
dendritic cells within lymph node and spleen sections has been 
described (Austyn et al 1988; Rosen 1989). However, this in 
vitro approach will have limited applicability in vivo. One 
approach for detecting cellular interactions with lymph node
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junctions in vivo will be the tracking of marked cells: although 
this area would have a major significance to our understanding 
of the physiological control of cell accessibility to lymphatic 
traffic tissues, it seems to lack impetus.
10.2.3 Thyl+ epidermal cells
There are other epidermal cells which could certainly be 
subjected to hapten exposure during skin-painting, including the 
la-inducible kératinocyte (Aiba et al 1984; Scheynius et al 
1986) and the Thyl+, class II MHC- epidermal dendritic cell 
(Bergstresser et al 1983).
As I described in chapter 2, the kératinocyte may be important 
in secondary hapten-specific responses, however I as yet have 
not mentioned the Thyl+ epidermal dendritic cell. This cell has 
been implicated in the suppression of contact sensitivity 
(Streilein et al 1984) as hapten-derivatized Thyl+ dendritic 
cells possess the capacity to down-regulate contact 
sensitization and thus acted in opposition to hapten-derivatized 
Langerhans cells (Sullivan et al 1986). The antagonistic 
activities of hapten-bearing Thyl+ dendritic cells and 
Langerhans cells become apparent in experiments assessing the 
development of contact sensitivity in Langerhans cell-depleted 
skin (Elmets et al 1983), a point which will be developed later.
More recently the Thyl+ epidermal dendritic cell has been shown 
to express a signal transducing gamma-delta T cell receptor
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(Kuziel et al 1987; Havran et al 1989). In conclusion, while 
the function of this interesting cell is becoming (less) clear, 
it shares an anatomical niche with the Langerhans cell and could 
certainly influence Langerhans cell activity although my 
colleagues at ICI have recently published data confirming that 
this influence is likely to be at the epidermis rather than in 
draining lymph nodes (Cunberbatch and Kimber 1990). Whatever 
the precise relationship, there are undoubtedly strong 
correlations between Langerhans cell association with hapten and 
the development of contact sensitivity. I have described (in 
chapters 1 and 3) the proposed link, through veiled cells to 
dendritic cell appearance in the draining lymph nodes and it is 
to these dendritic cells I now turn.
10.2.4 Biphasic hapten distribution in dendritic cell-enriched 
lymph node cell populations
It was noticeable that the dendritic cells isolated from the 
draining lymph nodes of FITC-painted mice were mainly cells 
possessing either high or low (but not negligible) levels of 
fluorescence (see section 7.2.1). A characteristic biphasic 
distribution was thus established. Such a distribution 
supported the proposal that there are non-fluorescent dendritic 
cells within lymph nodes prior to sensitization and that the 
ensuing hapten-induced increase in lymph node dendritic cells 
contained highly fluorescent cells. The two apparently normal 
distributions of fluorescence around the high and low 
fluorescence means clearly implied discrete populations. Of
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significance was the observation that while in naive dendritic 
cell-enriched fractions all the dendritic cells had no 
fluorescence, in FITC-primed, dendritic cell-enriched fractions 
this population was not apparent. Instead, a very low 
fluorescing population of dendritic cells was detected. It is 
possible that this low fluorescing population acquires hapten 
from incoming highly fluorescent dendritic cells, although 
whether this would be a co-operative transfer rather than a 
bystander effect is unclear.
I proposed designation of immigrant and resident dendritic cell 
populations in chapter 9. It should be reiterated that this may 
reflect the existence within the node of functionally discrete 
populations of dendritic cells with different responsibilities. 
In support of this, it has been demonstrated that while 
Langerhans cells may take up and process antigen, dendritic 
cells may only be capable of presenting it (see chapter 1 and 
Romani et al 1989). Could immigrant hapten-bearing dendritic 
cells, with a very recent Langerhans cell history, be 
responsible solely for transfer of hapten into lymph nodes, 
where they off-load immunogenic aliquots of hapten to 
specialized, hapten-presenting dendritic cells? This area could 
be readily examined by utilising fluorescent cell sorting to 
isolate high and low fluorescent dendritic cells. Dual 
fluorescent label analysis would then enable cell phenotyping 
and such results could be correlated with the relative 
stimulatory activity of the populations either a) in vitro
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proliferation assays or b) to adoptively transfer contact 
sensitivity to naive mice.
10.2.5 An epidermal refractory period?
Related to both the appearance of FITC-bearing dendritic cells 
in draining lymph nodes and the biphasic fluorescence of these 
dendritic cell populations was the apparently altered hapten 
transfer to lymph nodes when skin areas undergo sequential 
hapten exposures. A number of points need developing.
I have described (see section 7.3) how a refractory period, 
resulting from a difference in the rates at which a) Langerhans 
cells leave the epidermis following hapten challenge and b) 
Langerhans cells are repleted in the epidermis, could reflect an 
area of epidermis unable to respond to hapten challenge. My 
proposal for quantification of epidermal Langerhans cells would 
help establish this differential rate, although it seems likely 
that such rates would differ.
The more important question is whether my results do indeed 
demonstrate this refractory period. Clearly the ratio of high 
to low fluorescent large cells was reduced significantly if FITC 
exposure was preceded by oxazolone or DNCB exposure. The data 
may be criticised however, because the large cells may not have 
been solely dendritic cells. Thus, in these experiments the 
flow cytometric procedures, including the large cell gate 
analysis were performed precisely as described previously for
278
dendritic cell-enriched fractions. Microscopical analysis of 
such fractions 18hrs following skin painting demonstrated that 
the large cells are dendritic cells (chapter 7). It is also 
apparent that at later time points (eg 4 days, chapter 6) the 
dendritic cell-enriched fraction also contains large 
proliferating cells (probably T-lymphoblasts). It may be 
significant that in sequential hapten experiments, the FITC-only 
lymph nodes have 18hrs of hapten exposure while the oxazolone 
and FTTC primed nodes have 42hrs of exposure. One would predict 
that this later group will have advanced further in terms of 
lymph node activation and thus the large cell fraction would 
contain large T-lymphoblasts, although their formation would 
have been very rapid considering the low doses of hapten used in 
these experiments. However, the existence of T-lymphoblasts, 
which would be non-fluorescent, could "dilute" the high 
fluorescent dendritic cells, giving the false impression that 
fluorescent dendritic cell migration to/appearance in the lymph 
node had been restricted. The real question therefore was,were 
the low fluorescent, large cells oxazolone-bearing dendritic 
cells (consistent with my refractory period proposal) or 
oxazolone specific T-lymphoblasts?
With the benefit of hindsight it would have been desirable to 
count visually fluorescent and non-fluorescent dendritic cells 
in the treatment groups, establishing real numbers and actual 
ratios of high to low fluorescent dendritic cells. I in fact 
only examined this indirectly, although the results I discuss do 
suggest that T-lymphoblasts were not involved. Thus, I have
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described in chapter 7 how DNCB-pre treated, FITC-primed, 
dendritic cell-enriched fractions had negligible proliferative 
activity in vitro, suggesting no proliferating, T-lymphoblasts 
present. However, as described in chapter 8, non-proliferating 
T-lymphoblasts may have been present and could have been the 
diluting factor.
Alternatively, I have also mentioned the identification of both 
FITC-bearing and TRITC-bearing dendritic cells in dendritic 
cell-enriched fractions from mice which had been treated with 
TRITC prior to FITC : dendritic cell appearance in such lymph 
nodes was clearly stimulated by both haptens.
Clearly, a definitive answer will only be forthcoming by 
combining full dendritic cell counts with the testing for 
hapten-unrestricted stimulation by dendritic cell-enriched 
fractions from each of the treatment groups. Such approaches 
have been initiated, although to date, the results are 
inconclusive (Kimber et al 1990).
10.3.1 Hapten-presentation in vitro
Once hapten-bearing dendritic cells arrive in the draining lymph 
node, having crossed any "marginal zone" barriers (Austyn et al 
1988) and possibly interacted with other dendritic cells in the 
node, their major activity will be the presentation of hapten to 
T-lymphocytes in the paracortex (Breel et al 1988; Fossum 1988). 
The ability of these hapten bearing dendritic cells to stimulate
280
lymph node proliferation in vitro is now reviewed. In addition, 
I think it an instructive exercise to make comparisons, as 
appropriate, with my earlier results and conclusions, regarding 
the stimulatory activity of in vitro haptenated cells for lymph 
node cell proliferation in vitro. Firstly, however, a brief 
examination of the proliferation assay I used to measure these 
stimulatory activities.
10.3.2.1 The Proliferation Assay
Assessment of the stimulatory activity of both in vivo 
haptenated dendritic cells and in vitro haptenated cells 
utilised an activated whole auricular lymph node cell population 
from mice painted 7-8 days previously on the ears with a contact 
sensitizing chemical. This responder population, as described 
earlier, had passed its peak proliferative response in vivo and 
although phenotypically heterogeneous will be rich in hapten- 
specific T-lymphocytes.
Hapten-specific proliferation stimulated by either in vivo 
haptenated dendritic cells or in vitro haptenated cells was 
dependent on the responder lymph node cells originating from 
sensitized mice. Primary proliferative responses within naive 
responder populations were not detectable within my assay. In 
addition, the response to in vitro haptenated cells was 
attributed to large proliferating cells of low buoyant density, 
a phenotype consistent with that of T-lymphoblasts. Therefore, 
my assay appeared to depend on the reactivation of hapten-
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specific T-lymphoblasts rather than stimulation of a true 
secondary proliferative response (which would entail activation 
of small T-lymphocytes, being the progeny of earlier blast 
activity). Such a distinction was not made for the stimulatory 
activity of in vivo haptenated dendritic cells and thus is a 
notable area to examine. I described in chapter 8 the 
requirements for activation of cooling T-lymphoblasts compared 
with activation of true memory T-lymphocytes, reflecting on such 
differences as the level of IL-2R expression (Kreiger et al 
1986) which are widely recognized as being different. Suffice 
to say, in vivo haptenated dendritic cells would be predicted to 
stimulate both and it was interesting to note that this was not 
the case in my assay. I did not consider this a major concern, 
because all I sought to establish was a reliable assay for 
hapten presentation. It may be the case, however, that if the 
culture duration had been increased beyond 48hrs then primary 
responses may have been detectable, although this is unlikely if 
one considers the very low frequency of hapten-specific T- 
lymphocytes in a naive lymphocyte population. Under such 
conditions, however, naive dendritic cells may well have 
stimulated a syngeneic mixed leucocyte reaction which has been 
previously reported (Nussenzweig and Steinman 1980) and would 
certainly have complicated matters.
10.3.2.2 Other assays for lymph node cell activation
This section is concluded by a brief mention of how measurement 
of lymph node cell activation could have been improved. The
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measurement of lymphocyte DNA synthesis by incorporation of % -  
TdR is a widely used, effective measure of lymphocyte 
proliferation. I adopted the practice of adding %-TdR 18hrs 
prior to termination of culture and as such the proliferation of 
lymphocytes was measured for just the final 18hr period. While 
DNA-synthesis in this period will indicate the cumulative effect 
of the first 30hrs of lymph node cell activation, assays are 
available which would reveal
a) which cells within the lymph node cells show enhanced 
proliferation (presumed T-lymphocytes) and
b) which genes were activated prior to DNA duplication, as a 
prerequisite for the cell division.
The first point may of course be resolved by preparing pure T- 
lymphocytes as a responder population. As mentioned in chapter 
6, I spent considerable time attempting this, without success. 
Of course, even with pure T-lymphocytes, the question would 
remain as to which T-lymphocyte phenotype was responding. 
Instead, I progressed with the assumption, that the 
proliferating cells were T-lymphocytes. This was reasonable in 
the light of the evidence presented in chapter 3, regarding the 
role of proliferating T-lymphocytes in contact sensitization.
An innovation, which would certainly have complemented, if not 
superseded my proliferation 'readout' is the use of the 
thymidine analogue bromodeoxyuridine (BrdU). Thus, a
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proliferating cell population could be pulsed with BrdU, 
permeabilised, labelled with green fluorescing anti-BrdU 
antibodies and analysed cytometrically for incorporation of 
BrdU. If red fluorescing antibodies were also used to label 
cell surface markers, then the dual label would give a precise 
indication of exactly which cell phenotypes were proliferating. 
(Becton-Dickinson.)
The question of which genes are activated in T-lymphocytes 
following hapten presentation to lymph node cells would prove 
difficult to ascertain at the molecular genetic level without 
use of say, pure T-lymphocyte populations, clones or cell lines. 
Approaches for detection of mRNA synthesis during cellular 
activation have been reported (Farrar et al 1986). It would 
certainly seem simpler, however, to assay production of secreted 
lymphokines, for example IFN gamma or IL-3 (Dotsika and 
Sanderson 1987) as a measure of lymphocyte activation; while 
this would not necessarily indicate all genes activated, it 
should be sufficient to indicate lymphocyte activation, as would 
enhanced expression of lymphokine-receptor.
10.3.3 Stimulation of enhanced proliferation in vitro
I describe in detail in chapter 8 the stimulatory activity of in 
vivo haptenated dendritic cell-enriched lymph node cells for 
hapten sensitized responders within the proliferation assay. 
Unlike my earlier findings using relatively high numbers of in 
vitro haptenated stimulator cells, the proliferative response to
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the dendritic cell-enriched fractions were not wholly hapten 
specific. Much of the work in chapter 8 examines this non­
specific stimulatory activity and I wish to extend my discussion 
of this effect.
The potency and duration of exposure to sensitizing doses of 
hapten determined whether dendritic cell-enriched fractions 
would have specific or non-specific stimulatory activity. I 
proposed that as the potency of sensitization increased, then 
the more non-specific factor production there would be. I 
considered that such factor production could have been by 
transforming T-lymphocytes which co-fractionated with dendritic 
cells. On addition of such cells to responder lymph node cells 
the hapten bearing dendritic cells stimulated hapten-specific T- 
lymphocytes while the T-lymphoblasts stimulated factor receptor­
expressing T-lymphocytes. This whole area of which cells are 
producing what factors would be an interesting but complex 
avenue to explore. A number of points need to be made.
Firstly, the dendritic cell-enriched fractions, at 12 or 18hrs 
post-painting, independent of the sensitizing regimes tested 
consisted of 60-70% dendritic cells, by microscopical analysis. 
At these time points the remaining 30-40% of cells failed to 
proliferate. While it cannot be discounted that the dendritic 
cells themselves produce a non specific factor, as sensitization 
proceeds, the 30-40% other cells may develop the factor- 
producing capacity. Possible approaches to adopt in clarifying 
this matter would include attempting to deplete the factor
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producing cell or factor itself by utilising a) antibody and 
complement treatment against T-lymphoblasts or b) testing a 
battery of anti-lymphokine antibodies, in an attempt to 
neutralize the non-specific activity. Both these methods would 
be problematical, not least because of the very large numbers of 
mice that would be involved and also the influence of antibody 
on necessary autocrine control loops within proliferating 
responder cells (see chapter 1).
Having attained a dendritic cell-driven, hapten-specific 
response in vitro I compared it with the response measured for 
in vitro haptenated cells. The intention was to draw any 
inferences about how hapten-bearing dendritic cells stimulated 
hapten specific lymph node cell proliferation and whether this 
differed from my conclusions regarding stimulation driven by in 
vitro haptenated cells.
10.3.4 Stimulation by in vitro haptenated cells
The major point from my studies (see chapter 6) with in vitro 
haptenated stimulator cells was that such cells are not directly 
stimulatory for T-lymphocytes when added to unfractionated lymph 
node cell responder populations. Thus, hapten bearing class II 
MHC negative cells were able to initiate sensitized lymph node 
cell proliferation. Further, the proliferative response they 
trigger may be dependent on silica-sensitive antigen processing 
cells: the in vitro haptenated cells may be considered as simply 
a hapten substrate for those endogenous antigen processing
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cells. I described in chapter 1 how macrophages (and others) 
may interact with, process and present antigens (primarily 
peptides) to T-lymphocytes. I suggest that endogenous 
macrophages (silica-sensitive) internalize in vitro haptenated 
cells, process such cells to hapten-peptide fragments and then 
present these fragments in conjunction with their own class 
II MHC-encoded antigens and accessory factor production, to 
T-lymphocytes within the lymph node cell population. I add that 
I was able to demonstrate the transfer of FITC from FITC- 
haptenated erythrocytes to a cellular component within 
sensitized lymph node cells when these two were cultured 
together in vitro.
The magnitude of proliferative responses will depend therefore 
on the processing and presenting ability of the endogenous 
antigen presenting cells, prior to this endogenous cell 
interacting with and activating T-lymphocytes. Clearly, this 
proposal undermines previously reported studies on the antigen 
presenting ability of in vitro haptenated cells when using 
responder populations other than pure (100%) T-lymphocytes. In 
fact, in in vitro studies using human T-lymphocytes it has been 
reported that the T-lymphocytes themselves may possess antigen 
presenting ability (Hewitt and Feldman 1989) although there are 
to my knowledge no such reports in mice. As I wished to measure 
proliferative T-lymphocyte responses as a function of varying 
levels of hapten and/or class II MHC-encoded antigens on 
exogenous antigen presenting cells, this was clearly 
unsatisfactory and I describe in chapter 8 how my work
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progressed to consider the stimulatory activity of in vivo 
haptenated dendritic cells.
10.3.5 In vivo haptenation compared with in vitro haptenation
At this point, I wish to consider one specific question: how did 
the stimulatory activity of in vivo haptenated dendritic cells 
compare with in vitro haptenated cells? The facts clearly were 
that
a) In vivo haptenated dendritic cell-enriched populations 
were significantly more stimulatory than in vitro 
haptenated lymph node cells, in my assay (some 
experiments suggested by a factor of 10^ - 10-*),
b) In vitro haptenated, naive dendritic cells had no 
significant stimulatory activity although it was clear 
that as the titre of in vitro haptenated stimulator cells 
in the culture was increased (from 60 responders: 1 
stimulator to 5 responders: 1 stimulator), then some weak 
stimulation of proliferation occurred and
c) The failure of in vitro haptenated dendritic cells was 
not attributable to lack of hapten on the cells.
My conclusion was that in vivo haptenated dendritic cells are 
potent stimulators of lymph node cell proliferation and that 
they provide more than simply a source of hapten substrate to
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sensitized lymph node cells. Of course, the immunogenicity of 
hapten 'applied' in vivo rather than in vitro may be very 
different. There may be other differences also, and it is not 
difficult to surmise what these may be. Thus, in vitro 
haptenated dendritic cells, while probably retaining class II 
MHC-encoded antigens (personal communication I Kimber) would no 
doubt lack controlled lymphokine secretion along with the 
ability to cluster. Both these attributes are significant in 
hapten-presentation but will be compromised by the rigours of in 
vitro haptenation.
Certainly, microscopic and flow cytometric analysis of such 
cells demonstrated some loss of viability and excessive 
clumping. What is clear is that if in vivo haptenated dendritic 
cells were simply a source of hapten substrate for further 
processing, then in vitro haptenated dendritic cells should be 
as good stimulators, which is not the case.
In addition, I mention (see 8.3.4) that the stimulatory activity 
of in vivo haptenated dendritic cells did not appear to be 
dependent on the processing activity of a silica-sensitive, 
endogenous antigen presenting cell. This suggests that 
macrophages are not involved in the process of stimulation by in 
vivo haptenated dendritic cells - the in vivo haptenated 
dendritic cells should not therefore be simply considered as a 
large antigen, requiring processing (Guidos et al 1987). The 
silica insensitivity does not, however, discount the possibility 
that membrane-bound peptidases on endogenous dendritic cells
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could be important in processing, a possibility raised in recent 
publications (Chain et al 1986; Chain et al 1989) and testable 
using peptidase inhibitors.
It is apparent that in vivo haptenated dendritic cells 
stimulated lymph node cell proliferation in a more efficient and 
direct manner than that by which in vitro haptenated cells did. 
It seems likely that such dendritic cells presented hapten 
directly to T-lymphocytes within ray assay. Thus, dendritic 
cells bearing hapten acquired in vivo present it in conjunction 
with their own class II MHC-encoded antigens directly to T- 
lymphocytes expressing appropriate T-cell receptors within the 
lymph node cell population. Any dependence of dendritic cell 
driven proliferation on accessory factors produced from other 
cells, eg IL-1, would be met by other cells present in the 
heterogeneous lymph node cell responder population. This could 
be analysed by considering the influence of class II MHC-encoded 
antigen restriction on the interaction of dendritic cells and 
responder lymph node cells, although even this would not be 
definitive. Thus, it could be argued that endogenous antigen 
presenting cells present class II-hapten complexes derived from 
the in vivo haptenated dendritic cells. The only definitive 
approach was to utilise pure T-lymphocyte populations.
10.3.6 Summary
I have progressed from discussion of the induction of hapten­
bearing dendritic cell appearance in local draining lymph nodes
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to the characterisation of the stimulatory activity of the in 
vivo haptenated dendritic cells in an in vitro proliferation 
assay. By comparing these characteristics with those 
established for in vitro haptenated stimulator cells, a number 
of inferences, some as yet to be substantiated, have been drawn, 
regarding the mechanism by which in vivo haptenated dendritic 
cells stimulate T-lymphocyte proliferation. I have related 
these findings to the early stages of afferent contact 
sensitization.
With this experimental system, I examined the influence of IFN 
gamma and other proteins in vivo on these early events in 
afferent sensitization and I will discuss this now.
10.4.1 Effects on cutaneous sensitization (dendritic cell 
trafficking) of intraperitoneal administration of foreign 
protein
The general approach I adopted here was to inject groups of mice 
24hrs prior to the usual skin-sensitizing regimes with aliquots 
of murine IFN gamma or various control substances. Tne normal 
sensitizing procedures were followed and I was then able to 
compare a number of parameters, all indicators of the 
progression of lymph node activation, to see what effect this 
altered IFN gamma environment had on activation.
It was clear from the data in chapter 9 that both heterologous 
proteins and murine IFN gantna influenced these parameters and
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the discussion relates these to the potential immune activity of 
both heterologous proteins and IFN gamma. Four main points 
require discussion.
1) Do heterologous proteins administered to the peritoneun 
stimulate an inflammatory response and if so, how 
quickly?
2) Can systemic distribution of effector molecules, for 
example IL-1, TNF, IFN gamma be identified and attributed 
to peritoneal inflammation?
3) Do such effector molecules have activity at the epidermis 
and/or lymph nodes within 24-36hrs of stimulating the 
peritoneum?
4) Do such effector molecules have particular regulatory 
activity in, for example, attracting Langerhans cells, 
restricting lymph node access or regulating other cell­
cell interactions?
Findings from other laboratories, discussed in chapter 9 suggest 
that the answer to all these questions is yes. A logical 
extension of my work would be to confirm that heterologous 
proteins administered to the peritoneum do trigger inflammatory 
responses and further to assess the resulting production and 
distribution of effector molecules capable of influencing the 
progression of contact sensitization. The existence of
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conditions such as rapid anaphylaxis suggest such responses can 
be extremely rapid.
10.4.2 Inflammation - cell fluxes
Examination of changes in peritoneal cell populations would give 
a direct indication of inflammatory responses occurring in the 
peritoneum (Melnicoff et al 1989). Thus, rapid flow cytometric 
analysis of peritoneal cell populations at different time points 
beyond peritoneal challenge, combined with phenotypic analysis 
of the cells would enable quantitative measurement of cellular 
changes in the peritoneum. For instance, in chapter 9 I 
proposed that the putative peritoneal changes attributable to 
injection of heterologous protein could include a diversion of 
migrant, hapten-bearing Langerhans cells to the peritoneum: the 
appearance of FITC-bearing cells in the peritoneum could be 
readily identified using cell cytometry.
10.4.3 Inflammation -other correlates
Inflammatory responses, including contact sensitization are 
characterized by a number of systemic changes including the 
level of acute phase proteins (APP; Kimber et al 1989b), 
cytokines (Oppenheim 1986) including TNF and IL-1 and also 
possible systemic increases in a number of other mediators 
including the arachidonic acid metabolites prostaglandin, 
platelet activating factor and the leukotrienes (reviewed in 
Zweiman 1988). While this area is too broad to develop here it
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is worth stating that all these molecules have immunomodulatory 
activities and therefore the potential to influence the 
progression of lymph node activation. In addition, a number of 
assays exist for assessing the quantity of these molecules and 
their biological activity, around the body. There are thus a 
broad spectrum of activities which may be measured and 
correlated with induction of peritoneal inflammation.
10.4.4 Other approaches
A number of other approaches warrant mention. The use of 
precisely-defined control groups could yield much about the 
putative inflammatory responses. Administration of heterologous 
proteins with adjuvants, for example incomplete Freunds 
adjuvant, would be predicted to enhance the inflammatory 
potential and thus the effects observed on regulation of lymph 
node activation. Conversely, the administration of 
prostaglandin inhibitors, for example indomethacin (Stevens et 
al 1989) would be predicted to restrict the development of 
inflammatory responses.
A similar approach, utilising monoclonal antibodies against 
potential effector molecules, may also prove fruitful. Such 
techniques aim to saturate the mouse lymphatic and vascular 
systems with titres of neutralizing antibody adequate to absorb 
specific 'directed' activities, for example IFN gamma (Skoglund 
et al 1988). An anti-LPS antibody would have been particularly 
useful in my studies as LPS can have numerous iinminological
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influences. Initial studies on these saturation techniques by 
ray colleagues at Warwick suggest that achieving (and accounting 
for) a wide tissue distribution of antibody will be one of the 
difficulties to overcome.
It is clear that in ray experimental model, a wide range of 
antibodies would need to be tested, because the molecules 
responsible for regulating lymph node activation are as yet 
unelucidated. Further, there may well be synergistic activities 
involved, for example IFN gamma and TNF (Weetman and Rees 1988) 
and thus multiple activities to target. I would add that none 
of these problems would appear to be insurmountable. Indeed, 
without pure lymphokine preparations to administer to mice, in 
vivo antibody administration is perhaps the only way to probe 
the precise role of lymphokine activities, apart from the use of 
transgenic lines with a specific lymphokine deletion or addition 
(reviewed in Shimizu et al 1989).
The potential scope of these experiments is clearly enormous. 
The route to take would be much clearer if a specific activity 
was implicated in the regulation of lymph node activation and 
this would be the first priority, beyond establishing peritoneal 
inflammation. Of course some of my results in chapter 9 did 
suggest that the interferon component, rather than the 
additional heterologous proteins, was responsible for modulating 
the ratio of high fluorescent to low fluorescent dendritic cells 
within lymph nodes draining FITC-painted skin.
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10.4.5 Analysis of the in vivo activity of IFN gamma
To examine the IFN gamma specificity of the effect of peritoneal 
injection on dendritic cell ratios, I utilised the heat 
sensitivity and species specificity (Celada et al 1984) of the 
murine IFN gamma preparation. Thus I was able to demonstrate 
that the significant activity, with influence in mice, was 
inactivated by heat treatment and was found in a murine but not 
human IFN gamna preparation. This later result distinguished 
the interferon preparations and proved species specificity. 
However, the preparations were defined by their antiviral 
activities in vitro rather than their immune activity and the 
specificity in my assay assumes that the region of the IFN gamma 
molecule stimulating both immune and antiviral activities is the 
same. The studies of IFN ganma epitopes using a range of mAb 
(Schreiber) suggest this common region does exist.
My results could be reinforced by using control injections of 
pure IFN gamma preparations, neutralizing anti-IFN ganma 
monoclonal antibodies for example R4-6A2 (Spitalny and Havell 
1984) or both. The use of R4-6A2 alone would enable analysis of 
the role of 'normal' (that is physiological) concentrations of 
IFN gamma on the progression of lymph node activation.
Finally, the IFN gamma activity within the preparations I used 
may usefully have been characterized in terms of 1) acid 
lability, with IFN gamma activity sensitive to pH treatment 
(Stewart et al 1980) and ability to absorb the regulatory factor
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on anti-IFN gamma monoclonal antibody columns (Spitalny and 
Havell 1984).
If IFN gamma activity was established as significant, its site 
of action would need examination. Does IFN gamma administered 
by a variety of routes have similar effects on lymph node 
activation and specifically, does the molecule act at the 
epidermis and/or lymph nodes on dendritic leucocytes? 
Alternatively, does the IFN gamma administered perhaps initiate 
an intermediary cell to release another lymphokine (or more IFN 
gamma; which would then act on the dendritic leucocytes?) An 
analysis of the effect of in vivo administered IFN gamma, tissue 
by tissue, as previously described (Skoskiewicz et al 1985) 
could enable the distribution of the IFN gamma molecule to be 
established. These studies could then be refined to give a 
cellular target for the IFN gamma. It is this final point with 
which I would like to conclude.
10.4.6 IFN gamma and dendritic leucocytes
The whole area of what effect IFN gamma (and other inflammatory 
lymphokines) may have on the dendritic leucocytes and cells 
which dendritic leucocytes interact with (and stimulate) has not 
been widely examined. I have previously described a number of 
potential effects but I also emphasised that only GM-CSF 
(Witmer-Pack et al 1987) and IL-1 (Koide et al 1987) have 
notable activities. Clearly there is a role for comparative 
studies both in vitro and in vivo.
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I have described how adhesion molecules are likely to be 
involved in dendritic leucocyte-cell interactions (see chapter 
2) and it is noteworthy that recent publications have 
demonstrated a role for such molecules during dendritic cell- 
driven responses. I also commented on how the expression of 
such molecules may be modulated by a variety of lymphokines 
including IFN gamma.
Thus, extending the studies of Steinman and co-workers on 
dendritic cell clustering, King and Katz (1989) demonstrate that 
a primary, non-antigen restricted clustering is regulated by 
both LFA-l-ICAM 1 and LFA-3-CD2 interaction. These preceded a 
CD4-Ia interaction, as previously described. The undoubted 
roles of both la and ICAM 1 in tandem were confirmed by the 
double transfectant studies of Altman et al (1989). I am sure 
that these lines of in vitro study together with the in vivo 
regulation of, for instance, adhesion marker expression by 
protocols such as those described by me will provide the full 
explanation for how IFN ganma and others may regulate lymph node 
activation and dendritic leucocyte function.
In addition, as our understanding of how dendritic leucocytes 
function and may be regulated both in vitro and in vivo 
increases, then an examination of these fascinating cells at the 
molecular genetic level will become more meaningful. It may 
well be that now is the opportune moment to subject dendritic 
leucocytes to a variety of lymphokine influences and to examine 
in detail the mRNA transcripts such treatments stimulate. A
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'polysomal precipitation', much along the lines of Hedrick and 
co-workers, may well lead to transcripts encoding the dendritic 
leucocyte homing receptor - such a finding could be as 
significant to our understanding of dendritic leucocyte activity 
(indeed cellular interactions in the lymphon in general) as was 
the isolation and ongoing functional characterisation of the 
alpha-beta T-cell receptor.
299

Abel, E A  and Wood, G S (1986) Mechanisms in contact 
dermatitis. Clin Rev Allergy, 4: 339-352.
Adams, R M  (1986) Diagnosis of allergic contact dermatitis of 
occupational original. Clin Rev Allergy, 4: 323-338.
Aiba, S, Aizawa, H, Obata M  and Tagami, 11 (1984) Dynamic
changes in epidermal la positive cells in allergic contact 
sensitivity reactions in mice. Br J Dermatol, 111, 507-516» 
Allen, P M  (1987) Antigen processing at the molecular level. 
Immunol Today 8, no 9 270-273.
Allen, P M  and Unanue, E R (1984) Differential requirements for 
antigen processing by macrophages for lysozyme specific-specific 
T cell hybridomas. J Immunol, 132, 1077-1079 .
Altman, D M, Hogg, N, Trowsdale, J and Wilkinson, D (1989)
Cotransfection of ICAM1 and HLA-DR reconstitutes human antigen 
presenting cell function in mouse L cells. Nature (London), 
338, 512-514.
Ameisen, J  C, Meade R and Askenase, P W  (1989) A new
interpretation of the involvement of serotoni in DTH. J 
Immunol, 142, 1,3171-3179 .
Anders son, U, Laskay T, Anders son, J, Kiessling, R and Deley, M 
(1986) Phenotypic characterisation of individual interferon 
ganma producing cells after 0KT3 antibody activation. Eur J 
Imnunol 16: 1457-1460.
A m o ,  J  (1981) The lymphoid system. The immune system: a 
course on the molecular and cellular basis of immunity. Ed 
McConnel, I, Munro, A and Waldman, H. Blackwell Scientific 
Publications Oxford.
Asano, Y  and Hodes, R J (1983) T cell regulation of B cell
301
activation. Cloned Lyt 1+2- T suppressor cells inhibit the MHC- 
restricted interaction of T helpers with B cells and/or 
accessory cells. J Exp Med, 158, 1178-1190 «
Asherson, G  L  and Barnes, R  M  R  (1973) Contact sensitivity in 
the mouse. XII The use of DNA synthesis in vivo to determine 
the anatomical localization of immunological unresponsiveness to 
picryl chloride. Immunology, 25, 495-508.
Asherson, G  L  and Mayhew B (1976) Induction of cell mediated 
immunity in the mouse: circunstantial evidence for highly 
immunogenic antigen in the regional lymph nodes following skin 
painting with contact sensitizing agents. Isr J Med Sci, 12, 
454 - 4 6 7  •
Asherson, G  L, Mayhew B and Per era, M A  C  C  (1979) The
production of contact sensitivity by the injection into the 
footpads of recipients of the lymph node cells from mice 1 day 
after painting the skin with contact sensitizing agent:
requirement for matching at the MHC between donor and recipient
mice. Imminology 37 , 2 4 1 - 2 4 5  •
Asherson, G  L  and Ptak, W  (1968) Contact and delayed
hypersensitivity in the mouse 1. Active sensitization and 
passive transfer. Immunology, 15 , 405-416 ,
Asherson, G  L, Zombala, M  and Mayhew B  (1977) Analysis of the 
induction phase of contact sensitivity by footpad transfer of 
regional lymph node cells. Macrophages and radioresistant T- 
lymphocytes induce immunity. Immunology, 32, 81 — 88«
Askenase, P  W, Bursztajn, S, Gerson, M  D and Gershon, R K (1980) 
T-cell dependent mast cell degranulation and release of serotoni 
in murine DTH. J Exp Med, 152, 1358-1374.
302
Askenase, P  W, Metzler, C  M  and Gershon, R K (1982a)
Localization of leucocytes in sites of CfTH and in lymph nodes: 
dependence on vasoactive amines. Immunology, 47, 239-204 • 
Askenase, P  W, Rosentein, R W  and Ptak, W  (1982b) T-cells
produce an antigen-binding factor with in vivo activity 
analogous to IgE antibody. J Exp Med, 157, 862-873 $
Askenase, P  W, Van Loveren, H, Krauter-Keps, S, Ron, Y, Meade, 
R, Theoharides, T  C, Nordlund, J  J, Severn, H, Gershon, M  D and 
Ptak, W (1983) Defective elicitation of D IH  in WA F  and Sl/Sl^ 
mast cell deficient mice. J Immunol, 131, 2687-2694 •
Ashwell, J  D  (1988) Are B lymphocytes the principal antigen 
presenting cell in vivo? J Immunol 140, 3697-3700.
Atkins, G  J, Johnston, M  D, Westmacott, L  M  and Burke, D C 
(1974) Induction of interferon in chick cells by temperature 
sensitive mutants of sindbis virus. J Gen Virol, 25, 381-390* 
Austyn, J  M  (1987) Lymphoid dendritic cells. Immunology 62, 
161-170.
Austyn, J  M  a n d  Gordon, S (1981) F4/80: a specific monoclonal
antimacrophage antibody. Eur J Immunol, 11, 805-815#
Austyn, J  M, Knpiec-Weglinski, J  W, Hankins, D F  and Morris, P J  
(1988) Homing to T cell-dependent areas of spleen, and binding 
with marginal zone. J Exp, Med, 167, 646-651.
Austyn, J  M  and Morris, P J  (1988) T-cell activation by 
dendritic cells: CD18-dependent clustering is not sufficient for 
mitogenesis. Immunology, 63, 537-543.
Babbitt, B, Allen, P M, Mutsueda, G, and Unanue, E R (1985)
Binding of immunogenic peptides to la histocompatibility 
molecules. Nature, 317, 359 — 360 •
303
Bach, F H, Bach, M  L  and Sondel, P  M  (1976) Differential 
function of MHC antigens in T-lyraphocyte activation. Nature,
259, 273-281.
Baker, D, Kimber, 1 and Hirk, J  L  (1989) Antigen specific 
regulation of T-lymphocyte proliferation responses to contact 
sensitizing chemicals in the guinea pig. Cell Imnunol, 119, 
153-159.
Baker, D, Parker, P, Healey, D G  and Turk, J  L  (1987) Induction 
of sensitization and tolerance in contact sensitivity with 
haptenated epidermal cells in the guinea pig. Immunology, 62, 
659-64.
Balfour, B M, McFarlin, D E and Sunerska T  (1974) Experimental 
studies on contact sensitivity. Monogr Allergy, 8, 27-39 
Barclay, A  N and Mason, D W  (1982) Induction of la antigen in 
rat epidermal cells and gut epithelium by immunological stimuli.
J Exp Med, 156, 1665-1673 .
Basham, T  Y  and Merigan, T  C  (1983) Recombinant interferon-g 
increases HLA-DR synthesis and expression. J Immunol, 130,1492-1494. 
Basham, T  Y, Nicholoff, B J, Merigan, T  C  and Morhenu, V B 
(1984) Recombinant g-interferon induces HLA-DR expression on 
cultured himan keratinocytes. J Invest Dermatol, 83, 88-90«
Benoist, C  O, Mathis, D J, Kan ter, M  R, Williams, V E II and 
McDevitt, H  O  (1983) Regions of allelic hypervariability in the 
murine A alpha immune response gene. Cell 34, 169-177.
Bergstresser, P R, Tigelaar, R E, Dees, J  H  and Streilein, J  W  
(1983) Thy 1 antigen-bearing DC populate murine epidermis. J 
Invest Dermatol 81, 286-288 ,
304
Bergstresser, P  R, TigeLaar, R E  and Streilein, J  W  (1984) Thy
1+ antigen-bearing DC in murine epidermis are derived from bone 
marrow precursors. J Invest Dermatol, 83, 83-87.
Berman, B, Chen, V  L, France, D  S, Dotz, W  I and Petroni, 6 
(1983) Anatomical mapping of epidermal Langerhans cell 
densities in adults. Br J Dermatol, 109, 553-559.
Bianchi, A  J  J, Hoejkaas, H, Benner, R, Tees, R, Nondin, A  A  and 
Schreier, M  H  (1981) Clones of helper T cells mediate antigen- 
specific, H-2-restricted CTIH. Nature (London), 290, 62-63» 
Bjorkman, P  J, Saper, M  A, Samraoui, B, Bennett, W  S, 
Strominger, J  L  and Wiley, D C  (1987) The foreign antigen 
binding site and T-cell recognition regions of class I 
histocompatibility antigens. Nature, 329, 512-518 »
Bottomly, K (1988) A functional dichotomy in CD4+ T- 
lymphocytes. Immunology Today, 9, 268-274 •
Boog, C  P, Boes, J and Melief, C  J  (1988) Role of dendritic 
cells in the regulation of class I restricted cytotoxic T- 
lymphocyte responses. J Inmunol, 140, 3331-3337.
Bray, G  W  (1937) Recent advances in allergy (3rd edition). 
Published by J & A Churchill, London.
Breathneach, S M  and Katz, S I (1984) Thyl+ DC in murine 
epidermis are bone marrow derived. J Invest Dermatol, 83, 74-77. 
Breel, M, Mebius, R E  and Kraal, G  (1987) Dendritic cells of 
the mouse recognized by two monoclonal antibodies. Eur J 
Immunol, 17, 1555-1559.
Breel, M, Mebius, R and Kraal, G (1988) The interaction of 
interdigitating cells and lymphocytes in vitro and in vivo. 
Immunology 63, 331-337.
305
Bull, J  E, Parker, D and Rirk, J  L  (1985) Predictive value of 
assessment of lymph node weight and T-lymphocyte proliferation 
in contact sensitivity. J Invest Dermatol, 85, 403-406«
Butler, I D, Deriso, P  E, Marder, P and Scheetz, M  E (1987) In 
vivo expression and regulation of murine IL-2 receptors after 
antigen sensitization. J Immunol, 138, 470-477«
Buus, S, Colon, S, Smith C, Freed, J  H, Miles, C  and Grey, H  M
(1986) Interaction between a "processed" ovalbumin peptide and 
la molecules. Proc Natl Acad Sci USA, 83, 3968-3971 •
Buus, S, Sette, A, Colon, S M, Miles, C and Grey, H  M  (1987) 
The relation between major histocompatibility complex (MHC) 
restriction and the capacity of la to bind immunogenic peptides. 
Science, 235, 1353-1358.
Buus, S and Werdelin, 0 (1986) A group specific inhibitor of 
lysosomal cysteine proteases selectively inhibits both 
proteolytic degradation and presentation of the antigen 
dinitrophenyl poly 1 lysine by guinea pig accessory cells to T 
cells. J Immunol, 136, 452-458 .
Cahill, R N P, Frost, H and T m k a ,  Z (1976) The effects of
antigen on the migration of recirculating lymphocytes through
single lymph nodes. J Exp Med, 143 , 870-888.
Cantor, H and Afoski, J (1975) Sum«*. Li*pUci<l ulU
<rVW ritfiitH. ♦  i  « I3i^ » “  W l #
Cantor, H and Boyse, E A  (1975) Functional subclasses of T-
lymphocytes bearing different Ly antigens. The generation of
functionally distinct T cell subclasses is a differentiative
process independent of antigen. J Exp Med, 141, 1376-1389,
Cantrell, D A, Collins, M  K L  and Crumpton, M  J  (1988)
Autocrine regulation of T-lymphocyte proliferation: differential
306
induction of IL-2 and IL-2R. Imnunology 65, 343-349.
Cantrell, D A  and Smith, K  A  (1983) Transient expression of IL- 
2 receptors. Consequences for T-cell growth. J Exp Med, 158, 
1895-1911
Carding, S R, West, J, Woods, A  and Bottamly, K (1989)
Differential activation of cytokine genes in normal CD4 bearing 
T cells is stimulus dependent. Eur J Immunol, 19, 231-238.
Cavender, D E, Haskard, D 0, Joseph, B and Ziff, M  (1986) 
Interleukin 1 increases the binding of human B and T-lymphocytes 
to endothelia cell monolayers. J  Immunol, 136, 203-207 
Cavender, D E, Saegusa, Y  and Ziff, M (1987) J Immunol, 139, 
1855-1860 5t<muLW cwi#lWliaj ull cf ly+fLaujte} |yTl4P,
Celada, A, Gray, P W, Rinderknect, E and Schreiber, R D (1984) 
Evidence for a gamma-interferon receptor that regulates 
macrophage tumouricidal activity. J Exp Med, 160, 55-74.
Celada, A  and Maki, R A  (1989) The expression of I-A correlates 
with the uptake of interferon-g by macrophages. Eur J Immunol, 
19, 205-208.
Chain, B M, Bou-Gharios, G  and Olsen I (1989) Clin Exp Ixmunol,
75, 87-92. pfcto* Mtaitfo 1^« pU m a
ef «ua 8  till •
Chain, B M, Kay, P M  and Feldmann, M  (1986) The cellular
pathway of antigen presentation: biochemical and functional 
analysis of antigen processing in dendritic cells and 
macrophages. Immunology 58, 271-276.
Chang, J  C  C, Ishioka, G  I and Moorhead, J  W  (1987)
Representation of the hapten dinitrophenol (DNP) to a DNP- 
specific T-cell line. Cell Immunol, 106, 1-11.
Chang, R J and Lee, S H (1986) Effects of interferon g and
307
tumour necosic factor alpha on the expression of an la antigen 
on a murine macrophage cell line. J Immunol, 137, 2853-2856. 
Cher, D J  and Mo smarm, T  R (1987) Two types of murine helper T 
cell clones. II. delayed type hypersensitivty is mediated by 
TH1 clones. J Immunol, 138 , 3688-3694#
Chervinski, H M, Schumacher, J  M, Brown, K  D and Mosmann, T  R
(1987) Two types of murine helper T cell clones. Ill Further 
differences in lymphokine synthesis between TH1 and TH2 clones 
revealed by RNA hybridization, functionally monospecific 
bioassays and monoclonal Ab. J Exp Med, 166, 1229-1244 « 
daman, H N, Chaperon, E  A  and Triplett, R F (1966) 
Immunocompetence of transferred thymus-marrow combinations. J 
Immunol, 97, 828-832 .
Claman, H N, Miller, S D, Con Ion, P J  and Moorhead, J  tf (1980)
Control of experimental contact sensitivity. Adv Immunol 30: 
121-157.
Cohen, S, McCluskey, R T  and Benecerraf, B (1967) Studies on 
the specificity of the cellular infiltrate of delayed 
hypersensitivity reactions. J Imnunol, 98, 269-273 •
Compana, D, Couston-Smith, E, Wong, L and Janessy, G  (1989)
Expression of TcR associated proteins during human T cell 
development. In Progress in Imnunology VII, ed Melchers, F et 
al, Springer-Verlag
Coombs, R R A  and Gell, P G  H  (1975) Classification of allergic 
reactions responsible for clinical hypersensitivity and disease. 
In Gell, Coombs, Lackman (eds) Clinical Aspects of Inn 3rd ed 
p761 Blackwell, Oxford.
Croll, A  D, Siggins, K W, Morris, A  G  and Pither, J  M  (1987)
308
The induction of IFN-g production and mRNA of interlevkin-2 and 
IFNg by phorbol esters and a calcium ionophore. Biochemical and 
Biophysical Research Communications Vol 146 no 3, 927-933. 
Crowley, M, Lnaba, K, Witmer-Pack, M and Steinnan, R M  (1989) 
The cell surface of mouse dendritic cells: FACS analyses of 
dendritic cells from different tissues, including thymus. Cell 
Immunol, 118, 108-125.
timber batch, M  and (timber, I (1990) Phenotypic characteristics 
of antigen-bearing cells in the draining lymph nodes of contact 
sensitized mice. Immunology, 71, 404-410.
Czemielewski, J, Vaigot, P  and Prunieras, M  (1985) Epidermal 
Langerhans cells - a cycling population. J Invest Dermatol, 84, 
424-426.
De Lisi, C  and Berzofsky, J  A  (1985) T cell antigenic sites 
tend to be amphipathic structures. Proc Natl Acad Sci USA, 82, 
7048-7053.
De Sousa, M  A  B and Parrott, D M V (1969) Induction and recall 
in contact sensitivity. Change in skin and draining lymph nodes 
of intact and thymectomized mice. J Exp Med, 130, 671-684. 
Dialynas, D P, Quan, Z S, Wall, K A, Quitans, J, Loken, M R, 
Pierres, M  and Fitch, F (1983) Characterisation of the murine T 
cell surface molecule designated L3T4, identified by monoclonal 
antibody GK1.5: similarity of L3T4 to the human Leu3/T4 
molecule. J Immunol, 131, 2443 - 2451 •
Diamantstein, T, Eckert, R, Volk, H  D  and Kupiek-Weglinski, J  W
(1988) Reversal by IFN gamma of inhibition of DTH induction by 
anti-CD4 or anti-IL-2 receptor (CD25) monoclonal antibodies. 
Evidence for the physiological role of the CD4+ TH1+ subset in
309
mice. Eur J Inmunol, 18, 2101-2103.
Dijkstra, C  D (1982) Characterisation of non lymphoid cells in 
rat spleen, with special reference to strongly la-positive 
branched cells in T-cell areas. J Reticuloendothelial Society 
32, 67-78 ,
Dotsika, E N and Sanderson, C J  (1987) Interleukin 3 production 
as a sensitive measure of T-lymphocyte activation in the mouse. 
Immunology, 62, 665-668.
Doyle, C  and Strominger, J  L  (1987) Interaction between CD4 and 
class II MHC molecules mediates cell adhesion. Nature, 330, 
256-259.
Drexhage, H  A, Mull ink, H, De Groot, J, Clarke, J and Balfour, B 
M (1979) A study of cells present in peripheral lymph of pigs 
with special reference to a type of cell resembling the 
Langerhans cell. Cell Tissue Re, 224 , 291-301 
Duijvestijn, A  M, Schreiber, A  B and Butcher, E C  (1986) 
Interferon-gamma regulates an antigen specific for endothelial 
cells involved in lymphocyte traffic. Proc Natl 4cad Sci USA, 
83, 9114-9118.
Dvorak, H  F, Dvorak, A  M, Simpson, A  M, Richerson, H  M, 
Laskowitz, S, Kamovsky, M  J  (1970) Cutaneous basophil 
hypersensitivity. II. A light and electron microscopic 
description. J Exp Med 132, 558-582.
Eisen, H  N, Orris, L  and Berman, S (1952) Elicitation of 
delayed allergic skin reactions with haptens. The dependence of 
elicitation on hapten combination with protein. J Exp Med, 95, 
473-487 .
Elmets, C A, Bergstresser, P R, Tigelaar, R E, Wood, P and
310
Streilein, J  W (1983) Analysis of the mechanism of 
unresponsiveness produced by haptens painted on skin exposed to 
low dose ultraviolet irradiation. J Exp Med, 158, 781-794 
Erard, D, Qiarreire, J, Auffredon, M  T, Galanaud, P and Bach, J  
F (1979) Regulation of contact sensitivity to DNFB in the 
mouse: effects of adult thymectomy and thymic factor. J 
Immunol, 123, 1573-1576 .
Ericsson, P 0, Hedlund, G, Dohlsten, M, Carlsson, R and Sjogren, 
H 0 (1989) Ganma interferon induces the appearance of a CD4- 
major histocompatibility complex class II"^® macrophage 
subpopulation in the rat peritoneal cavity. Scand J Immunol, 
29, 679-687.
Farr, A, Anderson, S, Marrack, P  and Kappler, J  (1985)
Expression of antigen specific, major histocompatibility complex 
restricted receptors by cortical and medullary thymocytes in 
situ. Cell, 43, 543-550 .
Farrar, U L, Birchenhal 1-Sparks, M C  and Young, H  B (1986)
Interleukin 2 induction of interferon-g mRNA synthesis. J 
Immunol, 137, 3836-3840.
Fathman, C  G  and Fitch, F W  (1982) Isolation characterisation 
and utilization of T-lymphocyte clones. Acad Press, New York, 
London.
Fischer, A, Durandy, A, Sterkers, G and Griscelli, C  (1986)
Role of the LFA-1 molecule in cellular interactions required for 
antibody production in humans. J Immunol, 136, 3198-3203. 
Flavell, R A, Allen, H, Huber, B, Wake, C  and Widera, G (1985)
Organisation and expression of the MHC of the C57 black/10 
mouse. Imm Rev, 84, 29-50.
311
Fleit, U  B, Wright, S D and Unkeless, J  C  (1982) Human 
neutrophil Fc receptor distribution and structure. Proc Natl 
Acad Sci USA, 79, 3275-3279,
Folsom, V, Gay, D  and Tonegawa, S (1985) The beta domain of the 
mouse E beta chain is important for restricted antigen 
presentation to helper T-cell hybridomas. Proc Natl Acad Sci
USA, 82, 1678-1682 .
Ford, W  L  and Atkins, R C  (1971) Specific unresponsiveness of 
recirculating lymphocytes after exposure to histocompatibility 
antigens in FI hybrid rats. Nature (New Biol) 234, 178-180# 
Fossum, S (1988) Lymph-borne dendritic leucocytes do not 
recirculate, but enter the lymph node paracortex to become 
interdigitating cells. Scand J Inmunol 27, 97-105.
Frey, J  B and Wenk, P (1957) Experimental studies on the 
pathogenesis of contact eczema in the guinea pig. Int Arch 
Allergy, 11, 81-90 .
Friedlander, M  H  and Baer, H  (1972) The role of the regional 
lymph node in sensitization and tolerance to simple chemicals. 
J Immunol, 109, 1122-1130 .
Gallagher, R B, Whelan, A  and Feighery, C (1986) Studies on the 
accessory requirement for T-lymphocyte activation by 
Concanavalin A. Clin Exp Inmunol, 66, 118-125.
Galli, S J and Dvorak, H  F  (1979) Basophils and mast cells. 
Structure , function and role in hypersensitivity. Cellular, 
molecular and clinical aspects of allergic diseases. Plenum 
Press, N Y 1-53.
Galli, S J  and Hammel, I (1984) Unequivocal DTH in mast cell- 
deficient and beige mice. Science, 226 , 710-713«
312
Germain, R N, Ashwell, J  D, Lechler, R I, Marguiles, K M, 
Nickerson, K  M, Suzuki, G  and Tou, J  Y  L  (1985) 'Exon- 
shuffling' maps control of antibody and T cell recognition sites 
to the NH2-terminal domain of the class II MHC polypeptide A 
beta. Proc Natl Acad Sci USA, 82 , 2940-2944.
Gillis, S and Mizel, S B (1981) T-cell lymphoma model for the 
analysis of IL-1 mediated T-cell activation. Proc Natl Acad Sci 
USA, 78, 1133-1137.
Gowans, J  L  and Knight, E J  (1964) The route of recirculation 
of lymphocytes in the rat. Proc R Soc Lond B Biol Sci, 159, 
257-
Green, D R, Flood, P M  and Gershon, R K (1983) Immunoregulatory 
T-cell pathways. Ann Rev Imm, 1, 439-63.
Greenbaum, L A, Herowitz, J B, Woods, A, Pasqualim, T, Reich, E 
P and Bottomly, K (1988) Autocrine growth of CD4+ve T cells: 
differential effects of IL-1 on helper and inflairmatory T cells. 
J Immunol, 140, 1555-1560.
Gresser, I, Guy-Grand, D, Maury, C  and Maunoury, M  T  (1981)
Interferon induces peripheral lymphadenopathy in mice. J 
Immunol, 127, 1569-1575 .
Grim, J  L and Maurer, P H (1989) Different TH cell subsets 
elicited in mice utilizing two different adjuvant vehicles: the 
role of endogenous IL1 in proliferative responses. Cell 
Immunol, 121, 134-145.
Gschnait, F  and Brenner, W (1979) Kinetics of epidermal 
Langerhans cell. J Invest Dermatol, 73: 566-69.
Guidos, C, Sinha, A  A  and Lee, K C  (1987) Functional 
differences and complementation between dendritic cells and
313
macrophages in T-cell activation. Immunology, 61, 269-276. 
Guillet, J  G, Ming-Zong Lai, Binner, T  J, Smith, J  A  and Gefter, 
J  L  (1986) Interaction of peptide antigens and class II major 
histocompatibility complex antigens. Nature, 324, 260-262. 
Halliday, G  M, Cavanagh, L  L  and Konrad-Muller, H (1988) 
Antigen presented in the local lymph node by cells from 
dimethylbenzanthrcence-treated murine epidermis activates 
suppressor cells. Cell Inmunol, 117, 289-302.
Haque, S, Saizawa, K, Rojo, J  and Janeaway, C  A  (1987) The 
influence of valence on the functional activities of monoclonal 
anti L3T4 antibodies: discrimination of signalling from other 
effects. J Immunol, 139 , 3207-3212 .
Harding, C  V and Unanue, E  R (1989) Antigen processing and 
intracellular la. Possible roles of endocytosis and protein 
synthesis in la function. J Immunol, 142, 12-19.
Harriott-Smith, T  G and Halliday, W  J  (1988) Suppression of 
contact hypersensitivity by short term ultraviolet irradiation: 
II. The role of urocanic acid. Clin exp Imnunol, 72, 174-177. 
Hart, D N J  and McKenzie, J  L  (1988) Isolation and 
characterisation of human tonsil dendritic cells. J Exp Med, 
168, 157-170.
Havran, U  L, Poenie, M, Tigelaar, R  E, Tsien, R Y  and Allison, J  
P (1989) Phenotypic and functional analysis of gamma-delta T 
cell receptor-positive murine dendritic epidermal clones. J 
Immunol, 142, 1422-1428.
Hayakawa, K and Hardy, R R (1988) Murine CD4+ T cell subsets 
defined. J Exp Med, 168, 1825-1838.
Haynes, B F (1986) In Leucocyte Typing II. Vol 1: Human T-
314
lymphocyte ed Reinherz, E L et al. N York, Springer-Verlag, 3- 
30.
Heber-Katz, E, Hams burg, D and Schwartz, R II (1983) The la
molecule of the antigen presenting cell plays a critical role in 
immune response gene regulation of T-cell activation. J Mol 
Cell Immunol, 1, 3-14 •
Hedrick, S, Matis, L, Hecht, T, Same Ison, L, Longo, D, Heber- 
Katz, E  and Schwartz, R (1982) The fine specificity of antigen 
and la determinant recognition by T cell hybridoma clones 
specific for pigeon cytochrome c. Cell, 30, 141-152 •
Hedrick, S, Nielson, E, Kavaler, J, Cohen, D and Davis, M  (1984) 
Sequence relationships between putative T cell receptor 
polypeptides and immunoglobulins. Nature (Lond), 308, 153-158. 
Hendriks, H R, Korn, C, Mebius, R E and Kraal, G  (1989) 
Interferon-gamna-increased adherence of lymphocytes to high 
endothelial venules. Immunology, 68, 221-226.
Herzog, W  R, Ferreri, N R, Ptak, W  and Askenase, P W (1989a) 
The DTH initiating T cell is double negative (CD4, CD8") and CD3 
negative and expresses IL-3R but not IL-2R. In press.
Herzog, U  R, Meade, R, Pettinichi, A, Ptak, W  and Askenase, P W 
(1989b) Nude mice produce a T cell derived antigen binding 
factor that mediates the early component of DTH. J Immunol, 
142, 1803-1812.
Hewitt, C  A  and Feldman, M  (1989) Hunan T cell clones present 
antigen. J Immunol, 142, 1429-1436.
Hill, S, Edwards, S J, Kimber, I and Knight, S C  (1990)
Systemic migration of dendritic cells during contact
sensitization. Imnunology, 71, 277-281.
315
Hirayama, Y, Inaba, K, Komatsubura, S, Yoshida, K, Kawai, J, 
Naito, K and Muramatsu, S (1987) Accessory cell functions of 
dendritic cells and macrophages in the thymic T-cell response to 
ConA. Immunology, 62, 393-399.
Hoefsmit, E C M ,  Durjvestijn, A  M  and Kamperdijk, E W  A  (1982) 
Relation between Langerhans cells, veiled cells and 
interdigitating cells. Imnunobiology, 161, 255-301 •
Hune, 0 A, Robinson, A  P, MacPherson, G G and Gordon, S (1983)
The mononuclear phagocyte system of the mouse defined by 
immunohistochemical localization of antigen F4/80. Relationship 
between macrophage, Langerhans cell, reticular cells and 
dendritic cells in lymphoid and hematopoietic organs. J Exp 
Med, 158, 1522-1536 ,
Hunig, T  (1984) The role of accessory cells in polyclonal T- 
cell activation. III. No requirement for recognition of H-2 
encoded antigen on accessory cells. Eur J Imnunol, 14, 483-489. 
Impériale, M  J  D, Faherty, D  A, Sproviero, J  F and Zauderer 
(1982) Fractionally distinct helper T cells enriched under 
different culture conditions co-operate with different B cells. 
J Immunol, 129, 1843-1848 .
Inaba, K, Schuler, G, Witmer, M  D, Valinsky, J, Atassi, B and 
SteInman, R M  (1986) Immunologic properties of purified 
epidermal LC. Distinct requirements for stimulation of primed 
and sensitized T lymphocytes. J Exp Med 164, 605-613.
Inaba, K and Steinman, R M  (1984) Resting and sensitized T 
lymphocytes exhibit distinct stimulatory (antigen presenting 
cell) requirements for growth and lymphokine release. J Exp 
Med, 160, 1717-1735
316
Inaba, K, Steinman, R M, Van Voorhis, W  C  and Muramatsu, S 
(1983a) Dendritic cells are critical accessory cells for 
thymus-dependent antibody responses in mouse and in man. Proc 
Natl Acad Sci USA, 80 , 6041-6045. 6«. f t y -  •
Issekutz, T  B  and Stoltz, J  M  (1989) Stimulation of lymphocyte 
migration by endotoxin, tumour neurosis factor and interferon. 
Cell Iitmunol, 120, 165-173.
Janeaway, C A  J  (1988) T-cell development: accessories or co­
receptors. Nature, 335 , 208-210 •
Janeaway, C A, Bottomly, K, Babick, J, Conrad, P, Conzen, S, 
Jones, B, Kaye, J, Katz, M, McVay, L, Murphy, D B, Tite J (1984)
Quantitative variation in la antigen expression plays a central 
role in immune regulation. Immunology Today, 5, 99-105« 
Janeaway, C A, Rojo, J, Saizawa, K, Dianzani, U, Portoles, P, 
Tite, J, Haque, S and Jones, B  (1989) The co-receptor function 
of murine CD4. Inm Reviews, no 109, 77-92.
Jarrett, E E E and Haig, D M  (1984) Mucosal mast cells in vivo 
and in vitro. Immunology Today, 5, 4, 115-119.
Jensen, P E (1988) Protein synthesis in antigen processing. J 
Immunol, 141, 2545-2550.
J e m e ,  N K (1974) Towards a network theory of the inmune 
system. Ann Inst Pasteur, Paris, 125C, 373-389 «
J e m e ,  N K and Nor din, A  A  (1963) Plaque foundation in agar by 
single antibody producing cells. Science, 140, 405 •
Jones, B (1987) Co-operation between T and B cells. A minimal 
model. Imm Reviews, 99, 5-18.
Julius, M H, Simpson, E and Herzen berg, L A  (1973) A rapid 
method for the isolation of functional thymus derived murine
317
lymphocytes. Eur J Immunol, 3 ,645-649.
Jutila, M A  and Banks, K L  (1986) Locally dividing macrophages 
in normal and inflamed mammary glands. Clin Exp Immunol, 66, 
615-624.
Kamperdijk, E W  A, Kapsenberg, M  L, Van den Berg, M  L  and 
Hoefsmit, E C  m  (1985) Characterisation of dendritic cells 
isolated from normal and stimulated rat lymph nodes. Cell 
Tissue Res 242: 469-477 •
Kaplan, G, Van Voorhis, Sarno, E N, Noguerra, N, Cohn, Z A 
(1983) The cutaneous infiltrate of leprosy. A transmission 
electron microscopy study. J Exp Med, 158, 1145-1159*
Kappler, J, Roehm, N and Marrack, P (1987) Cell, 49, 273-280;° 
Katz, S I, Tamaki, K and Sachs, D H (1979) Epidermal LC are 
derived from cells originating in the bone marrow. Nature 
(London), 282, 324-326 «
Kaye, J, Gillis, S, Mizel, S B, Shevach, E M, Malek, T  R, 
Dimarello, C  A, Lachman, L  B  and Janeaway, C  A  (1984) Growth of 
a cloned T helper cell line induced by a monoclonal antibody 
specific for the antigen receptor. J Immunol, 133, 1339-1345. 
Kelly, R H  (1970) Localization of afferent lymph cells within 
the draining node during a primary immune response. Nature, 
227, 510-513.
Kelly, R H, Balfour, B M, Armstrong, J  A  and Griffiths, S (1978)
Functional anatomy of lymph nodes. II. Peripheral lymph-borne 
mononuclear cells. Anat Rec 190, 5-22,
Khansari, D N, Murgo, A  J  and Faith, R E (1990) Effects of 
stress on the immune system. Iimunology Today, 11, 170-175.
Khurana-Hershey, G  K and Schreiber, R D (1989) Biosynthetic 
a
T-cell tolerance by clonal elimination in the thymus.
318
analysis of the human IFNg receptor: Identification of 
glycosylation intermediates. J Biol Chein, 264, 11981-11988 •
Kim, J, Woods, A, Becker-Dmm, E and Bottamly, K (1985) 
Distinct functional phenotypes of cloned la-restricted helper T 
cells. J Exp Med, 162, 188-201 .
Kimber, I (1989) Aspects of the immune response to contact 
allergens: opportunities for the development and modification of 
predictive test methods. Food Chemical Toxicology Vol 27 no 11, 
755-762.
Kimber, I, Bentley, A  and Hilton, J (1990) In press.0 
Kimber, I, Hill, S, Mitchell, J  W, Peters, S W  and Knight, S C 
(1990) Antigenic competition in contact sensitivity. Evidence 
for changes in dendritic cell migration and antigen handling. 
Immunology, 71, 271-276.
Kimber, I, Mitchell, J  A  and Griffin, A C  (1986) Development of 
a murine local lymph node assay for determination of sensitizing 
potential. Food Chem Toxicol, 24, 585-586 #
Kimber, I, Pierce, B B, Mitchell, J A  and Kinnaird, A  (1987a)
Depression of lymph node cell proliferation induced by 
oxazolone. Int Arch Allergy, 84 , 256-262 .
Kimber, I, Shepherd, C J, Mitchell, J A, Turk, J L and Baker, D 
(1989) Regulation of lymphocyte proliferation in contact 
sensitivity: homeostatic mechanisms and a possible explanation 
of antigenic competition. Immunology, 66, 577-582.
Kimber, I, Sparshott, S M, Bell, E B and Ford, W  L  (1987b) The 
effects of interferon on the recirculation of lymphocytes in the 
rat. Immunology 60, 585-591.
Kimber, I, Ward, R K, Shepherd, C J, Smith, M N, McAdan, K P W J
° The contact sensitizing properties of Nickel.
319
and Raynes, J  G  (1989b) Acute phase proteins and the 
serological evaluation of experimental contact sensitivity in 
the mouse. Int Arch Allergy, 89, 149-155.
Kimber, I and Weisenberger, C  (1989) A murine local lymph node 
assay for the identification of contact allergens. Archives of 
Toxicology 63: 274-282.
Kindred, B (1979) Nude mice in immunology. Prof Allergy, 26, 
137-238.
King, P D and Katz, D  R  (1989) Human tonsillar dendritic cell 
induced T-cell responses: analysis of molecular mechanisms using 
monoclonal antibodies. Eur J Immunol, 19, 581-587.
Kinnaird, A, Peters, S  U, Foster, J  R and Kimber, I (1989)
Dendritic cell accumulation in draining lymph nodes during the 
induction of contact allergy in mice. Int Arch Allergy 89, 202- 
210.
Klareskog, L, Tjemlund, U M, Forsum, U  and Peterson, P A  (1977)
Epidermal LC express la antigens. Nature, 268 , 248-250,
Klein, J  (1975) Biology of the mouse histocompatibility-2 
complex. Springer-Verlag, New York.
Klinkert, W  E  F, Labadie, J  H and Bowers, U  E (1982) Accessory 
and stimulating properties of DC and macrophages isolated from 
various rat tissues. J Exp Med, 156, 1-19 •
Knight, S C  (1987) Lymphocyte proliferation assay. 
Lymphocytes: A practical approach. Ed GGB Klaus, URL Press. 
Knight, S C, Bedford, P and Hunt, R (1985b) The role of 
dendritic cells in the initiation of immune responses to contact 
sensitizers. II Studies in nude mice. Cell Imnunol, 94, 435- 
439.
320
Knight, S C, Kreju, J, Maikovsky, M, Colizzi, V, Gautam, A  and 
Asherson, G  L  (1985a) The role of dendritic cells in the 
initiation of immune responses to contact sensitizers. I in 
vivo exposure to antigen. Cell Immunol, 94 , 427-434.
Knight, S C, Martin, J, Stackpoole, A  and Clark, J  (1983) 
Induction of immune responses in vivo with small numbers of 
veiled (dendritic) cells. Proc Natl Acad Sci USA, 80, 6032-6035 , 
Koide, S L, Inaba, W  and Steinman, R M  (1987) Interleukin-1 
enhances T-dependent immune responses by amplifying the function 
of dendritic cells. J  Exp Med, 165, 515-530.
Koide, S L and Steinnan, R  M  (1987) Induction of murine IL-1: 
stimuli and responsive primary cells. Proc Natl Acad Sci USA,
84 , 3802-3806 •
Koide, S L and Steinman, R M  (1988) Induction of interleukin 1 
alpha mRNA during the antigen-dependent interaction of
sensitized T-lymphoblasts with macrophages. J Exp Med, 168, 
409-416.
Koide, G  and Knop, J  (1987) Different cellular reaction 
patterns of epidermal Langerhans cells after application of 
contact sensitizing, toxic and tolerogenic compounds. A
comparative ultras true tur a 1 and morphometric time-course
analysis. J Invest Dermatol, 89, 1, 20-23.
Kovac, Z and Sdwartz, R  H  (1985) The molecular basis of the 
requirement for antigen-processing of pigeon cytochrome c prior 
to T cell activation. J Itnnunol 134, 3233-3240 .
Kraal, G, Breel, M, Janse, M  and Bruin, G  (1986) Langerhans 
cells, veiled cells and interdigitating cells in the mouse 
recognized by a monoclonal antibody. J Exp Med, 163, 981-997,
321
Kreiger, J  I, Chesnut, R  W  and Grey, H  M  (1986) Capacity of B 
cells to function as stimulators of a primary mixed leucocyte 
reaction. J Immunol, 137, 3117-3123.
Krensky, A  M, Sanchez-Madrid, F, Robbins, E, Nagy, J, Springer, 
T  A  and Burakoff, S J  (1983) The functional significance, 
distribution and structure of LFA-1, LFA-2 and LFA-3: cell 
surface antigens associated with CTL target interactions. J 
Immunol, 131, 611-616.
Kruisbeek, A  M, Davis, M  L, Matis, L  A  and Longo, D  L  (1984)
Self-recognition specificity expressed by T cells from nude 
mice. J Exp Med, 160, 839-857»
Kupiec-Weglinski, J  W, Austyn, J M  and Morris, P J  (1988)
Migration patterns of dendritic cells in the mouse. Traffic 
from the blood, and T-cell dependent and - independent entry to 
lymphoid tissues. J Exp Med, 167, 632-645.
Kurt-Jones, E A, Be H e r ,  D  I, Mizel, S B  and Unanue, E  R (1985)
Identification of a membrane associated interleukin-1 in 
macrophages. Proc Natl Acad Sci USA, 82, 1204-1208.
Kuziel, W  A, Takashima, A, Bonyhadi, M, Bergstresser, P R, 
Allison, J  P, Tigelaar, R  E  and Tucker, P  W  (1987) Regulation 
of T-cell receptor gamma chain RNA expression in murine Thyl+ve 
dendritic epidermal cells. Nature (London), 328 , 263-266 . 
Landsteiner, K and Qiase, M  W  (1942) Experiments on transfer of 
cutaneous sensitivity to simple compounds. Proc Soc Exp Biol 
Med 49, 668-690.
Lanzavecchia, A  and Staerz, U D (1987) Lysis of nonnucleated 
red blood cells by cytotoxic T-lymphocytes. Eur J Immunol, 17, 
1073-1074.
322
Larhanmar, D, Hanmorling, U, Denaro, M, Lund, T, Flavell, R  A, 
Rask, L and Peterson, P  (1983) Structure of the murine immune 
I-A beta locus; sequence of the I-A beta gene and an adjacent 
beta-chain second domain exon. Cell 34, 179-188 ,
Le Meur, M, Ger linger, P, Bernoist, C, Mathis, D  (1985) 
Correcting an immune response deficiency by creating E alpha 
gene transgenic mice. Nature, 316, 38-42.
Lechler, R I, Norcross, M  A  and Germain, R N (1985) Qualitative 
and quantitative studies of antigen-presenting cell function by 
using I-A expressing L-cells. J Imnunol, 135 , 5 , 2914-2922, 
Lechler, R I, Ronchase, F, Braunstein, N S and Germain, R N 
(1986) I-A restricted T cell antigen recognition. Analysis of 
the roles of A alpha and A beta using DNA mediated gene 
transfer. J Exp Med, 163, 678-6%.
Lee, P, Mutsueda, G  R and Allen, P M  (1988) T cell recognition 
of fibrinogen. A determinant on the A alpha chain does not 
require processing. J Immunol, 140, 1063-1068 «
Leonard, tf J  J, Depper, J  M, Uchiyama, T, Smith, K A, Waldraann, 
T  A  and Greene, W C  (1982) A monoclonal antibody that appears 
to recognize the receptor for human T-cell growth factor: 
partial characterization of the receptor. Nature (Lond) 300, 
267 - 269.
Leszczynski, D, Ferry, B, Schellekens, H, Meade, P H and Hayry, 
P (1986) Antagonistic effects of IFNg and steroids on tissue 
antigenicity. J Exp Med, 164, 1470-1477.
Lichtman, A  H, Chin, J, Schmidt, J  A  and Abbas, A  K (1988) Role 
of interleukin 1 in the activation of T-lymphocytes. Proc Natl 
Acad Sci USA, 85, 9699-9703.
3 2 3
Lomedico, P  T, Gubler, U, Hellmann, C  P, Dukovich, M, Girl, J  G, 
Pan Y, C  E, Collier, K, Seminow, R, Qiua, A  D and Mizel, S B 
(1984) Cloning and expression of murine interlevkin-1 c DNA in 
Escherichia coli. Nature (London), 312, 458-462.
Lowenthal, J  W, Cerrotini", J  and MacDonald, R (1986) IL-1 
dependent induction of both IL-2 secretion and IL-2 receptor 
expression by thymoma cells. J Immunol, 137, 1226-1231. 
Luckason, J  R, White, J  G  and Kersey, J  H  (1974) Mitogenic 
properties of a calcium ionophore A23187. Proc Natl Acad Sci 
USA, 71, 5088-5090.
Luquette, M  H, Calderon, J, Lanier, L  and Schreiber, R D (1989)
as quoted in Schreiber et al 1989.
Lynch, D H, Gurish, M  F  and Daynes, R A  (1981) Relationship 
between epidermal LC density, ATPase activity and the induction 
of contact hypersensitivity. J Immunol, 126, 5, 1892-1897.
Macatonia, S E, Edwards, A  J  and Knight, S C  (1986) Dendritic 
cells and the initiation of contact sensitivity to fluoroscein 
isothiocyanate. Immunology, 59, 509-514.
Macatonia, S E, Knight, S  C, Edwards, A  J, Griffiths, S and 
Fryer, P (1987) Localization of antigen on lymph node dendritic 
cells after exposure to the contact sensitizer fluoroscein 
isothiocyanate. Functional and morphological studies. J Exp 
Med, 166, 1654-1667.
MacDonald, H R, Blanc, C, Lees, R K  and Sordat, B (1986)
Abnormal distribution of T  cell subsets in athymic mice. J 
Immunol, 136 , 4337-4339 ,
MacDonald, H R, Lees, R  K, Bron, C, Sordat, B and Miescher, G
324
(1987) T cell antigen receptor expression in athymic nu/nu 
mice. J Exp Med, 166, 195-209 *
Machler, E and Chase, M  W  (1969) Studies on the sensitization 
of animals with simple chemical compounds. XII. The influence 
of excision of allogeneic depots on onset of delayed 
hypersensitivity and tolerance. J Exp Med, 129, 103-121 ,
Maguire, H  C, Guidotti, M  and Weidanz, W  P  (1989) Local murine 
recombinant gamma interferon enhances the acquisition of 
allergic contact dermatitis in the mouse. Int Arch Allergy, 88, 
345-347.
Maizel, A  L, Melita, S R, Ford, R J  and Lachman, L  B (1981)
Effect of interleukin-2 on human thymocytes and purified human T 
cells. J Exp Med, 153, 470-475 .
Male, D and Pryce (1988) Synergy between interferons and 
monokines in MHC induction on brain endothelium. Immunology 
Letters, 17, 267-272.
March, C, Mosley, B, Alf, L  et al (1985) Cloning, sequence and 
expression of two distinct human IL-1 complementary DNAs. 
Nature (London) 315, 641-648.
Martin, S, Maruta, K, Burkert, V, Gillis, S and Kolb, H (1988)
IL-1 and IFN-gamma increase vascular permeability. Immunology, 
64, 301-305.
Matis, L A, Glimcher, L  H, Paul, U  E  and Schwartz, R H (1983)
Magnitude of response of histocompatibility-restricted T-cell 
clones is a function of the product of the concentrations of 
antigen and la molecules. Proc Natl Acad Sci USA, 80, 6019-6023» 
May, W  S, Sabryoun, N, Wolf, M and Cuatrecasas, P (1985) Role 
of intracellular calcium mobilization in the regulation of
325
protein kinase c-mediated membrane processes. Nature (Lond), 
317, 549-551.
McCarron, R M, Kempski, 0, Spatz, M  and McFarlin, D  E  (1985)
Presentation of myelin basic protein by murine cerebral vascular 
endothelial cells. J Immunol, 134, 5 , 3100-3104.
Mcconnel, I, Munro, A  and Waldman, H  (1981) 2nd Edition. The 
immune system. Blackwell Scientific Publications, Oxford. 
McDevitt, H and Benaceraf, B  (1972) SCIENCE, 1 7 5 , Z 7 3 - Z 8 1  .  *  
McFarlin, D  C  and Balfour, B  M  (1973) Contact sensitivity in 
the pig. Immunology 25, 9 9 5 -1 0 1 0  «
Meade, R, Van Loveren, II, Pannentier, H, Iverson, G  M  and 
Askenase, P  W  (1988) The antigen binding T-cell factor PCI-F 
sensitizes mast cells for in vitro release of serotonin. J 
Immunol, 141, 2704-2713.
Melnicoff, M J, Horan, P K and Morahan, P S (1989) Kinetics of 
changes in peritoneal cell populations following acute 
inflammation. Cell Immunol, 118, 178-91.
Mekori, Y  A  and Chang, J  C  C  (1987) Effect of IgE - mediated 
mast cell degranulation on the expression of experimental 
contact sensitivity in the mouse. Cell Immunol, 108, 1-9. 
Mekori, Y  A  and Galli, S J  (1985) Undiminished immunologic 
tolerance to contact sensitization in mast cell deficient W/Wv 
and Sl/Sld mice. J Inmunol, 135, 879-885 ,
Hiller, J  F A  P and Mitchell, G  F (1968) Cell to cell 
interaction in the immune response. I. Haemolysin-forming 
cells in neonatally thymectomized mice reconstituted with thymus 
or thoracic duct lymphocytes. J Exp Med, 128, 801-820«
Mills, J  A  (1966) The immunologic significance of antigen
326
induced lymphocyte transformation in vitro. J Immunol, 97, 239-248, 
Mitchison, N  A  (1971) Carrier effects in secondary responses to 
hapten protein conjugates. I. Measurement of the effect with 
transferred cells and objection to the local environment 
hypothesis. Eur J Immunol, 1, 10-27,
Mitchison, N A  and Eichman, K  (1988) "Suppressor activity as a 
composite property" and "suppression needs a new hypothesis". 
Editorial discussions in Scand J Immunol 28, 271-276.
Moorhead, J  W  (1978) Tolerance and contact sensitivity to DNFB 
in mice. J Immunol, 120, 1, 137-143.
Morris, A  G and Ward, G  A  (1987) Interferons and lymphokines: a 
practical approach. IRL press, Oxford, London, 61-71.
Mo smarm, T  R, Cherwinski, H, Bond, M  W, Giedlin, M  A  and 
Coffman, R L (1986) Two types of murine helper T cell clone.
I. Definition according to profiles of lymphokine activities 
and secreted proteins. J Imnunol, 136 , 2348-2357 ,
Murphy, G F, Bhan, A  K, Sato, S, Mihm, M  C  and Harris, T  J
(1981) A new immunologic marker for human LC. New Eng J Med,
304, 791-792.
Nathan, C, Murray, H, Wiebe, M  and Robson, B (1983)
Identification of IFN gamma as the lymphokine that activates 
macrophage oxidative metabolism and antimicrobial activity. J 
Exp Med, 158, 670-689.
Nisbet-Bown, E, Qieung, R K, Lee, J  W  W  and Geifaud, E W  (1985)
Antigen-dependent increase in cytosolic free calcium in specific 
human T-lymphocyte clones. Nature (Lond), 316, 545-547.
Nonnent, A  M, Salter, R D, Parham, P, Englehard, V H, Littman, D 
R  (1988) Cell-cell adhesion mediated by CD8 and MHC class I
327
molecules. Nature, 336, 79-81.
Nussenzweig, M  C  and Steinman, R  M  (1980) Contribution of 
dendritic cells to stimulation of the murine syngeneic mixed 
leucocyte reaction. J Exp Med, 151, 1196-1212#
Nussenzweig, M  C, Steinman, R  M, Witmer, M  D and Gutchinov, B
(1982) A monoclonal antibody specific for mouse dendritic 
cells. Proc Natl Acad Sei USA, 79, 161-165.
O'Brien, A  D, Scher, I and Formal, S B (1979) Effect of silica 
on the innate resistance of inbred mice to Salmonella 
typhimurium infection. Infection and Immunity Vol 25 no 2, 513- 
520.
O'Rourke, E  J, Halstead, S B, Allison, A  C and Platts-Mills, T  A  
E  (1978) Specific lethality of silica for human peripheral 
blood mononuclear phagocytes in vitro. J Imm Methods 19, 137-151 
Oort, J  and Türk, J  L  (1965) A histological and 
autoradiographic study of lymph nodes during the development of 
contact sensitivity in the guinea pig. Br J Exp Pathol, 46, 
147-154.
Oppenheim, J  J, Kovacs, E J, Matsushima, K and Durum, S K (1986)
There is more than one interleukin 1. Immunology Today, 7, no 
2, 45-46.
Oppenheim, J  J, Wolstencroft, R  A  and Gell, P  G  H  (1967)
Delayed hypersensitivity in the guinea pig to a protein hapten 
conjugate and its relationship to in vitro transformation of 
lymph node, spleen, thymus and peripheral blood lymphocytes. 
Immunology, 12, 89-95 *
Owen, J  J  T  and Jenkinson, E  J  (1981) Embryology of the 
lymphoid system. In Prog Allergy 29, 1-27.
328
Owen, J  J  T, Jenkinson, E  J, Kingston, R, Williams, G T  and 
Smith, C  A  (1989) The role of the thymus in the development of 
T-cells. in Progress in Immunology VII, ed Melchers, F et al, 
Springer Verlag.
Owens, T, de St Groth, F and Miller, J  F A  P  (1987) Co­
aggregation of the T-cell receptor with CD4 and other T-cell 
surface molecules enhances T-cell activation. Pro Natl Acad Sci 
USA, 84 , 9209-9213*
Pace, J  L, Russel, S W, Torres, B  A, Johnson, H  M  and Gray, P  W
(1983) Recombinant murine IFN gamma induces priming step in 
macrophage activation for tumour cell killing. J Immunol, 130, 
2011-2016 .
Parker, R E (1983) Introductory statistics for biology. 2nd 
edition, publ Arnold (London).
Phanuphak, P, Moorhead, J  W  and Claman, H (1974) Tolerance and 
contact sensitivity to DNFB in mice. J Immunol, Vol 112, no 1, 
115-121.
Pierres, M, Goridis, C  and Golstein, P (1982) Inhibition of 
murine T-cell mediated cytolysis and T cell proliferation by a 
rat mAb imnunoprecipitating two lymphoid cell surface 
polypeptides of 94kD and 180kD. Eur J Imnunol, 12, 60-69.
Pober, J  S, Collins, T, Gimbome, M  A, Cotran, R  S, Gilting, J  
D, Fiers, W, Clayberger, A  M, Krensky, A  M, Burakoff, J J  and 
Reiss, C  S (1983) Lymphocyte recognize human vascular 
endothelial and dermal fibroblasts la antigens induced by 
recombinant immune interferon. Nature, 305, 726-729.
Pober, J  S and Cotran, R S (1989) Endothelial activation and 
inflammation. In Progress in Immunology VII. Editors Melchers,
329
F et al, Springer-Veriag.
Pober, J  S, Gimbome, M  A, Lapierre, L  A, Hendrick, D L, Fiers, 
W, Rothlein, R, and Springer, T  A  (1986) J Immunol 137, 1893- 
18%.
Pont, S, Naquet, P, Marchotto, S, Regnier-Vigouroux, A, Blanc, 
A, Pierres, A  and Pierres, M  J  (1986) Identification of 5 
topographic domains of the mouse LFA-1 molecule - subunit 
assignment and functional involvement in lymphoid cell 
interactions. J Immunol, 136 , 3750-3759,
Pont, S, Regnier-Vigouroux, A, Marchotto, S and Pierros, M 
(1987) Accessory molecules and T  cell activation. II. 
Antibody binding to L3T4a inhibits la-independent mouse T cell 
proliferation. Eur J Imnunol, 17 , 429-432.
Portoles, P and Janeaway, C  A  (1989) Ease of inhibition of the 
responses of a cloned CD4+ T cell line by anti CD4 is inversely 
related to the affinity of its receptor for different class II 
MHC ligands. Eur J Immunol, 83 ”8 7.
Powers, G  D, Abbas, A  K and Miller, R  A  (1988) Frequencies of 
IL-2 and IL-4 secreting T cells in naive and antigen stimulated 
lymphocyte populations. J Immunol, 140, 3352-3357.
Pritchard, H  and Micklem, H S (1972) Immune responses in
congenitally thymus-less mice. I. Absence of response to 
oxazolone. Clin Exp Immunol, 10, 151-161.
Ptak, W, Askenase, P tf, Rosentein, R  W  and Gershon, R K (1982)
Transfer of an antigen-specific immediate hypersensitivity-like 
reaction with an antigen binding factor produced by T-cells. 
Proc Natl Acad Sci USA, 79, 1%9-1973 .
Pugh, C  W, MacPherson, G  G  and Steer, H  W  (1983)
330
Characterisation of non lymphoid cells derived from rat 
peripheral lymph. J Exp Med, 1983, 1758-1779.
Rand, C  E, Trevillyan, J  M, Das g up ta, J V, Wong, L  L  and 
Schlossman, S F  (1988) The CD4 antigen is complexed in 
detergent lysates to a protein tyrosine kinase (pp 58) from 
human T-lymphocytes. Proc Natl Acad Sci USA, 85, 5190-5194 •
Res, P, Kapsenberg, M  L, Bos, J  D and Stiekema, F  (1987) The 
crucial role of human dendritic antigen presenting cell subsets 
in nickel specific T-cell proliferation. J Invest Dermatol, 88,
5, 551-554 .
Roberts, D, Katz, D R, Mukherjee, S and Rook, G  A  W  (1988)
Induction of DTH response to PPD: dendritic cells in synergy 
with 5-HT can substitute for macrophages. Immunology 63, 697-700. 
Robinson, M  K (1989) Optimization of an in vitro lymphocyte 
blastogenesis assay for predictive assessment of immunologic 
responsiveness to contact sensitizers. J Invest Dermatol, 92, 
860-867.
Rock, K L  and Benaceraf, B S (1983) Antigen presentation by 
hapten-specific B-lymphocytes. I. Role of surface
immunoglobulin receptors. J Exp Med 157, 1618-1634.
Romani, N, Koide, S, Crowley, M, Witmer-Pack, M, Livingstone, A 
M, Fathman, C G, Inaba, K and Steinman, R M  (1989) Presentation 
of exogenous protein antigens by dendritic cells to T-cell 
clones. J Exp Med, 169, 1169-1178.
Rosen, S D  (1989) A lymphocyte homing receptor: a member of an 
emerging class of cell adhesion molecules. In Progress in 
Immunology VII, editor Melchers, F et al. Springer-Verlag. 
Rosenthal, A  S and Shevach, E M  (1973) Function of macrophages
331
in antigen recognition by guinea pig T-lymphocytes. I. 
Requirement for histocompatible macrophages and lymphocytes. J 
Exp Med 138, 1194-1229.
Roska, A  K and Lipsky, P E (1985) Dissection of the functions 
of antigen-presenting cells in the induction of T cell 
activation. J Immunol, 135, 5, 2953-2961»
Rothbard, J  W  and Taylor, W  R (1988) A sequence pattern common 
to T-cell epitopes. EMBO J, 7, 93-101.
Schattner, A, Merlin, G, Shapiro, A, Revel, M and Wallach, D 
(1982a) Comparison of (2'-5') oligo-adenylate synthqtase and 
interferon blood levels in mice early after viral infection. J 
Interferon Res, 2, 285- m -
Schattner, A, Meshorer, A, Revel, M  and Wallach, D (1982b)
Interferon as a possible cause for virus related 
lymphocytopenia. Isr J Med Sci, 18, 965_971 «
Schattner, A, Meshorer, A  and Wallach, D (1983) Involvement of 
interferon in virus-induced lymphopenia. Cell Immunol, 79, 11-25, 
Scheynius, A, Johansson, C  and Van der Meade, P H (1986) In 
vivo induction of la antigens on rat keratinocytes by IFNg. Br 
J Dermatol, 115 , 543-549 t
Scheynius, A  and Tjernlund, U (1984) Hunan keratinocytes 
express HLA-DR antigens in the tuberculin reaction. Scand J 
Immunol, 19, 141-147 .
Schreiber, R D, Calderon, J, Hershey, G  K and Gray, P W  (1989)
The molecular and cellular biology of the IFNg receptor. 
Progress in Immunology VII, ed Melchers, F et al, Springer- 
Verlag.
Schuler, G and Steinman, R M  (1985) Murine epidermal LC mature
332
into potent immunostimulatory dendritic cells in vitro. J Exp 
Med, 161, 526-546.
Schueizer, J  and Marks, F (1977) A  developmental study of the 
distribution and frequency of LC in relation to formation of 
patterning in mouse tail epidermis. J Inves Dermatol, 69, 198-204 • 
Sedgley, M and Ford, W  L  (1976) The migration of lymphocytes 
across specialized vascular endotheliun. I. The entry of 
lymphocytes into the isolated mesenteric lymph node of the rat. 
Cell Tissue Kinet, 9, 231 -242 ,
Sette, A, Binis, S, Ape 11a, E, Smith, J  A, Chesnut, R, Miles, C, 
Colon, S M and Grey, H  M  (1989b) Prediction of MHC binding 
regions of protein antigens by sequence pattern analysis. Proc 
Natl Acad Sci USA, 86, 3296-3300.
Sette, A, Buus, S, Colon, S, Miles, C  and Grey H  M  (1988) I-Ad 
binding peptides derived from unrelated protein antigens share a 
common structural motif. J Immunol, 141, 45-48.
Sette, A, Buus, S, Colon, S, Miles, C and Grey, H M (1989a)
Structural analysis of peptides capable of binding to more than 
one la antigen. J Immunol, 142, 35-40.
Sette, A, Buus, S, Colon, S, Smith, J  A, Miles, C  and Grey, 11 M 
(1987) Structural characteristic of an antigen required for its 
interaction with la and recognition by T cells. Nature (London)
328, 395-399.
Shalaby, M R, Sverdesky, L P and McKay, P A  (1985) In vivo 
augmentation of NK activity by combined treatment with 
recombinant gamma interferon and interleukin-2. J Interferon 
Res, 5, 571-581.
Shelley, W  B and Juhlin, L  (1976) Langerhans cells form a
333
reticuloepithelial trap for external contact antigens. Nature 
Vol 261, 46-47
Shimada, S, Caughman, S W, Sharrow, S 0, Stephany, D  and Katz, S 
I (1987) Enhanced antigen-presenting capacity of cultured LC is 
associated with markedly increased expression of la antigen. J 
Immunol, Vol 139 , 2551-555.
Shimizu, A, Kinashi, T, Ishida, Y  and Honjo, T  (1989) Structure 
and function of lymphokines and their receptors. Progress in 
Immunology VII, ed Melchers, F et al, Springer-Verlag. 
Shimonkevitch, R, Kappler, J, Marrack, P and Grey, H (1983) 
Antigen recognition by H-2 restricted T cells. I. Cell-free 
antigen processing. J Exp Med, 158 : 303-316 •
Shinohara, N, Blues tone, J  A  and Sachs, D H  (1986) Cloned 
cytotoxic T-lymphocytes that recognize an I-A region product in 
the context of a class I antigen. J Exp Med, 163, 972-980. 
Sideras, P, Funa, K, ZaLqberg-Quintana, I, Xanthopoulos, K G, 
Kisielow, P and Palacios, R (1988) Analysis by in situ 
hybridization of cells expressing mRNA for IL-4 in the 
developing thymus and in peripheral lymphocytes from mice. Proc 
Natl Acad Sci USA, 85, 218-221.
Silberberg, I, Baer, R L  and Rosenthal, S A  (1976a) The role of 
LC in allergic contact hypersensitivity. A review of findings 
in man and guinea pig. J Invest Dermatol, 66: 210-217. 
Silberberg-Sinakin, I, Baer, R  I and Thor bee ke, G  J  (1978) 
Langerhans cells: a review of their nature with emphasis on 
their immunologic functions. Prog Allergy, 24, 268-283 • 
Silberberg-Sinakin, 1, Thorbecke, G  J, Baer, R L, Rosenthal, S A  
and Berezowsky, V (1976b) Antigen bearing LC in skin dermal
334
lymphatics and in lymph nodes. Cell Immunol, 25: 137 - 151 • 
Simpson, E  (1987) Function of the (4IC. Lymphocyte '87.
Published by British Society of Immunologists.
Skoglund, C, Scheynius, A, Holmdahl, R  and Van der Meade, P H 
(1988) Enhancement of DIH reaction and inhibition of the
expression of class 2 transplantation antigens by in vivo 
treatment with antibodies against gamma IFN. Clin Exp Immunol, 
71, 428-32.
Skoskiewicz, M  J, Colvin, R B, Schneeberger, E E  and Russell, P 
S (1985) Widespread and selective induction of major 
histocompatbility complex-determined antigens in vivo by gamna 
interferon. J Exp Med, 162, 1645-1664.
Spickett, G  P and Dalgleish, A  G  (1988) Review. Cellular 
immunology of HIV infection. Clinical and Experimental 
Imnunology 71, 1-7.
Spitalny, G and Havell, E A (1984) Monoclonal antibody to 
murine gamma-interferon inhibits lymphokine-induced antiviral 
and macrophage tumoricidal activities. J Exp Med, 159, 1560- 
1565.
Springer, T  A, Dustin, M  L, Kishimoto, T  K and Marlin, S D 
(1987) The lymphocyte function associated LFA-1, CDZ and LFA-3 
molecules: cell adhesion receptors of the immune system. Ann 
Rev Immunol 5, 223-52.
Steeg, P S ,  Moore, R N, Johnson, H M  and Oppenheim, J  J  (1982)
Regulation of murine macrophage la antigen expression by a 
lymphokine with immune interferon activity. J Exp Med, 156, 
1780-1791 .
Steinman, R M  (1988) Cytokines amplify the function of
335
accessory cells. Immunology Letters, 17, 197-202.
Steinnan, R  M  and Cohn, Z  A  (1973) Identification of a novel 
cell type in peripheral lymphoid organs of mice. I. 
Morphology, quantitation, tissue distribution. J Exp Med, 137, 
1142- H62 .
Steinnan, R  M  and Cohn, Z A  (1974) Identification of a novel 
cell type in peripheral lymphoid organs of mice. III.
Functional properties in vivo. J Exp Med, 139, 380-397. 
Steinman, R M  and Nussenzweig, M  C  (1980) Dendritic cells: 
features and functions. Imnunol Review, 53, 127-147 •
Steinman, R M  and Witmer, M  D  (1978) Lymphoid dendritic cells 
are potent stimulators of the primary mixed leucocyte reaction 
in mice. Proc Natl Acad Sci USA, 75, 5132-5136.
Steinman, R M, Witmer, M D, Kaplan, G and Cohn, Z A  (1979) 
Purification of spleen dendritic cells, new surface markers and 
maintenance in vitro. J Exp Med, 149, 1-16»
Stevens, M  G, Exon, J H and Olsen, D P (1989) In vivo effects 
of interferon-g and indomethacin on murine alveolar macrophage 
activity. Cell Immunol, 123, 83-95.
Stevens, T  L, Bessie, A, Sanders, V, Fernand ez - Bo t ra n , R, 
Coffman, R  L, Mossmann, T  R and Vitteta, E S (1988) Subsets of 
antigen-specific helper T-cells regulate iso type secretion by 
antigen specific B cells. Nature (London),334, 1 5 5 ~ Z 5 8  s 
Stewart, W  E  et al (1980) Interferon Nomenclature. Nature, 
286, 110.
Stingl, G, Katz. S I, Clement, L, Green, I and Shevach, E M 
(1978c) Imnunologic functions of la bearing epidermal LC. J 
Immunol, 121, 2005-2013 ,
336
Stingl, G, Katz, S I, Shevach, E M, Wolff-Schreier, E  and Green, 
I (1978a) Detection of la antigens on LC in guinea pig skin. J 
Immunol, 120, 570-578.
Stingl, G, Wolff-Schreier, E C, Pichler, W  J, Gschnait, F, 
Knapp, W  a nd Wolff, W  (1977) Epidermal LC bear Fc and C3 
receptors. Nature, 268, 245-246 «
Strelein, J  W, Gramner, S F, Yoshikawa, T, Demidem, A  and 
Vermeer, M  (1990) Functional dichotomy between Langerhans cells 
that present antigen to naive and to memory/effector T- 
lymphocytes. Imm Reviews, 117, 159-185.
Streilein, J  W, Sullivan, S, Bergstresser, P  R and Tigelaar, R  E 
(1984) Suppression that accompanies the induction of contact 
hypersensitivity may be due to excess hapten. J Invest Dermatol 
82, 419 *
Sullivan, S, Bergs tresser, P  R, Tigelaar, R E and Streilein, J  W  
(1986) Induction and regulation of contact hypersensitivity by 
resident bone marrow-derived dendritic epidermal cells: 
Langerhans cells and Thy-1+ epidermal cells. J Imnunol, 137, 
2460-246 7.
Swain, S L  (1983) T cell subsets and the recognition of MHC 
class. Immunol Rev 74, 129-142,,
Tai-You Ha, Reed, N D, and Crowle, P K (1986) Immune response 
potential of mast cell-deficient W/W'' mice. Int Arch Allergy, 
80, 85-94.
Takahashi, S and Hashimoto, K (1985) Derivation of Langerhans 
cell granules from cytomembrane. J Invest Dermatol, 84, 469-71. 
Toews, G  B, Bergs tresser, P R and Streilein, J  W  (1980)
Langerhans cells: sentinels of skin-associated lymphoid tissue.
337
J Invest Dermatol, 75, 78-82.
Toews, G  B, Bergs tresser, P R, Streiiein, J  W  and Sullivan, S 
(1979 ) Epidermal LC density determines whether contact 
hypersensitivity or unresponsiveness follows skin-painting with 
DNFB. J Immunol, 124, 445-53.
Tomkins, P T, Hard, G A  and Norris, A  G (1988) Role of 
interferon-gamma in T-cell responses to SFV-infected murine 
brain cells. Immunology, 63, 355-362.
Trinchieri, G  a nd Perussia, B (1985) Immune interferon: a 
pleiotropic lymphokine with multiple effects. Immunology Today, 
6, 131-136.
Trunch, A, Albert, F, Golstein, P and Schmidt-Verhulst, A  M 
(1985) Early steps of lymphocyte activation bypassed by synergy 
between calcium ionophores and phorbol esters. Nature (London), 
313, 318-320 .
Tsien, R Y, Pozzan, T  and Rink, T  J  (1982) T-cell mitogens 
cause early changes in cytoplasmic free Ca^+ and membrane 
potential in lymphocytes. Nature (Lond) 295, 68-71.
Turk, J  L (1976) Leprosy as a model of subacute and chronic 
immunologic diseases. J Invest Dermatol, 67, 457-63.
Turk, J  L  and Stone, S H (1963) In 'Cell Bound Antibodies' (S 
Ames and M Koprowski, eds) pl42. Wistar Institute Press, 
Philadelphia, Pennsylvania.
Unanue, E R  (1984) Antigen-presenting function of the 
macrophage. Ann Rev Imm 2, 395-428.
Unanue, E R, Be lier, D I, Lu, C  Y  and Allen, P M (1984) Antigen 
presentation: comments on its regulation and mechanism. J 
Immunol, 132, 1-7.
338
Unkeless, J  C  (1979) Characterisation of a monoclonal antibody 
directed against the mouse macrophage and lymphocyte FcR. J Exp 
Med 150, 580 - 596 .
Vadas, M  A, Miller, J  F and McKenzie, I F (1976) Ly and la
antigen phenotypes of T cells involved in delayed-type 
hypersensitivity and in suppression. J Exp Med, 144, 10-18«
Van Loveren, H  and Askenase, P W  (1984) Delayed type 
hypersensitivity is mediated by a sequence of two different T 
cell activities. J Immunol, 133 , 2397-2401 ,
Van Loveren, H, Kato, K, Meade, R, Green, D R, Horowitz, M, 
Ptak, W  and Askenase, P W  (1984) Characterisation of two 
different Lytl+ T cell populations that mediate CTIH. J Immunol, 
133 , 2402-2411 .
Van Loveren, H, Meade, R and Askenase, P W  (1983) An early 
component of delayed type hypersensitivity mediated by T cells 
and mast cells. J Exp Med, 157, 1604-1617.
Van Loveren, H, Ratzlaff, R E, Kato, K, Meade, R, Ferguson, T  A, 
Iverson, G  M, Janeaway, C  A  and Askenase, P  U  (1986) Immune 
serum from mice contact sensitized with picryl chloride contains 
an antigen specific T cell factor that transfers immediate 
cutaneous reactivity. Eur J Immunol, 16, 1203-1208.
Van Voochis, U  C, Hair, L  S, Steinman, R M  and Kaplan, G  (1982b) 
Human dendritic cells: enrichment and characterisation from 
human peripheral blood. J Exp Med, 155, 1172-1187.
Van Voorhis, W  C, Steinman, R M, Hair, L S, Luban, J, Witmer, M 
D, Koide, S and Cohn, Z A (1983) Specific antimononuclear 
phagocyte antibodies: application to the purification of 
dendritic cells and the tissue localization of macrophages. J
339
Exp Med, 158, 126-145. patj* 3^3«
Veil let te, A, Bookman, M  A, Horak, E M  and Bolen, J  B (1988)
The CD4 and 0)8 T cell surface antigens are associated with the 
internal membrane tyrosine-protein kinase p56ick. Cell 55, 301-308» 
Vitetta, E, Pure, E, I sacks on, P, Buck, L  and Uhr, J  W  (1980)
The activation of murine B cells - the role of surface 
immunoglobulin. Immunol Rev, 52, 211-230,
Volkman, A  (1976) Disparity in origin of mononuclear phagocyte 
populations. J Reticuloendothelial Soc, 19, 249-255 *
Volkman, A  (1966) J Exp Med, 124, 241.°
Wagner, C  R, Vetto, R  M  and Burger, D  R  (1985) Expression of I- 
Region associated antigen (la) and IL-1 by subcultured human 
endothelial cells. Cell Immunol, 93, 91-104.
Walden, P. Nagy, Z  A  and Klein, J  (1985) Induction of 
regulatory T-lymphocyte responses by liposomes carrying major 
histocompatibility complex molecules and foreign antigen. 
Nature (London), 315, 327-329.
Watts, T  H, Gaub, H  E  and McConnell, H  M  (1986) T cell-mediated 
association of peptide antigen and major histocompatibility 
complex protein detected by energy transfer in an evanescent 
wave-field. Nature Vol 320, 179-180 «
Weaver, C  T, Duncan, L  M  and Unanue, E R (1989) T-cell 
induction of macrophage IL-1 during antigen presentation. J 
Immunol, 142, 3469-3476.
de Week, A  L  (1977) Fed Proc Fed Am Soc Exp Biol, 36, 1742.
Weetman, A P and Rees, A J (1988) Synergistic effects of 
recombinant tunour necrosis factor and interferon gamma on rat 
thyroid cell growth and la antigen expression. Immunology, 63, 
Analysis of peritoneal exudate cells in rats.
340
285-289.
Weiss, M  J, Daley, J  F, Hodgson, J  C  and Reinherz, E  L (1984)
Calcium dependency of antigen-specific (t3-ti) and alternative 
(Til) pathways of human T-cell activation. Proc Natl Acad Sci 
USA, 81, 6836-6840.
Williams, A  (1987) A year in the life of the immunoglobulin 
super-family. Immunology Today, 8, 10~14 «
Williams, T  J  et al (1988) as quoted in Cotran, R S and Pober, 
J S in Progress in Immunology VII, ed Melcher F et al 1989, 
Springer-Verlag.
Witmer-Pack, M  D, Olivier, W, Valinsky, J, Schuler, G and 
Steinman, R M  (1987) Granulocyte/macrophage colony-stimulating 
factor is essential for the viability and function of cultured 
murine epidermal Langerhans cells. J Exp Med, 166, 1484-1498. 
Wolf, M, Le Vine III, H, May Jr, W  S, Cuatrecasas, P and 
Sabryoun, M  (1985) A model for intracellular translocation of 
protein kinase c involving synergism between Ca2+ and phorbol 
ester. Nature (London) 317, 549-551.
Wolff, W  and Schreiner, E  (1970) Uptake, intracellular 
transport and degradation of exogenous proteins by Langerhans 
cells. J Invest Dermatology, 54, 37-47.
Wolff, W  and Stingl, G  (1983) The Langerhans cell. J Invest 
Dermatol 80 (supplement), 17-20 «
Wong, G  H W, Clark-Lewis, I, McKimm-Breschkin, J  L, Harris, A  W  
and Schroder, J  W  (1983) Interferon gamma induces enhanced 
expression of la and H-2 antigens on beta-lymphoid, macrophage 
and myeloid cell lines. J Immunol, 131, 788-793,
Wood, P, Asher son, G  L, May hew, B, Thomas, W  R and Zembala, M
341
(1977) Control of the immune reaction: T cells in immunized 
mice which depress the in vivo DNA synthesis response in lymph 
nodes to skin-painting with the contact sensitizing agent picryl 
chloride. Cell Irnnunol, 30, 25-34.
Yague, J  R, White, J, Coleclough, C, Kappler, J, Palmer, E  and 
Marrack, P (1985) The T cell receptor: the alpha and beta 
chains define idiotype and antigen and MHC specificity. Cell, 
42, 81-91 .
Yanagi, Y, Yoskikaki, Y, Leggett, K, Clark, S, Alexander, I and 
Mak, T  (1984) A human T  cell specific cDNA clone encodes a 
protein having extensive homology to immunoglobulin chains. 
Nature (Lond), 308, 145-149.
Youngner and Salvin, S B  (1973) Production and properties of 
migration inhibition factor and interferon in the circulation of 
mice with delayed hypersensitivity. J Immunol, 111, 1914-18.
Yu, C  L, Haskard, D O, Cavender, D, Johnson, A  R and Ziff, M 
(1985) Hunan gamma interferon increases the binding of T- 
lymphocytes to endothelial cells. Clin Exp Immunol, 62, 554"560# 
Ziegler, K  and Unanue, E  R  (1981) Identification of a 
macrophage antigen-processing event required for I-region- 
restricted antigen presentation to T-lymphocytes. J Immunol,
127, 1869-1875.
Ziegler, H  K and Unanue, E R (1982) Decrease in macrophage 
antigen catabolism caused by ammonia and chloroquine is 
associated with inhibition of antigen presentation to T-cells. 
Proc Natl Acad Sci USA, 79, 175-178 «
Zinkemagel, R M  and Doherty, P  C  (1974) Activity of sensitized 
thymus-derived lymphocytes in lymphocytic choriomenigitis
342
reflects immunological surveillance against altered self 
components. Nature (Lond), 257, 547-548#
Z w e im a n , B (1988) Mediators of allergic inflamnation in the 
skin. Clin Allergy, 18, 419-433.
. ____
f*al>a; •) Granelli ■* f?perno* A and Sjiinman, R'H 1*1 #3) 
*3)endriVic ccJlv 1 ¿vloce T~ fe r<J*a.se. B cell
fftitors an inUrUoUn /L d*p«nd«nt wd<av>*M,
ifExp. rW .; 158, Z0U0-X054-#
Va. 
Hair,
Voorli* f kJ'C •; ValinUy, 3"»* Hoffman, E  ,,
U S  and SUman, £* H ( l<?<&3)
Rilafn/e, efficacy o f  i^ oman Monocutes and <b*dn{ic  
accessory ceils T  till replication #
TExp. rl«d., 152, .
Ulx*n, X/
cells as
343
PUBLISHED 
PAPERS 
N O T 
FILMED 
FOR 
CO PYR IG H T 
REASONS
